data_5l3l_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5l3l _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.3 m . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 121.36 0.6 . . . . 50.0 112.555 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.39 -146.09 50.07 Favored Glycine 0 C--O 1.227 -0.303 0 CA-C-N 115.892 -0.594 . . . . 50.0 114.373 172.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.59 -23.52 72.18 Favored Glycine 0 C--O 1.211 -1.321 0 C-N-CA 121.124 -0.56 . . . . 50.0 112.937 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -69.13 -27.39 65.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.649 0.725 . . . . 50.0 110.66 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.6 tp -70.73 -39.88 73.11 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.91 -0.774 . . . . 50.0 108.91 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 69.2 t -67.18 -41.04 86.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.065 -0.516 . . . . 50.0 109.883 178.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -59.17 -46.22 88.97 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 122.889 0.476 . . . . 50.0 110.191 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 48.2 m -63.04 -39.93 96.21 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 116.528 -0.305 . . . . 25.0 111.467 177.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.4 mt -62.0 -39.2 91.44 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 121.622 -0.674 . . . . 50.0 110.56 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -69.01 -38.17 79.1 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 116.934 -0.121 . . . . 50.0 110.724 176.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -65.64 -44.78 85.37 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.06 -0.4 . . . . 50.0 112.054 177.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.1 t -72.79 -39.35 59.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.154 0.428 . . . . 50.0 112.154 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 t -98.7 -15.7 19.28 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 115.033 1.494 . . . . 50.0 115.033 -176.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.24 -142.31 37.27 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-O 122.101 0.834 . . . . 25.0 113.3 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -72.95 -11.23 60.5 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 123.615 0.766 . . . . 50.0 112.886 -177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.7 mtp180 . . . . . 0 C--N 1.325 -0.492 0 N-CA-C 114.066 1.136 . . . . 50.0 114.066 -172.583 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.7 m . . . . . 0 C--O 1.238 0.468 0 CA-C-O 121.21 0.529 . . . . 50.0 111.671 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.45 -143.54 48.28 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-O 121.917 0.732 . . . . 50.0 114.861 172.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.4 -23.04 71.67 Favored Glycine 0 C--O 1.21 -1.394 0 CA-C-N 115.112 -0.544 . . . . 50.0 113.49 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -69.94 -28.78 65.85 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 118.126 0.963 . . . . 50.0 109.402 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.23 -42.43 84.05 Favored 'General case' 0 C--O 1.216 -0.68 0 N-CA-C 107.604 -1.258 . . . . 50.0 107.604 177.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.5 t -64.87 -40.76 90.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.057 -0.974 . . . . 50.0 110.793 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -60.67 -48.65 80.83 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 122.189 0.995 . . . . 50.0 108.647 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.9 m -59.61 -41.58 90.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.667 -0.697 . . . . 25.0 111.314 177.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.6 mt -64.43 -39.94 94.8 Favored 'General case' 0 CA--C 1.539 0.519 0 O-C-N 121.826 -0.546 . . . . 50.0 111.09 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -65.55 -35.98 82.45 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 118.293 0.497 . . . . 50.0 109.747 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -68.78 -49.55 57.67 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 120.091 -0.644 . . . . 50.0 112.717 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.8 t -70.45 -42.74 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 O-C-N 122.098 -0.376 . . . . 50.0 111.37 -175.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 58.3 m -87.68 -16.84 33.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.787 0.803 . . . . 50.0 111.357 -175.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.59 -167.09 53.81 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 108.795 -1.722 . . . . 25.0 108.795 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -71.09 0.22 8.11 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 122.061 0.934 . . . . 50.0 112.74 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.6 mtm180 . . . . . 0 N--CA 1.479 0.996 0 N-CA-C 113.181 0.808 . . . . 50.0 113.181 178.344 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.224 -0.248 0 N-CA-C 109.891 -0.411 . . . . 50.0 109.891 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.52 31.61 79.22 Favored Glycine 0 C--O 1.217 -0.923 0 C-N-CA 120.791 -0.719 . . . . 50.0 114.01 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.73 -24.88 15.29 Favored Glycine 0 C--O 1.224 -0.527 0 C-N-CA 121.239 -0.505 . . . . 50.0 113.143 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.39 -28.22 69.09 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.512 0.673 . . . . 50.0 110.057 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.36 -43.69 96.96 Favored 'General case' 0 C--O 1.216 -0.68 0 CA-C-N 116.04 -0.527 . . . . 50.0 110.886 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 80.5 t -67.53 -40.26 84.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.67 -0.695 . . . . 50.0 109.418 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -61.05 -47.17 87.6 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.274 0.559 . . . . 50.0 110.096 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.7 m -61.05 -42.07 97.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.114 -0.494 . . . . 25.0 111.077 177.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.9 mt -63.54 -38.78 92.43 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.916 -0.49 . . . . 50.0 110.89 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -67.54 -37.46 82.75 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 121.136 -0.226 . . . . 50.0 110.461 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -68.1 -45.86 72.56 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 122.033 -0.417 . . . . 50.0 112.075 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 82.1 t -70.77 -42.7 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 112.048 0.388 . . . . 50.0 112.048 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.3 m -96.99 -15.49 21.06 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.958 1.096 . . . . 50.0 113.958 -173.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.18 -161.79 49.8 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-O 122.424 1.013 . . . . 25.0 112.789 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -68.76 0.55 4.17 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.405 -0.897 . . . . 50.0 113.173 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? . . . . . 0 C--N 1.324 -0.524 0 O-C-N 121.165 -0.959 . . . . 50.0 111.511 -179.391 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.518 -0.271 0 N-CA-C 105.973 -1.862 . . . . 50.0 105.973 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.66 32.61 79.23 Favored Glycine 0 C--O 1.218 -0.897 0 C-N-CA 120.481 -0.866 . . . . 50.0 114.232 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.0 -25.54 19.32 Favored Glycine 0 C--O 1.219 -0.804 0 C-N-CA 121.045 -0.598 . . . . 50.0 113.969 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -63.95 -27.78 69.37 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 118.199 0.999 . . . . 50.0 110.583 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 24.6 tp -65.62 -40.57 92.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.064 -0.517 . . . . 50.0 110.178 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 85.1 t -69.49 -39.4 78.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.361 -0.607 . . . . 50.0 109.361 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -59.62 -46.39 89.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.685 0.755 . . . . 50.0 109.778 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.0 m -63.56 -39.66 94.99 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.971 -0.559 . . . . 25.0 111.299 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.5 mt -63.03 -38.19 90.18 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.905 -0.497 . . . . 50.0 110.976 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -66.37 -39.17 88.94 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.208 -0.293 . . . . 50.0 110.208 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -65.94 -48.04 72.69 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.599 0.592 . . . . 50.0 112.599 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.3 t -71.96 -41.59 68.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 112.024 0.379 . . . . 50.0 112.024 -175.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.0 m -90.65 -18.38 25.21 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.151 0.797 . . . . 50.0 113.151 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.36 -138.19 48.66 Favored Glycine 0 C--N 1.322 -0.218 0 CA-C-O 122.253 0.918 . . . . 25.0 113.917 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -70.56 -13.34 62.06 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.795 0.838 . . . . 50.0 112.486 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.5 mtp180 . . . . . 0 C--N 1.323 -0.544 0 N-CA-C 113.124 0.787 . . . . 50.0 113.124 -171.825 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.222 -0.379 0 N-CA-C 109.763 -0.458 . . . . 50.0 109.763 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.12 31.13 79.68 Favored Glycine 0 C--O 1.218 -0.868 0 N-CA-C 114.78 0.672 . . . . 50.0 114.78 174.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.74 -25.05 20.93 Favored Glycine 0 C--O 1.22 -0.777 0 C-N-CA 121.027 -0.606 . . . . 50.0 113.203 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -63.77 -28.27 69.76 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.724 0.774 . . . . 50.0 109.532 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 35.0 tp -63.67 -39.54 94.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.794 -0.639 . . . . 50.0 111.004 176.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.5 t -70.63 -39.88 76.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.352 -0.61 . . . . 50.0 109.352 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -61.07 -48.2 82.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.418 0.628 . . . . 50.0 110.028 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.6 m -61.55 -40.03 93.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.039 -0.528 . . . . 25.0 110.829 178.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.1 mt -62.97 -37.06 85.61 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 121.81 -0.556 . . . . 50.0 111.458 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -64.45 -45.98 85.08 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.688 -0.486 . . . . 50.0 109.688 175.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -63.46 -46.18 87.4 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.977 0.732 . . . . 50.0 112.977 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.7 t -71.42 -40.56 72.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 111.887 0.328 . . . . 50.0 111.887 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 77.0 m -86.64 -30.31 21.87 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.45 1.278 . . . . 50.0 114.45 -174.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.14 -127.55 45.15 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.227 -0.987 . . . . 25.0 115.224 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -56.47 -33.1 65.6 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 116.362 1.986 . . . . 50.0 116.362 -173.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 . . . . . 0 C--N 1.323 -0.546 0 N-CA-C 114.058 1.133 . . . . 50.0 114.058 -174.322 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.838 0.351 . . . . 50.0 111.518 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.37 -146.46 48.81 Favored Glycine 0 C--N 1.324 -0.127 0 C-N-CA 120.746 -0.74 . . . . 50.0 111.624 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.75 -26.4 69.91 Favored Glycine 0 C--O 1.21 -1.37 0 C-N-CA 121.006 -0.616 . . . . 50.0 112.471 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -61.12 -30.93 70.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.695 0.747 . . . . 50.0 111.222 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.83 -44.91 68.98 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 109.326 -0.62 . . . . 50.0 109.326 178.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.2 t -63.71 -43.07 97.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.573 -0.739 . . . . 50.0 109.979 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -62.72 -41.73 99.3 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.563 0.697 . . . . 50.0 110.216 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 48.2 m -68.62 -38.9 80.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.34 -0.391 . . . . 25.0 110.293 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.8 mt -63.54 -37.18 86.32 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 121.964 -0.46 . . . . 50.0 110.364 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -65.48 -42.16 92.51 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 110.292 -0.262 . . . . 50.0 110.292 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -64.84 -45.66 85.17 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.595 0.591 . . . . 50.0 112.595 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.2 t -73.77 -43.37 53.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 111.788 0.292 . . . . 50.0 111.788 -176.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 69.3 m -87.45 -28.44 22.09 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.291 0.849 . . . . 50.0 113.291 -175.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.14 -142.46 41.34 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.572 -0.823 . . . . 25.0 112.34 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -66.55 -18.77 65.55 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 123.911 0.884 . . . . 50.0 113.11 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 . . . . . 0 C--N 1.326 -0.426 0 N-CA-C 112.114 0.413 . . . . 50.0 112.114 -178.692 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.517 -0.308 0 N-CA-C 107.487 -1.301 . . . . 50.0 107.487 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.28 -145.36 49.55 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.238 -0.982 . . . . 50.0 110.724 -178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.87 -24.63 70.13 Favored Glycine 0 C--O 1.205 -1.676 0 C-N-CA 120.974 -0.631 . . . . 50.0 113.255 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -61.02 -34.98 75.68 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.314 1.057 . . . . 50.0 111.473 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 25.5 tp -69.38 -39.88 77.76 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.153 -0.684 . . . . 50.0 109.153 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 89.2 t -66.9 -40.43 85.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.741 -0.663 . . . . 50.0 110.203 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -61.76 -40.68 96.01 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.031 -0.729 . . . . 50.0 109.031 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.2 m -68.39 -38.75 81.63 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 116.245 -0.434 . . . . 25.0 110.854 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.6 mt -61.61 -36.95 82.18 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 121.585 -0.697 . . . . 50.0 109.971 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -68.77 -37.82 79.6 Favored 'General case' 0 C--O 1.216 -0.683 0 O-C-N 122.27 -0.269 . . . . 50.0 111.436 174.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -65.85 -41.12 92.09 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.821 -0.55 . . . . 50.0 112.224 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.6 t -77.48 -37.24 24.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 112.286 0.476 . . . . 50.0 112.286 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 70.0 m -129.56 -37.53 1.58 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.895 1.813 . . . . 50.0 115.895 -175.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 51.21 -109.7 0.83 Allowed Glycine 0 N--CA 1.462 0.416 0 N-CA-C 116.133 1.213 . . . . 25.0 116.133 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -58.08 -23.12 53.44 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.967 0.907 . . . . 50.0 113.394 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 51.9 mmm-85 . . . . . 0 C--N 1.326 -0.423 0 O-C-N 122.166 -0.334 . . . . 50.0 111.282 179.061 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.467 0.377 0 N-CA-C 110.232 -0.285 . . . . 50.0 110.232 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -44.6 131.65 7.5 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 114.546 0.579 . . . . 50.0 114.546 -175.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.95 -57.82 4.56 Favored Glycine 0 C--O 1.216 -0.993 0 O-C-N 122.827 -0.219 . . . . 50.0 113.479 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -64.93 -38.49 91.14 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.763 0.792 . . . . 50.0 112.564 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.1 tp -68.38 -37.28 80.27 Favored 'General case' 0 C--O 1.211 -0.968 0 N-CA-C 109.31 -0.626 . . . . 50.0 109.31 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.8 t -69.84 -38.31 75.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.647 -0.706 . . . . 50.0 109.85 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -58.95 -46.85 87.02 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.507 0.67 . . . . 50.0 109.3 174.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.5 m -65.38 -38.48 90.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.156 -0.475 . . . . 25.0 112.052 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.6 mt -61.98 -40.11 94.48 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.486 -0.759 . . . . 50.0 109.422 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -67.43 -35.43 79.22 Favored 'General case' 0 C--O 1.217 -0.637 0 O-C-N 122.166 -0.334 . . . . 50.0 111.069 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -66.31 -51.14 60.35 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 122.071 -0.393 . . . . 50.0 112.059 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.2 t -71.0 -42.61 76.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.29 0.478 . . . . 50.0 112.29 -174.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 51.2 m -86.76 -22.26 26.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.26 0.552 . . . . 50.0 112.069 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.19 -149.11 48.05 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-O 122.208 0.893 . . . . 25.0 112.4 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -64.51 -6.26 7.08 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.234 -0.983 . . . . 50.0 113.086 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.0 mmp_? . . . . . 0 C--O 1.217 -0.648 0 O-C-N 120.971 -1.08 . . . . 50.0 111.595 -179.8 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.217 -0.618 0 CA-C-O 120.818 0.342 . . . . 50.0 111.247 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.69 28.7 65.83 Favored Glycine 0 C--O 1.219 -0.839 0 C-N-CA 120.842 -0.694 . . . . 50.0 114.274 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.8 -20.96 35.85 Favored Glycine 0 C--O 1.221 -0.672 0 CA-C-O 119.681 -0.511 . . . . 50.0 113.607 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -62.23 -27.62 69.12 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 117.867 0.834 . . . . 50.0 110.483 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.77 -43.09 94.51 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 116.071 -0.513 . . . . 50.0 111.007 177.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 74.9 t -66.66 -38.85 82.45 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.844 0 N-CA-C 108.847 -0.798 . . . . 75.0 108.847 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -58.79 -48.11 82.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.956 0.407 . . . . 50.0 110.536 177.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.4 m -63.27 -40.37 97.21 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.954 -0.466 . . . . 25.0 111.545 177.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.0 mt -63.08 -36.98 85.41 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 121.944 -0.473 . . . . 50.0 110.777 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -69.14 -38.64 78.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.857 0.361 . . . . 50.0 110.384 176.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -64.01 -39.1 93.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.206 0.526 . . . . 50.0 111.015 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 79.7 t -79.77 -43.46 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 112.377 0.51 . . . . 50.0 112.377 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.5 m -148.98 34.62 0.75 Allowed 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 115.14 1.533 . . . . 50.0 115.14 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.55 -46.98 93.2 Favored Glycine 0 C--O 1.223 -0.573 0 C-N-CA 119.858 -1.163 . . . . 25.0 113.555 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -61.97 -43.85 97.98 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.535 0.683 . . . . 50.0 112.552 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 . . . . . 0 C--N 1.324 -0.503 0 N-CA-C 112.786 0.661 . . . . 50.0 112.786 -177.137 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.223 -0.292 0 N-CA-C 106.971 -1.492 . . . . 50.0 106.971 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.34 30.81 75.14 Favored Glycine 0 C--O 1.22 -0.768 0 C-N-CA 120.787 -0.721 . . . . 50.0 114.535 174.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.29 -25.34 9.28 Favored Glycine 0 C--O 1.221 -0.667 0 C-N-CA 121.138 -0.553 . . . . 50.0 114.047 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -65.05 -27.03 68.52 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.239 1.02 . . . . 50.0 110.409 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 27.6 tp -61.46 -40.01 92.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.967 -0.56 . . . . 50.0 110.167 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 90.5 t -71.97 -36.38 57.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.273 -0.421 . . . . 50.0 109.982 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.0 -45.36 93.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.43 0.634 . . . . 50.0 109.368 176.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.5 m -63.18 -40.03 96.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.109 -0.496 . . . . 25.0 111.113 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.0 mt -61.65 -38.27 87.09 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.752 -0.593 . . . . 50.0 110.472 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -67.52 -39.56 85.09 Favored 'General case' 0 C--O 1.219 -0.538 0 O-C-N 122.004 -0.435 . . . . 50.0 110.8 175.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -66.63 -46.81 74.6 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.722 0.638 . . . . 50.0 112.722 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.4 t -71.58 -42.46 71.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 111.683 0.253 . . . . 50.0 111.683 -176.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 34.9 m -90.39 -26.51 19.87 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.223 0.823 . . . . 50.0 113.223 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.23 -145.74 49.41 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-O 122.204 0.891 . . . . 25.0 113.479 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -58.24 -17.85 22.19 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.918 1.081 . . . . 50.0 113.918 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 . . . . . 0 C--N 1.328 -0.346 0 O-C-N 121.735 -0.603 . . . . 50.0 112.371 -177.741 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.226 -0.172 0 CA-C-O 120.8 0.333 . . . . 50.0 111.164 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.37 -143.69 48.67 Favored Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 120.691 -0.766 . . . . 50.0 113.39 175.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.38 -21.15 75.85 Favored Glycine 0 C--O 1.213 -1.172 0 C-N-CA 121.284 -0.484 . . . . 50.0 113.197 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -69.35 -27.19 65.13 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 117.618 0.709 . . . . 50.0 109.325 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.27 -43.53 67.0 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 121.522 0.677 . . . . 50.0 109.528 174.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.5 t -64.15 -38.5 82.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.164 -0.926 . . . . 50.0 110.057 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -61.59 -48.36 81.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.164 0.507 . . . . 50.0 110.94 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 50.2 m -63.59 -35.94 82.16 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.966 -0.459 . . . . 25.0 111.293 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.6 mt -64.61 -39.77 94.3 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.707 -0.479 . . . . 50.0 109.707 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -67.32 -36.73 82.08 Favored 'General case' 0 C--O 1.219 -0.508 0 O-C-N 121.79 -0.569 . . . . 50.0 110.586 176.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -64.9 -51.56 61.29 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 121.923 -0.485 . . . . 50.0 111.753 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -73.48 -30.78 30.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 112.847 0.684 . . . . 50.0 112.847 -174.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.5 m -99.08 -22.05 15.88 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.16 0.8 . . . . 50.0 113.16 -177.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.39 -163.47 53.86 Favored Glycine 0 C--N 1.321 -0.303 0 CA-C-O 121.834 0.685 . . . . 25.0 111.887 -177.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -71.32 -7.17 45.3 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.751 0.821 . . . . 50.0 111.444 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 115.526 -0.761 . . . . 50.0 111.849 -177.641 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.224 -0.268 0 N-CA-C 108.814 -0.81 . . . . 50.0 108.814 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.77 33.3 84.77 Favored Glycine 0 C--O 1.218 -0.879 0 N-CA-C 114.937 0.735 . . . . 50.0 114.937 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.63 -25.37 7.41 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.999 -0.62 . . . . 50.0 113.311 -178.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -63.45 -31.15 72.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.562 0.681 . . . . 50.0 109.224 177.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 33.2 tp -61.79 -41.86 98.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.923 -0.58 . . . . 50.0 111.448 176.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.9 t -67.52 -41.5 85.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.267 -0.642 . . . . 50.0 109.267 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -61.67 -40.61 95.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.397 0.618 . . . . 50.0 109.966 177.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.8 m -66.69 -40.58 88.58 Favored 'General case' 0 C--O 1.215 -0.725 0 O-C-N 121.933 -0.479 . . . . 25.0 111.216 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.4 mt -62.21 -38.82 90.62 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.63 -0.669 . . . . 50.0 110.563 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -67.04 -39.69 87.01 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.197 -0.456 . . . . 50.0 110.453 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -66.76 -47.75 71.23 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.27 0.47 . . . . 50.0 112.27 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.9 t -67.5 -43.68 87.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.405 0.52 . . . . 50.0 112.405 -175.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -95.26 -15.93 22.83 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.511 0.93 . . . . 50.0 113.511 -176.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.01 -142.87 46.16 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-O 122.067 0.815 . . . . 25.0 112.595 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -71.1 0.36 7.82 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.052 1.13 . . . . 50.0 114.052 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 . . . . . 0 C--N 1.328 -0.328 0 O-C-N 121.462 -0.774 . . . . 50.0 110.95 178.781 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.219 -0.512 0 N-CA-C 110.051 -0.352 . . . . 50.0 110.051 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.17 23.0 63.6 Favored Glycine 0 C--O 1.214 -1.098 0 N-CA-C 115.642 1.017 . . . . 50.0 115.642 174.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.42 -26.47 24.23 Favored Glycine 0 C--O 1.218 -0.85 0 CA-C-O 119.577 -0.568 . . . . 50.0 112.801 -178.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.99 -28.64 67.86 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.796 0.808 . . . . 50.0 110.4 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 30.7 tp -60.95 -40.16 92.29 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.522 -0.763 . . . . 50.0 111.236 176.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 82.5 t -69.58 -41.27 80.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.012 -0.736 . . . . 50.0 109.012 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -64.0 -40.82 97.22 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.914 0.864 . . . . 50.0 109.925 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.3 m -66.83 -40.06 87.87 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.726 -0.67 . . . . 25.0 110.456 178.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.7 mt -62.62 -37.87 87.96 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.118 -0.363 . . . . 50.0 110.415 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -62.32 -45.68 92.14 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.829 -0.544 . . . . 50.0 110.115 175.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -66.9 -45.8 76.86 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.125 0.787 . . . . 50.0 113.125 -176.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.4 t -69.26 -38.5 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 120.875 0.369 . . . . 50.0 111.357 -177.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.5 m -88.06 -24.37 23.47 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.579 0.955 . . . . 50.0 113.579 -175.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.76 -144.42 38.36 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-O 121.693 0.607 . . . . 25.0 113.707 177.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -65.29 -12.08 48.05 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.135 0.791 . . . . 50.0 113.135 -178.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.9 mtm180 . . . . . 0 C--N 1.323 -0.579 0 N-CA-C 113.383 0.882 . . . . 50.0 113.383 -173.497 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.456 -0.172 0 N-CA-C 113.135 0.791 . . . . 50.0 113.135 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.78 -143.16 47.5 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.022 -0.608 . . . . 50.0 112.172 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.98 -23.75 71.3 Favored Glycine 0 C--O 1.213 -1.167 0 C-N-CA 121.047 -0.597 . . . . 50.0 113.073 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -65.36 -35.62 81.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.827 0.813 . . . . 50.0 110.347 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 41.2 tp -66.38 -43.31 86.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.381 0.61 . . . . 50.0 109.625 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.8 t -67.08 -39.67 83.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.78 -0.645 . . . . 50.0 110.289 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -64.16 -43.44 95.16 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.115 0.483 . . . . 50.0 110.294 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.8 m -62.76 -41.26 99.13 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.143 -0.348 . . . . 25.0 110.609 177.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.4 mt -60.73 -37.22 81.01 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.792 -0.568 . . . . 50.0 110.501 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -71.79 -34.74 69.66 Favored 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 112.072 0.397 . . . . 50.0 112.072 176.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -64.93 -38.26 90.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.285 0.564 . . . . 50.0 110.259 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.1 t -74.29 -42.51 50.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 112.795 0.665 . . . . 50.0 112.795 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.9 m -140.65 -4.87 1.22 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 118.775 2.879 . . . . 50.0 118.775 -176.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.59 170.45 29.06 Favored Glycine 0 C--O 1.218 -0.895 0 O-C-N 121.551 -0.718 . . . . 25.0 112.996 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -62.93 -47.31 83.78 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.003 1.112 . . . . 50.0 114.003 -175.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 45.0 mtm-85 . . . . . 0 C--N 1.317 -0.829 0 C-N-CA 124.156 0.982 . . . . 50.0 108.995 176.556 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.212 -0.884 0 N-CA-C 107.264 -1.384 . . . . 50.0 107.264 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.95 23.82 5.77 Favored Glycine 0 C--O 1.217 -0.929 0 N-CA-C 119.133 2.413 . . . . 50.0 119.133 175.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.63 -25.6 15.33 Favored Glycine 0 C--O 1.217 -0.911 0 CA-C-N 118.191 0.995 . . . . 50.0 112.485 -176.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -59.81 -29.92 68.57 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.184 0.993 . . . . 50.0 110.183 175.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.1 tp -61.43 -37.98 85.48 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.132 -0.94 . . . . 50.0 112.062 176.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.5 t -68.57 -41.37 82.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.145 -0.687 . . . . 50.0 109.145 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.44 -43.48 98.79 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.433 -0.58 . . . . 50.0 109.433 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.9 m -64.28 -39.56 94.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.568 -0.287 . . . . 25.0 110.714 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.8 mt -65.84 -38.39 88.75 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.824 -0.548 . . . . 50.0 110.85 178.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -66.21 -39.57 89.73 Favored 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 110.183 -0.302 . . . . 50.0 110.183 176.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -66.12 -44.01 85.48 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.499 0.555 . . . . 50.0 112.499 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.3 t -76.51 -41.06 34.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.368 0.507 . . . . 50.0 112.368 -176.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 40.3 m -93.29 -31.12 14.82 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.851 1.056 . . . . 50.0 113.851 -174.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.69 -137.91 49.01 Favored Glycine 0 CA--C 1.518 0.256 0 CA-C-O 121.89 0.716 . . . . 25.0 113.346 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -55.71 -25.26 39.24 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.172 1.175 . . . . 50.0 114.172 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 . . . . . 0 N--CA 1.468 0.463 0 O-C-N 121.904 -0.497 . . . . 50.0 111.967 -177.339 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 106.25 -1.759 . . . . 50.0 106.25 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.01 31.73 77.63 Favored Glycine 0 C--O 1.215 -1.059 0 C-N-CA 120.823 -0.703 . . . . 50.0 114.339 175.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.95 -22.27 19.2 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 121.069 -0.586 . . . . 50.0 114.245 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -65.51 -28.49 69.22 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.607 1.203 . . . . 50.0 110.353 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.0 tp -61.91 -41.82 98.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.088 -0.506 . . . . 50.0 110.361 174.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.6 t -68.85 -40.61 81.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.495 -0.557 . . . . 50.0 109.495 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -61.85 -36.76 82.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.063 0.459 . . . . 50.0 110.328 178.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.2 m -70.38 -39.95 74.27 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-N 116.527 -0.306 . . . . 25.0 111.168 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.2 mt -62.06 -38.21 87.93 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.469 -0.769 . . . . 50.0 110.59 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -65.13 -42.55 93.75 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 116.692 -0.231 . . . . 50.0 110.681 176.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -64.97 -45.69 84.62 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.927 0.343 . . . . 50.0 111.927 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.4 t -70.7 -42.95 77.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.049 0.388 . . . . 50.0 112.049 -176.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -98.09 -21.65 16.66 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 116.11 1.893 . . . . 50.0 116.11 -173.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.4 -142.77 47.52 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.457 -0.878 . . . . 25.0 113.306 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -68.08 -11.08 58.39 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 114.474 1.287 . . . . 50.0 114.474 -176.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 . . . . . 0 N--CA 1.467 0.378 0 O-C-N 121.582 -0.699 . . . . 50.0 111.97 -178.732 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 66.9 m . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 115.363 1.616 . . . . 50.0 115.363 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.73 -134.96 4.6 Favored Glycine 0 C--O 1.222 -0.613 0 N-CA-C 114.635 0.614 . . . . 50.0 114.635 -173.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.99 -21.02 60.83 Favored Glycine 0 C--O 1.218 -0.881 0 C-N-CA 121.115 -0.564 . . . . 50.0 112.711 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -64.59 -33.3 75.6 Favored 'General case' 0 C--O 1.214 -0.802 0 O-C-N 122.178 -0.601 . . . . 50.0 110.503 176.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.4 tp -68.85 -39.68 79.77 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.689 -0.485 . . . . 50.0 109.689 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.95 -40.83 90.45 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 N-CA-C 108.983 -0.747 . . . . 50.0 108.983 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.68 -49.14 78.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.862 -0.153 . . . . 50.0 111.048 176.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.3 m -60.99 -41.18 95.97 Favored 'General case' 0 C--O 1.219 -0.551 0 C-N-CA 121.12 -0.232 . . . . 25.0 111.005 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.1 mt -63.72 -40.4 96.67 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 121.782 -0.574 . . . . 50.0 110.557 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -68.04 -35.39 78.17 Favored 'General case' 0 C--O 1.217 -0.628 0 O-C-N 121.955 -0.466 . . . . 50.0 110.653 177.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -66.99 -44.77 79.54 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.971 -0.455 . . . . 50.0 112.064 178.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.8 t -79.91 -42.68 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 O-C-N 121.886 -0.509 . . . . 50.0 111.629 -177.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.0 m -89.93 -22.28 22.05 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 114.042 1.127 . . . . 50.0 114.042 -174.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.82 -164.71 54.82 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 109.878 -1.289 . . . . 25.0 109.878 -176.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -73.01 0.79 10.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.519 0.676 . . . . 50.0 112.777 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 . . . . . 0 C--N 1.326 -0.419 0 O-C-N 121.66 -0.65 . . . . 50.0 111.403 179.193 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.469 0.491 0 N-CA-C 113.074 0.768 . . . . 50.0 113.074 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.89 -146.85 9.48 Favored Glycine 0 C--O 1.225 -0.459 0 C-N-CA 121.174 -0.536 . . . . 50.0 111.97 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -58.12 -23.71 53.03 Favored Glycine 0 C--O 1.212 -1.269 0 C-N-CA 121.236 -0.507 . . . . 50.0 113.301 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -59.17 -27.02 65.29 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.388 0.514 . . . . 50.0 112.388 176.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 45.9 tp -68.69 -43.2 76.6 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.256 -0.646 . . . . 50.0 109.256 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.88 -39.65 86.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.627 -0.879 . . . . 50.0 108.627 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -64.01 -44.7 91.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.214 0.531 . . . . 50.0 110.657 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.3 m -66.39 -37.03 84.35 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 121.812 -0.555 . . . . 25.0 110.351 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.3 mt -63.54 -37.67 88.2 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 121.912 -0.492 . . . . 50.0 110.373 177.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -66.11 -37.95 86.99 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 122.316 -0.24 . . . . 50.0 110.981 175.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -66.39 -47.88 71.89 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 122.03 -0.418 . . . . 50.0 112.071 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.7 t -77.98 -38.62 24.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 113.167 0.803 . . . . 50.0 113.167 -173.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 50.8 t -89.41 -17.04 29.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.938 0.875 . . . . 50.0 110.801 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.96 -169.72 55.04 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 109.773 -1.331 . . . . 25.0 109.773 -176.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -67.84 3.59 1.44 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.464 1.283 . . . . 50.0 114.464 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.354 0 O-C-N 121.757 -0.589 . . . . 50.0 112.446 -178.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 106.595 -1.631 . . . . 50.0 106.595 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.78 32.71 80.16 Favored Glycine 0 C--O 1.213 -1.165 0 N-CA-C 116.088 1.195 . . . . 50.0 116.088 171.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.33 -35.8 3.73 Favored Glycine 0 C--O 1.218 -0.858 0 CA-C-N 117.46 0.63 . . . . 50.0 113.609 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -59.02 -32.05 69.37 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.792 0.796 . . . . 50.0 110.592 178.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 44.0 tp -60.38 -38.55 84.28 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.748 -0.66 . . . . 50.0 110.872 176.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.8 t -71.93 -41.29 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.2 -0.454 . . . . 50.0 110.15 -177.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -62.93 -39.28 94.13 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.928 -0.767 . . . . 50.0 108.928 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 32.5 m -63.7 -43.11 97.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.869 -0.605 . . . . 25.0 110.214 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.7 mt -62.95 -39.58 95.05 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 121.691 -0.631 . . . . 50.0 111.079 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -63.65 -43.75 95.83 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.824 -0.35 . . . . 50.0 110.108 177.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -65.08 -47.11 78.43 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.602 0.593 . . . . 50.0 112.602 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.2 t -70.05 -41.42 79.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 120.879 0.371 . . . . 50.0 111.552 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 66.2 m -83.7 -30.98 26.33 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.142 0.793 . . . . 50.0 113.142 -175.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.71 -134.84 35.35 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.658 -0.782 . . . . 25.0 112.427 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -64.9 -13.54 57.06 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 114.08 1.141 . . . . 50.0 114.08 -178.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 . . . . . 0 C--N 1.326 -0.434 0 N-CA-C 116.05 1.87 . . . . 50.0 116.05 -176.459 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 107.246 -1.39 . . . . 50.0 107.246 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.68 -144.5 48.91 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.477 -0.868 . . . . 50.0 112.424 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.95 -21.07 67.39 Favored Glycine 0 C--O 1.216 -0.971 0 CA-C-O 119.551 -0.583 . . . . 50.0 114.063 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -67.07 -38.48 85.84 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.398 1.099 . . . . 50.0 110.317 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tt -67.48 -43.64 80.49 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.114 -1.069 . . . . 50.0 108.114 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.0 t -62.07 -42.69 95.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.648 -0.706 . . . . 50.0 111.152 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -62.13 -39.39 92.4 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.941 0.401 . . . . 50.0 110.285 178.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.2 m -67.47 -41.22 84.97 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.213 -0.292 . . . . 25.0 110.213 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.9 mt -60.83 -41.08 95.06 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 122.038 -0.414 . . . . 50.0 110.3 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -68.75 -34.72 76.06 Favored 'General case' 0 C--O 1.217 -0.647 0 O-C-N 122.396 -0.19 . . . . 50.0 111.367 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -67.22 -46.71 72.99 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.96 -0.463 . . . . 50.0 111.609 176.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.9 t -71.49 -39.69 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 120.981 0.419 . . . . 50.0 111.769 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 9.1 t -96.93 -24.2 15.95 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.525 1.305 . . . . 50.0 114.525 -172.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.24 -160.34 49.62 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 110.515 -1.034 . . . . 25.0 110.515 -174.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.79 0.53 5.54 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.683 0.994 . . . . 50.0 113.683 -177.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 . . . . . 0 C--N 1.326 -0.444 0 N-CA-C 114.863 1.431 . . . . 50.0 114.863 -173.157 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.207 -1.139 0 CA-C-O 122.853 1.311 . . . . 25.0 113.978 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -77.92 -22.64 49.31 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 122.132 0.968 . . . . 50.0 111.757 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -79.18 147.05 68.49 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.339 -0.846 . . . . 50.0 108.732 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.11 152.32 27.65 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 118.346 -0.636 . . . . 50.0 112.968 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.1 m -97.45 35.29 1.66 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.404 -0.817 . . . . 25.0 111.037 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -76.41 -17.06 59.54 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.264 1.209 . . . . 50.0 114.264 -173.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.5 p 54.78 173.6 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.684 1.194 . . . . 25.0 113.406 -174.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.1 tp -138.9 109.32 6.52 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.561 0.696 . . . . 50.0 110.425 -175.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.3 m -132.86 167.98 19.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.337 -0.847 . . . . 50.0 112.555 -172.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.39 -146.09 50.07 Favored Glycine 0 C--O 1.227 -0.303 0 CA-C-N 115.892 -0.594 . . . . 50.0 114.373 172.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.59 -23.52 72.18 Favored Glycine 0 C--O 1.211 -1.321 0 C-N-CA 121.124 -0.56 . . . . 50.0 112.937 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -69.13 -27.39 65.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.649 0.725 . . . . 50.0 110.66 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.6 tp -70.73 -39.88 73.11 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.91 -0.774 . . . . 50.0 108.91 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 69.2 t -67.18 -41.04 86.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.065 -0.516 . . . . 50.0 109.883 178.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -59.17 -46.22 88.97 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 122.889 0.476 . . . . 50.0 110.191 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 48.2 m -63.04 -39.93 96.21 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 116.528 -0.305 . . . . 25.0 111.467 177.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.4 mt -62.0 -39.2 91.44 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 121.622 -0.674 . . . . 50.0 110.56 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -69.01 -38.17 79.1 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 116.934 -0.121 . . . . 50.0 110.724 176.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -65.64 -44.78 85.37 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.06 -0.4 . . . . 50.0 112.054 177.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.1 t -72.79 -39.35 59.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.154 0.428 . . . . 50.0 112.154 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 t -98.7 -15.7 19.28 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 115.033 1.494 . . . . 50.0 115.033 -176.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.24 -142.31 37.27 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-O 122.101 0.834 . . . . 25.0 113.3 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -72.95 -11.23 60.5 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 123.615 0.766 . . . . 50.0 112.886 -177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.7 mtp180 -72.52 -15.05 61.78 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 114.066 1.136 . . . . 50.0 114.066 -172.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.43 168.97 45.42 Favored Glycine 0 C--O 1.226 -0.395 0 C-N-CA 121.07 -0.586 . . . . 50.0 112.508 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -151.77 168.37 25.27 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 122.29 -0.535 . . . . 50.0 110.075 -175.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.41 ' CE1' ' HA ' ' A' ' 61' ' ' ALA . 34.3 m-85 -114.51 159.6 20.19 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.126 -0.694 . . . . 50.0 109.126 175.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -128.03 177.4 6.91 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.546 -0.297 . . . . 50.0 110.201 -175.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 m -59.71 129.56 42.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.56 0.219 . . . . 50.0 110.898 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.28 -52.14 1.87 Allowed Pre-proline 0 N--CA 1.469 0.499 0 N-CA-C 115.722 1.749 . . . . 50.0 115.722 176.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -83.73 151.66 13.03 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 N-CA-C 113.637 0.591 . . . . 50.0 113.637 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.12 26.0 0.89 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.013 -1.477 . . . . 25.0 107.013 174.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.9 p -90.41 147.21 23.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.2 -0.909 . . . . 50.0 113.405 -170.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.05 -29.84 68.06 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 115.804 -0.635 . . . . 50.0 110.333 173.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.7 m -85.17 166.2 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.706 -0.679 . . . . 50.0 111.487 -176.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.19 90.5 0.21 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 115.047 1.499 . . . . 50.0 115.047 -176.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -131.63 60.02 1.68 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.351 -0.981 . . . . 50.0 108.351 174.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.78 136.94 58.22 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.553 -0.536 . . . . 50.0 109.553 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.1 t -163.39 -178.34 5.84 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 105.881 -1.896 . . . . 25.0 105.881 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -82.79 165.44 19.87 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.086 -1.079 . . . . 50.0 108.086 175.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 178.93 137.23 2.82 Favored Glycine 0 C--O 1.221 -0.711 0 N-CA-C 110.058 -1.217 . . . . 25.0 110.058 175.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.6 tp -62.03 -29.4 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-O 121.459 0.647 . . . . 50.0 111.926 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.4 t -68.09 -35.16 70.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 O-C-N 121.112 -0.992 . . . . 50.0 109.865 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -68.1 -29.61 68.58 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.904 0.705 . . . . 50.0 112.904 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -99.8 -27.43 13.64 Favored 'General case' 0 C--O 1.21 -0.997 0 N-CA-C 113.491 0.923 . . . . 50.0 113.491 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 75.2 m -102.18 -19.71 14.98 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 115.14 1.533 . . . . 50.0 115.14 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 47.6 t -113.25 -49.17 2.92 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 117.733 0.242 . . . . 50.0 111.631 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -74.58 -29.15 61.22 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.377 0.608 . . . . 50.0 109.39 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -125.49 -171.33 2.35 Favored 'General case' 0 C--O 1.215 -0.718 0 N-CA-C 105.944 -1.873 . . . . 50.0 105.944 172.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.6 t -113.59 145.16 41.7 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.66 -1.607 . . . . 25.0 106.66 173.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 29.2 p -123.99 168.63 12.57 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 122.569 0.347 . . . . 50.0 110.164 -175.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.76 165.29 13.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.453 -0.34 . . . . 50.0 110.537 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.5 tp -57.94 -42.23 84.45 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.763 1.023 . . . . 50.0 113.763 -176.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.49 -37.06 84.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.165 0.507 . . . . 25.0 110.094 -176.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.2 tp -69.26 -46.02 68.29 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.854 -0.612 . . . . 50.0 109.592 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.9 tt -58.97 -35.8 73.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.278 0.561 . . . . 50.0 111.638 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -61.65 -23.63 66.19 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.572 0.953 . . . . 50.0 113.572 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.7 p -70.35 -14.11 62.43 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 121.536 -0.727 . . . . 25.0 112.765 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -87.69 6.98 32.16 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.02 0.378 . . . . 50.0 112.02 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.9 m -58.89 148.82 28.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.888 0.375 . . . . 50.0 110.176 172.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.41 ' HA ' ' CE1' ' A' ' 27' ' ' TYR . . . -75.32 155.15 36.87 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.731 -0.84 . . . . 25.0 108.731 176.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.4 p -73.67 146.24 85.54 Favored Pre-proline 0 N--CA 1.443 -0.817 0 CA-C-N 116.111 -0.495 . . . . 25.0 110.665 -177.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.93 149.98 48.94 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 121.934 1.756 . . . . 50.0 112.816 174.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.46 161.03 19.15 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.352 -0.981 . . . . 25.0 108.352 176.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -146.49 149.92 34.58 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 106.883 -1.525 . . . . 50.0 106.883 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.2 t -150.1 148.81 29.43 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 105.224 -2.139 . . . . 25.0 105.224 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 . . . . . 1 C--O 1.307 4.101 0 CA-C-O 114.02 -2.895 . . . . 25.0 111.642 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 124.131 1.92 . . . . 25.0 114.211 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -99.82 -164.82 1.16 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.624 -1.171 . . . . 50.0 111.06 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -60.9 147.87 84.52 Favored Pre-proline 0 C--N 1.329 -0.305 0 C-N-CA 122.348 0.259 . . . . 50.0 111.33 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -75.89 152.69 36.98 Favored 'Trans proline' 0 C--N 1.344 0.305 0 N-CA-C 113.943 0.709 . . . . 50.0 113.943 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.4 p -82.38 46.62 1.06 Allowed 'General case' 0 C--O 1.209 -1.041 0 C-N-CA 124.24 1.016 . . . . 25.0 113.165 -176.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -76.91 -57.2 3.98 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.28 0.474 . . . . 50.0 112.28 -177.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.7 p -141.84 163.33 33.18 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 109.873 -0.417 . . . . 25.0 109.873 -175.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.2 tp -128.5 115.03 17.52 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 123.298 0.639 . . . . 50.0 109.556 -176.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.7 m -133.3 166.23 22.98 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.21 0.529 . . . . 50.0 111.671 -173.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.45 -143.54 48.28 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-O 121.917 0.732 . . . . 50.0 114.861 172.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.4 -23.04 71.67 Favored Glycine 0 C--O 1.21 -1.394 0 CA-C-N 115.112 -0.544 . . . . 50.0 113.49 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -69.94 -28.78 65.85 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 118.126 0.963 . . . . 50.0 109.402 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.23 -42.43 84.05 Favored 'General case' 0 C--O 1.216 -0.68 0 N-CA-C 107.604 -1.258 . . . . 50.0 107.604 177.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.5 t -64.87 -40.76 90.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.057 -0.974 . . . . 50.0 110.793 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -60.67 -48.65 80.83 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 122.189 0.995 . . . . 50.0 108.647 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.9 m -59.61 -41.58 90.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.667 -0.697 . . . . 25.0 111.314 177.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.6 mt -64.43 -39.94 94.8 Favored 'General case' 0 CA--C 1.539 0.519 0 O-C-N 121.826 -0.546 . . . . 50.0 111.09 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -65.55 -35.98 82.45 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 118.293 0.497 . . . . 50.0 109.747 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -68.78 -49.55 57.67 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 120.091 -0.644 . . . . 50.0 112.717 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.8 t -70.45 -42.74 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 O-C-N 122.098 -0.376 . . . . 50.0 111.37 -175.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 58.3 m -87.68 -16.84 33.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.787 0.803 . . . . 50.0 111.357 -175.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.59 -167.09 53.81 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 108.795 -1.722 . . . . 25.0 108.795 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -71.09 0.22 8.11 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 122.061 0.934 . . . . 50.0 112.74 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.6 mtm180 -73.05 -10.12 59.46 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.181 0.808 . . . . 50.0 113.181 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.63 170.74 44.67 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-O 122.229 0.905 . . . . 50.0 113.254 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -155.33 169.54 23.98 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.073 -1.454 . . . . 50.0 107.073 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -111.16 142.86 42.79 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.376 -0.972 . . . . 50.0 108.376 173.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -114.48 150.58 34.59 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.863 -0.792 . . . . 50.0 108.863 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.9 t 58.05 -137.07 0.92 Allowed 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.589 -0.523 . . . . 50.0 109.589 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.8 ppt_? -135.69 158.23 74.61 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 108.983 -0.747 . . . . 50.0 108.983 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -71.93 160.6 47.26 Favored 'Trans proline' 0 C--N 1.354 0.862 0 N-CA-C 115.051 1.135 . . . . 50.0 115.051 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.0 65.9 2.12 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 113.422 0.897 . . . . 25.0 113.422 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.4 m -70.12 138.02 51.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.569 -0.287 . . . . 50.0 110.728 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 12.3 mpt_? -92.16 -28.27 17.18 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.265 0.555 . . . . 50.0 110.69 175.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.3 m -90.14 159.11 2.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 CA-C-N 115.765 -0.652 . . . . 50.0 111.678 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.0 m -72.61 56.55 0.39 Allowed 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 114.175 1.176 . . . . 50.0 114.175 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -113.55 77.42 1.05 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 104.575 -2.38 . . . . 50.0 104.575 174.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 -54.58 111.85 0.89 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.812 0.815 . . . . 50.0 110.567 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.3 m -100.6 139.37 36.38 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.759 -1.2 . . . . 25.0 107.759 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.88 160.58 21.1 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.141 -0.689 . . . . 50.0 109.141 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -131.95 160.1 23.48 Favored Glycine 0 C--O 1.225 -0.44 0 N-CA-C 111.501 -0.639 . . . . 25.0 111.501 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.7 tp -57.25 -33.87 44.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 112.726 0.639 . . . . 50.0 112.726 -175.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.41 -27.22 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 O-C-N 121.458 -0.776 . . . . 50.0 111.211 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -71.51 -42.74 67.62 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 120.795 -1.191 . . . . 50.0 109.451 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -83.12 -26.61 30.84 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 119.061 -1.055 . . . . 50.0 112.356 -175.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 70.3 m -98.66 -22.31 15.99 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 116.75 2.13 . . . . 50.0 116.75 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 35.8 t -113.0 -41.9 3.66 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.644 0.656 . . . . 50.0 112.426 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -79.2 -24.9 42.83 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.304 -0.628 . . . . 50.0 109.304 175.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 28.9 mtt180 -131.36 175.51 9.07 Favored 'General case' 0 C--O 1.215 -0.761 0 N-CA-C 104.803 -2.295 . . . . 50.0 104.803 175.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.5 t -94.17 152.81 18.46 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 106.376 -1.712 . . . . 25.0 106.376 172.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.6 p -134.71 165.99 23.97 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 123.591 0.557 . . . . 50.0 111.413 -177.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -121.77 163.97 18.22 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.403 0.52 . . . . 50.0 112.403 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.4 tp -53.1 -44.21 67.45 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.582 0.956 . . . . 50.0 113.582 -176.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.58 -40.01 90.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.658 0.742 . . . . 25.0 111.699 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.4 tp -69.82 -45.09 68.63 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 121.866 -0.521 . . . . 50.0 110.981 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 tt -59.14 -35.07 72.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.709 0.29 . . . . 50.0 111.397 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -62.28 -23.54 66.77 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.652 0.982 . . . . 50.0 113.652 177.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.2 p -76.34 -15.24 60.01 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 121.352 -0.842 . . . . 25.0 113.067 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -90.26 -0.29 57.56 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.485 -0.76 . . . . 50.0 111.271 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 78.4 m -70.51 147.1 49.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.428 0.632 . . . . 50.0 110.34 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.51 152.74 39.32 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 122.712 1.244 . . . . 25.0 111.192 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 51.6 p -119.68 137.48 25.64 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 102.736 -3.061 . . . . 25.0 102.736 171.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.07 168.15 25.49 Favored 'Trans proline' 0 C--N 1.35 0.612 0 O-C-N 122.264 0.613 . . . . 50.0 111.293 -175.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.64 143.85 57.5 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.601 -1.259 . . . . 25.0 107.601 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -69.86 -43.6 71.55 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.046 0.758 . . . . 50.0 113.046 -175.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.7 t -164.97 136.09 4.06 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 106.487 -1.672 . . . . 25.0 106.487 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 . . . . . 0 C--O 1.288 3.101 0 CA-C-O 113.396 -3.192 . . . . 25.0 109.39 174.536 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 123.751 1.738 . . . . 25.0 114.806 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -88.89 163.28 15.69 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 120.905 -1.122 . . . . 50.0 109.13 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -62.95 141.02 97.59 Favored Pre-proline 0 N--CA 1.468 0.427 0 N-CA-C 109.272 -0.64 . . . . 50.0 109.272 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.84 156.76 24.07 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 N-CA-C 114.626 0.972 . . . . 50.0 114.626 -173.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.2 p -89.11 40.84 1.0 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.195 -0.911 . . . . 25.0 110.387 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.99 -22.58 63.12 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.046 0.758 . . . . 50.0 113.046 -175.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.5 p 58.36 174.6 0.06 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 114.739 1.385 . . . . 25.0 114.739 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.4 tp -142.9 111.58 6.34 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.587 -1.634 . . . . 50.0 106.587 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -159.81 -171.11 3.13 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.837 -0.62 . . . . 50.0 109.891 -173.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.52 31.61 79.22 Favored Glycine 0 C--O 1.217 -0.923 0 C-N-CA 120.791 -0.719 . . . . 50.0 114.01 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.73 -24.88 15.29 Favored Glycine 0 C--O 1.224 -0.527 0 C-N-CA 121.239 -0.505 . . . . 50.0 113.143 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.39 -28.22 69.09 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.512 0.673 . . . . 50.0 110.057 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.36 -43.69 96.96 Favored 'General case' 0 C--O 1.216 -0.68 0 CA-C-N 116.04 -0.527 . . . . 50.0 110.886 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 80.5 t -67.53 -40.26 84.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.67 -0.695 . . . . 50.0 109.418 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -61.05 -47.17 87.6 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.274 0.559 . . . . 50.0 110.096 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.7 m -61.05 -42.07 97.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.114 -0.494 . . . . 25.0 111.077 177.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.9 mt -63.54 -38.78 92.43 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.916 -0.49 . . . . 50.0 110.89 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -67.54 -37.46 82.75 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 121.136 -0.226 . . . . 50.0 110.461 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -68.1 -45.86 72.56 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 122.033 -0.417 . . . . 50.0 112.075 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 82.1 t -70.77 -42.7 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 112.048 0.388 . . . . 50.0 112.048 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.3 m -96.99 -15.49 21.06 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.958 1.096 . . . . 50.0 113.958 -173.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.18 -161.79 49.8 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-O 122.424 1.013 . . . . 25.0 112.789 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -68.76 0.55 4.17 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.405 -0.897 . . . . 50.0 113.173 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -83.41 -11.67 57.31 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 121.165 -0.959 . . . . 50.0 111.511 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.96 174.08 46.66 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-O 121.939 0.744 . . . . 50.0 112.934 173.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -156.47 167.98 28.77 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.428 -0.582 . . . . 50.0 109.428 -174.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -100.49 147.27 26.07 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.48 0.657 . . . . 50.0 109.727 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -125.47 -177.96 4.07 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.757 -0.831 . . . . 50.0 108.757 -175.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.1 t -54.93 126.45 24.49 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.715 -0.846 . . . . 50.0 108.715 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -97.11 132.17 26.2 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.072 -0.513 . . . . 50.0 111.178 -170.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.2 153.83 70.87 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 118.182 -0.745 . . . . 50.0 113.612 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.2 168.34 15.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.498 -0.774 . . . . 25.0 110.552 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.0 m -145.59 165.26 29.19 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 105.804 -1.924 . . . . 50.0 105.804 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.4 mtm105 -65.52 -25.09 67.3 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.098 0.408 . . . . 50.0 111.104 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.8 m -88.92 145.55 7.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.283 -1.006 . . . . 50.0 108.283 175.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.6 m -75.11 70.22 2.07 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.907 0.706 . . . . 50.0 112.907 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -126.47 32.85 5.1 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.275 0.559 . . . . 50.0 110.011 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -72.07 158.24 36.31 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.026 -1.101 . . . . 50.0 108.026 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 73.8 p -146.84 159.39 43.58 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.003 -0.739 . . . . 25.0 109.003 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -67.96 140.69 56.42 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.332 -0.988 . . . . 50.0 108.332 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.76 161.56 14.44 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-O 121.536 0.52 . . . . 25.0 112.576 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.0 tp -65.3 -30.27 49.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 121.164 0.506 . . . . 50.0 110.259 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.2 t -64.7 -40.11 87.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 121.393 -0.817 . . . . 50.0 109.182 175.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -63.46 -27.15 69.09 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 114.724 1.379 . . . . 50.0 114.724 -178.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -101.65 -25.01 14.02 Favored 'General case' 0 C--O 1.206 -1.189 0 N-CA-C 112.793 0.664 . . . . 50.0 112.793 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 72.7 m -106.27 -24.0 12.41 Favored 'General case' 0 C--O 1.213 -0.834 0 N-CA-C 114.67 1.359 . . . . 50.0 114.67 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 44.9 t -104.27 -46.27 4.46 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 118.463 0.574 . . . . 50.0 110.874 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -72.5 -33.53 67.0 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.186 0.517 . . . . 50.0 109.899 177.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -134.07 -178.51 5.06 Favored 'General case' 0 C--O 1.213 -0.862 0 N-CA-C 107.412 -1.329 . . . . 50.0 107.412 177.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.7 p -93.08 154.51 18.06 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.143 -0.688 . . . . 25.0 109.143 175.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 32.1 p -139.04 164.88 28.6 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 122.434 0.293 . . . . 50.0 110.369 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -106.06 158.19 16.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.186 -0.461 . . . . 50.0 111.286 -178.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.0 tp -59.13 -45.48 90.83 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.684 0.624 . . . . 50.0 112.684 178.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.81 -37.02 82.85 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-O 120.901 0.381 . . . . 25.0 111.07 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.1 tp -68.5 -45.15 73.1 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.121 -0.696 . . . . 50.0 109.121 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 tt -60.53 -34.04 73.54 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.052 0.453 . . . . 50.0 111.023 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -62.5 -24.65 67.59 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.48 0.918 . . . . 50.0 113.48 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.6 p -76.66 -14.26 59.98 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.391 -0.818 . . . . 25.0 111.667 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -85.24 1.14 49.5 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.124 0.416 . . . . 50.0 112.124 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 80.6 m -70.2 152.73 43.93 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.98 0.419 . . . . 50.0 110.119 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.15 164.58 16.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.432 0.634 . . . . 25.0 110.706 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.9 p -66.2 142.92 98.12 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 115.696 -0.684 . . . . 25.0 109.916 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -69.93 154.59 66.89 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 CA-C-O 121.46 0.525 . . . . 50.0 113.032 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -124.8 160.71 28.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.12 -0.945 . . . . 25.0 109.564 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -76.66 151.43 36.16 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.884 -0.784 . . . . 50.0 108.884 177.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.2 p -154.37 146.53 23.73 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 104.831 -2.285 . . . . 25.0 104.831 174.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 . . . . . 1 C--O 1.307 4.084 0 CA-C-O 114.53 -2.652 . . . . 25.0 111.564 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.205 -1.281 0 CA-C-O 124.463 2.078 . . . . 25.0 112.521 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -66.03 -18.84 65.61 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 112.5 -2.136 . . . . 50.0 111.509 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.48 149.11 71.52 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 114.743 -1.117 . . . . 50.0 111.763 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -71.68 177.28 7.07 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 121.378 1.385 . . . . 50.0 112.015 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.2 p 53.9 69.43 0.71 Allowed 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 122.277 1.037 . . . . 25.0 110.564 -177.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -65.43 -16.55 63.74 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.303 1.223 . . . . 50.0 114.303 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.05 152.1 43.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.465 0.65 . . . . 25.0 111.119 -176.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.9 mt -129.3 130.1 45.73 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 115.008 -0.996 . . . . 50.0 109.721 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -166.09 -179.35 5.1 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 105.973 -1.862 . . . . 50.0 105.973 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.66 32.61 79.23 Favored Glycine 0 C--O 1.218 -0.897 0 C-N-CA 120.481 -0.866 . . . . 50.0 114.232 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.0 -25.54 19.32 Favored Glycine 0 C--O 1.219 -0.804 0 C-N-CA 121.045 -0.598 . . . . 50.0 113.969 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -63.95 -27.78 69.37 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 118.199 0.999 . . . . 50.0 110.583 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 24.6 tp -65.62 -40.57 92.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.064 -0.517 . . . . 50.0 110.178 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 85.1 t -69.49 -39.4 78.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.361 -0.607 . . . . 50.0 109.361 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -59.62 -46.39 89.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.685 0.755 . . . . 50.0 109.778 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.0 m -63.56 -39.66 94.99 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.971 -0.559 . . . . 25.0 111.299 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.5 mt -63.03 -38.19 90.18 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.905 -0.497 . . . . 50.0 110.976 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -66.37 -39.17 88.94 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.208 -0.293 . . . . 50.0 110.208 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -65.94 -48.04 72.69 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.599 0.592 . . . . 50.0 112.599 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.3 t -71.96 -41.59 68.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 112.024 0.379 . . . . 50.0 112.024 -175.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.0 m -90.65 -18.38 25.21 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.151 0.797 . . . . 50.0 113.151 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.36 -138.19 48.66 Favored Glycine 0 C--N 1.322 -0.218 0 CA-C-O 122.253 0.918 . . . . 25.0 113.917 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -70.56 -13.34 62.06 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.795 0.838 . . . . 50.0 112.486 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.5 mtp180 -79.22 -16.03 57.13 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.124 0.787 . . . . 50.0 113.124 -171.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.5 171.4 48.02 Favored Glycine 0 C--O 1.226 -0.358 0 C-N-CA 121.07 -0.586 . . . . 50.0 113.536 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -158.11 166.11 33.29 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.489 -0.56 . . . . 50.0 109.489 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -130.46 153.93 48.28 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.863 0.69 . . . . 50.0 112.863 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -103.74 137.15 42.17 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.613 0.721 . . . . 50.0 111.604 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.96 65.73 8.81 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.358 -0.837 . . . . 50.0 113.15 -177.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.03 147.84 49.04 Favored Pre-proline 0 N--CA 1.472 0.631 0 O-C-N 121.866 -0.522 . . . . 50.0 110.37 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.89 162.28 39.59 Favored 'Trans proline' 0 C--N 1.349 0.601 0 O-C-N 121.796 0.366 . . . . 50.0 112.981 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.88 19.58 8.48 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.32 0.581 . . . . 25.0 110.411 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 p -92.08 161.55 14.72 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.575 -0.528 . . . . 50.0 109.575 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 41.7 mtt180 -62.08 -23.57 66.59 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 112.346 0.498 . . . . 50.0 112.346 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.6 m -122.45 143.3 35.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 108.973 -0.751 . . . . 50.0 108.973 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 52.7 m -115.26 85.77 2.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.335 -0.393 . . . . 50.0 110.153 -178.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -69.46 -42.65 74.62 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 121.003 -0.279 . . . . 50.0 111.421 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -151.68 158.19 43.09 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 106.695 -1.594 . . . . 50.0 106.695 176.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.31 154.62 21.79 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 103.391 -2.818 . . . . 25.0 103.391 166.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.1 ptp85 -127.47 -177.65 4.16 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.097 0.777 . . . . 50.0 113.097 -173.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.42 -111.94 4.58 Favored Glycine 0 C--O 1.227 -0.287 0 CA-C-N 116.117 -0.492 . . . . 25.0 113.839 172.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.0 tp -61.23 -34.34 60.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 112.22 0.452 . . . . 50.0 112.22 -177.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.5 t -73.56 -39.24 53.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 O-C-N 121.1 -1.0 . . . . 50.0 109.97 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -65.05 -44.15 89.95 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.241 0.543 . . . . 50.0 111.686 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.63 -30.1 56.74 Favored 'General case' 0 C--O 1.208 -1.105 0 N-CA-C 113.667 0.988 . . . . 50.0 113.667 -175.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 90.9 m -108.97 -20.22 13.12 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 115.652 1.723 . . . . 50.0 115.652 -175.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.3 t -109.09 -47.64 3.4 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.782 0.719 . . . . 50.0 110.701 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -75.24 -33.97 61.36 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.517 -0.473 . . . . 50.0 110.154 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -129.0 -178.89 4.81 Favored 'General case' 0 C--O 1.214 -0.79 0 N-CA-C 109.043 -0.725 . . . . 50.0 109.043 172.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.0 m -89.54 149.76 22.74 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.687 0.617 . . . . 25.0 109.686 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 26.3 p -129.99 166.72 19.5 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.224 0.535 . . . . 50.0 111.984 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -117.2 160.5 20.96 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.812 -0.631 . . . . 50.0 110.12 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 61.6 tp -56.98 -48.5 78.27 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.188 1.181 . . . . 50.0 114.188 -177.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.53 -37.71 84.74 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-O 120.974 0.416 . . . . 25.0 111.455 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.4 tp -67.79 -47.07 70.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.318 -0.401 . . . . 50.0 110.048 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.7 tt -60.88 -35.24 76.12 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.371 0.605 . . . . 50.0 110.622 -177.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -60.56 -21.91 63.08 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.901 1.074 . . . . 50.0 113.901 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.5 p -73.77 -14.27 61.09 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.338 -0.851 . . . . 25.0 112.594 -178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -92.64 6.25 48.05 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 112.344 0.498 . . . . 50.0 112.344 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 72.6 m -71.06 153.22 42.76 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.452 -1.314 . . . . 50.0 107.452 172.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.73 149.92 46.44 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.387 0.613 . . . . 25.0 110.431 -176.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.0 p -113.46 147.49 37.6 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 108.49 -0.93 . . . . 25.0 108.49 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.46 159.18 43.51 Favored 'Trans proline' 0 C--N 1.343 0.272 0 CA-C-O 121.53 0.554 . . . . 50.0 113.267 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.51 161.07 17.17 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.749 -0.834 . . . . 25.0 108.749 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -81.77 153.53 26.45 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.839 -1.171 . . . . 50.0 107.839 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 72.5 p -141.98 154.5 45.08 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 105.789 -1.93 . . . . 25.0 105.789 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 . . . . . 0 C--O 1.3 3.732 0 CA-C-O 116.553 -1.689 . . . . 25.0 111.299 -176.144 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 123.943 1.83 . . . . 25.0 114.903 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -79.08 160.39 27.1 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 120.71 -1.244 . . . . 50.0 109.219 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 70.6 mtt-85 -66.06 145.72 99.0 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.27 -0.423 . . . . 50.0 110.015 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -74.72 162.02 38.4 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 118.275 -0.683 . . . . 50.0 112.956 -177.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.3 m -133.3 91.73 2.91 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 107.538 -1.282 . . . . 25.0 107.538 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -76.73 -6.43 52.17 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 114.335 1.235 . . . . 50.0 114.335 -174.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.6 p -109.44 155.05 21.77 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.421 -0.955 . . . . 25.0 108.421 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.3 tp -88.69 103.96 16.43 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 122.35 1.071 . . . . 50.0 110.839 -173.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 t -156.01 -169.42 3.07 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.618 -1.174 . . . . 50.0 109.763 -172.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.12 31.13 79.68 Favored Glycine 0 C--O 1.218 -0.868 0 N-CA-C 114.78 0.672 . . . . 50.0 114.78 174.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.74 -25.05 20.93 Favored Glycine 0 C--O 1.22 -0.777 0 C-N-CA 121.027 -0.606 . . . . 50.0 113.203 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -63.77 -28.27 69.76 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.724 0.774 . . . . 50.0 109.532 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 35.0 tp -63.67 -39.54 94.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.794 -0.639 . . . . 50.0 111.004 176.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.5 t -70.63 -39.88 76.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.352 -0.61 . . . . 50.0 109.352 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -61.07 -48.2 82.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.418 0.628 . . . . 50.0 110.028 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.6 m -61.55 -40.03 93.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.039 -0.528 . . . . 25.0 110.829 178.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.1 mt -62.97 -37.06 85.61 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 121.81 -0.556 . . . . 50.0 111.458 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -64.45 -45.98 85.08 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.688 -0.486 . . . . 50.0 109.688 175.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -63.46 -46.18 87.4 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.977 0.732 . . . . 50.0 112.977 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.7 t -71.42 -40.56 72.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 111.887 0.328 . . . . 50.0 111.887 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 77.0 m -86.64 -30.31 21.87 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.45 1.278 . . . . 50.0 114.45 -174.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.14 -127.55 45.15 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.227 -0.987 . . . . 25.0 115.224 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -56.47 -33.1 65.6 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 116.362 1.986 . . . . 50.0 116.362 -173.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -82.19 -15.68 52.34 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 114.058 1.133 . . . . 50.0 114.058 -174.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.47 -177.97 52.24 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 109.831 -1.308 . . . . 50.0 109.831 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -157.14 169.49 24.66 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.793 -0.447 . . . . 50.0 109.793 -175.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -153.98 155.1 34.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.475 0.655 . . . . 50.0 110.458 174.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -87.31 134.95 33.49 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.321 -2.103 . . . . 50.0 105.321 176.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.5 t -142.02 137.0 30.81 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.361 0.504 . . . . 50.0 112.361 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.6 145.56 8.62 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 106.794 -1.558 . . . . 50.0 106.794 175.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.59 142.0 35.47 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 114.038 -3.508 . . . . 50.0 112.001 175.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.68 -18.64 19.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.461 0.648 . . . . 25.0 110.652 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.0 m 60.24 163.28 0.06 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 113.028 -1.896 . . . . 50.0 115.694 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -69.33 -26.52 64.75 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.67 0.748 . . . . 50.0 110.869 -176.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.5 m -118.51 164.83 14.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 103.369 -2.826 . . . . 50.0 103.369 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.1 m -70.46 65.01 0.29 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 115.44 1.645 . . . . 50.0 115.44 -175.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 43.0 mmt180 -127.46 65.7 1.32 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.996 -1.112 . . . . 50.0 107.996 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -68.98 150.47 47.66 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.711 -1.218 . . . . 50.0 107.711 176.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.1 m -153.98 161.72 41.75 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.128 0.422 . . . . 25.0 111.363 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 48.01 -161.41 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 117.013 2.227 . . . . 50.0 117.013 172.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.2 168.25 23.96 Favored Glycine 0 CA--C 1.51 -0.265 0 CA-C-N 115.832 -0.622 . . . . 25.0 111.937 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 tp -56.39 -35.94 45.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 122.69 0.396 . . . . 50.0 111.864 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.2 -35.66 72.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 O-C-N 121.59 -0.694 . . . . 50.0 111.511 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -68.04 -35.57 78.47 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 121.164 -0.96 . . . . 50.0 110.878 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -86.25 -35.62 19.88 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 113.944 1.09 . . . . 50.0 113.944 -175.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 98.1 m -103.09 -22.38 13.78 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 115.644 1.72 . . . . 50.0 115.644 -176.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 44.4 t -104.44 -43.33 5.21 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.222 0.464 . . . . 50.0 111.508 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -88.5 -16.88 31.56 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.534 0.683 . . . . 50.0 110.265 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -134.66 177.58 7.67 Favored 'General case' 0 C--O 1.218 -0.569 0 N-CA-C 105.96 -1.867 . . . . 50.0 105.96 173.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.4 p -94.46 153.9 17.7 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 106.849 -1.537 . . . . 25.0 106.849 171.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 27.0 p -138.46 165.83 25.83 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.319 0.489 . . . . 50.0 112.319 -176.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -100.17 155.9 17.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.662 -0.699 . . . . 50.0 111.058 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 35.6 tp -58.04 -44.61 87.46 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.306 0.854 . . . . 50.0 113.306 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.5 -38.33 86.94 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 120.857 0.36 . . . . 25.0 111.286 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.3 tp -66.34 -43.75 85.2 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.248 -0.649 . . . . 50.0 109.248 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.2 tt -58.65 -37.02 75.07 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.129 0.49 . . . . 50.0 111.209 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -63.21 -19.68 64.74 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.312 1.227 . . . . 50.0 114.312 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.1 p -75.25 -14.01 60.48 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 121.304 -0.872 . . . . 25.0 112.827 -178.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -93.36 8.03 42.09 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.039 0.447 . . . . 50.0 111.648 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 65.3 m -72.83 155.18 40.18 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.603 -0.888 . . . . 50.0 108.603 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.11 -169.82 2.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.536 0.684 . . . . 25.0 111.727 -176.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.8 p -91.15 134.93 29.03 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 108.021 -1.103 . . . . 25.0 108.021 176.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.8 147.24 74.74 Favored 'Trans proline' 0 C--O 1.236 0.391 0 N-CA-C 115.668 1.372 . . . . 50.0 115.668 -177.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.14 78.41 4.56 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.758 -1.11 . . . . 25.0 110.56 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt 57.42 45.33 20.01 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.791 0.805 . . . . 50.0 110.639 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 59.0 p -134.67 160.58 37.66 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 104.633 -2.358 . . . . 25.0 104.633 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 . . . . . 0 C--O 1.293 3.384 0 CA-C-O 113.952 -2.928 . . . . 25.0 110.854 -175.742 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.212 -0.881 0 CA-C-O 123.291 1.52 . . . . 25.0 113.971 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -96.59 163.05 13.19 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 115.236 -0.893 . . . . 50.0 109.3 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -108.66 150.2 40.44 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.471 -0.332 . . . . 50.0 110.442 -178.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -76.21 175.97 10.65 Favored 'Trans proline' 0 C--N 1.348 0.506 0 N-CA-C 113.617 0.583 . . . . 50.0 113.617 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.6 t 75.29 114.52 0.06 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.615 1.566 . . . . 25.0 113.198 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -83.12 -6.84 59.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.233 -0.894 . . . . 50.0 110.757 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.9 p -117.87 148.93 41.65 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.297 -1.001 . . . . 25.0 108.297 177.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.1 tp -114.76 119.66 37.4 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.617 -0.883 . . . . 50.0 108.617 -176.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.33 167.32 26.41 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.004 -0.543 . . . . 50.0 111.518 -173.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.37 -146.46 48.81 Favored Glycine 0 C--N 1.324 -0.127 0 C-N-CA 120.746 -0.74 . . . . 50.0 111.624 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.75 -26.4 69.91 Favored Glycine 0 C--O 1.21 -1.37 0 C-N-CA 121.006 -0.616 . . . . 50.0 112.471 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -61.12 -30.93 70.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.695 0.747 . . . . 50.0 111.222 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.83 -44.91 68.98 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 109.326 -0.62 . . . . 50.0 109.326 178.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.2 t -63.71 -43.07 97.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.573 -0.739 . . . . 50.0 109.979 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -62.72 -41.73 99.3 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.563 0.697 . . . . 50.0 110.216 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 48.2 m -68.62 -38.9 80.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.34 -0.391 . . . . 25.0 110.293 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.8 mt -63.54 -37.18 86.32 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 121.964 -0.46 . . . . 50.0 110.364 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -65.48 -42.16 92.51 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 110.292 -0.262 . . . . 50.0 110.292 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -64.84 -45.66 85.17 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.595 0.591 . . . . 50.0 112.595 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.2 t -73.77 -43.37 53.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 111.788 0.292 . . . . 50.0 111.788 -176.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 69.3 m -87.45 -28.44 22.09 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.291 0.849 . . . . 50.0 113.291 -175.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.14 -142.46 41.34 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.572 -0.823 . . . . 25.0 112.34 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -66.55 -18.77 65.55 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 123.911 0.884 . . . . 50.0 113.11 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -66.58 -21.76 66.14 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.114 0.413 . . . . 50.0 112.114 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.8 173.29 49.32 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.976 -0.631 . . . . 50.0 112.103 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -158.43 170.57 21.93 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.677 -0.86 . . . . 50.0 108.677 -176.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.87 158.57 43.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 122.08 0.943 . . . . 50.0 112.776 175.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -97.96 136.83 37.67 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 105.577 -2.009 . . . . 50.0 105.577 174.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.4 t -76.29 83.05 3.06 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.689 0.626 . . . . 50.0 112.689 -177.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.08 -42.54 0.86 Allowed Pre-proline 0 CA--C 1.554 1.134 0 N-CA-C 119.047 2.98 . . . . 50.0 119.047 176.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -80.91 -169.5 0.81 Allowed 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.246 1.964 . . . . 50.0 114.093 -175.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 72.78 -123.18 0.05 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.215 1.406 . . . . 25.0 113.819 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.2 m -54.99 127.34 28.49 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.709 1.003 . . . . 50.0 113.709 -171.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -68.15 -24.65 65.01 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.36 -0.836 . . . . 50.0 112.74 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.2 m -118.8 140.99 40.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.836 0.827 . . . . 50.0 112.815 -174.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.8 m -87.89 33.7 0.72 Allowed 'General case' 0 C--O 1.217 -0.618 0 CA-C-N 115.251 -0.886 . . . . 50.0 112.554 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -75.41 -8.66 57.29 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 122.135 -0.353 . . . . 50.0 111.516 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -132.26 138.91 48.06 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.433 -1.692 . . . . 50.0 106.433 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.6 m -76.54 52.64 0.81 Allowed 'General case' 0 C--O 1.217 -0.657 0 N-CA-C 117.703 2.483 . . . . 25.0 117.703 -171.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 57.1 ttm-85 -65.47 -42.25 92.46 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.337 -0.847 . . . . 50.0 111.58 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.7 144.15 28.72 Favored Glycine 0 C--O 1.222 -0.597 0 C-N-CA 120.902 -0.666 . . . . 25.0 113.717 -174.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.6 tp -56.58 -36.95 49.91 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 CA-C-N 114.663 -0.768 . . . . 50.0 110.767 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.15 -39.46 85.62 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 O-C-N 121.575 -0.703 . . . . 75.0 110.2 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -69.47 -26.53 64.62 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 121.238 -0.914 . . . . 50.0 111.893 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -85.74 -39.92 16.65 Favored 'General case' 0 C--O 1.208 -1.123 0 C-N-CA 121.058 -0.257 . . . . 50.0 111.174 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 73.2 m -101.01 -21.06 15.14 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 116.763 2.135 . . . . 50.0 116.763 -173.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.4 t -111.24 -41.71 4.1 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 118.453 0.57 . . . . 50.0 111.661 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -80.18 -17.18 53.11 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.154 0.502 . . . . 50.0 109.847 176.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -144.36 179.55 7.18 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 103.902 -2.629 . . . . 50.0 103.902 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.6 m -98.13 154.92 17.41 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.05 -1.093 . . . . 25.0 108.05 173.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 22.6 p -139.23 162.2 35.55 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.484 -0.191 . . . . 50.0 110.484 -178.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -112.95 164.52 13.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.93 -0.577 . . . . 50.0 112.285 -176.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.9 tp -54.92 -45.84 74.83 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.519 -0.764 . . . . 50.0 112.97 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.8 -41.01 94.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.723 0.296 . . . . 25.0 111.218 -177.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.6 tp -69.84 -46.17 66.2 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.172 0.511 . . . . 50.0 109.867 178.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.2 tt -59.52 -34.6 72.83 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 121.906 -0.496 . . . . 50.0 111.393 -175.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -62.3 -21.7 65.45 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.899 1.074 . . . . 50.0 113.899 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 37.5 p -73.85 -14.19 61.04 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.473 -0.767 . . . . 25.0 112.354 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -89.91 5.08 47.92 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 112.354 0.501 . . . . 50.0 112.354 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 69.1 m -70.94 156.38 39.68 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.356 -0.609 . . . . 50.0 109.356 175.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.44 163.07 16.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.567 0.699 . . . . 25.0 112.35 -177.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.3 p -93.32 138.36 23.11 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.454 -0.793 . . . . 25.0 109.765 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.71 146.3 60.07 Favored 'Trans proline' 0 C--N 1.346 0.417 0 N-CA-C 115.987 1.495 . . . . 50.0 115.987 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.69 64.96 8.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.643 -1.162 . . . . 25.0 112.374 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt 58.83 25.99 14.25 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 121.782 0.801 . . . . 50.0 112.295 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 43.5 t -144.71 118.03 9.01 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 104.919 -2.252 . . . . 25.0 104.919 175.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 . . . . . 0 C--O 1.3 3.719 0 CA-C-O 114.981 -2.438 . . . . 25.0 115.021 -171.112 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.934 0 CA-C-O 123.131 1.443 . . . . 25.0 114.142 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -79.81 159.72 26.4 Favored 'General case' 0 C--O 1.231 0.103 0 O-C-N 121.242 -0.911 . . . . 50.0 108.981 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 86.3 mtt85 -70.77 147.33 94.26 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.089 -0.708 . . . . 50.0 109.089 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -77.27 155.23 32.74 Favored 'Trans proline' 0 C--N 1.344 0.309 0 N-CA-C 113.532 0.551 . . . . 50.0 113.532 -176.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.8 m -116.0 60.09 0.72 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.371 -0.831 . . . . 25.0 110.892 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -64.97 -38.93 92.58 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.737 0.779 . . . . 50.0 109.307 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.2 p -123.44 147.79 46.8 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.653 -1.158 . . . . 25.0 109.341 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.9 mt -138.11 137.17 37.45 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 114.79 -1.096 . . . . 50.0 108.913 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -154.81 162.38 41.13 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 107.487 -1.301 . . . . 50.0 107.487 178.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.28 -145.36 49.55 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.238 -0.982 . . . . 50.0 110.724 -178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.87 -24.63 70.13 Favored Glycine 0 C--O 1.205 -1.676 0 C-N-CA 120.974 -0.631 . . . . 50.0 113.255 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -61.02 -34.98 75.68 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.314 1.057 . . . . 50.0 111.473 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 25.5 tp -69.38 -39.88 77.76 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.153 -0.684 . . . . 50.0 109.153 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 89.2 t -66.9 -40.43 85.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.741 -0.663 . . . . 50.0 110.203 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -61.76 -40.68 96.01 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.031 -0.729 . . . . 50.0 109.031 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.2 m -68.39 -38.75 81.63 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 116.245 -0.434 . . . . 25.0 110.854 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.6 mt -61.61 -36.95 82.18 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 121.585 -0.697 . . . . 50.0 109.971 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -68.77 -37.82 79.6 Favored 'General case' 0 C--O 1.216 -0.683 0 O-C-N 122.27 -0.269 . . . . 50.0 111.436 174.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -65.85 -41.12 92.09 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.821 -0.55 . . . . 50.0 112.224 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.6 t -77.48 -37.24 24.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 112.286 0.476 . . . . 50.0 112.286 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 70.0 m -129.56 -37.53 1.58 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.895 1.813 . . . . 50.0 115.895 -175.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 51.21 -109.7 0.83 Allowed Glycine 0 N--CA 1.462 0.416 0 N-CA-C 116.133 1.213 . . . . 25.0 116.133 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -58.08 -23.12 53.44 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.967 0.907 . . . . 50.0 113.394 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 51.9 mmm-85 -70.69 -17.43 62.84 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.166 -0.334 . . . . 50.0 111.282 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.68 159.27 23.68 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.992 -0.443 . . . . 50.0 111.992 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -162.3 164.58 27.44 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 106.098 -1.815 . . . . 50.0 106.098 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -154.1 157.66 39.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.346 0.593 . . . . 50.0 109.592 173.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -83.75 154.79 23.4 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.444 -0.947 . . . . 50.0 108.444 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.5 p -71.3 91.44 0.98 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.083 0.944 . . . . 50.0 110.812 177.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.8 tpt85 -61.91 -47.29 91.72 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 118.877 2.917 . . . . 50.0 118.877 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.91 161.09 33.45 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 CA-C-N 118.709 0.575 . . . . 50.0 112.888 -175.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.32 156.27 44.18 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.358 -1.349 . . . . 25.0 107.358 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.89 135.59 33.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.984 0.421 . . . . 50.0 111.174 -178.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.75 0.31 57.5 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.975 0.893 . . . . 50.0 110.558 177.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.3 m -120.58 171.62 8.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 106.55 -1.648 . . . . 50.0 106.55 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.37 27.46 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 117.515 2.413 . . . . 50.0 117.515 -175.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -88.19 66.54 8.52 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.577 -0.897 . . . . 50.0 108.577 176.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.88 136.43 57.84 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.277 -1.379 . . . . 50.0 107.277 176.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.1 m -144.58 163.06 35.03 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.614 -0.266 . . . . 25.0 110.86 -172.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -69.05 161.8 28.25 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.975 0.417 . . . . 50.0 110.7 177.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -156.37 163.55 32.06 Favored Glycine 0 CA--C 1.511 -0.167 0 N-CA-C 106.173 -2.771 . . . . 25.0 106.173 174.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.4 tp -66.91 -36.43 77.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 119.117 1.458 . . . . 50.0 111.484 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.2 t -69.01 -40.06 80.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 121.153 -0.967 . . . . 50.0 108.542 175.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -65.09 -27.87 69.06 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 113.739 1.015 . . . . 50.0 113.739 -177.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -93.84 -27.5 16.4 Favored 'General case' 0 C--O 1.209 -1.058 0 N-CA-C 113.052 0.76 . . . . 50.0 113.052 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 94.7 m -107.84 -20.28 13.25 Favored 'General case' 0 C--O 1.212 -0.903 0 N-CA-C 115.421 1.638 . . . . 50.0 115.421 -177.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 37.8 t -106.3 -47.68 3.75 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.719 0.691 . . . . 50.0 110.201 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -73.78 -27.63 61.24 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.058 0.456 . . . . 50.0 110.103 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 55.3 mtp85 -136.29 -179.69 5.83 Favored 'General case' 0 C--O 1.214 -0.813 0 N-CA-C 109.055 -0.72 . . . . 50.0 109.055 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.2 t -91.62 150.32 21.22 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.598 -1.26 . . . . 25.0 107.598 173.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 28.0 p -133.74 175.17 9.69 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.158 0.504 . . . . 50.0 111.795 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -129.48 160.2 33.92 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.933 -0.48 . . . . 50.0 110.584 -175.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.2 tp -54.46 -52.08 62.98 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.745 1.387 . . . . 50.0 114.745 -177.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.22 -37.12 84.17 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-O 121.083 0.468 . . . . 25.0 111.143 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.9 tp -66.5 -46.72 75.3 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.626 -0.509 . . . . 50.0 109.626 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 tt -62.11 -35.14 77.81 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.021 0.439 . . . . 50.0 111.693 -175.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -59.47 -24.24 63.4 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.324 0.861 . . . . 50.0 113.324 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 35.1 p -70.61 -14.15 62.37 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.27 0.841 . . . . 25.0 113.27 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -93.26 6.39 48.23 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.562 0.578 . . . . 50.0 112.562 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 65.7 m -79.02 159.97 27.37 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.964 0.411 . . . . 50.0 110.311 176.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.0 163.57 26.57 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.473 0.654 . . . . 25.0 111.426 -175.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.3 p -114.51 154.08 46.6 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 108.952 -0.759 . . . . 25.0 108.952 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.22 162.81 37.89 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 120.476 0.784 . . . . 50.0 113.429 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.64 165.87 15.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.047 -0.524 . . . . 25.0 110.417 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -67.23 159.45 29.07 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.499 -0.556 . . . . 50.0 109.499 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 t 61.0 34.51 19.32 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 122.765 1.269 . . . . 25.0 111.302 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 C--O 1.302 3.852 0 CA-C-O 112.976 -3.393 . . . . 25.0 111.199 176.381 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 124.13 1.919 . . . . 25.0 113.894 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -73.11 152.15 41.32 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 113.977 -1.465 . . . . 50.0 110.497 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -60.98 146.76 87.07 Favored Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 113.004 0.742 . . . . 50.0 113.004 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -79.88 176.85 9.0 Favored 'Trans proline' 0 C--O 1.238 0.486 0 N-CA-C 110.579 -0.585 . . . . 50.0 110.579 174.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.0 t -145.77 38.48 1.11 Allowed 'General case' 0 C--O 1.218 -0.588 0 CA-C-O 120.938 0.399 . . . . 25.0 110.927 175.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -89.52 -34.43 16.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.637 0.732 . . . . 50.0 110.819 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.7 p -130.98 158.04 41.35 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.049 -0.978 . . . . 25.0 109.718 -177.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.7 mt -142.55 139.05 31.27 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 108.424 -0.954 . . . . 50.0 108.424 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -132.39 -156.82 0.78 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.916 -0.314 . . . . 50.0 110.232 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -44.6 131.65 7.5 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 114.546 0.579 . . . . 50.0 114.546 -175.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.95 -57.82 4.56 Favored Glycine 0 C--O 1.216 -0.993 0 O-C-N 122.827 -0.219 . . . . 50.0 113.479 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -64.93 -38.49 91.14 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.763 0.792 . . . . 50.0 112.564 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.1 tp -68.38 -37.28 80.27 Favored 'General case' 0 C--O 1.211 -0.968 0 N-CA-C 109.31 -0.626 . . . . 50.0 109.31 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.8 t -69.84 -38.31 75.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.647 -0.706 . . . . 50.0 109.85 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -58.95 -46.85 87.02 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.507 0.67 . . . . 50.0 109.3 174.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.5 m -65.38 -38.48 90.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.156 -0.475 . . . . 25.0 112.052 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.6 mt -61.98 -40.11 94.48 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.486 -0.759 . . . . 50.0 109.422 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -67.43 -35.43 79.22 Favored 'General case' 0 C--O 1.217 -0.637 0 O-C-N 122.166 -0.334 . . . . 50.0 111.069 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -66.31 -51.14 60.35 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 122.071 -0.393 . . . . 50.0 112.059 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.2 t -71.0 -42.61 76.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.29 0.478 . . . . 50.0 112.29 -174.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 51.2 m -86.76 -22.26 26.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.26 0.552 . . . . 50.0 112.069 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.19 -149.11 48.05 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-O 122.208 0.893 . . . . 25.0 112.4 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -64.51 -6.26 7.08 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.234 -0.983 . . . . 50.0 113.086 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.0 mmp_? -77.69 -20.51 53.51 Favored 'General case' 0 C--O 1.217 -0.648 0 O-C-N 120.971 -1.08 . . . . 50.0 111.595 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.68 176.77 51.62 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.638 -0.985 . . . . 50.0 110.638 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -153.76 169.22 23.87 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.079 -0.711 . . . . 50.0 109.079 -174.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -124.13 143.04 50.71 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.895 -0.78 . . . . 50.0 108.895 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -100.42 145.68 27.93 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.313 -0.625 . . . . 50.0 109.313 -176.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 48.5 t -132.49 144.69 50.62 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.227 -0.656 . . . . 50.0 109.227 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -141.06 136.69 16.22 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.078 -0.51 . . . . 50.0 110.005 -173.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -70.74 145.13 50.69 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 117.041 -1.506 . . . . 50.0 113.031 177.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -151.12 16.67 0.75 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.652 -0.704 . . . . 25.0 109.489 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.3 m -93.05 3.29 55.99 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.117 1.154 . . . . 50.0 114.117 -174.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? 68.32 -30.07 0.17 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.727 1.611 . . . . 50.0 114.355 -176.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.7 m -129.43 151.24 35.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.319 -0.993 . . . . 50.0 108.319 174.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 56.4 m -134.44 111.33 10.05 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.485 -0.561 . . . . 50.0 109.485 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -92.84 -11.62 33.14 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.382 0.61 . . . . 50.0 109.917 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -151.92 161.6 42.38 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 100.491 -3.892 . . . . 50.0 100.491 175.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 26.0 m -64.74 139.87 58.81 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.773 0.715 . . . . 25.0 109.139 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 -103.13 -26.2 13.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.119 0.485 . . . . 50.0 112.06 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.34 169.17 31.54 Favored Glycine 0 C--O 1.223 -0.569 0 N-CA-C 116.535 1.374 . . . . 25.0 116.535 -177.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.0 tp -57.0 -35.27 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 N-CA-C 113.462 0.912 . . . . 50.0 113.462 -175.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -71.08 -26.52 27.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 O-C-N 120.391 -1.443 . . . . 50.0 110.581 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -77.75 -38.64 46.51 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 121.731 -0.606 . . . . 50.0 110.839 -177.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -81.11 -25.79 36.69 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.098 -0.641 . . . . 50.0 112.242 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 78.5 m -102.91 -19.63 14.57 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.883 1.808 . . . . 50.0 115.883 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 18.9 t -113.2 -39.89 4.05 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.057 0.844 . . . . 50.0 111.617 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -83.57 -16.98 43.3 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.268 -0.641 . . . . 50.0 109.268 177.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 17.9 mtt85 -142.58 179.89 6.7 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 106.636 -1.616 . . . . 50.0 106.636 171.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.2 p -93.34 151.14 19.96 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.237 -1.394 . . . . 25.0 107.237 171.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 26.2 p -128.98 162.55 27.34 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.848 0.356 . . . . 50.0 111.778 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -101.59 158.24 16.23 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.742 -0.663 . . . . 50.0 110.539 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.9 tp -58.69 -43.78 90.08 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.32 0.489 . . . . 50.0 112.32 176.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.07 -34.13 74.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.934 0.397 . . . . 25.0 110.38 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.5 tp -69.01 -46.63 67.52 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.021 -0.733 . . . . 50.0 109.021 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.2 tt -60.85 -33.72 73.5 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.22 0.534 . . . . 50.0 110.814 -177.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -60.89 -24.43 65.97 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.827 1.047 . . . . 50.0 113.827 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.3 p -71.28 -14.25 62.16 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.168 0.803 . . . . 25.0 113.168 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -91.4 0.06 57.57 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 112.087 0.403 . . . . 50.0 112.087 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 83.1 m -70.57 149.86 46.67 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.525 -0.546 . . . . 50.0 109.525 176.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.06 154.14 39.34 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.226 -0.657 . . . . 25.0 109.226 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.4 p -67.94 147.53 98.47 Favored Pre-proline 0 N--CA 1.447 -0.59 0 N-CA-C 108.861 -0.792 . . . . 25.0 108.861 177.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.31 163.35 38.26 Favored 'Trans proline' 0 CA--C 1.522 -0.12 0 C-N-CA 119.937 0.425 . . . . 50.0 111.741 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.89 152.65 15.62 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.277 -0.874 . . . . 25.0 111.004 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -131.64 152.73 50.61 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.915 -1.142 . . . . 50.0 107.915 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.2 t -162.53 80.56 0.51 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.774 0.797 . . . . 25.0 109.186 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.298 3.633 0 CA-C-O 115.016 -2.421 . . . . 25.0 113.364 -175.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.01 0 CA-C-O 123.233 1.492 . . . . 25.0 114.29 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -117.32 164.28 15.07 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.164 -0.925 . . . . 50.0 108.525 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 55.5 ptt85 -108.81 154.32 41.86 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.626 -0.261 . . . . 50.0 110.618 -176.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -72.33 160.86 45.98 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 118.39 -0.607 . . . . 50.0 112.406 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.2 t -132.98 51.38 2.16 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.639 -0.709 . . . . 25.0 110.32 -176.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -70.94 -36.28 72.55 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.769 0.655 . . . . 50.0 112.769 -174.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.6 p -127.39 145.53 50.78 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.051 -1.092 . . . . 25.0 108.051 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -132.19 -100.37 0.28 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.503 -0.771 . . . . 50.0 109.104 -176.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 68.22 178.56 0.24 Allowed 'General case' 0 C--O 1.217 -0.618 0 C-N-CA 124.729 1.212 . . . . 50.0 111.247 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.69 28.7 65.83 Favored Glycine 0 C--O 1.219 -0.839 0 C-N-CA 120.842 -0.694 . . . . 50.0 114.274 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.8 -20.96 35.85 Favored Glycine 0 C--O 1.221 -0.672 0 CA-C-O 119.681 -0.511 . . . . 50.0 113.607 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -62.23 -27.62 69.12 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 117.867 0.834 . . . . 50.0 110.483 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.77 -43.09 94.51 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 116.071 -0.513 . . . . 50.0 111.007 177.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 74.9 t -66.66 -38.85 82.45 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.844 0 N-CA-C 108.847 -0.798 . . . . 75.0 108.847 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -58.79 -48.11 82.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.956 0.407 . . . . 50.0 110.536 177.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.4 m -63.27 -40.37 97.21 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.954 -0.466 . . . . 25.0 111.545 177.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.0 mt -63.08 -36.98 85.41 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 121.944 -0.473 . . . . 50.0 110.777 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -69.14 -38.64 78.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.857 0.361 . . . . 50.0 110.384 176.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -64.01 -39.1 93.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.206 0.526 . . . . 50.0 111.015 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 79.7 t -79.77 -43.46 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 112.377 0.51 . . . . 50.0 112.377 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.5 m -148.98 34.62 0.75 Allowed 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 115.14 1.533 . . . . 50.0 115.14 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.55 -46.98 93.2 Favored Glycine 0 C--O 1.223 -0.573 0 C-N-CA 119.858 -1.163 . . . . 25.0 113.555 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -61.97 -43.85 97.98 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.535 0.683 . . . . 50.0 112.552 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -83.09 -8.7 59.49 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.786 0.661 . . . . 50.0 112.786 -177.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.96 157.69 23.78 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-O 122.091 0.828 . . . . 50.0 111.264 -175.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -153.2 162.43 41.31 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 106.769 -1.567 . . . . 50.0 106.769 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -120.17 152.64 37.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 122.268 1.032 . . . . 50.0 113.18 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -122.65 166.96 14.04 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.501 -1.666 . . . . 50.0 106.501 -176.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.3 t -122.69 128.15 50.2 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.285 -1.376 . . . . 50.0 107.285 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -142.63 137.65 15.49 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.539 -0.541 . . . . 50.0 109.539 -172.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -72.87 148.47 45.92 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 116.676 -1.749 . . . . 50.0 112.401 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.26 12.4 9.5 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.942 -0.572 . . . . 25.0 110.302 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.3 t -154.59 165.4 36.61 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.033 -1.099 . . . . 50.0 108.033 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -69.88 -30.22 67.62 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.25 0.344 . . . . 50.0 111.448 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -84.43 155.09 3.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.167 0.508 . . . . 50.0 111.454 -175.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.0 t -132.67 137.06 46.83 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.345 -0.984 . . . . 50.0 108.345 177.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -127.48 44.88 2.83 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-O 121.505 0.669 . . . . 50.0 109.363 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.5 ttm-85 52.61 53.92 11.44 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 117.261 2.319 . . . . 50.0 117.261 176.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 26.7 p -78.94 156.5 28.51 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.651 -0.704 . . . . 25.0 109.219 172.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -95.9 154.69 17.1 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 106.952 -1.499 . . . . 50.0 106.952 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -163.39 162.82 35.19 Favored Glycine 0 C--O 1.225 -0.427 0 C-N-CA 120.54 -0.838 . . . . 25.0 112.232 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.2 tp -61.72 -37.38 77.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 117.033 0.417 . . . . 50.0 111.183 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.5 p -65.29 -28.88 45.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 O-C-N 121.588 -0.695 . . . . 50.0 110.575 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.4 -25.12 63.99 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.468 -0.77 . . . . 50.0 111.088 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -99.15 -26.59 14.15 Favored 'General case' 0 C--O 1.199 -1.554 0 N-CA-C 114.251 1.204 . . . . 50.0 114.251 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 82.8 m -113.57 8.59 17.75 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.26 1.208 . . . . 50.0 114.26 -177.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 40.0 t -133.09 -56.72 0.92 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.82 0.343 . . . . 50.0 110.253 176.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -72.34 -24.84 61.35 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.316 0.579 . . . . 50.0 110.15 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 97.0 mtt-85 -136.86 -178.64 5.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.743 -1.206 . . . . 50.0 107.743 177.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.4 p -97.76 152.09 19.5 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 124.01 0.819 . . . . 25.0 109.114 174.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 27.3 p -134.91 -178.63 5.17 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.038 -0.727 . . . . 50.0 109.038 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -139.45 167.55 21.83 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.623 -1.251 . . . . 50.0 107.623 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 68.3 tp -58.33 -40.41 82.07 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 123.261 0.624 . . . . 50.0 111.92 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.53 -42.6 99.06 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.091 0.472 . . . . 25.0 110.673 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.8 tp -70.68 -44.65 66.56 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.709 -0.478 . . . . 50.0 109.709 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.0 tt -60.07 -34.1 72.97 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 121.947 -0.471 . . . . 50.0 111.556 -177.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -61.64 -26.78 68.22 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.996 0.739 . . . . 50.0 112.996 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.8 p -70.29 -14.56 62.65 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 121.589 -0.695 . . . . 25.0 112.824 -178.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -93.42 7.85 42.87 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.008 0.432 . . . . 50.0 111.217 177.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 23.8 t -67.91 159.03 31.36 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.139 -1.43 . . . . 50.0 107.139 172.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.64 166.62 23.29 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 110.132 -0.322 . . . . 25.0 110.132 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.5 p 70.09 149.2 0.12 Allowed Pre-proline 0 N--CA 1.485 1.276 0 C-N-CA 126.084 1.754 . . . . 25.0 112.744 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -73.08 145.65 39.88 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 115.989 -2.207 . . . . 50.0 115.627 -175.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.89 137.88 55.6 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.007 -1.452 . . . . 25.0 110.107 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 69.4 tttt 50.59 38.79 19.74 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.625 0.77 . . . . 50.0 112.912 176.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.9 m 51.12 43.33 29.15 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.885 1.069 . . . . 25.0 113.885 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 C--O 1.297 3.561 0 CA-C-O 115.016 -2.421 . . . . 25.0 112.314 176.557 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 122.814 1.292 . . . . 25.0 113.957 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -124.05 174.64 7.48 Favored 'General case' 0 C--O 1.227 -0.122 0 CA-C-N 115.481 -0.781 . . . . 50.0 109.848 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.44 153.55 44.11 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 108.826 -0.805 . . . . 50.0 108.826 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -73.19 161.37 43.25 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 118.516 -0.522 . . . . 50.0 113.227 -177.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.5 t -142.97 78.15 1.6 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.258 -1.016 . . . . 25.0 108.258 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -75.36 -7.09 53.08 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.696 0.76 . . . . 50.0 112.448 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.6 p -118.1 149.19 41.42 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.507 -0.923 . . . . 25.0 108.507 176.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.1 mt -137.17 129.71 30.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.699 -0.682 . . . . 50.0 109.654 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.4 t -162.88 -172.81 3.21 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.971 -1.492 . . . . 50.0 106.971 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.34 30.81 75.14 Favored Glycine 0 C--O 1.22 -0.768 0 C-N-CA 120.787 -0.721 . . . . 50.0 114.535 174.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.29 -25.34 9.28 Favored Glycine 0 C--O 1.221 -0.667 0 C-N-CA 121.138 -0.553 . . . . 50.0 114.047 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -65.05 -27.03 68.52 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.239 1.02 . . . . 50.0 110.409 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 27.6 tp -61.46 -40.01 92.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.967 -0.56 . . . . 50.0 110.167 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 90.5 t -71.97 -36.38 57.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.273 -0.421 . . . . 50.0 109.982 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.0 -45.36 93.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.43 0.634 . . . . 50.0 109.368 176.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.5 m -63.18 -40.03 96.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.109 -0.496 . . . . 25.0 111.113 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.0 mt -61.65 -38.27 87.09 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.752 -0.593 . . . . 50.0 110.472 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -67.52 -39.56 85.09 Favored 'General case' 0 C--O 1.219 -0.538 0 O-C-N 122.004 -0.435 . . . . 50.0 110.8 175.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -66.63 -46.81 74.6 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.722 0.638 . . . . 50.0 112.722 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.4 t -71.58 -42.46 71.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 111.683 0.253 . . . . 50.0 111.683 -176.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 34.9 m -90.39 -26.51 19.87 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.223 0.823 . . . . 50.0 113.223 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.23 -145.74 49.41 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-O 122.204 0.891 . . . . 25.0 113.479 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -58.24 -17.85 22.19 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.918 1.081 . . . . 50.0 113.918 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -69.14 -23.05 63.92 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.735 -0.603 . . . . 50.0 112.371 -177.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.03 173.41 49.85 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 110.232 -1.147 . . . . 50.0 110.232 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -151.3 168.36 25.0 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 122.481 -0.423 . . . . 50.0 110.577 -177.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -112.71 158.96 19.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.404 0.621 . . . . 50.0 110.548 177.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -127.05 176.56 7.25 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.398 -1.334 . . . . 50.0 107.398 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.3 m -56.53 -24.43 46.63 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 117.033 2.235 . . . . 50.0 117.033 -174.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.27 150.72 0.1 Allowed Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 115.138 1.533 . . . . 50.0 115.138 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.62 146.38 54.73 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 116.733 -1.712 . . . . 50.0 114.47 -175.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.94 177.33 7.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.712 -0.676 . . . . 25.0 109.853 -178.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.6 m -68.39 170.69 8.46 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.067 -0.515 . . . . 50.0 112.071 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.8 mmt-85 -65.71 -26.01 67.57 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.562 0.578 . . . . 50.0 112.562 177.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.68 171.67 15.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 123.095 0.558 . . . . 50.0 110.969 -172.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.9 p 42.89 46.33 4.57 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.145 0.978 . . . . 50.0 113.548 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -83.29 50.22 1.71 Allowed 'General case' 0 C--O 1.213 -0.866 0 CA-C-N 115.618 -0.719 . . . . 50.0 112.165 -175.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -82.72 47.34 1.18 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.854 0.835 . . . . 50.0 112.462 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.5 p -103.3 156.68 17.55 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.29 -0.868 . . . . 25.0 109.313 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -75.07 156.43 36.12 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.509 -0.923 . . . . 50.0 108.509 175.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -164.18 138.88 5.52 Favored Glycine 0 C--O 1.224 -0.473 0 C-N-CA 120.617 -0.802 . . . . 25.0 111.94 174.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.0 tp -64.41 -32.28 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 122.511 -0.405 . . . . 50.0 110.088 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.9 -32.64 59.05 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.463 0 O-C-N 121.842 -0.536 . . . . 50.0 110.479 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -74.06 -34.2 63.96 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 121.616 -0.678 . . . . 50.0 110.208 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -71.94 -40.66 68.57 Favored 'General case' 0 C--O 1.21 -0.978 0 C-N-CA 120.21 -0.596 . . . . 50.0 112.182 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 76.6 m -103.13 -21.69 13.86 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 116.992 2.219 . . . . 50.0 116.992 -172.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 47.3 t -105.56 -44.71 4.62 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.638 0.653 . . . . 50.0 110.584 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -81.42 -23.02 37.82 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.061 0.458 . . . . 50.0 110.011 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.29 -179.37 5.63 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 109.117 -0.698 . . . . 50.0 109.117 176.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.6 t -89.01 149.14 23.39 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.759 -1.2 . . . . 25.0 107.759 175.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 21.5 p -139.25 161.41 37.49 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.135 0.493 . . . . 50.0 112.261 178.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -112.56 161.38 16.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.331 -0.85 . . . . 50.0 111.124 -176.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 68.5 tp -58.35 -45.02 88.97 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.125 -0.489 . . . . 50.0 111.897 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.24 -39.46 90.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.889 0.376 . . . . 25.0 111.023 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.8 tp -68.8 -45.39 71.39 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.831 -0.433 . . . . 50.0 109.831 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.0 tt -60.01 -35.96 76.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.202 0.525 . . . . 50.0 110.961 -177.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -60.63 -25.28 66.17 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.226 0.824 . . . . 50.0 113.226 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.8 p -74.69 -14.03 60.69 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.402 -0.811 . . . . 25.0 112.982 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -91.93 2.26 56.66 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.604 0.24 . . . . 50.0 111.161 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 72.3 m -71.39 157.41 38.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.175 -0.676 . . . . 50.0 109.175 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.2 158.86 17.73 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.053 -0.721 . . . . 25.0 109.053 177.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 p 67.95 153.99 0.14 Allowed Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 125.313 1.445 . . . . 25.0 111.637 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.03 155.92 56.62 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 117.397 -1.269 . . . . 50.0 114.931 -174.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.68 103.34 1.71 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.098 -0.955 . . . . 25.0 111.037 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -73.27 161.25 30.73 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.824 -0.625 . . . . 50.0 110.4 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.4 m 51.42 54.29 11.35 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.815 1.413 . . . . 25.0 114.815 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 . . . . . 0 C--O 1.291 3.271 0 CA-C-O 113.771 -3.014 . . . . 25.0 111.265 173.841 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.854 0 CA-C-O 123.202 1.477 . . . . 25.0 114.31 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -130.89 160.75 33.54 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.192 -1.04 . . . . 50.0 108.192 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.55 143.16 78.66 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 120.512 0.196 . . . . 50.0 110.994 -177.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -77.2 159.67 33.26 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 118.038 -0.842 . . . . 50.0 112.525 177.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.5 m -131.67 75.24 1.63 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.995 -0.548 . . . . 25.0 111.962 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.12 -17.65 61.96 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.524 0.678 . . . . 50.0 110.357 178.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.1 p -130.88 154.78 47.72 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 101.795 -3.409 . . . . 25.0 101.795 172.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.5 tp -134.59 128.59 33.49 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.997 -0.372 . . . . 50.0 109.997 -172.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.74 168.4 23.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.8 0.333 . . . . 50.0 111.164 -173.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.37 -143.69 48.67 Favored Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 120.691 -0.766 . . . . 50.0 113.39 175.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.38 -21.15 75.85 Favored Glycine 0 C--O 1.213 -1.172 0 C-N-CA 121.284 -0.484 . . . . 50.0 113.197 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -69.35 -27.19 65.13 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 117.618 0.709 . . . . 50.0 109.325 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.27 -43.53 67.0 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 121.522 0.677 . . . . 50.0 109.528 174.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.5 t -64.15 -38.5 82.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.164 -0.926 . . . . 50.0 110.057 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -61.59 -48.36 81.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.164 0.507 . . . . 50.0 110.94 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 50.2 m -63.59 -35.94 82.16 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.966 -0.459 . . . . 25.0 111.293 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.6 mt -64.61 -39.77 94.3 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.707 -0.479 . . . . 50.0 109.707 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -67.32 -36.73 82.08 Favored 'General case' 0 C--O 1.219 -0.508 0 O-C-N 121.79 -0.569 . . . . 50.0 110.586 176.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -64.9 -51.56 61.29 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 121.923 -0.485 . . . . 50.0 111.753 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -73.48 -30.78 30.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 112.847 0.684 . . . . 50.0 112.847 -174.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.5 m -99.08 -22.05 15.88 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.16 0.8 . . . . 50.0 113.16 -177.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.39 -163.47 53.86 Favored Glycine 0 C--N 1.321 -0.303 0 CA-C-O 121.834 0.685 . . . . 25.0 111.887 -177.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -71.32 -7.17 45.3 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.751 0.821 . . . . 50.0 111.444 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 -72.66 -9.7 58.92 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.526 -0.761 . . . . 50.0 111.849 -177.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.53 163.05 34.13 Favored Glycine 0 C--O 1.23 -0.12 0 N-CA-C 115.098 0.799 . . . . 50.0 115.098 172.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -153.46 166.73 31.77 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.659 -1.237 . . . . 50.0 107.659 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -118.87 143.01 47.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.061 0.457 . . . . 50.0 110.154 177.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -104.69 146.04 29.5 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.205 -1.406 . . . . 50.0 107.205 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.3 t -143.69 149.39 37.14 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.565 0.221 . . . . 50.0 110.662 -177.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.8 ppt_? -154.23 153.87 28.88 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 107.945 -1.131 . . . . 50.0 107.945 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -70.67 154.1 64.33 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 118.419 -0.587 . . . . 50.0 112.533 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -107.39 18.54 21.45 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.552 0.575 . . . . 25.0 112.552 -175.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.8 t -150.63 166.08 31.4 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.624 -0.88 . . . . 50.0 108.624 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -65.98 -18.16 65.15 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.768 0.427 . . . . 50.0 110.882 177.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.7 m -118.34 134.47 61.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.313 0.578 . . . . 50.0 109.488 176.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.5 p -104.69 46.52 0.91 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.775 0.798 . . . . 50.0 111.466 -177.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 68.1 mtt85 -66.25 -16.61 64.16 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.194 -0.457 . . . . 50.0 111.21 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -149.73 178.38 8.92 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 103.047 -2.946 . . . . 50.0 103.047 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.7 m 57.16 58.09 4.14 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.347 1.24 . . . . 25.0 114.347 177.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.3 tpp180 -63.92 140.85 58.91 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.933 -1.485 . . . . 50.0 108.346 174.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -117.9 165.4 12.67 Favored Glycine 0 C--N 1.32 -0.335 0 CA-C-N 115.809 -0.632 . . . . 25.0 112.651 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.2 tp -67.01 -35.17 73.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.728 -0.842 . . . . 50.0 108.728 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.2 p -66.76 -32.12 56.6 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 N-CA-C 109.334 -0.617 . . . . 75.0 109.334 178.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -72.68 -36.97 68.03 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.381 -0.824 . . . . 50.0 110.364 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -72.83 -39.48 66.55 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.861 0.689 . . . . 50.0 112.861 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 47.4 m -104.6 -22.37 13.26 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 116.547 2.054 . . . . 50.0 116.547 -171.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 33.8 t -104.72 -44.5 4.84 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.388 0.54 . . . . 50.0 110.689 -177.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -80.79 -18.63 46.95 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.865 0.364 . . . . 50.0 110.635 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 45.1 mtt-85 -141.49 172.46 12.66 Favored 'General case' 0 C--O 1.207 -1.152 0 N-CA-C 106.102 -1.814 . . . . 50.0 106.102 174.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 34.8 t -84.57 150.66 25.06 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.664 -0.495 . . . . 25.0 109.664 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -113.15 167.23 10.71 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 121.454 0.645 . . . . 50.0 112.738 -178.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -126.41 151.91 47.05 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.183 -1.784 . . . . 50.0 106.183 175.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 35.1 tp -59.72 -44.29 93.8 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.71 0.633 . . . . 50.0 112.71 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.34 -38.18 88.53 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-O 121.043 0.449 . . . . 25.0 111.174 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.1 tp -65.07 -45.03 86.99 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.309 -0.626 . . . . 50.0 109.309 177.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.0 tt -64.01 -33.24 75.29 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.172 0.51 . . . . 50.0 110.836 -177.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -62.34 -24.76 67.52 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.432 0.901 . . . . 50.0 113.432 178.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.7 p -69.01 -14.44 63.04 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.538 -0.726 . . . . 25.0 112.291 -177.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -92.43 5.82 49.29 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.448 -0.342 . . . . 50.0 111.559 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 83.7 m -72.23 156.67 38.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.184 0.516 . . . . 50.0 110.216 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.44 163.13 19.66 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.588 -0.893 . . . . 25.0 108.588 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.3 p -69.62 131.66 89.61 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 107.909 -1.145 . . . . 25.0 107.909 178.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -72.39 155.19 55.79 Favored 'Trans proline' 0 C--N 1.343 0.253 0 N-CA-C 115.228 1.203 . . . . 50.0 115.228 -175.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.31 164.2 26.89 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.871 -1.058 . . . . 25.0 109.261 176.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -80.7 66.2 6.13 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.028 0.442 . . . . 50.0 111.958 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.5 m -92.89 61.78 3.57 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.73 0.776 . . . . 25.0 111.078 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 . . . . . 0 C--O 1.291 3.282 0 CA-C-O 113.994 -2.908 . . . . 25.0 111.626 -179.981 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.853 0 CA-C-O 123.145 1.45 . . . . 25.0 114.261 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -74.5 162.85 28.41 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 108.246 -1.02 . . . . 50.0 108.246 176.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.3 ptp85 -59.81 143.46 87.19 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 109.838 -0.43 . . . . 50.0 109.838 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -73.67 160.03 44.67 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 117.764 -1.024 . . . . 50.0 112.522 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.0 m -121.13 82.89 1.99 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.434 -0.95 . . . . 25.0 108.434 177.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -62.98 -26.1 68.68 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.251 0.548 . . . . 50.0 110.63 -178.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 p -119.49 117.47 28.51 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 102.556 -3.127 . . . . 25.0 102.556 168.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.9 tp -86.74 106.2 17.5 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.943 0.878 . . . . 50.0 109.155 -174.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -154.56 -163.65 1.64 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.955 -1.021 . . . . 50.0 108.814 -173.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.77 33.3 84.77 Favored Glycine 0 C--O 1.218 -0.879 0 N-CA-C 114.937 0.735 . . . . 50.0 114.937 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.63 -25.37 7.41 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.999 -0.62 . . . . 50.0 113.311 -178.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -63.45 -31.15 72.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.562 0.681 . . . . 50.0 109.224 177.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 33.2 tp -61.79 -41.86 98.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.923 -0.58 . . . . 50.0 111.448 176.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.9 t -67.52 -41.5 85.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.267 -0.642 . . . . 50.0 109.267 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -61.67 -40.61 95.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.397 0.618 . . . . 50.0 109.966 177.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.8 m -66.69 -40.58 88.58 Favored 'General case' 0 C--O 1.215 -0.725 0 O-C-N 121.933 -0.479 . . . . 25.0 111.216 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.4 mt -62.21 -38.82 90.62 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.63 -0.669 . . . . 50.0 110.563 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -67.04 -39.69 87.01 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.197 -0.456 . . . . 50.0 110.453 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -66.76 -47.75 71.23 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.27 0.47 . . . . 50.0 112.27 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.9 t -67.5 -43.68 87.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.405 0.52 . . . . 50.0 112.405 -175.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -95.26 -15.93 22.83 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.511 0.93 . . . . 50.0 113.511 -176.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.01 -142.87 46.16 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-O 122.067 0.815 . . . . 25.0 112.595 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -71.1 0.36 7.82 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.052 1.13 . . . . 50.0 114.052 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -75.39 -20.41 58.95 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.462 -0.774 . . . . 50.0 110.95 178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.8 162.07 34.65 Favored Glycine 0 C--O 1.225 -0.448 0 N-CA-C 111.869 -0.492 . . . . 50.0 111.869 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -149.1 167.97 24.47 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.214 -1.032 . . . . 50.0 108.214 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -120.85 152.26 38.62 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.614 0.721 . . . . 50.0 110.79 174.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -128.04 155.44 44.34 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.764 -1.199 . . . . 50.0 107.764 -176.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.5 p -78.15 63.26 3.05 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 108.282 -1.007 . . . . 50.0 108.282 172.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -82.5 156.87 68.21 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.34 -0.846 . . . . 50.0 111.55 -172.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -70.15 154.34 66.29 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 117.852 -0.966 . . . . 50.0 113.841 -178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -157.6 177.28 11.57 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 105.05 -2.204 . . . . 25.0 105.05 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.5 m -77.99 -83.79 0.08 Allowed 'General case' 0 C--O 1.215 -0.722 0 N-CA-C 118.266 2.691 . . . . 50.0 118.266 -176.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 -67.08 1.04 2.2 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 114.1 -1.409 . . . . 50.0 114.495 -171.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 17.1 m -68.66 153.82 8.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 114.959 -1.019 . . . . 50.0 110.271 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.1 m -103.31 13.64 33.34 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 115.593 -0.73 . . . . 50.0 111.716 -174.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 52.54 44.19 30.28 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.662 -0.699 . . . . 50.0 112.077 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -67.11 160.78 25.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.189 -0.914 . . . . 50.0 110.802 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 t -72.63 176.29 5.62 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.625 -0.716 . . . . 25.0 112.011 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? 66.02 127.05 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.424 1.89 . . . . 50.0 113.484 -176.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 163.96 162.92 15.75 Favored Glycine 0 C--N 1.315 -0.591 0 N-CA-C 108.673 -1.771 . . . . 25.0 108.673 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.0 tp -56.68 -34.28 42.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 112.896 0.702 . . . . 50.0 112.896 -174.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.77 -32.54 58.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 121.563 -0.711 . . . . 75.0 110.804 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -76.44 -32.1 58.25 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 121.368 -0.832 . . . . 50.0 111.343 -177.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -82.91 -27.71 30.45 Favored 'General case' 0 C--O 1.214 -0.766 0 C-N-CA 120.258 -0.577 . . . . 50.0 112.371 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 99.8 m -107.45 -28.97 9.51 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 116.335 1.976 . . . . 50.0 116.335 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 73.6 m -94.98 -41.75 8.99 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.819 0.736 . . . . 50.0 111.019 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -90.82 -18.27 25.16 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.204 0.526 . . . . 50.0 111.118 -177.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 80.3 mtm-85 -135.94 174.93 10.07 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 105.853 -1.906 . . . . 50.0 105.853 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.5 p -91.86 149.07 21.77 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.45 -1.315 . . . . 25.0 107.45 173.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 28.9 p -133.16 163.95 28.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.891 0.377 . . . . 50.0 111.385 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -124.16 166.23 16.18 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.099 -0.501 . . . . 50.0 110.344 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.3 tp -54.03 -48.97 69.94 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.651 1.352 . . . . 50.0 114.651 -176.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.13 -41.46 96.77 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 121.124 0.488 . . . . 25.0 111.122 -177.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.9 tp -65.9 -44.97 83.64 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.065 0.46 . . . . 50.0 109.93 177.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 tt -61.1 -35.02 75.89 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.128 0.489 . . . . 50.0 111.535 -178.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -61.81 -26.76 68.31 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.341 0.867 . . . . 50.0 113.341 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.6 p -68.25 -14.25 62.85 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 113.011 0.745 . . . . 25.0 113.011 -178.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -94.89 13.16 25.69 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 120.939 0.399 . . . . 50.0 111.721 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 2.2 m -61.77 162.36 8.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.231 0.538 . . . . 50.0 109.926 170.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.15 163.54 26.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.792 0.329 . . . . 25.0 110.666 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.9 p 70.07 152.4 0.14 Allowed Pre-proline 0 N--CA 1.481 1.086 0 C-N-CA 126.075 1.75 . . . . 25.0 111.602 -178.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.81 156.91 56.25 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 116.405 -1.93 . . . . 50.0 113.18 -177.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.83 125.03 22.58 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.344 -0.984 . . . . 25.0 108.344 178.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 51.0 tttt -132.07 17.9 4.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.825 0.822 . . . . 50.0 109.992 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 62.1 m -154.23 148.48 25.94 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 105.348 -2.093 . . . . 25.0 105.348 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 . . . . . 0 C--O 1.293 3.366 0 CA-C-O 113.111 -3.328 . . . . 25.0 112.376 -178.38 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.923 0 CA-C-O 123.287 1.518 . . . . 25.0 114.28 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -86.0 171.7 11.22 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.202 -0.936 . . . . 50.0 108.718 176.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 81.0 mtt85 -58.66 143.88 81.08 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 109.353 -0.61 . . . . 50.0 109.353 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -78.26 163.27 27.79 Favored 'Trans proline' 0 C--N 1.346 0.397 0 O-C-N 122.038 0.494 . . . . 50.0 113.234 -177.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.5 t -121.35 84.13 2.19 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 107.768 -1.197 . . . . 25.0 107.768 176.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -78.31 -11.29 59.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.979 0.419 . . . . 50.0 112.017 -177.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.6 p -94.17 150.89 19.9 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.856 -0.794 . . . . 25.0 108.856 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.2 tp -81.07 104.03 11.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 122.228 1.013 . . . . 50.0 111.337 -175.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 t -153.47 -164.03 1.81 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.943 -1.026 . . . . 50.0 110.051 -173.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.17 23.0 63.6 Favored Glycine 0 C--O 1.214 -1.098 0 N-CA-C 115.642 1.017 . . . . 50.0 115.642 174.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.42 -26.47 24.23 Favored Glycine 0 C--O 1.218 -0.85 0 CA-C-O 119.577 -0.568 . . . . 50.0 112.801 -178.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.99 -28.64 67.86 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.796 0.808 . . . . 50.0 110.4 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 30.7 tp -60.95 -40.16 92.29 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.522 -0.763 . . . . 50.0 111.236 176.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 82.5 t -69.58 -41.27 80.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.012 -0.736 . . . . 50.0 109.012 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -64.0 -40.82 97.22 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.914 0.864 . . . . 50.0 109.925 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.3 m -66.83 -40.06 87.87 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.726 -0.67 . . . . 25.0 110.456 178.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.7 mt -62.62 -37.87 87.96 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.118 -0.363 . . . . 50.0 110.415 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -62.32 -45.68 92.14 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.829 -0.544 . . . . 50.0 110.115 175.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -66.9 -45.8 76.86 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.125 0.787 . . . . 50.0 113.125 -176.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.4 t -69.26 -38.5 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 120.875 0.369 . . . . 50.0 111.357 -177.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.5 m -88.06 -24.37 23.47 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.579 0.955 . . . . 50.0 113.579 -175.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.76 -144.42 38.36 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-O 121.693 0.607 . . . . 25.0 113.707 177.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -65.29 -12.08 48.05 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.135 0.791 . . . . 50.0 113.135 -178.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.9 mtm180 -79.88 -22.88 42.34 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.383 0.882 . . . . 50.0 113.383 -173.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.78 179.26 52.85 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-O 122.068 0.815 . . . . 50.0 111.612 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -160.46 173.56 15.4 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.176 -1.416 . . . . 50.0 107.176 -175.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -146.37 161.04 41.22 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.241 0.543 . . . . 50.0 109.707 173.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -95.36 139.29 31.86 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.99 -0.745 . . . . 50.0 108.99 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.78 -23.22 63.32 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.86 0.689 . . . . 50.0 112.86 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.03 149.5 36.98 Favored Pre-proline 0 N--CA 1.468 0.427 0 N-CA-C 108.643 -0.873 . . . . 50.0 108.643 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.8 144.83 55.07 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 117.476 -1.216 . . . . 50.0 114.086 -178.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.15 107.52 8.43 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.492 -0.558 . . . . 25.0 109.492 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.6 t -153.52 161.2 42.46 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.175 -0.676 . . . . 50.0 109.175 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.32 -22.68 63.76 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.265 0.555 . . . . 50.0 110.711 176.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.9 m -109.12 159.21 8.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.504 -0.771 . . . . 50.0 110.379 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.6 t -99.59 147.71 25.07 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.261 -1.385 . . . . 50.0 107.261 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -126.19 34.04 4.92 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.219 -0.66 . . . . 50.0 109.219 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 48.9 ptt85 38.17 46.71 0.89 Allowed 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 122.913 1.339 . . . . 50.0 114.126 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.07 129.71 37.96 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 113.584 -1.643 . . . . 25.0 111.004 -178.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -68.84 164.31 22.26 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.26 0.35 . . . . 50.0 110.847 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 145.6 -157.68 27.43 Favored Glycine 0 C--O 1.224 -0.508 0 C-N-CA 120.993 -0.622 . . . . 25.0 113.288 177.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.2 tp -50.35 -34.9 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 113.026 0.75 . . . . 50.0 113.026 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.9 t -68.03 -42.86 85.62 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.694 0 O-C-N 121.262 -0.899 . . . . 50.0 110.597 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -65.54 -36.45 83.84 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.735 0.779 . . . . 50.0 110.245 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -73.63 -38.4 65.06 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 113.588 0.958 . . . . 50.0 113.588 -179.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 73.6 m -105.38 -21.96 13.13 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 116.722 2.119 . . . . 50.0 116.722 -174.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.6 t -104.35 -36.55 7.56 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 118.094 0.406 . . . . 50.0 111.131 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -91.53 -24.59 19.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.901 0.382 . . . . 50.0 110.072 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 42.1 mtm105 -125.15 172.73 9.27 Favored 'General case' 0 C--O 1.208 -1.081 0 N-CA-C 106.622 -1.621 . . . . 50.0 106.622 168.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.4 m -79.27 -10.62 59.86 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 116.993 2.22 . . . . 25.0 116.993 -174.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 64.25 -173.17 0.17 Allowed 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 114.391 1.256 . . . . 50.0 114.391 -176.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.78 151.61 35.11 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 105.277 -2.12 . . . . 50.0 105.277 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.9 tp -64.35 -40.94 96.86 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.188 0.518 . . . . 50.0 111.314 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.15 -39.59 86.56 Favored 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 109.367 -0.605 . . . . 25.0 109.367 -177.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.7 tp -63.9 -45.11 90.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.367 -0.833 . . . . 50.0 110.449 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.2 tt -61.54 -36.48 80.7 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.156 0.503 . . . . 50.0 111.139 -176.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -61.78 -23.48 66.23 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.829 1.048 . . . . 50.0 113.829 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 36.8 p -72.23 -14.31 61.75 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.054 0.761 . . . . 25.0 113.054 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -95.65 8.27 43.9 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.151 0.501 . . . . 50.0 112.348 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 73.3 m -75.07 155.34 37.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.897 0.379 . . . . 50.0 110.264 174.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.08 167.38 11.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.532 -0.303 . . . . 25.0 110.236 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.4 p 67.3 156.17 0.14 Allowed Pre-proline 0 N--CA 1.483 1.18 0 C-N-CA 125.908 1.683 . . . . 25.0 113.683 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.81 168.41 24.67 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 117.295 -1.336 . . . . 50.0 113.079 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.01 140.7 58.89 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.907 -0.775 . . . . 25.0 108.907 176.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -89.66 8.12 33.14 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.321 -0.4 . . . . 50.0 110.89 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.0 p -156.8 158.57 37.05 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.159 -1.052 . . . . 25.0 108.159 -177.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 C--O 1.293 3.36 0 CA-C-O 113.906 -2.95 . . . . 25.0 111.309 175.417 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.884 0 CA-C-O 122.63 1.205 . . . . 25.0 113.612 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -74.24 159.4 32.53 Favored 'General case' 0 CA--C 1.526 0.022 0 N-CA-C 108.836 -0.802 . . . . 50.0 108.836 178.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -115.42 147.01 37.77 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 110.05 -0.352 . . . . 50.0 110.05 -177.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.29 160.13 26.18 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 CA-C-O 121.438 0.516 . . . . 50.0 113.137 -177.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.7 m -118.16 84.74 2.22 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 104.877 -2.268 . . . . 25.0 104.877 174.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -64.61 -21.29 66.68 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 116.278 1.955 . . . . 50.0 116.278 -169.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.9 p 36.1 68.33 0.25 Allowed 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 124.007 1.861 . . . . 25.0 113.635 -176.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.4 tp -74.03 109.84 7.84 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 111.658 -2.519 . . . . 50.0 108.962 -176.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.5 t -140.46 168.34 20.04 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.218 -0.901 . . . . 50.0 113.135 -169.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.78 -143.16 47.5 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.022 -0.608 . . . . 50.0 112.172 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.98 -23.75 71.3 Favored Glycine 0 C--O 1.213 -1.167 0 C-N-CA 121.047 -0.597 . . . . 50.0 113.073 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -65.36 -35.62 81.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.827 0.813 . . . . 50.0 110.347 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 41.2 tp -66.38 -43.31 86.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.381 0.61 . . . . 50.0 109.625 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.8 t -67.08 -39.67 83.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.78 -0.645 . . . . 50.0 110.289 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -64.16 -43.44 95.16 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.115 0.483 . . . . 50.0 110.294 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.8 m -62.76 -41.26 99.13 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.143 -0.348 . . . . 25.0 110.609 177.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.4 mt -60.73 -37.22 81.01 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.792 -0.568 . . . . 50.0 110.501 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -71.79 -34.74 69.66 Favored 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 112.072 0.397 . . . . 50.0 112.072 176.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -64.93 -38.26 90.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.285 0.564 . . . . 50.0 110.259 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.1 t -74.29 -42.51 50.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 112.795 0.665 . . . . 50.0 112.795 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.9 m -140.65 -4.87 1.22 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 118.775 2.879 . . . . 50.0 118.775 -176.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.59 170.45 29.06 Favored Glycine 0 C--O 1.218 -0.895 0 O-C-N 121.551 -0.718 . . . . 25.0 112.996 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -62.93 -47.31 83.78 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.003 1.112 . . . . 50.0 114.003 -175.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 45.0 mtm-85 -82.55 -6.03 59.09 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 124.156 0.982 . . . . 50.0 108.995 176.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.9 9.88 58.84 Favored Glycine 0 C--O 1.214 -1.133 0 CA-C-N 114.89 -1.05 . . . . 50.0 115.467 -170.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -152.59 164.15 38.22 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 119.254 1.527 . . . . 50.0 111.338 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -130.22 143.09 50.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.842 -0.617 . . . . 50.0 110.69 172.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.12 152.31 20.65 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.894 -1.521 . . . . 50.0 106.894 174.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 81.1 p -72.46 -9.51 58.63 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.997 0.74 . . . . 50.0 112.997 178.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 64.18 131.9 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.829 0 N-CA-C 116.194 1.924 . . . . 50.0 116.194 175.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.21 132.69 23.1 Favored 'Trans proline' 0 C--O 1.238 0.511 0 C-N-CA 115.899 -2.267 . . . . 50.0 111.992 174.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -164.07 171.18 15.49 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.703 -1.221 . . . . 25.0 107.703 -177.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.479 ' C ' ' H ' ' A' ' 35' ' ' VAL . 1.0 OUTLIER -83.14 -168.93 2.28 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.377 -0.601 . . . . 50.0 109.377 173.319 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.6 ttt85 67.01 -4.09 0.86 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.955 1.302 . . . . 50.0 112.79 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.479 ' H ' ' C ' ' A' ' 33' ' ' SER . 27.2 m -69.86 151.61 9.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 114.826 -1.079 . . . . 50.0 109.295 178.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.6 m -101.28 5.69 42.52 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 113.187 0.81 . . . . 50.0 113.187 -172.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.7 mmm-85 51.81 33.71 11.84 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.714 1.375 . . . . 50.0 114.714 177.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 61.7 mtm180 -116.57 145.69 43.18 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 100.428 -3.916 . . . . 50.0 100.428 170.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.9 m -52.66 110.72 0.54 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.989 0.805 . . . . 25.0 112.492 -175.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -139.27 -14.21 1.14 Allowed 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 114.399 1.259 . . . . 50.0 114.399 -176.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -118.0 159.88 14.04 Favored Glycine 0 C--N 1.312 -0.787 0 CA-C-N 113.862 -1.517 . . . . 25.0 111.884 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.2 tp -55.6 -39.05 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 114.132 1.16 . . . . 50.0 114.132 -175.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.6 p -71.81 -27.79 28.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 O-C-N 120.426 -1.421 . . . . 50.0 110.49 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -77.74 -27.51 50.48 Favored 'General case' 0 C--N 1.317 -0.806 0 O-C-N 121.676 -0.64 . . . . 50.0 112.556 -176.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -94.21 -31.17 14.23 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.26 -0.427 . . . . 50.0 111.367 177.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 84.0 m -95.26 -28.05 15.2 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 115.122 1.527 . . . . 50.0 115.122 -176.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.8 t -110.23 -47.82 3.25 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.79 0.663 . . . . 50.0 112.79 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -72.9 -29.85 63.46 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.911 -0.774 . . . . 50.0 108.911 177.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -118.53 -164.76 1.05 Allowed 'General case' 0 C--O 1.209 -1.042 0 N-CA-C 104.846 -2.279 . . . . 50.0 104.846 167.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.4 m -121.74 147.56 45.75 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 106.425 -1.695 . . . . 25.0 106.425 169.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.1 p -123.74 165.05 17.93 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.501 0.501 . . . . 50.0 110.761 -175.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -103.2 158.56 16.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.62 -0.718 . . . . 50.0 109.484 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.1 tp -59.81 -38.37 81.78 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.659 0.614 . . . . 50.0 112.659 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.77 -41.72 99.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.664 0.268 . . . . 25.0 110.51 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.5 tp -65.86 -46.47 78.35 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.444 -0.946 . . . . 50.0 108.444 177.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.3 tt -56.42 -36.19 68.69 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.454 0.538 . . . . 50.0 112.454 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -63.16 -22.29 66.77 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 113.401 0.889 . . . . 50.0 113.401 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.2 p -73.5 -19.04 61.03 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.58 -0.7 . . . . 25.0 112.22 -178.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -82.32 4.99 21.63 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 120.837 0.351 . . . . 50.0 111.788 176.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 16.5 t -61.6 144.7 53.99 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.055 -0.72 . . . . 50.0 109.055 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.1 149.04 42.37 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.438 -0.801 . . . . 25.0 110.328 177.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.4 p 67.71 135.45 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 125.975 1.71 . . . . 25.0 111.427 -176.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.06 165.44 19.22 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 120.464 0.776 . . . . 50.0 112.795 -176.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.02 134.41 56.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.318 0.58 . . . . 25.0 110.471 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.96 151.68 36.19 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.019 -0.734 . . . . 50.0 109.019 -176.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.6 t 51.92 46.18 27.02 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.67 0.748 . . . . 25.0 112.951 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 . . . . . 0 C--O 1.304 3.933 0 CA-C-O 114.276 -2.774 . . . . 25.0 113.508 -179.321 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.208 -1.108 0 CA-C-O 123.708 1.718 . . . . 25.0 114.728 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -69.02 -21.51 64.12 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.899 -1.046 . . . . 50.0 111.954 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -106.55 140.4 21.29 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.053 -0.976 . . . . 50.0 108.847 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.74 163.23 34.07 Favored 'Trans proline' 0 C--N 1.347 0.488 0 O-C-N 122.184 0.57 . . . . 50.0 113.206 -177.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.5 m -124.04 32.56 5.52 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.777 0.798 . . . . 25.0 111.839 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -91.66 -16.36 27.13 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.238 -0.892 . . . . 50.0 110.691 -177.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.7 p -121.29 152.21 39.18 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.692 -1.14 . . . . 25.0 108.424 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -127.01 -94.26 0.46 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.397 -0.964 . . . . 50.0 108.397 -178.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 69.51 -165.84 0.17 Allowed 'General case' 0 C--O 1.212 -0.884 0 N-CA-C 107.264 -1.384 . . . . 50.0 107.264 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.95 23.82 5.77 Favored Glycine 0 C--O 1.217 -0.929 0 N-CA-C 119.133 2.413 . . . . 50.0 119.133 175.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.63 -25.6 15.33 Favored Glycine 0 C--O 1.217 -0.911 0 CA-C-N 118.191 0.995 . . . . 50.0 112.485 -176.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -59.81 -29.92 68.57 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.184 0.993 . . . . 50.0 110.183 175.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.1 tp -61.43 -37.98 85.48 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.132 -0.94 . . . . 50.0 112.062 176.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.5 t -68.57 -41.37 82.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.145 -0.687 . . . . 50.0 109.145 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.44 -43.48 98.79 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.433 -0.58 . . . . 50.0 109.433 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.9 m -64.28 -39.56 94.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.568 -0.287 . . . . 25.0 110.714 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.8 mt -65.84 -38.39 88.75 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.824 -0.548 . . . . 50.0 110.85 178.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -66.21 -39.57 89.73 Favored 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 110.183 -0.302 . . . . 50.0 110.183 176.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -66.12 -44.01 85.48 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.499 0.555 . . . . 50.0 112.499 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.3 t -76.51 -41.06 34.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.368 0.507 . . . . 50.0 112.368 -176.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 40.3 m -93.29 -31.12 14.82 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.851 1.056 . . . . 50.0 113.851 -174.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.69 -137.91 49.01 Favored Glycine 0 CA--C 1.518 0.256 0 CA-C-O 121.89 0.716 . . . . 25.0 113.346 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -55.71 -25.26 39.24 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.172 1.175 . . . . 50.0 114.172 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -65.72 -21.38 66.52 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.904 -0.497 . . . . 50.0 111.967 -177.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.12 172.77 46.81 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 110.353 -1.099 . . . . 50.0 110.353 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -155.12 169.9 23.06 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.851 -0.796 . . . . 50.0 108.851 -177.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -140.98 155.87 46.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.793 0.806 . . . . 50.0 111.273 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -96.18 162.21 13.62 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.81 -1.552 . . . . 50.0 106.81 175.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.1 t 56.2 -100.55 0.11 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.378 0.671 . . . . 50.0 112.223 -176.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -166.36 159.56 12.15 Favored Pre-proline 0 C--O 1.238 0.465 0 N-CA-C 103.588 -2.745 . . . . 50.0 103.588 176.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.3 -178.29 3.2 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 118.138 -0.775 . . . . 50.0 113.139 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.45 135.39 57.24 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.269 0.557 . . . . 25.0 109.819 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.8 m -148.86 148.53 29.99 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.643 -1.984 . . . . 50.0 105.643 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -72.19 -32.57 66.92 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-O 120.996 0.427 . . . . 50.0 111.93 -177.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.6 m -72.54 148.17 9.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-O 121.735 0.779 . . . . 50.0 113.051 -177.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 p -78.13 67.93 4.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.993 0.901 . . . . 50.0 111.69 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.0 mmt-85 -125.9 57.14 1.38 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.494 0.664 . . . . 50.0 112.03 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.3 mtt180 -93.81 66.55 3.71 Favored 'General case' 0 C--O 1.213 -0.847 0 N-CA-C 106.112 -1.81 . . . . 50.0 106.112 170.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 t -144.85 25.21 1.46 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.834 -1.075 . . . . 25.0 110.259 -175.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -144.73 159.19 43.25 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.14 -1.059 . . . . 50.0 108.14 176.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 172.25 163.18 25.69 Favored Glycine 0 CA--C 1.5 -0.852 0 C-N-CA 120.699 -0.763 . . . . 25.0 112.634 175.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.6 tp -61.62 -32.89 55.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 111.925 0.343 . . . . 50.0 111.925 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.3 t -66.37 -38.7 82.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 121.519 -0.738 . . . . 50.0 109.423 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.04 -28.35 68.79 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 121.601 -0.687 . . . . 50.0 111.439 178.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -85.29 -36.1 21.06 Favored 'General case' 0 C--O 1.207 -1.132 0 N-CA-C 113.702 1.001 . . . . 50.0 113.702 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 82.9 m -114.88 7.77 15.78 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 115.532 1.679 . . . . 50.0 115.532 -172.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 30.3 t -132.49 -53.9 0.95 Allowed 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 109.545 -0.539 . . . . 50.0 109.545 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -73.66 -24.22 59.95 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.213 0.53 . . . . 50.0 110.067 176.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -136.53 176.66 8.5 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.046 -1.094 . . . . 50.0 108.046 175.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.9 m -91.09 151.06 21.15 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.85 0.719 . . . . 25.0 109.108 173.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.8 p -136.87 178.54 7.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.868 0.366 . . . . 50.0 110.194 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -145.95 168.63 20.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.556 -0.905 . . . . 50.0 108.556 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.7 tp -52.16 -48.28 65.02 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 115.073 1.509 . . . . 50.0 115.073 -173.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.84 -42.22 88.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.92 0.39 . . . . 25.0 111.559 -177.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.7 tp -69.63 -45.35 68.69 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.958 0.409 . . . . 50.0 110.139 178.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 tt -60.5 -36.08 77.48 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.857 0.361 . . . . 50.0 111.618 -177.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -61.0 -24.56 66.24 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.585 0.957 . . . . 50.0 113.585 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.0 p -70.58 -14.21 62.4 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 121.678 -0.639 . . . . 25.0 112.719 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -92.81 2.48 56.74 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 122.276 0.23 . . . . 50.0 111.609 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 81.6 m -72.21 152.16 42.41 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.222 -1.399 . . . . 50.0 107.222 173.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.9 167.51 12.76 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.866 -0.791 . . . . 25.0 108.866 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.5 p 67.6 150.15 0.12 Allowed Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 125.614 1.566 . . . . 25.0 111.406 -175.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.83 151.54 57.22 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 114.787 -3.008 . . . . 50.0 113.246 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.13 134.12 42.84 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.097 -1.075 . . . . 25.0 108.097 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -121.24 -29.0 4.59 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.693 0.627 . . . . 50.0 112.693 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.3 t 69.27 138.43 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.881 1.272 . . . . 25.0 111.834 -177.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 . . . . . 0 C--O 1.304 3.933 0 CA-C-O 115.858 -2.02 . . . . 25.0 114.366 -177.503 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.832 0 CA-C-O 122.432 1.11 . . . . 25.0 113.68 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -96.6 177.17 5.75 Favored 'General case' 0 C--O 1.225 -0.189 0 N-CA-C 108.712 -0.847 . . . . 50.0 108.712 178.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -59.73 147.76 77.44 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.355 -0.384 . . . . 50.0 110.958 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.88 -179.14 5.1 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 120.529 0.819 . . . . 50.0 111.139 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.0 m 55.9 58.72 4.21 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 121.798 0.809 . . . . 25.0 112.134 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -63.8 -24.76 67.89 Favored 'General case' 0 C--O 1.213 -0.819 0 CA-C-N 115.013 -0.994 . . . . 50.0 113.156 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -74.48 124.4 26.51 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 108.487 -0.931 . . . . 25.0 108.487 178.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.6 mt -114.36 126.0 54.5 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 122.347 1.07 . . . . 50.0 111.14 -175.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -159.06 -174.77 4.9 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 106.25 -1.759 . . . . 50.0 106.25 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.01 31.73 77.63 Favored Glycine 0 C--O 1.215 -1.059 0 C-N-CA 120.823 -0.703 . . . . 50.0 114.339 175.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.95 -22.27 19.2 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 121.069 -0.586 . . . . 50.0 114.245 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -65.51 -28.49 69.22 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.607 1.203 . . . . 50.0 110.353 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.0 tp -61.91 -41.82 98.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.088 -0.506 . . . . 50.0 110.361 174.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.6 t -68.85 -40.61 81.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.495 -0.557 . . . . 50.0 109.495 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -61.85 -36.76 82.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.063 0.459 . . . . 50.0 110.328 178.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.2 m -70.38 -39.95 74.27 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-N 116.527 -0.306 . . . . 25.0 111.168 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.2 mt -62.06 -38.21 87.93 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.469 -0.769 . . . . 50.0 110.59 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -65.13 -42.55 93.75 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 116.692 -0.231 . . . . 50.0 110.681 176.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -64.97 -45.69 84.62 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.927 0.343 . . . . 50.0 111.927 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.4 t -70.7 -42.95 77.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.049 0.388 . . . . 50.0 112.049 -176.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -98.09 -21.65 16.66 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 116.11 1.893 . . . . 50.0 116.11 -173.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.4 -142.77 47.52 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.457 -0.878 . . . . 25.0 113.306 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -68.08 -11.08 58.39 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 114.474 1.287 . . . . 50.0 114.474 -176.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -66.43 -22.68 66.22 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.582 -0.699 . . . . 50.0 111.97 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.28 167.82 43.84 Favored Glycine 0 C--O 1.227 -0.339 0 N-CA-C 111.179 -0.768 . . . . 50.0 111.179 -178.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -152.98 165.47 35.42 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 122.053 -0.674 . . . . 50.0 109.275 -177.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -105.28 147.4 28.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.574 0.702 . . . . 50.0 111.461 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -141.95 140.03 32.65 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.41 -1.33 . . . . 50.0 107.41 179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.4 t -136.23 134.79 38.48 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.191 -1.04 . . . . 50.0 108.191 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.97 154.23 20.07 Favored Pre-proline 0 C--O 1.24 0.556 0 N-CA-C 105.829 -1.915 . . . . 50.0 105.829 -179.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.55 163.01 27.21 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 114.981 -2.88 . . . . 50.0 111.986 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.4 1.11 12.34 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.133 -1.062 . . . . 25.0 108.133 174.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 p -99.87 162.45 12.98 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.925 -1.139 . . . . 50.0 107.925 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -63.23 -23.85 67.61 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.238 0.459 . . . . 50.0 112.238 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.1 m -115.73 151.81 17.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 109.497 -0.557 . . . . 50.0 109.497 178.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.0 m -85.5 71.04 10.82 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 113.559 0.948 . . . . 50.0 113.559 -175.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.6 mtt85 -78.38 -10.14 59.56 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.57 0.952 . . . . 50.0 113.57 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -90.43 150.59 21.77 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-O 121.184 0.516 . . . . 50.0 111.519 -174.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.76 -175.02 1.94 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.654 -1.157 . . . . 25.0 112.915 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -44.34 140.46 2.25 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 115.04 1.496 . . . . 50.0 115.04 -176.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -153.12 172.2 32.08 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 108.754 -1.739 . . . . 25.0 108.754 174.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.2 tp -59.32 -33.09 49.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 120.919 0.39 . . . . 50.0 111.426 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.22 -35.79 75.03 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 O-C-N 121.565 -0.709 . . . . 50.0 110.576 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -66.52 -35.66 80.78 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 121.507 -0.746 . . . . 50.0 111.312 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -89.15 -21.44 23.33 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 114.52 1.304 . . . . 50.0 114.52 -173.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -120.27 -10.84 9.28 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 116.913 2.19 . . . . 50.0 116.913 178.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 41.9 t -103.87 -38.35 7.06 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.654 0.661 . . . . 50.0 109.503 173.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -99.47 -11.28 21.22 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 122.085 0.945 . . . . 50.0 111.48 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -132.92 174.25 10.54 Favored 'General case' 0 C--O 1.212 -0.887 0 N-CA-C 103.563 -2.754 . . . . 50.0 103.563 168.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.5 m -88.36 -18.16 29.03 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 117.898 2.555 . . . . 25.0 117.898 -173.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 46.96 -173.69 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 117.117 2.265 . . . . 50.0 117.117 -173.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -152.9 165.88 34.1 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 105.621 -1.992 . . . . 50.0 105.621 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 42.4 tp -63.97 -37.2 86.54 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.471 0.915 . . . . 50.0 113.471 -176.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.76 -43.89 71.29 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.118 -0.697 . . . . 25.0 109.118 -174.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.2 tp -61.25 -41.92 97.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.001 -0.545 . . . . 50.0 110.161 175.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 tt -60.15 -36.8 78.34 Favored 'General case' 0 C--N 1.318 -0.775 0 O-C-N 121.738 -0.601 . . . . 50.0 110.702 -178.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -64.4 -27.09 68.77 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.938 0.718 . . . . 50.0 112.938 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 33.1 p -71.29 -14.14 62.12 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.033 0.753 . . . . 25.0 113.033 -178.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -85.47 5.8 29.64 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.563 0.209 . . . . 50.0 111.563 176.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.4 m -61.51 155.41 22.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.835 0.826 . . . . 50.0 111.18 173.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.19 151.87 19.14 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.393 -1.336 . . . . 25.0 107.393 170.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.2 p 67.68 147.62 0.11 Allowed Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 125.889 1.675 . . . . 25.0 113.902 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -78.48 165.57 25.08 Favored 'Trans proline' 0 C--N 1.348 0.543 0 N-CA-C 113.463 0.524 . . . . 50.0 113.463 -177.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.53 160.3 30.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.625 -0.716 . . . . 25.0 110.312 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -83.69 158.56 21.78 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.781 -0.645 . . . . 50.0 110.433 177.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 36.1 p -86.21 63.09 7.82 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.41 0.624 . . . . 25.0 110.763 175.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.3 3.73 0 CA-C-O 113.953 -2.927 . . . . 25.0 113.228 -177.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 124.76 2.219 . . . . 25.0 114.185 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -75.61 173.58 10.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 112.805 -1.998 . . . . 50.0 110.829 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -62.13 151.4 81.24 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.181 -0.463 . . . . 50.0 111.655 -178.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.12 -176.91 3.3 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 120.97 1.113 . . . . 50.0 112.201 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.6 t 63.34 49.25 3.28 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.052 0.845 . . . . 25.0 113.213 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -68.57 -16.73 63.96 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.675 -0.861 . . . . 50.0 108.675 172.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.4 p -84.68 141.34 30.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.622 -0.717 . . . . 25.0 109.068 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.69 133.62 49.58 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.895 -0.593 . . . . 50.0 109.584 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 66.9 m -127.2 -60.46 1.2 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 115.363 1.616 . . . . 50.0 115.363 -177.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.73 -134.96 4.6 Favored Glycine 0 C--O 1.222 -0.613 0 N-CA-C 114.635 0.614 . . . . 50.0 114.635 -173.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.99 -21.02 60.83 Favored Glycine 0 C--O 1.218 -0.881 0 C-N-CA 121.115 -0.564 . . . . 50.0 112.711 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -64.59 -33.3 75.6 Favored 'General case' 0 C--O 1.214 -0.802 0 O-C-N 122.178 -0.601 . . . . 50.0 110.503 176.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.4 tp -68.85 -39.68 79.77 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.689 -0.485 . . . . 50.0 109.689 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.95 -40.83 90.45 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 N-CA-C 108.983 -0.747 . . . . 50.0 108.983 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.68 -49.14 78.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.862 -0.153 . . . . 50.0 111.048 176.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.3 m -60.99 -41.18 95.97 Favored 'General case' 0 C--O 1.219 -0.551 0 C-N-CA 121.12 -0.232 . . . . 25.0 111.005 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.1 mt -63.72 -40.4 96.67 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 121.782 -0.574 . . . . 50.0 110.557 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -68.04 -35.39 78.17 Favored 'General case' 0 C--O 1.217 -0.628 0 O-C-N 121.955 -0.466 . . . . 50.0 110.653 177.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -66.99 -44.77 79.54 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.971 -0.455 . . . . 50.0 112.064 178.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.8 t -79.91 -42.68 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 O-C-N 121.886 -0.509 . . . . 50.0 111.629 -177.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.0 m -89.93 -22.28 22.05 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 114.042 1.127 . . . . 50.0 114.042 -174.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.82 -164.71 54.82 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 109.878 -1.289 . . . . 25.0 109.878 -176.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -73.01 0.79 10.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.519 0.676 . . . . 50.0 112.777 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -67.92 -15.91 63.83 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.66 -0.65 . . . . 50.0 111.403 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.6 173.45 39.82 Favored Glycine 0 CA--C 1.508 -0.366 0 N-CA-C 111.642 -0.583 . . . . 50.0 111.642 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -159.65 166.7 30.07 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.416 -0.586 . . . . 50.0 109.416 -176.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -101.8 143.42 31.73 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.782 -0.645 . . . . 50.0 109.869 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -117.87 172.54 7.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.074 -0.512 . . . . 50.0 109.875 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.1 t -73.71 67.43 1.15 Allowed 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.502 0.926 . . . . 50.0 113.502 -176.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.58 -47.6 0.37 Allowed Pre-proline 0 N--CA 1.475 0.8 0 N-CA-C 118.874 2.916 . . . . 50.0 118.874 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.55 149.67 62.25 Favored 'Trans proline' 0 C--N 1.344 0.305 0 CA-C-N 119.027 0.688 . . . . 50.0 112.609 -176.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -161.75 174.74 12.8 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.623 -0.88 . . . . 25.0 108.623 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.05 -179.86 4.01 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.78 0.675 . . . . 50.0 110.815 175.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.92 -26.18 48.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.359 0.599 . . . . 50.0 110.157 175.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.3 m -94.1 -160.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 107.004 -1.48 . . . . 50.0 107.004 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.8 p -73.11 -135.51 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 109.083 -0.71 . . . . 50.0 109.083 170.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.8 mmt-85 55.74 50.27 14.59 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.39 0.614 . . . . 50.0 111.492 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 81.9 mtt85 -57.57 132.87 54.51 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.257 -1.016 . . . . 50.0 108.257 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.5 p -121.68 141.87 50.72 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.139 -0.319 . . . . 25.0 110.139 -175.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.2 ptt180 57.91 175.84 0.06 Allowed 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.197 1.554 . . . . 50.0 115.197 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.7 153.52 14.69 Favored Glycine 0 C--O 1.216 -1.019 0 N-CA-C 111.245 -0.742 . . . . 25.0 111.245 176.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.2 tp -57.2 -32.58 40.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 113.688 0.996 . . . . 50.0 113.688 -173.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.0 t -67.42 -38.61 81.06 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 O-C-N 121.297 -0.877 . . . . 50.0 109.238 176.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -66.53 -34.68 78.46 Favored 'General case' 0 C--O 1.215 -0.731 0 O-C-N 121.334 -0.854 . . . . 50.0 110.666 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -77.47 -39.42 46.63 Favored 'General case' 0 C--O 1.21 -1.008 0 N-CA-C 113.093 0.775 . . . . 50.0 113.093 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 83.6 m -102.71 -10.87 18.82 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 116.675 2.102 . . . . 50.0 116.675 -172.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 31.6 t -118.12 -43.02 2.76 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 120.889 0.375 . . . . 50.0 111.684 -178.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -78.09 -15.15 59.15 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.128 0.49 . . . . 50.0 110.597 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 17.7 ptt-85 -157.65 178.91 9.74 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 103.342 -2.836 . . . . 50.0 103.342 174.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.4 m -86.79 155.74 20.18 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 118.039 0.381 . . . . 25.0 110.791 178.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.8 p -133.24 177.63 7.53 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.582 -0.896 . . . . 50.0 108.582 177.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -129.52 164.16 24.36 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.746 -0.835 . . . . 50.0 108.746 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 68.6 tp -56.22 -41.99 76.55 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.558 0.743 . . . . 50.0 112.283 177.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.79 -40.03 95.69 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 121.929 -0.482 . . . . 25.0 110.511 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.0 tp -69.86 -44.81 69.07 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.919 -0.771 . . . . 50.0 108.919 178.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.7 tt -59.47 -35.25 73.72 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 121.581 -0.7 . . . . 50.0 111.655 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -60.53 -28.12 68.16 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.589 0.589 . . . . 50.0 112.589 177.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.2 p -71.43 -15.75 62.36 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.902 0.705 . . . . 25.0 112.902 -177.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -90.56 -0.86 57.83 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 121.181 -0.208 . . . . 50.0 111.35 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 82.3 m -72.39 147.54 46.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.467 0.651 . . . . 50.0 110.925 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.25 163.32 15.44 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.537 -1.283 . . . . 25.0 107.537 175.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.9 p -118.05 145.76 37.6 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 107.649 -1.241 . . . . 25.0 107.649 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -61.26 143.13 98.09 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 120.944 1.096 . . . . 50.0 112.691 177.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.97 88.76 3.1 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.826 -0.625 . . . . 25.0 109.888 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.3 ttmt 53.83 45.66 27.36 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 116.024 -0.534 . . . . 50.0 111.711 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.9 t -52.79 -46.79 67.77 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.957 0.885 . . . . 25.0 112.59 -178.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 . . . . . 0 C--O 1.292 3.301 0 CA-C-O 113.599 -3.096 . . . . 25.0 110.268 175.803 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 123.492 1.615 . . . . 25.0 114.457 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -88.68 168.28 12.65 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.225 -0.922 . . . . 50.0 109.465 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 66.8 mtp85 -60.74 138.35 93.28 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 109.929 -0.397 . . . . 50.0 109.929 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -84.28 168.11 11.85 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 120.699 0.932 . . . . 50.0 112.747 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.1 m -146.12 91.85 2.12 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.978 -0.749 . . . . 25.0 108.978 176.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.48 -37.59 74.26 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.824 0.821 . . . . 50.0 110.393 -176.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.4 p -113.91 145.24 41.77 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.659 -1.155 . . . . 25.0 107.929 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -126.71 134.74 50.6 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.137 -0.938 . . . . 50.0 108.58 -176.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -145.91 -46.83 0.21 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.074 0.768 . . . . 50.0 113.074 -177.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.89 -146.85 9.48 Favored Glycine 0 C--O 1.225 -0.459 0 C-N-CA 121.174 -0.536 . . . . 50.0 111.97 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -58.12 -23.71 53.03 Favored Glycine 0 C--O 1.212 -1.269 0 C-N-CA 121.236 -0.507 . . . . 50.0 113.301 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -59.17 -27.02 65.29 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.388 0.514 . . . . 50.0 112.388 176.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 45.9 tp -68.69 -43.2 76.6 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.256 -0.646 . . . . 50.0 109.256 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.88 -39.65 86.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.627 -0.879 . . . . 50.0 108.627 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -64.01 -44.7 91.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.214 0.531 . . . . 50.0 110.657 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.3 m -66.39 -37.03 84.35 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 121.812 -0.555 . . . . 25.0 110.351 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.3 mt -63.54 -37.67 88.2 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 121.912 -0.492 . . . . 50.0 110.373 177.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -66.11 -37.95 86.99 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 122.316 -0.24 . . . . 50.0 110.981 175.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -66.39 -47.88 71.89 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 122.03 -0.418 . . . . 50.0 112.071 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.7 t -77.98 -38.62 24.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 113.167 0.803 . . . . 50.0 113.167 -173.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 50.8 t -89.41 -17.04 29.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.938 0.875 . . . . 50.0 110.801 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.96 -169.72 55.04 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 109.773 -1.331 . . . . 25.0 109.773 -176.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -67.84 3.59 1.44 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.464 1.283 . . . . 50.0 114.464 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -25.25 68.22 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 121.757 -0.589 . . . . 50.0 112.446 -178.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.93 158.72 34.77 Favored Glycine 0 C--O 1.219 -0.83 0 N-CA-C 108.417 -1.873 . . . . 50.0 108.417 -174.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -152.82 169.17 23.45 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.012 -1.477 . . . . 50.0 107.012 -173.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -135.96 142.71 44.6 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.97 -0.381 . . . . 50.0 109.97 176.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -160.72 162.55 32.56 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.475 -0.935 . . . . 50.0 108.475 178.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.0 t 49.49 46.38 23.44 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 115.107 1.521 . . . . 50.0 115.107 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.7 133.66 62.25 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.469 -0.787 . . . . 50.0 112.103 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.22 160.87 46.11 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 114.675 -3.083 . . . . 50.0 111.741 173.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -153.77 170.5 20.79 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.888 -1.153 . . . . 25.0 107.888 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m 58.53 175.02 0.06 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 116.974 2.213 . . . . 50.0 116.974 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -100.97 -8.93 21.97 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.374 -0.83 . . . . 50.0 110.785 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.1 m -127.4 -177.31 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.197 -1.409 . . . . 50.0 107.197 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 m -70.65 -135.16 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 122.995 0.518 . . . . 50.0 111.566 173.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 57.54 35.7 26.07 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.66 0.784 . . . . 50.0 111.392 178.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.8 149.78 30.14 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.474 0.916 . . . . 50.0 113.474 -177.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.4 m -75.42 173.51 10.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.178 -0.919 . . . . 25.0 113.338 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -65.06 164.56 12.66 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.7 -0.682 . . . . 50.0 110.206 174.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.3 -178.58 35.38 Favored Glycine 0 C--O 1.223 -0.544 0 N-CA-C 110.823 -0.911 . . . . 25.0 110.823 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.5 tt -62.48 -27.07 42.07 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 N-CA-C 113.973 1.101 . . . . 50.0 113.973 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.6 p -63.68 -30.83 50.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 O-C-N 120.832 -1.167 . . . . 50.0 109.535 177.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -71.78 -27.34 62.89 Favored 'General case' 0 C--O 1.218 -0.585 0 O-C-N 121.294 -0.879 . . . . 50.0 110.547 177.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -87.4 -32.45 19.54 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.397 -0.819 . . . . 50.0 113.141 -176.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 94.0 m -109.32 -15.33 14.28 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 115.266 1.58 . . . . 50.0 115.266 -176.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 31.8 t -113.68 -50.45 2.84 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.651 0.659 . . . . 50.0 111.653 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -68.83 -30.27 68.77 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.301 0.572 . . . . 50.0 109.853 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.43 173.46 11.48 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 105.471 -2.048 . . . . 50.0 105.471 170.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.9 t -86.46 148.51 25.52 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.364 0.529 . . . . 25.0 110.459 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 20.6 p -114.66 -178.47 3.38 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 122.56 0.344 . . . . 50.0 110.892 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -134.45 162.97 30.75 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.506 -0.553 . . . . 50.0 109.506 -177.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -51.51 -53.9 32.76 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.868 1.062 . . . . 50.0 113.868 -176.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.45 -32.85 74.69 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 121.014 0.435 . . . . 25.0 111.943 -174.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.4 tp -69.2 -47.49 64.71 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.94 -0.763 . . . . 50.0 108.94 176.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.2 tt -61.6 -34.82 76.3 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.464 0.649 . . . . 50.0 111.182 -177.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -58.92 -24.8 62.84 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.645 0.98 . . . . 50.0 113.645 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.3 p -69.02 -19.01 64.11 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.34 0.867 . . . . 25.0 113.34 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -89.6 5.44 45.63 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.107 0.479 . . . . 50.0 111.71 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 31.7 t -64.71 150.98 46.25 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.562 -1.273 . . . . 50.0 107.562 173.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.46 140.82 58.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.32 0.581 . . . . 25.0 110.904 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.3 p -68.86 135.74 89.9 Favored Pre-proline 0 N--CA 1.445 -0.713 0 N-CA-C 107.405 -1.331 . . . . 25.0 107.405 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.28 152.66 75.6 Favored 'Trans proline' 0 CA--C 1.517 -0.348 0 CA-C-O 121.614 0.589 . . . . 50.0 113.368 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.86 48.38 0.95 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.104 -0.953 . . . . 25.0 111.848 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 64.5 tttt 53.87 35.31 21.37 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.776 0.83 . . . . 50.0 111.418 -177.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.5 t -147.81 145.64 28.83 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 106.872 -1.529 . . . . 25.0 106.872 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 . . . . . 0 C--O 1.295 3.483 0 CA-C-O 114.816 -2.516 . . . . 25.0 113.069 -176.6 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.205 -1.252 0 CA-C-O 123.403 1.573 . . . . 25.0 114.769 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -67.26 -24.37 65.78 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 114.992 -1.004 . . . . 50.0 112.699 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -117.27 146.35 38.05 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.598 -0.728 . . . . 50.0 110.386 -179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -77.43 162.93 30.34 Favored 'Trans proline' 0 C--N 1.345 0.395 0 N-CA-C 114.644 0.978 . . . . 50.0 114.644 -175.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 75.6 m -140.67 76.51 1.56 Allowed 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 108.212 -1.033 . . . . 25.0 108.212 176.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.09 -9.33 58.51 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.286 1.588 . . . . 50.0 115.286 -173.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.4 p 37.85 84.95 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 116.478 2.029 . . . . 25.0 116.478 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.5 mt -61.48 122.68 15.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.685 -1.143 . . . . 50.0 111.64 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -161.94 -168.84 2.03 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 106.595 -1.631 . . . . 50.0 106.595 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.78 32.71 80.16 Favored Glycine 0 C--O 1.213 -1.165 0 N-CA-C 116.088 1.195 . . . . 50.0 116.088 171.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.33 -35.8 3.73 Favored Glycine 0 C--O 1.218 -0.858 0 CA-C-N 117.46 0.63 . . . . 50.0 113.609 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -59.02 -32.05 69.37 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.792 0.796 . . . . 50.0 110.592 178.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 44.0 tp -60.38 -38.55 84.28 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.748 -0.66 . . . . 50.0 110.872 176.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.8 t -71.93 -41.29 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.2 -0.454 . . . . 50.0 110.15 -177.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -62.93 -39.28 94.13 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.928 -0.767 . . . . 50.0 108.928 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 32.5 m -63.7 -43.11 97.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.869 -0.605 . . . . 25.0 110.214 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.7 mt -62.95 -39.58 95.05 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 121.691 -0.631 . . . . 50.0 111.079 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -63.65 -43.75 95.83 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.824 -0.35 . . . . 50.0 110.108 177.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -65.08 -47.11 78.43 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.602 0.593 . . . . 50.0 112.602 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.2 t -70.05 -41.42 79.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 120.879 0.371 . . . . 50.0 111.552 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 66.2 m -83.7 -30.98 26.33 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.142 0.793 . . . . 50.0 113.142 -175.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.71 -134.84 35.35 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.658 -0.782 . . . . 25.0 112.427 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -64.9 -13.54 57.06 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 114.08 1.141 . . . . 50.0 114.08 -178.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -78.42 -25.87 46.16 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 116.05 1.87 . . . . 50.0 116.05 -176.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.52 177.0 49.76 Favored Glycine 0 C--O 1.227 -0.303 0 N-CA-C 110.636 -0.986 . . . . 50.0 110.636 -175.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -154.67 169.43 23.92 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 114.023 1.12 . . . . 50.0 114.023 -175.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -106.21 143.01 34.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.349 -0.841 . . . . 50.0 110.959 176.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -130.7 171.02 13.56 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.028 -0.73 . . . . 50.0 109.028 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.8 t -99.63 137.57 37.93 Favored 'General case' 0 C--O 1.22 -0.454 0 N-CA-C 109.238 -0.653 . . . . 50.0 109.238 177.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.538 ' H ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -139.69 -52.33 0.02 OUTLIER Pre-proline 0 N--CA 1.476 0.837 0 N-CA-C 117.643 2.461 . . . . 50.0 117.643 -177.563 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.538 ' HD2' ' H ' ' A' ' 30' ' ' ARG . 97.7 Cg_endo -77.94 156.69 30.75 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 CA-C-N 118.592 0.533 . . . . 50.0 112.919 -178.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -100.93 143.65 30.82 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.471 -0.937 . . . . 25.0 108.471 175.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.9 m -105.45 157.03 17.64 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.156 -1.424 . . . . 50.0 107.156 175.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -64.09 -28.85 70.06 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 111.78 0.289 . . . . 50.0 111.78 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.16 164.42 31.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.403 -0.962 . . . . 50.0 108.403 178.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.0 p -75.15 -165.4 0.39 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 122.441 0.296 . . . . 50.0 110.966 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 45.39 36.65 2.47 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 115.598 1.703 . . . . 50.0 115.598 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.8 mtt-85 -122.5 148.87 44.65 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.106 -0.497 . . . . 50.0 111.016 175.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.7 t 63.71 178.58 0.16 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.964 1.306 . . . . 25.0 113.419 177.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -100.71 159.87 14.82 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 106.208 -1.775 . . . . 50.0 106.208 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -167.71 118.42 0.78 Allowed Glycine 0 C--O 1.223 -0.585 0 C-N-CA 119.248 -1.453 . . . . 25.0 114.431 176.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.4 tp -62.24 -34.77 65.65 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.57 0 N-CA-C 108.646 -0.872 . . . . 50.0 108.646 176.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.04 -42.73 87.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 O-C-N 121.891 -0.506 . . . . 50.0 110.026 176.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -69.49 -19.01 63.74 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 121.21 -0.931 . . . . 50.0 113.474 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -101.29 -20.55 15.18 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 114.285 1.217 . . . . 50.0 114.285 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 78.8 m -110.72 -27.71 8.77 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.311 1.597 . . . . 50.0 115.311 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 63.0 m -97.85 -46.15 6.05 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 118.541 0.61 . . . . 50.0 110.665 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -72.76 -27.54 62.08 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.338 0.589 . . . . 50.0 110.464 -176.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -149.17 172.2 15.21 Favored 'General case' 0 C--O 1.21 -1.01 0 N-CA-C 104.845 -2.279 . . . . 50.0 104.845 176.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.2 t -81.16 156.14 25.85 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 117.753 0.251 . . . . 25.0 110.661 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 26.9 p -134.89 176.54 8.56 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.455 -0.572 . . . . 50.0 109.455 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -131.98 164.05 27.02 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.69 -0.856 . . . . 50.0 108.69 -177.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.6 tp -56.68 -42.27 78.76 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 123.32 0.648 . . . . 50.0 112.383 177.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.9 -40.54 96.75 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-O 121.095 0.474 . . . . 25.0 110.625 -177.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.2 tp -69.22 -44.15 72.65 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.473 -0.566 . . . . 50.0 109.473 178.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 tt -60.44 -34.56 74.16 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.955 0.407 . . . . 50.0 110.975 -176.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -60.12 -30.09 69.04 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.237 0.828 . . . . 50.0 113.237 177.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.3 p -71.49 -14.02 61.99 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.893 0.701 . . . . 25.0 112.893 -177.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -86.8 -2.95 58.97 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 112.187 0.44 . . . . 50.0 112.187 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 79.4 m -69.9 154.0 42.54 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.32 -0.993 . . . . 50.0 108.32 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.36 166.35 13.35 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.241 -1.022 . . . . 25.0 108.241 178.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.3 p 62.0 154.55 0.11 Allowed Pre-proline 0 N--CA 1.483 1.189 0 N-CA-C 116.574 2.064 . . . . 25.0 116.574 174.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.05 163.67 32.64 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 116.639 -1.774 . . . . 50.0 112.997 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.9 159.28 23.12 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.156 -0.475 . . . . 25.0 110.364 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.8 tptt 65.02 22.22 12.38 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.198 0.999 . . . . 50.0 112.24 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 96.5 p -152.95 161.75 42.16 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.707 -1.96 . . . . 25.0 105.707 174.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 . . . . . 0 C--O 1.285 2.931 0 CA-C-O 112.923 -3.418 . . . . 25.0 108.797 174.09 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.804 0 CA-C-O 122.659 1.219 . . . . 25.0 114.078 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -113.54 165.22 12.71 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-N 115.698 -0.683 . . . . 50.0 109.18 178.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -109.01 149.6 39.85 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 111.912 0.338 . . . . 50.0 111.912 -176.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -76.09 -177.07 3.39 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 120.448 0.765 . . . . 50.0 111.831 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.0 t 58.16 46.53 15.84 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.673 0.749 . . . . 25.0 111.733 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -72.52 -25.18 61.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.236 -0.893 . . . . 50.0 112.093 -178.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.9 p -84.77 151.82 24.11 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 122.168 0.985 . . . . 25.0 112.792 -177.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.0 mt -123.61 135.47 53.97 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 114.49 -1.232 . . . . 50.0 109.75 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.19 162.49 40.78 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.246 -1.39 . . . . 50.0 107.246 177.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.68 -144.5 48.91 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.477 -0.868 . . . . 50.0 112.424 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.95 -21.07 67.39 Favored Glycine 0 C--O 1.216 -0.971 0 CA-C-O 119.551 -0.583 . . . . 50.0 114.063 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -67.07 -38.48 85.84 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.398 1.099 . . . . 50.0 110.317 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tt -67.48 -43.64 80.49 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.114 -1.069 . . . . 50.0 108.114 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.0 t -62.07 -42.69 95.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.648 -0.706 . . . . 50.0 111.152 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -62.13 -39.39 92.4 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.941 0.401 . . . . 50.0 110.285 178.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.2 m -67.47 -41.22 84.97 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.213 -0.292 . . . . 25.0 110.213 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.9 mt -60.83 -41.08 95.06 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 122.038 -0.414 . . . . 50.0 110.3 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -68.75 -34.72 76.06 Favored 'General case' 0 C--O 1.217 -0.647 0 O-C-N 122.396 -0.19 . . . . 50.0 111.367 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -67.22 -46.71 72.99 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.96 -0.463 . . . . 50.0 111.609 176.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.9 t -71.49 -39.69 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 120.981 0.419 . . . . 50.0 111.769 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 9.1 t -96.93 -24.2 15.95 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.525 1.305 . . . . 50.0 114.525 -172.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.24 -160.34 49.62 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 110.515 -1.034 . . . . 25.0 110.515 -174.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.79 0.53 5.54 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.683 0.994 . . . . 50.0 113.683 -177.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -69.04 -16.78 63.78 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 114.863 1.431 . . . . 50.0 114.863 -173.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.2 164.87 40.66 Favored Glycine 0 C--O 1.22 -0.781 0 N-CA-C 110.919 -0.872 . . . . 50.0 110.919 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -153.38 168.3 26.52 Favored 'General case' 0 C--N 1.322 -0.629 0 O-C-N 121.947 -0.737 . . . . 50.0 110.768 -174.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -100.21 158.38 15.91 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.697 -0.853 . . . . 50.0 108.697 177.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -141.78 -178.01 5.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.193 0.521 . . . . 50.0 111.204 -175.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.1 t -55.82 137.09 50.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.576 -0.738 . . . . 50.0 110.905 178.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.9 ppt_? -141.7 160.53 55.94 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.571 -0.741 . . . . 50.0 110.071 -175.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.99 164.95 32.36 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 117.691 -1.072 . . . . 50.0 113.867 -177.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.43 145.54 49.43 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.185 -1.043 . . . . 25.0 108.185 177.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 64.8 p -84.29 -176.4 6.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.205 0.526 . . . . 50.0 111.245 -176.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -69.36 -17.46 63.69 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 115.015 1.487 . . . . 50.0 115.015 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.4 m -83.36 -171.96 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.938 0.399 . . . . 50.0 110.209 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.54 -160.83 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.628 0.771 . . . . 50.0 112.463 174.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 59.93 29.11 18.69 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.924 0.889 . . . . 50.0 111.598 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 47.6 mtt180 -76.72 132.23 39.2 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-O 120.905 0.383 . . . . 50.0 110.121 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.4 t -162.08 152.55 17.19 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 102.002 -3.333 . . . . 25.0 102.002 173.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -93.97 -40.47 10.1 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.172 0.434 . . . . 50.0 112.172 -176.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.31 -159.12 18.95 Favored Glycine 0 C--O 1.216 -1.026 0 CA-C-O 119.725 -0.486 . . . . 25.0 111.951 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.2 tp -52.37 -27.63 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 115.081 1.512 . . . . 50.0 115.081 -177.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.1 t -66.89 -34.23 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 O-C-N 120.916 -1.115 . . . . 50.0 110.166 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -67.51 -35.12 78.51 Favored 'General case' 0 C--N 1.319 -0.754 0 O-C-N 121.808 -0.557 . . . . 50.0 109.911 176.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -73.99 -43.63 57.41 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.99 0.737 . . . . 50.0 112.99 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 81.0 m -105.5 -14.83 15.18 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 116.129 1.9 . . . . 50.0 116.129 -171.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.7 t -113.18 -42.93 3.44 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.515 0.598 . . . . 50.0 111.425 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -83.56 -20.93 32.93 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.33 0.586 . . . . 50.0 110.101 176.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 94.1 mtm-85 -131.85 -176.42 4.05 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 103.42 -2.807 . . . . 50.0 103.42 173.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.4 m -109.61 151.9 26.23 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 104.819 -2.289 . . . . 25.0 104.819 171.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 27.6 p -129.22 163.33 25.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.723 0.297 . . . . 50.0 110.943 -174.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -114.12 169.57 8.92 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.975 -0.75 . . . . 50.0 108.975 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 61.9 tp -55.06 -45.77 75.35 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.685 0.794 . . . . 50.0 111.784 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.87 -42.62 99.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.013 0.435 . . . . 25.0 111.382 -176.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.2 tp -68.86 -45.57 70.7 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.305 0.574 . . . . 50.0 109.607 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 tt -61.1 -33.61 73.64 Favored 'General case' 0 C--N 1.317 -0.806 0 O-C-N 121.891 -0.506 . . . . 50.0 111.04 -178.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -63.3 -24.67 67.96 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.511 0.93 . . . . 50.0 113.511 178.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.5 p -70.85 -14.37 62.38 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.137 -0.977 . . . . 25.0 111.856 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -97.87 0.63 47.0 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.399 -0.364 . . . . 50.0 110.963 177.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 29.5 t -76.9 148.55 36.36 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.036 -1.098 . . . . 50.0 108.036 174.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -95.62 139.09 32.36 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.096 -0.705 . . . . 25.0 109.096 174.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.4 ' HB ' ' HD2' ' A' ' 63' ' ' PRO . 5.3 p 66.11 159.46 0.13 Allowed Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 124.562 1.145 . . . . 25.0 112.722 176.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.4 ' HD2' ' HB ' ' A' ' 62' ' ' THR . 92.7 Cg_endo -71.74 163.31 39.33 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 118.31 -0.66 . . . . 50.0 113.362 -177.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.2 122.8 14.73 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.423 0.63 . . . . 25.0 111.065 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -68.42 -19.02 64.57 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.252 1.204 . . . . 50.0 114.252 -177.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.1 t -159.56 90.61 0.95 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.948 0.404 . . . . 25.0 111.282 -177.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 . . . . . 0 C--O 1.302 3.861 0 CA-C-O 115.854 -2.022 . . . . 25.0 114.246 178.455 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.3 m . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 121.36 0.6 . . . . 25.0 112.555 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.39 -146.09 50.07 Favored Glycine 0 C--O 1.227 -0.303 0 CA-C-N 115.892 -0.594 . . . . 25.0 114.373 172.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.59 -23.52 72.18 Favored Glycine 0 C--O 1.211 -1.321 0 C-N-CA 121.124 -0.56 . . . . 25.0 112.937 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -69.13 -27.39 65.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.649 0.725 . . . . 25.0 110.66 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.6 tp -70.73 -39.88 73.11 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.91 -0.774 . . . . 25.0 108.91 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 69.2 t -67.18 -41.04 86.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.065 -0.516 . . . . 25.0 109.883 178.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -59.17 -46.22 88.97 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 122.889 0.476 . . . . 25.0 110.191 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 48.2 m -63.04 -39.93 96.21 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 116.528 -0.305 . . . . 25.0 111.467 177.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.4 mt -62.0 -39.2 91.44 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 121.622 -0.674 . . . . 25.0 110.56 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -69.01 -38.17 79.1 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 116.934 -0.121 . . . . 25.0 110.724 176.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -65.64 -44.78 85.37 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.06 -0.4 . . . . 25.0 112.054 177.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.1 t -72.79 -39.35 59.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.154 0.428 . . . . 25.0 112.154 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 t -98.7 -15.7 19.28 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 115.033 1.494 . . . . 25.0 115.033 -176.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.24 -142.31 37.27 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-O 122.101 0.834 . . . . 25.0 113.3 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -72.95 -11.23 60.5 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 123.615 0.766 . . . . 25.0 112.886 -177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.7 mtp180 . . . . . 0 C--N 1.325 -0.492 0 N-CA-C 114.066 1.136 . . . . 25.0 114.066 -172.583 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.7 m . . . . . 0 C--O 1.238 0.468 0 CA-C-O 121.21 0.529 . . . . 25.0 111.671 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.45 -143.54 48.28 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-O 121.917 0.732 . . . . 25.0 114.861 172.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.4 -23.04 71.67 Favored Glycine 0 C--O 1.21 -1.394 0 CA-C-N 115.112 -0.544 . . . . 25.0 113.49 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -69.94 -28.78 65.85 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 118.126 0.963 . . . . 25.0 109.402 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.23 -42.43 84.05 Favored 'General case' 0 C--O 1.216 -0.68 0 N-CA-C 107.604 -1.258 . . . . 25.0 107.604 177.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.5 t -64.87 -40.76 90.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.057 -0.974 . . . . 25.0 110.793 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -60.67 -48.65 80.83 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 122.189 0.995 . . . . 25.0 108.647 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.9 m -59.61 -41.58 90.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.667 -0.697 . . . . 25.0 111.314 177.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.6 mt -64.43 -39.94 94.8 Favored 'General case' 0 CA--C 1.539 0.519 0 O-C-N 121.826 -0.546 . . . . 25.0 111.09 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -65.55 -35.98 82.45 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 118.293 0.497 . . . . 25.0 109.747 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -68.78 -49.55 57.67 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 120.091 -0.644 . . . . 25.0 112.717 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.8 t -70.45 -42.74 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 O-C-N 122.098 -0.376 . . . . 25.0 111.37 -175.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 58.3 m -87.68 -16.84 33.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.787 0.803 . . . . 25.0 111.357 -175.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.59 -167.09 53.81 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 108.795 -1.722 . . . . 25.0 108.795 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -71.09 0.22 8.11 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 122.061 0.934 . . . . 25.0 112.74 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.6 mtm180 . . . . . 0 N--CA 1.479 0.996 0 N-CA-C 113.181 0.808 . . . . 25.0 113.181 178.344 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.224 -0.248 0 N-CA-C 109.891 -0.411 . . . . 25.0 109.891 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.52 31.61 79.22 Favored Glycine 0 C--O 1.217 -0.923 0 C-N-CA 120.791 -0.719 . . . . 25.0 114.01 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.73 -24.88 15.29 Favored Glycine 0 C--O 1.224 -0.527 0 C-N-CA 121.239 -0.505 . . . . 25.0 113.143 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.39 -28.22 69.09 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.512 0.673 . . . . 25.0 110.057 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.36 -43.69 96.96 Favored 'General case' 0 C--O 1.216 -0.68 0 CA-C-N 116.04 -0.527 . . . . 25.0 110.886 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 80.5 t -67.53 -40.26 84.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.67 -0.695 . . . . 25.0 109.418 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -61.05 -47.17 87.6 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.274 0.559 . . . . 25.0 110.096 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.7 m -61.05 -42.07 97.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.114 -0.494 . . . . 25.0 111.077 177.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.9 mt -63.54 -38.78 92.43 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.916 -0.49 . . . . 25.0 110.89 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -67.54 -37.46 82.75 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 121.136 -0.226 . . . . 25.0 110.461 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -68.1 -45.86 72.56 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 122.033 -0.417 . . . . 25.0 112.075 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 82.1 t -70.77 -42.7 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 112.048 0.388 . . . . 25.0 112.048 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.3 m -96.99 -15.49 21.06 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.958 1.096 . . . . 25.0 113.958 -173.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.18 -161.79 49.8 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-O 122.424 1.013 . . . . 25.0 112.789 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -68.76 0.55 4.17 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.405 -0.897 . . . . 25.0 113.173 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? . . . . . 0 C--N 1.324 -0.524 0 O-C-N 121.165 -0.959 . . . . 25.0 111.511 -179.391 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.518 -0.271 0 N-CA-C 105.973 -1.862 . . . . 25.0 105.973 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.66 32.61 79.23 Favored Glycine 0 C--O 1.218 -0.897 0 C-N-CA 120.481 -0.866 . . . . 25.0 114.232 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.0 -25.54 19.32 Favored Glycine 0 C--O 1.219 -0.804 0 C-N-CA 121.045 -0.598 . . . . 25.0 113.969 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -63.95 -27.78 69.37 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 118.199 0.999 . . . . 25.0 110.583 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 24.6 tp -65.62 -40.57 92.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.064 -0.517 . . . . 25.0 110.178 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 85.1 t -69.49 -39.4 78.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.361 -0.607 . . . . 25.0 109.361 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -59.62 -46.39 89.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.685 0.755 . . . . 25.0 109.778 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.0 m -63.56 -39.66 94.99 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.971 -0.559 . . . . 25.0 111.299 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.5 mt -63.03 -38.19 90.18 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.905 -0.497 . . . . 25.0 110.976 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -66.37 -39.17 88.94 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.208 -0.293 . . . . 25.0 110.208 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -65.94 -48.04 72.69 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.599 0.592 . . . . 25.0 112.599 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.3 t -71.96 -41.59 68.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 112.024 0.379 . . . . 25.0 112.024 -175.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.0 m -90.65 -18.38 25.21 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.151 0.797 . . . . 25.0 113.151 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.36 -138.19 48.66 Favored Glycine 0 C--N 1.322 -0.218 0 CA-C-O 122.253 0.918 . . . . 25.0 113.917 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -70.56 -13.34 62.06 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.795 0.838 . . . . 25.0 112.486 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.5 mtp180 . . . . . 0 C--N 1.323 -0.544 0 N-CA-C 113.124 0.787 . . . . 25.0 113.124 -171.825 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.222 -0.379 0 N-CA-C 109.763 -0.458 . . . . 25.0 109.763 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.12 31.13 79.68 Favored Glycine 0 C--O 1.218 -0.868 0 N-CA-C 114.78 0.672 . . . . 25.0 114.78 174.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.74 -25.05 20.93 Favored Glycine 0 C--O 1.22 -0.777 0 C-N-CA 121.027 -0.606 . . . . 25.0 113.203 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -63.77 -28.27 69.76 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.724 0.774 . . . . 25.0 109.532 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 35.0 tp -63.67 -39.54 94.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.794 -0.639 . . . . 25.0 111.004 176.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.5 t -70.63 -39.88 76.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.352 -0.61 . . . . 25.0 109.352 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -61.07 -48.2 82.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.418 0.628 . . . . 25.0 110.028 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.6 m -61.55 -40.03 93.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.039 -0.528 . . . . 25.0 110.829 178.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.1 mt -62.97 -37.06 85.61 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 121.81 -0.556 . . . . 25.0 111.458 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -64.45 -45.98 85.08 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.688 -0.486 . . . . 25.0 109.688 175.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -63.46 -46.18 87.4 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.977 0.732 . . . . 25.0 112.977 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.7 t -71.42 -40.56 72.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 111.887 0.328 . . . . 25.0 111.887 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 77.0 m -86.64 -30.31 21.87 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.45 1.278 . . . . 25.0 114.45 -174.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.14 -127.55 45.15 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.227 -0.987 . . . . 25.0 115.224 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -56.47 -33.1 65.6 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 116.362 1.986 . . . . 25.0 116.362 -173.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 . . . . . 0 C--N 1.323 -0.546 0 N-CA-C 114.058 1.133 . . . . 25.0 114.058 -174.322 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.838 0.351 . . . . 25.0 111.518 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.37 -146.46 48.81 Favored Glycine 0 C--N 1.324 -0.127 0 C-N-CA 120.746 -0.74 . . . . 25.0 111.624 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.75 -26.4 69.91 Favored Glycine 0 C--O 1.21 -1.37 0 C-N-CA 121.006 -0.616 . . . . 25.0 112.471 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -61.12 -30.93 70.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.695 0.747 . . . . 25.0 111.222 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.83 -44.91 68.98 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 109.326 -0.62 . . . . 25.0 109.326 178.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.2 t -63.71 -43.07 97.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.573 -0.739 . . . . 25.0 109.979 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -62.72 -41.73 99.3 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.563 0.697 . . . . 25.0 110.216 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 48.2 m -68.62 -38.9 80.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.34 -0.391 . . . . 25.0 110.293 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.8 mt -63.54 -37.18 86.32 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 121.964 -0.46 . . . . 25.0 110.364 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -65.48 -42.16 92.51 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 110.292 -0.262 . . . . 25.0 110.292 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -64.84 -45.66 85.17 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.595 0.591 . . . . 25.0 112.595 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.2 t -73.77 -43.37 53.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 111.788 0.292 . . . . 25.0 111.788 -176.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 69.3 m -87.45 -28.44 22.09 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.291 0.849 . . . . 25.0 113.291 -175.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.14 -142.46 41.34 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.572 -0.823 . . . . 25.0 112.34 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -66.55 -18.77 65.55 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 123.911 0.884 . . . . 25.0 113.11 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 . . . . . 0 C--N 1.326 -0.426 0 N-CA-C 112.114 0.413 . . . . 25.0 112.114 -178.692 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.517 -0.308 0 N-CA-C 107.487 -1.301 . . . . 25.0 107.487 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.28 -145.36 49.55 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.238 -0.982 . . . . 25.0 110.724 -178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.87 -24.63 70.13 Favored Glycine 0 C--O 1.205 -1.676 0 C-N-CA 120.974 -0.631 . . . . 25.0 113.255 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -61.02 -34.98 75.68 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.314 1.057 . . . . 25.0 111.473 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 25.5 tp -69.38 -39.88 77.76 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.153 -0.684 . . . . 25.0 109.153 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 89.2 t -66.9 -40.43 85.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.741 -0.663 . . . . 25.0 110.203 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -61.76 -40.68 96.01 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.031 -0.729 . . . . 25.0 109.031 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.2 m -68.39 -38.75 81.63 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 116.245 -0.434 . . . . 25.0 110.854 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.6 mt -61.61 -36.95 82.18 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 121.585 -0.697 . . . . 25.0 109.971 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -68.77 -37.82 79.6 Favored 'General case' 0 C--O 1.216 -0.683 0 O-C-N 122.27 -0.269 . . . . 25.0 111.436 174.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -65.85 -41.12 92.09 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.821 -0.55 . . . . 25.0 112.224 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.6 t -77.48 -37.24 24.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 112.286 0.476 . . . . 25.0 112.286 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 70.0 m -129.56 -37.53 1.58 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.895 1.813 . . . . 25.0 115.895 -175.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 51.21 -109.7 0.83 Allowed Glycine 0 N--CA 1.462 0.416 0 N-CA-C 116.133 1.213 . . . . 25.0 116.133 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -58.08 -23.12 53.44 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.967 0.907 . . . . 25.0 113.394 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 51.9 mmm-85 . . . . . 0 C--N 1.326 -0.423 0 O-C-N 122.166 -0.334 . . . . 25.0 111.282 179.061 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.467 0.377 0 N-CA-C 110.232 -0.285 . . . . 25.0 110.232 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -44.6 131.65 7.5 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 114.546 0.579 . . . . 25.0 114.546 -175.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.95 -57.82 4.56 Favored Glycine 0 C--O 1.216 -0.993 0 O-C-N 122.827 -0.219 . . . . 25.0 113.479 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -64.93 -38.49 91.14 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.763 0.792 . . . . 25.0 112.564 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.1 tp -68.38 -37.28 80.27 Favored 'General case' 0 C--O 1.211 -0.968 0 N-CA-C 109.31 -0.626 . . . . 25.0 109.31 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.8 t -69.84 -38.31 75.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.647 -0.706 . . . . 25.0 109.85 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -58.95 -46.85 87.02 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.507 0.67 . . . . 25.0 109.3 174.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.5 m -65.38 -38.48 90.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.156 -0.475 . . . . 25.0 112.052 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.6 mt -61.98 -40.11 94.48 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.486 -0.759 . . . . 25.0 109.422 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -67.43 -35.43 79.22 Favored 'General case' 0 C--O 1.217 -0.637 0 O-C-N 122.166 -0.334 . . . . 25.0 111.069 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -66.31 -51.14 60.35 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 122.071 -0.393 . . . . 25.0 112.059 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.2 t -71.0 -42.61 76.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.29 0.478 . . . . 25.0 112.29 -174.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 51.2 m -86.76 -22.26 26.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.26 0.552 . . . . 25.0 112.069 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.19 -149.11 48.05 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-O 122.208 0.893 . . . . 25.0 112.4 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -64.51 -6.26 7.08 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.234 -0.983 . . . . 25.0 113.086 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.0 mmp_? . . . . . 0 C--O 1.217 -0.648 0 O-C-N 120.971 -1.08 . . . . 25.0 111.595 -179.8 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.217 -0.618 0 CA-C-O 120.818 0.342 . . . . 25.0 111.247 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.69 28.7 65.83 Favored Glycine 0 C--O 1.219 -0.839 0 C-N-CA 120.842 -0.694 . . . . 25.0 114.274 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.8 -20.96 35.85 Favored Glycine 0 C--O 1.221 -0.672 0 CA-C-O 119.681 -0.511 . . . . 25.0 113.607 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -62.23 -27.62 69.12 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 117.867 0.834 . . . . 25.0 110.483 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.77 -43.09 94.51 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 116.071 -0.513 . . . . 25.0 111.007 177.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 74.9 t -66.66 -38.85 82.45 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.844 0 N-CA-C 108.847 -0.798 . . . . 25.0 108.847 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -58.79 -48.11 82.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.956 0.407 . . . . 25.0 110.536 177.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.4 m -63.27 -40.37 97.21 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.954 -0.466 . . . . 25.0 111.545 177.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.0 mt -63.08 -36.98 85.41 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 121.944 -0.473 . . . . 25.0 110.777 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -69.14 -38.64 78.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.857 0.361 . . . . 25.0 110.384 176.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -64.01 -39.1 93.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.206 0.526 . . . . 25.0 111.015 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 79.7 t -79.77 -43.46 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 112.377 0.51 . . . . 25.0 112.377 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.5 m -148.98 34.62 0.75 Allowed 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 115.14 1.533 . . . . 25.0 115.14 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.55 -46.98 93.2 Favored Glycine 0 C--O 1.223 -0.573 0 C-N-CA 119.858 -1.163 . . . . 25.0 113.555 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -61.97 -43.85 97.98 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.535 0.683 . . . . 25.0 112.552 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 . . . . . 0 C--N 1.324 -0.503 0 N-CA-C 112.786 0.661 . . . . 25.0 112.786 -177.137 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.223 -0.292 0 N-CA-C 106.971 -1.492 . . . . 25.0 106.971 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.34 30.81 75.14 Favored Glycine 0 C--O 1.22 -0.768 0 C-N-CA 120.787 -0.721 . . . . 25.0 114.535 174.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.29 -25.34 9.28 Favored Glycine 0 C--O 1.221 -0.667 0 C-N-CA 121.138 -0.553 . . . . 25.0 114.047 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -65.05 -27.03 68.52 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.239 1.02 . . . . 25.0 110.409 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 27.6 tp -61.46 -40.01 92.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.967 -0.56 . . . . 25.0 110.167 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 90.5 t -71.97 -36.38 57.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.273 -0.421 . . . . 25.0 109.982 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.0 -45.36 93.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.43 0.634 . . . . 25.0 109.368 176.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.5 m -63.18 -40.03 96.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.109 -0.496 . . . . 25.0 111.113 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.0 mt -61.65 -38.27 87.09 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.752 -0.593 . . . . 25.0 110.472 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -67.52 -39.56 85.09 Favored 'General case' 0 C--O 1.219 -0.538 0 O-C-N 122.004 -0.435 . . . . 25.0 110.8 175.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -66.63 -46.81 74.6 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.722 0.638 . . . . 25.0 112.722 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.4 t -71.58 -42.46 71.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 111.683 0.253 . . . . 25.0 111.683 -176.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 34.9 m -90.39 -26.51 19.87 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.223 0.823 . . . . 25.0 113.223 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.23 -145.74 49.41 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-O 122.204 0.891 . . . . 25.0 113.479 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -58.24 -17.85 22.19 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.918 1.081 . . . . 25.0 113.918 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 . . . . . 0 C--N 1.328 -0.346 0 O-C-N 121.735 -0.603 . . . . 25.0 112.371 -177.741 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.226 -0.172 0 CA-C-O 120.8 0.333 . . . . 25.0 111.164 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.37 -143.69 48.67 Favored Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 120.691 -0.766 . . . . 25.0 113.39 175.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.38 -21.15 75.85 Favored Glycine 0 C--O 1.213 -1.172 0 C-N-CA 121.284 -0.484 . . . . 25.0 113.197 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -69.35 -27.19 65.13 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 117.618 0.709 . . . . 25.0 109.325 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.27 -43.53 67.0 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 121.522 0.677 . . . . 25.0 109.528 174.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.5 t -64.15 -38.5 82.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.164 -0.926 . . . . 25.0 110.057 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -61.59 -48.36 81.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.164 0.507 . . . . 25.0 110.94 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 50.2 m -63.59 -35.94 82.16 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.966 -0.459 . . . . 25.0 111.293 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.6 mt -64.61 -39.77 94.3 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.707 -0.479 . . . . 25.0 109.707 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -67.32 -36.73 82.08 Favored 'General case' 0 C--O 1.219 -0.508 0 O-C-N 121.79 -0.569 . . . . 25.0 110.586 176.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -64.9 -51.56 61.29 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 121.923 -0.485 . . . . 25.0 111.753 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -73.48 -30.78 30.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 112.847 0.684 . . . . 25.0 112.847 -174.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.5 m -99.08 -22.05 15.88 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.16 0.8 . . . . 25.0 113.16 -177.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.39 -163.47 53.86 Favored Glycine 0 C--N 1.321 -0.303 0 CA-C-O 121.834 0.685 . . . . 25.0 111.887 -177.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -71.32 -7.17 45.3 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.751 0.821 . . . . 25.0 111.444 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 115.526 -0.761 . . . . 25.0 111.849 -177.641 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.224 -0.268 0 N-CA-C 108.814 -0.81 . . . . 25.0 108.814 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.77 33.3 84.77 Favored Glycine 0 C--O 1.218 -0.879 0 N-CA-C 114.937 0.735 . . . . 25.0 114.937 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.63 -25.37 7.41 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.999 -0.62 . . . . 25.0 113.311 -178.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -63.45 -31.15 72.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.562 0.681 . . . . 25.0 109.224 177.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 33.2 tp -61.79 -41.86 98.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.923 -0.58 . . . . 25.0 111.448 176.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.9 t -67.52 -41.5 85.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.267 -0.642 . . . . 25.0 109.267 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -61.67 -40.61 95.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.397 0.618 . . . . 25.0 109.966 177.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.8 m -66.69 -40.58 88.58 Favored 'General case' 0 C--O 1.215 -0.725 0 O-C-N 121.933 -0.479 . . . . 25.0 111.216 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.4 mt -62.21 -38.82 90.62 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.63 -0.669 . . . . 25.0 110.563 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -67.04 -39.69 87.01 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.197 -0.456 . . . . 25.0 110.453 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -66.76 -47.75 71.23 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.27 0.47 . . . . 25.0 112.27 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.9 t -67.5 -43.68 87.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.405 0.52 . . . . 25.0 112.405 -175.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -95.26 -15.93 22.83 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.511 0.93 . . . . 25.0 113.511 -176.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.01 -142.87 46.16 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-O 122.067 0.815 . . . . 25.0 112.595 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -71.1 0.36 7.82 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.052 1.13 . . . . 25.0 114.052 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 . . . . . 0 C--N 1.328 -0.328 0 O-C-N 121.462 -0.774 . . . . 25.0 110.95 178.781 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.219 -0.512 0 N-CA-C 110.051 -0.352 . . . . 25.0 110.051 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.17 23.0 63.6 Favored Glycine 0 C--O 1.214 -1.098 0 N-CA-C 115.642 1.017 . . . . 25.0 115.642 174.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.42 -26.47 24.23 Favored Glycine 0 C--O 1.218 -0.85 0 CA-C-O 119.577 -0.568 . . . . 25.0 112.801 -178.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.99 -28.64 67.86 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.796 0.808 . . . . 25.0 110.4 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 30.7 tp -60.95 -40.16 92.29 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.522 -0.763 . . . . 25.0 111.236 176.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 82.5 t -69.58 -41.27 80.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.012 -0.736 . . . . 25.0 109.012 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -64.0 -40.82 97.22 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.914 0.864 . . . . 25.0 109.925 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.3 m -66.83 -40.06 87.87 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.726 -0.67 . . . . 25.0 110.456 178.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.7 mt -62.62 -37.87 87.96 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.118 -0.363 . . . . 25.0 110.415 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -62.32 -45.68 92.14 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.829 -0.544 . . . . 25.0 110.115 175.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -66.9 -45.8 76.86 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.125 0.787 . . . . 25.0 113.125 -176.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.4 t -69.26 -38.5 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 120.875 0.369 . . . . 25.0 111.357 -177.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.5 m -88.06 -24.37 23.47 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.579 0.955 . . . . 25.0 113.579 -175.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.76 -144.42 38.36 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-O 121.693 0.607 . . . . 25.0 113.707 177.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -65.29 -12.08 48.05 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.135 0.791 . . . . 25.0 113.135 -178.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.9 mtm180 . . . . . 0 C--N 1.323 -0.579 0 N-CA-C 113.383 0.882 . . . . 25.0 113.383 -173.497 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.456 -0.172 0 N-CA-C 113.135 0.791 . . . . 25.0 113.135 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.78 -143.16 47.5 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.022 -0.608 . . . . 25.0 112.172 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.98 -23.75 71.3 Favored Glycine 0 C--O 1.213 -1.167 0 C-N-CA 121.047 -0.597 . . . . 25.0 113.073 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -65.36 -35.62 81.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.827 0.813 . . . . 25.0 110.347 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 41.2 tp -66.38 -43.31 86.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.381 0.61 . . . . 25.0 109.625 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.8 t -67.08 -39.67 83.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.78 -0.645 . . . . 25.0 110.289 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -64.16 -43.44 95.16 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.115 0.483 . . . . 25.0 110.294 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.8 m -62.76 -41.26 99.13 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.143 -0.348 . . . . 25.0 110.609 177.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.4 mt -60.73 -37.22 81.01 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.792 -0.568 . . . . 25.0 110.501 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -71.79 -34.74 69.66 Favored 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 112.072 0.397 . . . . 25.0 112.072 176.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -64.93 -38.26 90.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.285 0.564 . . . . 25.0 110.259 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.1 t -74.29 -42.51 50.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 112.795 0.665 . . . . 25.0 112.795 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.9 m -140.65 -4.87 1.22 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 118.775 2.879 . . . . 25.0 118.775 -176.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.59 170.45 29.06 Favored Glycine 0 C--O 1.218 -0.895 0 O-C-N 121.551 -0.718 . . . . 25.0 112.996 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -62.93 -47.31 83.78 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.003 1.112 . . . . 25.0 114.003 -175.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 45.0 mtm-85 . . . . . 0 C--N 1.317 -0.829 0 C-N-CA 124.156 0.982 . . . . 25.0 108.995 176.556 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.212 -0.884 0 N-CA-C 107.264 -1.384 . . . . 25.0 107.264 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.95 23.82 5.77 Favored Glycine 0 C--O 1.217 -0.929 0 N-CA-C 119.133 2.413 . . . . 25.0 119.133 175.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.63 -25.6 15.33 Favored Glycine 0 C--O 1.217 -0.911 0 CA-C-N 118.191 0.995 . . . . 25.0 112.485 -176.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -59.81 -29.92 68.57 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.184 0.993 . . . . 25.0 110.183 175.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.1 tp -61.43 -37.98 85.48 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.132 -0.94 . . . . 25.0 112.062 176.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.5 t -68.57 -41.37 82.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.145 -0.687 . . . . 25.0 109.145 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.44 -43.48 98.79 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.433 -0.58 . . . . 25.0 109.433 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.9 m -64.28 -39.56 94.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.568 -0.287 . . . . 25.0 110.714 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.8 mt -65.84 -38.39 88.75 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.824 -0.548 . . . . 25.0 110.85 178.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -66.21 -39.57 89.73 Favored 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 110.183 -0.302 . . . . 25.0 110.183 176.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -66.12 -44.01 85.48 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.499 0.555 . . . . 25.0 112.499 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.3 t -76.51 -41.06 34.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.368 0.507 . . . . 25.0 112.368 -176.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 40.3 m -93.29 -31.12 14.82 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.851 1.056 . . . . 25.0 113.851 -174.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.69 -137.91 49.01 Favored Glycine 0 CA--C 1.518 0.256 0 CA-C-O 121.89 0.716 . . . . 25.0 113.346 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -55.71 -25.26 39.24 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.172 1.175 . . . . 25.0 114.172 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 . . . . . 0 N--CA 1.468 0.463 0 O-C-N 121.904 -0.497 . . . . 25.0 111.967 -177.339 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 106.25 -1.759 . . . . 25.0 106.25 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.01 31.73 77.63 Favored Glycine 0 C--O 1.215 -1.059 0 C-N-CA 120.823 -0.703 . . . . 25.0 114.339 175.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.95 -22.27 19.2 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 121.069 -0.586 . . . . 25.0 114.245 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -65.51 -28.49 69.22 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.607 1.203 . . . . 25.0 110.353 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.0 tp -61.91 -41.82 98.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.088 -0.506 . . . . 25.0 110.361 174.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.6 t -68.85 -40.61 81.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.495 -0.557 . . . . 25.0 109.495 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -61.85 -36.76 82.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.063 0.459 . . . . 25.0 110.328 178.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.2 m -70.38 -39.95 74.27 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-N 116.527 -0.306 . . . . 25.0 111.168 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.2 mt -62.06 -38.21 87.93 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.469 -0.769 . . . . 25.0 110.59 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -65.13 -42.55 93.75 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 116.692 -0.231 . . . . 25.0 110.681 176.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -64.97 -45.69 84.62 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.927 0.343 . . . . 25.0 111.927 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.4 t -70.7 -42.95 77.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.049 0.388 . . . . 25.0 112.049 -176.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -98.09 -21.65 16.66 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 116.11 1.893 . . . . 25.0 116.11 -173.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.4 -142.77 47.52 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.457 -0.878 . . . . 25.0 113.306 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -68.08 -11.08 58.39 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 114.474 1.287 . . . . 25.0 114.474 -176.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 . . . . . 0 N--CA 1.467 0.378 0 O-C-N 121.582 -0.699 . . . . 25.0 111.97 -178.732 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 66.9 m . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 115.363 1.616 . . . . 25.0 115.363 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.73 -134.96 4.6 Favored Glycine 0 C--O 1.222 -0.613 0 N-CA-C 114.635 0.614 . . . . 25.0 114.635 -173.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.99 -21.02 60.83 Favored Glycine 0 C--O 1.218 -0.881 0 C-N-CA 121.115 -0.564 . . . . 25.0 112.711 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -64.59 -33.3 75.6 Favored 'General case' 0 C--O 1.214 -0.802 0 O-C-N 122.178 -0.601 . . . . 25.0 110.503 176.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.4 tp -68.85 -39.68 79.77 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.689 -0.485 . . . . 25.0 109.689 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.95 -40.83 90.45 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 N-CA-C 108.983 -0.747 . . . . 25.0 108.983 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.68 -49.14 78.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.862 -0.153 . . . . 25.0 111.048 176.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.3 m -60.99 -41.18 95.97 Favored 'General case' 0 C--O 1.219 -0.551 0 C-N-CA 121.12 -0.232 . . . . 25.0 111.005 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.1 mt -63.72 -40.4 96.67 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 121.782 -0.574 . . . . 25.0 110.557 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -68.04 -35.39 78.17 Favored 'General case' 0 C--O 1.217 -0.628 0 O-C-N 121.955 -0.466 . . . . 25.0 110.653 177.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -66.99 -44.77 79.54 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.971 -0.455 . . . . 25.0 112.064 178.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.8 t -79.91 -42.68 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 O-C-N 121.886 -0.509 . . . . 25.0 111.629 -177.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.0 m -89.93 -22.28 22.05 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 114.042 1.127 . . . . 25.0 114.042 -174.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.82 -164.71 54.82 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 109.878 -1.289 . . . . 25.0 109.878 -176.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -73.01 0.79 10.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.519 0.676 . . . . 25.0 112.777 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 . . . . . 0 C--N 1.326 -0.419 0 O-C-N 121.66 -0.65 . . . . 25.0 111.403 179.193 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.469 0.491 0 N-CA-C 113.074 0.768 . . . . 25.0 113.074 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.89 -146.85 9.48 Favored Glycine 0 C--O 1.225 -0.459 0 C-N-CA 121.174 -0.536 . . . . 25.0 111.97 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -58.12 -23.71 53.03 Favored Glycine 0 C--O 1.212 -1.269 0 C-N-CA 121.236 -0.507 . . . . 25.0 113.301 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -59.17 -27.02 65.29 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.388 0.514 . . . . 25.0 112.388 176.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 45.9 tp -68.69 -43.2 76.6 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.256 -0.646 . . . . 25.0 109.256 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.88 -39.65 86.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.627 -0.879 . . . . 25.0 108.627 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -64.01 -44.7 91.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.214 0.531 . . . . 25.0 110.657 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.3 m -66.39 -37.03 84.35 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 121.812 -0.555 . . . . 25.0 110.351 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.3 mt -63.54 -37.67 88.2 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 121.912 -0.492 . . . . 25.0 110.373 177.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -66.11 -37.95 86.99 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 122.316 -0.24 . . . . 25.0 110.981 175.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -66.39 -47.88 71.89 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 122.03 -0.418 . . . . 25.0 112.071 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.7 t -77.98 -38.62 24.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 113.167 0.803 . . . . 25.0 113.167 -173.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 50.8 t -89.41 -17.04 29.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.938 0.875 . . . . 25.0 110.801 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.96 -169.72 55.04 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 109.773 -1.331 . . . . 25.0 109.773 -176.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -67.84 3.59 1.44 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.464 1.283 . . . . 25.0 114.464 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.354 0 O-C-N 121.757 -0.589 . . . . 25.0 112.446 -178.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 106.595 -1.631 . . . . 25.0 106.595 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.78 32.71 80.16 Favored Glycine 0 C--O 1.213 -1.165 0 N-CA-C 116.088 1.195 . . . . 25.0 116.088 171.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.33 -35.8 3.73 Favored Glycine 0 C--O 1.218 -0.858 0 CA-C-N 117.46 0.63 . . . . 25.0 113.609 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -59.02 -32.05 69.37 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.792 0.796 . . . . 25.0 110.592 178.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 44.0 tp -60.38 -38.55 84.28 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.748 -0.66 . . . . 25.0 110.872 176.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.8 t -71.93 -41.29 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.2 -0.454 . . . . 25.0 110.15 -177.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -62.93 -39.28 94.13 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.928 -0.767 . . . . 25.0 108.928 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 32.5 m -63.7 -43.11 97.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.869 -0.605 . . . . 25.0 110.214 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.7 mt -62.95 -39.58 95.05 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 121.691 -0.631 . . . . 25.0 111.079 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -63.65 -43.75 95.83 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.824 -0.35 . . . . 25.0 110.108 177.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -65.08 -47.11 78.43 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.602 0.593 . . . . 25.0 112.602 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.2 t -70.05 -41.42 79.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 120.879 0.371 . . . . 25.0 111.552 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 66.2 m -83.7 -30.98 26.33 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.142 0.793 . . . . 25.0 113.142 -175.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.71 -134.84 35.35 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.658 -0.782 . . . . 25.0 112.427 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -64.9 -13.54 57.06 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 114.08 1.141 . . . . 25.0 114.08 -178.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 . . . . . 0 C--N 1.326 -0.434 0 N-CA-C 116.05 1.87 . . . . 25.0 116.05 -176.459 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 107.246 -1.39 . . . . 25.0 107.246 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.68 -144.5 48.91 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.477 -0.868 . . . . 25.0 112.424 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.95 -21.07 67.39 Favored Glycine 0 C--O 1.216 -0.971 0 CA-C-O 119.551 -0.583 . . . . 25.0 114.063 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -67.07 -38.48 85.84 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.398 1.099 . . . . 25.0 110.317 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tt -67.48 -43.64 80.49 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.114 -1.069 . . . . 25.0 108.114 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.0 t -62.07 -42.69 95.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.648 -0.706 . . . . 25.0 111.152 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -62.13 -39.39 92.4 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.941 0.401 . . . . 25.0 110.285 178.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.2 m -67.47 -41.22 84.97 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.213 -0.292 . . . . 25.0 110.213 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.9 mt -60.83 -41.08 95.06 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 122.038 -0.414 . . . . 25.0 110.3 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -68.75 -34.72 76.06 Favored 'General case' 0 C--O 1.217 -0.647 0 O-C-N 122.396 -0.19 . . . . 25.0 111.367 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -67.22 -46.71 72.99 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.96 -0.463 . . . . 25.0 111.609 176.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.9 t -71.49 -39.69 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 120.981 0.419 . . . . 25.0 111.769 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 9.1 t -96.93 -24.2 15.95 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.525 1.305 . . . . 25.0 114.525 -172.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.24 -160.34 49.62 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 110.515 -1.034 . . . . 25.0 110.515 -174.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.79 0.53 5.54 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.683 0.994 . . . . 25.0 113.683 -177.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 . . . . . 0 C--N 1.326 -0.444 0 N-CA-C 114.863 1.431 . . . . 25.0 114.863 -173.157 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.207 -1.139 0 CA-C-O 122.853 1.311 . . . . 25.0 113.978 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -77.92 -22.64 49.31 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 122.132 0.968 . . . . 25.0 111.757 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -79.18 147.05 68.49 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.339 -0.846 . . . . 25.0 108.732 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.11 152.32 27.65 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 118.346 -0.636 . . . . 25.0 112.968 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.1 m -97.45 35.29 1.66 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.404 -0.817 . . . . 25.0 111.037 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -76.41 -17.06 59.54 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.264 1.209 . . . . 25.0 114.264 -173.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.5 p 54.78 173.6 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.684 1.194 . . . . 25.0 113.406 -174.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.1 tp -138.9 109.32 6.52 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.561 0.696 . . . . 25.0 110.425 -175.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.3 m -132.86 167.98 19.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.337 -0.847 . . . . 25.0 112.555 -172.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.39 -146.09 50.07 Favored Glycine 0 C--O 1.227 -0.303 0 CA-C-N 115.892 -0.594 . . . . 25.0 114.373 172.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.59 -23.52 72.18 Favored Glycine 0 C--O 1.211 -1.321 0 C-N-CA 121.124 -0.56 . . . . 25.0 112.937 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -69.13 -27.39 65.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.649 0.725 . . . . 25.0 110.66 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.6 tp -70.73 -39.88 73.11 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.91 -0.774 . . . . 25.0 108.91 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 69.2 t -67.18 -41.04 86.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.065 -0.516 . . . . 25.0 109.883 178.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -59.17 -46.22 88.97 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 122.889 0.476 . . . . 25.0 110.191 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 48.2 m -63.04 -39.93 96.21 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 116.528 -0.305 . . . . 25.0 111.467 177.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.4 mt -62.0 -39.2 91.44 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 121.622 -0.674 . . . . 25.0 110.56 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -69.01 -38.17 79.1 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 116.934 -0.121 . . . . 25.0 110.724 176.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -65.64 -44.78 85.37 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.06 -0.4 . . . . 25.0 112.054 177.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.1 t -72.79 -39.35 59.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.154 0.428 . . . . 25.0 112.154 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 t -98.7 -15.7 19.28 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 115.033 1.494 . . . . 25.0 115.033 -176.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.24 -142.31 37.27 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-O 122.101 0.834 . . . . 25.0 113.3 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -72.95 -11.23 60.5 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 123.615 0.766 . . . . 25.0 112.886 -177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.7 mtp180 -72.52 -15.05 61.78 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 114.066 1.136 . . . . 25.0 114.066 -172.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.43 168.97 45.42 Favored Glycine 0 C--O 1.226 -0.395 0 C-N-CA 121.07 -0.586 . . . . 25.0 112.508 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -151.77 168.37 25.27 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 122.29 -0.535 . . . . 25.0 110.075 -175.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.428 ' CE1' ' HA ' ' A' ' 61' ' ' ALA . 34.3 m-85 -114.51 159.6 20.19 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.126 -0.694 . . . . 25.0 109.126 175.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -128.03 177.4 6.91 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.546 -0.297 . . . . 25.0 110.201 -175.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 m -59.71 129.56 42.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.56 0.219 . . . . 25.0 110.898 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.28 -52.14 1.87 Allowed Pre-proline 0 N--CA 1.469 0.499 0 N-CA-C 115.722 1.749 . . . . 25.0 115.722 176.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -83.73 151.66 13.03 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 N-CA-C 113.637 0.591 . . . . 25.0 113.637 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.12 26.0 0.89 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.013 -1.477 . . . . 25.0 107.013 174.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.9 p -90.41 147.21 23.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.2 -0.909 . . . . 25.0 113.405 -170.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.05 -29.84 68.06 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 115.804 -0.635 . . . . 25.0 110.333 173.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.7 m -85.17 166.2 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.706 -0.679 . . . . 25.0 111.487 -176.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.19 90.5 0.21 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 115.047 1.499 . . . . 25.0 115.047 -176.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -131.63 60.02 1.68 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.351 -0.981 . . . . 25.0 108.351 174.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.78 136.94 58.22 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.553 -0.536 . . . . 25.0 109.553 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.1 t -163.39 -178.34 5.84 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 105.881 -1.896 . . . . 25.0 105.881 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -82.79 165.44 19.87 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.086 -1.079 . . . . 25.0 108.086 175.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 178.93 137.23 2.82 Favored Glycine 0 C--O 1.221 -0.711 0 N-CA-C 110.058 -1.217 . . . . 25.0 110.058 175.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.451 HD11 ' HG ' ' A' ' 56' ' ' LEU . 7.6 tp -62.03 -29.4 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-O 121.459 0.647 . . . . 25.0 111.926 -177.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.4 t -68.09 -35.16 70.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 O-C-N 121.112 -0.992 . . . . 25.0 109.865 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -68.1 -29.61 68.58 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.904 0.705 . . . . 25.0 112.904 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -99.8 -27.43 13.64 Favored 'General case' 0 C--O 1.21 -0.997 0 N-CA-C 113.491 0.923 . . . . 25.0 113.491 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 75.2 m -102.18 -19.71 14.98 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 115.14 1.533 . . . . 25.0 115.14 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 47.6 t -113.25 -49.17 2.92 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 117.733 0.242 . . . . 25.0 111.631 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -74.58 -29.15 61.22 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.377 0.608 . . . . 25.0 109.39 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -125.49 -171.33 2.35 Favored 'General case' 0 C--O 1.215 -0.718 0 N-CA-C 105.944 -1.873 . . . . 25.0 105.944 172.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.6 t -113.59 145.16 41.7 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.66 -1.607 . . . . 25.0 106.66 173.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 29.2 p -123.99 168.63 12.57 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 122.569 0.347 . . . . 25.0 110.164 -175.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.76 165.29 13.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.453 -0.34 . . . . 25.0 110.537 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.5 tp -57.94 -42.23 84.45 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.763 1.023 . . . . 25.0 113.763 -176.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.49 -37.06 84.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.165 0.507 . . . . 25.0 110.094 -176.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.2 tp -69.26 -46.02 68.29 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.854 -0.612 . . . . 25.0 109.592 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.451 ' HG ' HD11 ' A' ' 42' ' ' ILE . 2.9 tt -58.97 -35.8 73.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.278 0.561 . . . . 25.0 111.638 -177.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -61.65 -23.63 66.19 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.572 0.953 . . . . 25.0 113.572 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.7 p -70.35 -14.11 62.43 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 121.536 -0.727 . . . . 25.0 112.765 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -87.69 6.98 32.16 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.02 0.378 . . . . 25.0 112.02 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.9 m -58.89 148.82 28.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.888 0.375 . . . . 25.0 110.176 172.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.428 ' HA ' ' CE1' ' A' ' 27' ' ' TYR . . . -75.32 155.15 36.87 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.731 -0.84 . . . . 25.0 108.731 176.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.4 p -73.67 146.24 85.54 Favored Pre-proline 0 N--CA 1.443 -0.817 0 CA-C-N 116.111 -0.495 . . . . 25.0 110.665 -177.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.93 149.98 48.94 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 121.934 1.756 . . . . 25.0 112.816 174.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.46 161.03 19.15 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.352 -0.981 . . . . 25.0 108.352 176.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -146.49 149.92 34.58 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 106.883 -1.525 . . . . 25.0 106.883 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.2 t -150.1 148.81 29.43 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 105.224 -2.139 . . . . 25.0 105.224 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 . . . . . 1 C--O 1.307 4.101 0 CA-C-O 114.02 -2.895 . . . . 25.0 111.642 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 124.131 1.92 . . . . 25.0 114.211 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -99.82 -164.82 1.16 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.624 -1.171 . . . . 25.0 111.06 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -60.9 147.87 84.52 Favored Pre-proline 0 C--N 1.329 -0.305 0 C-N-CA 122.348 0.259 . . . . 25.0 111.33 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -75.89 152.69 36.98 Favored 'Trans proline' 0 C--N 1.344 0.305 0 N-CA-C 113.943 0.709 . . . . 25.0 113.943 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.4 p -82.38 46.62 1.06 Allowed 'General case' 0 C--O 1.209 -1.041 0 C-N-CA 124.24 1.016 . . . . 25.0 113.165 -176.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -76.91 -57.2 3.98 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.28 0.474 . . . . 25.0 112.28 -177.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.7 p -141.84 163.33 33.18 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 109.873 -0.417 . . . . 25.0 109.873 -175.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.2 tp -128.5 115.03 17.52 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 123.298 0.639 . . . . 25.0 109.556 -176.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.7 m -133.3 166.23 22.98 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.21 0.529 . . . . 25.0 111.671 -173.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.45 -143.54 48.28 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-O 121.917 0.732 . . . . 25.0 114.861 172.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.4 -23.04 71.67 Favored Glycine 0 C--O 1.21 -1.394 0 CA-C-N 115.112 -0.544 . . . . 25.0 113.49 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -69.94 -28.78 65.85 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 118.126 0.963 . . . . 25.0 109.402 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.23 -42.43 84.05 Favored 'General case' 0 C--O 1.216 -0.68 0 N-CA-C 107.604 -1.258 . . . . 25.0 107.604 177.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.5 t -64.87 -40.76 90.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.057 -0.974 . . . . 25.0 110.793 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -60.67 -48.65 80.83 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 122.189 0.995 . . . . 25.0 108.647 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.9 m -59.61 -41.58 90.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.667 -0.697 . . . . 25.0 111.314 177.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.6 mt -64.43 -39.94 94.8 Favored 'General case' 0 CA--C 1.539 0.519 0 O-C-N 121.826 -0.546 . . . . 25.0 111.09 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -65.55 -35.98 82.45 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 118.293 0.497 . . . . 25.0 109.747 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -68.78 -49.55 57.67 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 120.091 -0.644 . . . . 25.0 112.717 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.8 t -70.45 -42.74 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 O-C-N 122.098 -0.376 . . . . 25.0 111.37 -175.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 58.3 m -87.68 -16.84 33.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.787 0.803 . . . . 25.0 111.357 -175.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.59 -167.09 53.81 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 108.795 -1.722 . . . . 25.0 108.795 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -71.09 0.22 8.11 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 122.061 0.934 . . . . 25.0 112.74 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.6 mtm180 -73.05 -10.12 59.46 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.181 0.808 . . . . 25.0 113.181 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.63 170.74 44.67 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-O 122.229 0.905 . . . . 25.0 113.254 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -155.33 169.54 23.98 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.073 -1.454 . . . . 25.0 107.073 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -111.16 142.86 42.79 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.376 -0.972 . . . . 25.0 108.376 173.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -114.48 150.58 34.59 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.863 -0.792 . . . . 25.0 108.863 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.428 ' H ' HG22 ' A' ' 42' ' ' ILE . 10.9 t 58.05 -137.07 0.92 Allowed 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.589 -0.523 . . . . 25.0 109.589 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.8 ppt_? -135.69 158.23 74.61 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 108.983 -0.747 . . . . 25.0 108.983 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -71.93 160.6 47.26 Favored 'Trans proline' 0 C--N 1.354 0.862 0 N-CA-C 115.051 1.135 . . . . 25.0 115.051 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.0 65.9 2.12 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 113.422 0.897 . . . . 25.0 113.422 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.4 m -70.12 138.02 51.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.569 -0.287 . . . . 25.0 110.728 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 12.3 mpt_? -92.16 -28.27 17.18 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.265 0.555 . . . . 25.0 110.69 175.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.3 m -90.14 159.11 2.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 CA-C-N 115.765 -0.652 . . . . 25.0 111.678 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.0 m -72.61 56.55 0.39 Allowed 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 114.175 1.176 . . . . 25.0 114.175 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -113.55 77.42 1.05 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 104.575 -2.38 . . . . 25.0 104.575 174.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 -54.58 111.85 0.89 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.812 0.815 . . . . 25.0 110.567 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.3 m -100.6 139.37 36.38 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.759 -1.2 . . . . 25.0 107.759 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.88 160.58 21.1 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.141 -0.689 . . . . 25.0 109.141 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -131.95 160.1 23.48 Favored Glycine 0 C--O 1.225 -0.44 0 N-CA-C 111.501 -0.639 . . . . 25.0 111.501 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.428 HG22 ' H ' ' A' ' 29' ' ' SER . 7.7 tp -57.25 -33.87 44.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 112.726 0.639 . . . . 25.0 112.726 -175.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.41 -27.22 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 O-C-N 121.458 -0.776 . . . . 25.0 111.211 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -71.51 -42.74 67.62 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 120.795 -1.191 . . . . 25.0 109.451 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -83.12 -26.61 30.84 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 119.061 -1.055 . . . . 25.0 112.356 -175.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 70.3 m -98.66 -22.31 15.99 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 116.75 2.13 . . . . 25.0 116.75 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 35.8 t -113.0 -41.9 3.66 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.644 0.656 . . . . 25.0 112.426 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -79.2 -24.9 42.83 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.304 -0.628 . . . . 25.0 109.304 175.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 28.9 mtt180 -131.36 175.51 9.07 Favored 'General case' 0 C--O 1.215 -0.761 0 N-CA-C 104.803 -2.295 . . . . 25.0 104.803 175.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.5 t -94.17 152.81 18.46 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 106.376 -1.712 . . . . 25.0 106.376 172.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.6 p -134.71 165.99 23.97 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 123.591 0.557 . . . . 25.0 111.413 -177.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -121.77 163.97 18.22 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.403 0.52 . . . . 25.0 112.403 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.4 tp -53.1 -44.21 67.45 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.582 0.956 . . . . 25.0 113.582 -176.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.58 -40.01 90.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.658 0.742 . . . . 25.0 111.699 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.4 tp -69.82 -45.09 68.63 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 121.866 -0.521 . . . . 25.0 110.981 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 tt -59.14 -35.07 72.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.709 0.29 . . . . 25.0 111.397 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -62.28 -23.54 66.77 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.652 0.982 . . . . 25.0 113.652 177.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.2 p -76.34 -15.24 60.01 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 121.352 -0.842 . . . . 25.0 113.067 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -90.26 -0.29 57.56 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.485 -0.76 . . . . 25.0 111.271 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 78.4 m -70.51 147.1 49.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.428 0.632 . . . . 25.0 110.34 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.51 152.74 39.32 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 122.712 1.244 . . . . 25.0 111.192 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 51.6 p -119.68 137.48 25.64 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 102.736 -3.061 . . . . 25.0 102.736 171.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.07 168.15 25.49 Favored 'Trans proline' 0 C--N 1.35 0.612 0 O-C-N 122.264 0.613 . . . . 25.0 111.293 -175.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.64 143.85 57.5 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.601 -1.259 . . . . 25.0 107.601 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -69.86 -43.6 71.55 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.046 0.758 . . . . 25.0 113.046 -175.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.7 t -164.97 136.09 4.06 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 106.487 -1.672 . . . . 25.0 106.487 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 . . . . . 0 C--O 1.288 3.101 0 CA-C-O 113.396 -3.192 . . . . 25.0 109.39 174.536 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 123.751 1.738 . . . . 25.0 114.806 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -88.89 163.28 15.69 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 120.905 -1.122 . . . . 25.0 109.13 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -62.95 141.02 97.59 Favored Pre-proline 0 N--CA 1.468 0.427 0 N-CA-C 109.272 -0.64 . . . . 25.0 109.272 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.84 156.76 24.07 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 N-CA-C 114.626 0.972 . . . . 25.0 114.626 -173.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.2 p -89.11 40.84 1.0 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.195 -0.911 . . . . 25.0 110.387 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.99 -22.58 63.12 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.046 0.758 . . . . 25.0 113.046 -175.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.5 p 58.36 174.6 0.06 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 114.739 1.385 . . . . 25.0 114.739 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.4 tp -142.9 111.58 6.34 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.587 -1.634 . . . . 25.0 106.587 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -159.81 -171.11 3.13 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.837 -0.62 . . . . 25.0 109.891 -173.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.52 31.61 79.22 Favored Glycine 0 C--O 1.217 -0.923 0 C-N-CA 120.791 -0.719 . . . . 25.0 114.01 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.73 -24.88 15.29 Favored Glycine 0 C--O 1.224 -0.527 0 C-N-CA 121.239 -0.505 . . . . 25.0 113.143 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.39 -28.22 69.09 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.512 0.673 . . . . 25.0 110.057 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.36 -43.69 96.96 Favored 'General case' 0 C--O 1.216 -0.68 0 CA-C-N 116.04 -0.527 . . . . 25.0 110.886 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 80.5 t -67.53 -40.26 84.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.67 -0.695 . . . . 25.0 109.418 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -61.05 -47.17 87.6 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.274 0.559 . . . . 25.0 110.096 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.7 m -61.05 -42.07 97.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.114 -0.494 . . . . 25.0 111.077 177.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.9 mt -63.54 -38.78 92.43 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.916 -0.49 . . . . 25.0 110.89 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -67.54 -37.46 82.75 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 121.136 -0.226 . . . . 25.0 110.461 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -68.1 -45.86 72.56 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 122.033 -0.417 . . . . 25.0 112.075 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 82.1 t -70.77 -42.7 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 112.048 0.388 . . . . 25.0 112.048 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.3 m -96.99 -15.49 21.06 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.958 1.096 . . . . 25.0 113.958 -173.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.18 -161.79 49.8 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-O 122.424 1.013 . . . . 25.0 112.789 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -68.76 0.55 4.17 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.405 -0.897 . . . . 25.0 113.173 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -83.41 -11.67 57.31 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 121.165 -0.959 . . . . 25.0 111.511 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.96 174.08 46.66 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-O 121.939 0.744 . . . . 25.0 112.934 173.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -156.47 167.98 28.77 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.428 -0.582 . . . . 25.0 109.428 -174.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -100.49 147.27 26.07 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.48 0.657 . . . . 25.0 109.727 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -125.47 -177.96 4.07 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.757 -0.831 . . . . 25.0 108.757 -175.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.1 t -54.93 126.45 24.49 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.715 -0.846 . . . . 25.0 108.715 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -97.11 132.17 26.2 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.072 -0.513 . . . . 25.0 111.178 -170.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.2 153.83 70.87 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 118.182 -0.745 . . . . 25.0 113.612 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.2 168.34 15.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.498 -0.774 . . . . 25.0 110.552 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.0 m -145.59 165.26 29.19 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 105.804 -1.924 . . . . 25.0 105.804 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.4 mtm105 -65.52 -25.09 67.3 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.098 0.408 . . . . 25.0 111.104 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.8 m -88.92 145.55 7.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.283 -1.006 . . . . 25.0 108.283 175.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.6 m -75.11 70.22 2.07 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.907 0.706 . . . . 25.0 112.907 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -126.47 32.85 5.1 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.275 0.559 . . . . 25.0 110.011 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -72.07 158.24 36.31 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.026 -1.101 . . . . 25.0 108.026 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 73.8 p -146.84 159.39 43.58 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.003 -0.739 . . . . 25.0 109.003 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -67.96 140.69 56.42 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.332 -0.988 . . . . 25.0 108.332 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.76 161.56 14.44 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-O 121.536 0.52 . . . . 25.0 112.576 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.0 tp -65.3 -30.27 49.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 121.164 0.506 . . . . 25.0 110.259 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.2 t -64.7 -40.11 87.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 121.393 -0.817 . . . . 25.0 109.182 175.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -63.46 -27.15 69.09 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 114.724 1.379 . . . . 25.0 114.724 -178.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -101.65 -25.01 14.02 Favored 'General case' 0 C--O 1.206 -1.189 0 N-CA-C 112.793 0.664 . . . . 25.0 112.793 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 72.7 m -106.27 -24.0 12.41 Favored 'General case' 0 C--O 1.213 -0.834 0 N-CA-C 114.67 1.359 . . . . 25.0 114.67 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 44.9 t -104.27 -46.27 4.46 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 118.463 0.574 . . . . 25.0 110.874 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -72.5 -33.53 67.0 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.186 0.517 . . . . 25.0 109.899 177.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -134.07 -178.51 5.06 Favored 'General case' 0 C--O 1.213 -0.862 0 N-CA-C 107.412 -1.329 . . . . 25.0 107.412 177.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.7 p -93.08 154.51 18.06 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.143 -0.688 . . . . 25.0 109.143 175.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 32.1 p -139.04 164.88 28.6 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 122.434 0.293 . . . . 25.0 110.369 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -106.06 158.19 16.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.186 -0.461 . . . . 25.0 111.286 -178.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.0 tp -59.13 -45.48 90.83 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.684 0.624 . . . . 25.0 112.684 178.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.81 -37.02 82.85 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-O 120.901 0.381 . . . . 25.0 111.07 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.1 tp -68.5 -45.15 73.1 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.121 -0.696 . . . . 25.0 109.121 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 tt -60.53 -34.04 73.54 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.052 0.453 . . . . 25.0 111.023 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -62.5 -24.65 67.59 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.48 0.918 . . . . 25.0 113.48 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.6 p -76.66 -14.26 59.98 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.391 -0.818 . . . . 25.0 111.667 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -85.24 1.14 49.5 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.124 0.416 . . . . 25.0 112.124 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 80.6 m -70.2 152.73 43.93 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.98 0.419 . . . . 25.0 110.119 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.15 164.58 16.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.432 0.634 . . . . 25.0 110.706 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.9 p -66.2 142.92 98.12 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 115.696 -0.684 . . . . 25.0 109.916 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -69.93 154.59 66.89 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 CA-C-O 121.46 0.525 . . . . 25.0 113.032 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -124.8 160.71 28.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.12 -0.945 . . . . 25.0 109.564 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -76.66 151.43 36.16 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.884 -0.784 . . . . 25.0 108.884 177.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.2 p -154.37 146.53 23.73 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 104.831 -2.285 . . . . 25.0 104.831 174.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 . . . . . 1 C--O 1.307 4.084 0 CA-C-O 114.53 -2.652 . . . . 25.0 111.564 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.205 -1.281 0 CA-C-O 124.463 2.078 . . . . 25.0 112.521 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -66.03 -18.84 65.61 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 112.5 -2.136 . . . . 25.0 111.509 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.48 149.11 71.52 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 114.743 -1.117 . . . . 25.0 111.763 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -71.68 177.28 7.07 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 121.378 1.385 . . . . 25.0 112.015 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.2 p 53.9 69.43 0.71 Allowed 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 122.277 1.037 . . . . 25.0 110.564 -177.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -65.43 -16.55 63.74 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.303 1.223 . . . . 25.0 114.303 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.05 152.1 43.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.465 0.65 . . . . 25.0 111.119 -176.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.9 mt -129.3 130.1 45.73 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 115.008 -0.996 . . . . 25.0 109.721 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -166.09 -179.35 5.1 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 105.973 -1.862 . . . . 25.0 105.973 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.66 32.61 79.23 Favored Glycine 0 C--O 1.218 -0.897 0 C-N-CA 120.481 -0.866 . . . . 25.0 114.232 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.0 -25.54 19.32 Favored Glycine 0 C--O 1.219 -0.804 0 C-N-CA 121.045 -0.598 . . . . 25.0 113.969 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -63.95 -27.78 69.37 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 118.199 0.999 . . . . 25.0 110.583 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 24.6 tp -65.62 -40.57 92.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.064 -0.517 . . . . 25.0 110.178 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 85.1 t -69.49 -39.4 78.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.361 -0.607 . . . . 25.0 109.361 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -59.62 -46.39 89.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.685 0.755 . . . . 25.0 109.778 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.0 m -63.56 -39.66 94.99 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.971 -0.559 . . . . 25.0 111.299 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.5 mt -63.03 -38.19 90.18 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.905 -0.497 . . . . 25.0 110.976 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -66.37 -39.17 88.94 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.208 -0.293 . . . . 25.0 110.208 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -65.94 -48.04 72.69 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.599 0.592 . . . . 25.0 112.599 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.3 t -71.96 -41.59 68.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 112.024 0.379 . . . . 25.0 112.024 -175.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.0 m -90.65 -18.38 25.21 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.151 0.797 . . . . 25.0 113.151 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.36 -138.19 48.66 Favored Glycine 0 C--N 1.322 -0.218 0 CA-C-O 122.253 0.918 . . . . 25.0 113.917 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -70.56 -13.34 62.06 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.795 0.838 . . . . 25.0 112.486 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.5 mtp180 -79.22 -16.03 57.13 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.124 0.787 . . . . 25.0 113.124 -171.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.5 171.4 48.02 Favored Glycine 0 C--O 1.226 -0.358 0 C-N-CA 121.07 -0.586 . . . . 25.0 113.536 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -158.11 166.11 33.29 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.489 -0.56 . . . . 25.0 109.489 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -130.46 153.93 48.28 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.863 0.69 . . . . 25.0 112.863 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -103.74 137.15 42.17 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.613 0.721 . . . . 25.0 111.604 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.96 65.73 8.81 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.358 -0.837 . . . . 25.0 113.15 -177.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.03 147.84 49.04 Favored Pre-proline 0 N--CA 1.472 0.631 0 O-C-N 121.866 -0.522 . . . . 25.0 110.37 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.89 162.28 39.59 Favored 'Trans proline' 0 C--N 1.349 0.601 0 O-C-N 121.796 0.366 . . . . 25.0 112.981 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.88 19.58 8.48 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.32 0.581 . . . . 25.0 110.411 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 p -92.08 161.55 14.72 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.575 -0.528 . . . . 25.0 109.575 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 41.7 mtt180 -62.08 -23.57 66.59 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 112.346 0.498 . . . . 25.0 112.346 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.6 m -122.45 143.3 35.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 108.973 -0.751 . . . . 25.0 108.973 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 52.7 m -115.26 85.77 2.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.335 -0.393 . . . . 25.0 110.153 -178.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -69.46 -42.65 74.62 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 121.003 -0.279 . . . . 25.0 111.421 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -151.68 158.19 43.09 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 106.695 -1.594 . . . . 25.0 106.695 176.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.31 154.62 21.79 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 103.391 -2.818 . . . . 25.0 103.391 166.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.1 ptp85 -127.47 -177.65 4.16 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.097 0.777 . . . . 25.0 113.097 -173.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.42 -111.94 4.58 Favored Glycine 0 C--O 1.227 -0.287 0 CA-C-N 116.117 -0.492 . . . . 25.0 113.839 172.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.0 tp -61.23 -34.34 60.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 112.22 0.452 . . . . 25.0 112.22 -177.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.5 t -73.56 -39.24 53.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 O-C-N 121.1 -1.0 . . . . 25.0 109.97 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -65.05 -44.15 89.95 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.241 0.543 . . . . 25.0 111.686 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.63 -30.1 56.74 Favored 'General case' 0 C--O 1.208 -1.105 0 N-CA-C 113.667 0.988 . . . . 25.0 113.667 -175.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 90.9 m -108.97 -20.22 13.12 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 115.652 1.723 . . . . 25.0 115.652 -175.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.3 t -109.09 -47.64 3.4 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.782 0.719 . . . . 25.0 110.701 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -75.24 -33.97 61.36 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.517 -0.473 . . . . 25.0 110.154 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -129.0 -178.89 4.81 Favored 'General case' 0 C--O 1.214 -0.79 0 N-CA-C 109.043 -0.725 . . . . 25.0 109.043 172.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.0 m -89.54 149.76 22.74 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.687 0.617 . . . . 25.0 109.686 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 26.3 p -129.99 166.72 19.5 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.224 0.535 . . . . 25.0 111.984 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -117.2 160.5 20.96 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.812 -0.631 . . . . 25.0 110.12 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 61.6 tp -56.98 -48.5 78.27 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.188 1.181 . . . . 25.0 114.188 -177.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.53 -37.71 84.74 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-O 120.974 0.416 . . . . 25.0 111.455 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.4 tp -67.79 -47.07 70.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.318 -0.401 . . . . 25.0 110.048 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.7 tt -60.88 -35.24 76.12 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.371 0.605 . . . . 25.0 110.622 -177.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -60.56 -21.91 63.08 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.901 1.074 . . . . 25.0 113.901 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.5 p -73.77 -14.27 61.09 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.338 -0.851 . . . . 25.0 112.594 -178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -92.64 6.25 48.05 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 112.344 0.498 . . . . 25.0 112.344 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 72.6 m -71.06 153.22 42.76 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.452 -1.314 . . . . 25.0 107.452 172.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.73 149.92 46.44 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.387 0.613 . . . . 25.0 110.431 -176.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.0 p -113.46 147.49 37.6 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 108.49 -0.93 . . . . 25.0 108.49 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.46 159.18 43.51 Favored 'Trans proline' 0 C--N 1.343 0.272 0 CA-C-O 121.53 0.554 . . . . 25.0 113.267 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.51 161.07 17.17 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.749 -0.834 . . . . 25.0 108.749 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -81.77 153.53 26.45 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.839 -1.171 . . . . 25.0 107.839 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 72.5 p -141.98 154.5 45.08 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 105.789 -1.93 . . . . 25.0 105.789 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 . . . . . 0 C--O 1.3 3.732 0 CA-C-O 116.553 -1.689 . . . . 25.0 111.299 -176.144 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 123.943 1.83 . . . . 25.0 114.903 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -79.08 160.39 27.1 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 120.71 -1.244 . . . . 25.0 109.219 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 70.6 mtt-85 -66.06 145.72 99.0 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.27 -0.423 . . . . 25.0 110.015 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -74.72 162.02 38.4 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 118.275 -0.683 . . . . 25.0 112.956 -177.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.3 m -133.3 91.73 2.91 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 107.538 -1.282 . . . . 25.0 107.538 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -76.73 -6.43 52.17 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 114.335 1.235 . . . . 25.0 114.335 -174.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.6 p -109.44 155.05 21.77 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.421 -0.955 . . . . 25.0 108.421 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.3 tp -88.69 103.96 16.43 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 122.35 1.071 . . . . 25.0 110.839 -173.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 t -156.01 -169.42 3.07 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.618 -1.174 . . . . 25.0 109.763 -172.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.12 31.13 79.68 Favored Glycine 0 C--O 1.218 -0.868 0 N-CA-C 114.78 0.672 . . . . 25.0 114.78 174.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.74 -25.05 20.93 Favored Glycine 0 C--O 1.22 -0.777 0 C-N-CA 121.027 -0.606 . . . . 25.0 113.203 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -63.77 -28.27 69.76 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.724 0.774 . . . . 25.0 109.532 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 35.0 tp -63.67 -39.54 94.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.794 -0.639 . . . . 25.0 111.004 176.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.5 t -70.63 -39.88 76.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.352 -0.61 . . . . 25.0 109.352 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -61.07 -48.2 82.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.418 0.628 . . . . 25.0 110.028 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.6 m -61.55 -40.03 93.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.039 -0.528 . . . . 25.0 110.829 178.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.1 mt -62.97 -37.06 85.61 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 121.81 -0.556 . . . . 25.0 111.458 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -64.45 -45.98 85.08 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.688 -0.486 . . . . 25.0 109.688 175.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -63.46 -46.18 87.4 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.977 0.732 . . . . 25.0 112.977 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.7 t -71.42 -40.56 72.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 111.887 0.328 . . . . 25.0 111.887 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 77.0 m -86.64 -30.31 21.87 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.45 1.278 . . . . 25.0 114.45 -174.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.14 -127.55 45.15 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.227 -0.987 . . . . 25.0 115.224 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -56.47 -33.1 65.6 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 116.362 1.986 . . . . 25.0 116.362 -173.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -82.19 -15.68 52.34 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 114.058 1.133 . . . . 25.0 114.058 -174.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.47 -177.97 52.24 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 109.831 -1.308 . . . . 25.0 109.831 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -157.14 169.49 24.66 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.793 -0.447 . . . . 25.0 109.793 -175.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -153.98 155.1 34.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.475 0.655 . . . . 25.0 110.458 174.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -87.31 134.95 33.49 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.321 -2.103 . . . . 25.0 105.321 176.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.5 t -142.02 137.0 30.81 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.361 0.504 . . . . 25.0 112.361 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.6 145.56 8.62 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 106.794 -1.558 . . . . 25.0 106.794 175.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.59 142.0 35.47 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 114.038 -3.508 . . . . 25.0 112.001 175.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.68 -18.64 19.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.461 0.648 . . . . 25.0 110.652 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.0 m 60.24 163.28 0.06 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 113.028 -1.896 . . . . 25.0 115.694 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -69.33 -26.52 64.75 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.67 0.748 . . . . 25.0 110.869 -176.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.5 m -118.51 164.83 14.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 103.369 -2.826 . . . . 25.0 103.369 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.1 m -70.46 65.01 0.29 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 115.44 1.645 . . . . 25.0 115.44 -175.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 43.0 mmt180 -127.46 65.7 1.32 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.996 -1.112 . . . . 25.0 107.996 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -68.98 150.47 47.66 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.711 -1.218 . . . . 25.0 107.711 176.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.1 m -153.98 161.72 41.75 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.128 0.422 . . . . 25.0 111.363 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 48.01 -161.41 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 117.013 2.227 . . . . 25.0 117.013 172.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.2 168.25 23.96 Favored Glycine 0 CA--C 1.51 -0.265 0 CA-C-N 115.832 -0.622 . . . . 25.0 111.937 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 tp -56.39 -35.94 45.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 122.69 0.396 . . . . 25.0 111.864 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.2 -35.66 72.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 O-C-N 121.59 -0.694 . . . . 25.0 111.511 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -68.04 -35.57 78.47 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 121.164 -0.96 . . . . 25.0 110.878 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -86.25 -35.62 19.88 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 113.944 1.09 . . . . 25.0 113.944 -175.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 98.1 m -103.09 -22.38 13.78 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 115.644 1.72 . . . . 25.0 115.644 -176.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 44.4 t -104.44 -43.33 5.21 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.222 0.464 . . . . 25.0 111.508 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -88.5 -16.88 31.56 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.534 0.683 . . . . 25.0 110.265 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -134.66 177.58 7.67 Favored 'General case' 0 C--O 1.218 -0.569 0 N-CA-C 105.96 -1.867 . . . . 25.0 105.96 173.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.4 p -94.46 153.9 17.7 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 106.849 -1.537 . . . . 25.0 106.849 171.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.411 ' HB2' HD23 ' A' ' 55' ' ' LEU . 27.0 p -138.46 165.83 25.83 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.319 0.489 . . . . 25.0 112.319 -176.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -100.17 155.9 17.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.662 -0.699 . . . . 25.0 111.058 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 35.6 tp -58.04 -44.61 87.46 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.306 0.854 . . . . 25.0 113.306 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.5 -38.33 86.94 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 120.857 0.36 . . . . 25.0 111.286 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.411 HD23 ' HB2' ' A' ' 51' ' ' CYS . 5.3 tp -66.34 -43.75 85.2 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.248 -0.649 . . . . 25.0 109.248 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.2 tt -58.65 -37.02 75.07 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.129 0.49 . . . . 25.0 111.209 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -63.21 -19.68 64.74 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.312 1.227 . . . . 25.0 114.312 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.1 p -75.25 -14.01 60.48 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 121.304 -0.872 . . . . 25.0 112.827 -178.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -93.36 8.03 42.09 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.039 0.447 . . . . 25.0 111.648 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 65.3 m -72.83 155.18 40.18 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.603 -0.888 . . . . 25.0 108.603 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.11 -169.82 2.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.536 0.684 . . . . 25.0 111.727 -176.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.8 p -91.15 134.93 29.03 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 108.021 -1.103 . . . . 25.0 108.021 176.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.8 147.24 74.74 Favored 'Trans proline' 0 C--O 1.236 0.391 0 N-CA-C 115.668 1.372 . . . . 25.0 115.668 -177.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.14 78.41 4.56 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.758 -1.11 . . . . 25.0 110.56 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt 57.42 45.33 20.01 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.791 0.805 . . . . 25.0 110.639 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 59.0 p -134.67 160.58 37.66 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 104.633 -2.358 . . . . 25.0 104.633 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 . . . . . 0 C--O 1.293 3.384 0 CA-C-O 113.952 -2.928 . . . . 25.0 110.854 -175.742 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.212 -0.881 0 CA-C-O 123.291 1.52 . . . . 25.0 113.971 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -96.59 163.05 13.19 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 115.236 -0.893 . . . . 25.0 109.3 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -108.66 150.2 40.44 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.471 -0.332 . . . . 25.0 110.442 -178.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -76.21 175.97 10.65 Favored 'Trans proline' 0 C--N 1.348 0.506 0 N-CA-C 113.617 0.583 . . . . 25.0 113.617 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.6 t 75.29 114.52 0.06 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.615 1.566 . . . . 25.0 113.198 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -83.12 -6.84 59.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.233 -0.894 . . . . 25.0 110.757 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.9 p -117.87 148.93 41.65 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.297 -1.001 . . . . 25.0 108.297 177.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.1 tp -114.76 119.66 37.4 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.617 -0.883 . . . . 25.0 108.617 -176.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.33 167.32 26.41 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.004 -0.543 . . . . 25.0 111.518 -173.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.37 -146.46 48.81 Favored Glycine 0 C--N 1.324 -0.127 0 C-N-CA 120.746 -0.74 . . . . 25.0 111.624 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.75 -26.4 69.91 Favored Glycine 0 C--O 1.21 -1.37 0 C-N-CA 121.006 -0.616 . . . . 25.0 112.471 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -61.12 -30.93 70.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.695 0.747 . . . . 25.0 111.222 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.83 -44.91 68.98 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 109.326 -0.62 . . . . 25.0 109.326 178.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.2 t -63.71 -43.07 97.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.573 -0.739 . . . . 25.0 109.979 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -62.72 -41.73 99.3 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.563 0.697 . . . . 25.0 110.216 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 48.2 m -68.62 -38.9 80.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.34 -0.391 . . . . 25.0 110.293 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.8 mt -63.54 -37.18 86.32 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 121.964 -0.46 . . . . 25.0 110.364 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -65.48 -42.16 92.51 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 110.292 -0.262 . . . . 25.0 110.292 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -64.84 -45.66 85.17 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.595 0.591 . . . . 25.0 112.595 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.2 t -73.77 -43.37 53.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 111.788 0.292 . . . . 25.0 111.788 -176.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 69.3 m -87.45 -28.44 22.09 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.291 0.849 . . . . 25.0 113.291 -175.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.14 -142.46 41.34 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.572 -0.823 . . . . 25.0 112.34 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -66.55 -18.77 65.55 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 123.911 0.884 . . . . 25.0 113.11 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -66.58 -21.76 66.14 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.114 0.413 . . . . 25.0 112.114 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.8 173.29 49.32 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.976 -0.631 . . . . 25.0 112.103 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -158.43 170.57 21.93 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.677 -0.86 . . . . 25.0 108.677 -176.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.87 158.57 43.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 122.08 0.943 . . . . 25.0 112.776 175.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -97.96 136.83 37.67 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 105.577 -2.009 . . . . 25.0 105.577 174.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.4 t -76.29 83.05 3.06 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.689 0.626 . . . . 25.0 112.689 -177.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.08 -42.54 0.86 Allowed Pre-proline 0 CA--C 1.554 1.134 0 N-CA-C 119.047 2.98 . . . . 25.0 119.047 176.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -80.91 -169.5 0.81 Allowed 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.246 1.964 . . . . 25.0 114.093 -175.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 72.78 -123.18 0.05 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.215 1.406 . . . . 25.0 113.819 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.2 m -54.99 127.34 28.49 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.709 1.003 . . . . 25.0 113.709 -171.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -68.15 -24.65 65.01 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.36 -0.836 . . . . 25.0 112.74 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.2 m -118.8 140.99 40.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.836 0.827 . . . . 25.0 112.815 -174.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.8 m -87.89 33.7 0.72 Allowed 'General case' 0 C--O 1.217 -0.618 0 CA-C-N 115.251 -0.886 . . . . 25.0 112.554 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -75.41 -8.66 57.29 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 122.135 -0.353 . . . . 25.0 111.516 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -132.26 138.91 48.06 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.433 -1.692 . . . . 25.0 106.433 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.6 m -76.54 52.64 0.81 Allowed 'General case' 0 C--O 1.217 -0.657 0 N-CA-C 117.703 2.483 . . . . 25.0 117.703 -171.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 57.1 ttm-85 -65.47 -42.25 92.46 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.337 -0.847 . . . . 25.0 111.58 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.7 144.15 28.72 Favored Glycine 0 C--O 1.222 -0.597 0 C-N-CA 120.902 -0.666 . . . . 25.0 113.717 -174.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.6 tp -56.58 -36.95 49.91 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 CA-C-N 114.663 -0.768 . . . . 25.0 110.767 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.15 -39.46 85.62 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 O-C-N 121.575 -0.703 . . . . 25.0 110.2 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -69.47 -26.53 64.62 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 121.238 -0.914 . . . . 25.0 111.893 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -85.74 -39.92 16.65 Favored 'General case' 0 C--O 1.208 -1.123 0 C-N-CA 121.058 -0.257 . . . . 25.0 111.174 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 73.2 m -101.01 -21.06 15.14 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 116.763 2.135 . . . . 25.0 116.763 -173.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.4 t -111.24 -41.71 4.1 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 118.453 0.57 . . . . 25.0 111.661 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -80.18 -17.18 53.11 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.154 0.502 . . . . 25.0 109.847 176.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -144.36 179.55 7.18 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 103.902 -2.629 . . . . 25.0 103.902 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.6 m -98.13 154.92 17.41 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.05 -1.093 . . . . 25.0 108.05 173.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 22.6 p -139.23 162.2 35.55 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.484 -0.191 . . . . 25.0 110.484 -178.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -112.95 164.52 13.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.93 -0.577 . . . . 25.0 112.285 -176.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.9 tp -54.92 -45.84 74.83 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.519 -0.764 . . . . 25.0 112.97 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.8 -41.01 94.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.723 0.296 . . . . 25.0 111.218 -177.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.6 tp -69.84 -46.17 66.2 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.172 0.511 . . . . 25.0 109.867 178.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.2 tt -59.52 -34.6 72.83 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 121.906 -0.496 . . . . 25.0 111.393 -175.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -62.3 -21.7 65.45 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.899 1.074 . . . . 25.0 113.899 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 37.5 p -73.85 -14.19 61.04 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.473 -0.767 . . . . 25.0 112.354 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -89.91 5.08 47.92 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 112.354 0.501 . . . . 25.0 112.354 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 69.1 m -70.94 156.38 39.68 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.356 -0.609 . . . . 25.0 109.356 175.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.44 163.07 16.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.567 0.699 . . . . 25.0 112.35 -177.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.3 p -93.32 138.36 23.11 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.454 -0.793 . . . . 25.0 109.765 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.71 146.3 60.07 Favored 'Trans proline' 0 C--N 1.346 0.417 0 N-CA-C 115.987 1.495 . . . . 25.0 115.987 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.69 64.96 8.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.643 -1.162 . . . . 25.0 112.374 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt 58.83 25.99 14.25 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 121.782 0.801 . . . . 25.0 112.295 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 43.5 t -144.71 118.03 9.01 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 104.919 -2.252 . . . . 25.0 104.919 175.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 . . . . . 0 C--O 1.3 3.719 0 CA-C-O 114.981 -2.438 . . . . 25.0 115.021 -171.112 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.934 0 CA-C-O 123.131 1.443 . . . . 25.0 114.142 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -79.81 159.72 26.4 Favored 'General case' 0 C--O 1.231 0.103 0 O-C-N 121.242 -0.911 . . . . 25.0 108.981 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 86.3 mtt85 -70.77 147.33 94.26 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.089 -0.708 . . . . 25.0 109.089 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -77.27 155.23 32.74 Favored 'Trans proline' 0 C--N 1.344 0.309 0 N-CA-C 113.532 0.551 . . . . 25.0 113.532 -176.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.8 m -116.0 60.09 0.72 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.371 -0.831 . . . . 25.0 110.892 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -64.97 -38.93 92.58 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.737 0.779 . . . . 25.0 109.307 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.2 p -123.44 147.79 46.8 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.653 -1.158 . . . . 25.0 109.341 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.9 mt -138.11 137.17 37.45 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 114.79 -1.096 . . . . 25.0 108.913 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -154.81 162.38 41.13 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 107.487 -1.301 . . . . 25.0 107.487 178.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.28 -145.36 49.55 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.238 -0.982 . . . . 25.0 110.724 -178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.87 -24.63 70.13 Favored Glycine 0 C--O 1.205 -1.676 0 C-N-CA 120.974 -0.631 . . . . 25.0 113.255 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -61.02 -34.98 75.68 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.314 1.057 . . . . 25.0 111.473 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 25.5 tp -69.38 -39.88 77.76 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.153 -0.684 . . . . 25.0 109.153 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 89.2 t -66.9 -40.43 85.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.741 -0.663 . . . . 25.0 110.203 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -61.76 -40.68 96.01 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.031 -0.729 . . . . 25.0 109.031 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.2 m -68.39 -38.75 81.63 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 116.245 -0.434 . . . . 25.0 110.854 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.6 mt -61.61 -36.95 82.18 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 121.585 -0.697 . . . . 25.0 109.971 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -68.77 -37.82 79.6 Favored 'General case' 0 C--O 1.216 -0.683 0 O-C-N 122.27 -0.269 . . . . 25.0 111.436 174.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -65.85 -41.12 92.09 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.821 -0.55 . . . . 25.0 112.224 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.6 t -77.48 -37.24 24.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 112.286 0.476 . . . . 25.0 112.286 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 70.0 m -129.56 -37.53 1.58 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.895 1.813 . . . . 25.0 115.895 -175.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 51.21 -109.7 0.83 Allowed Glycine 0 N--CA 1.462 0.416 0 N-CA-C 116.133 1.213 . . . . 25.0 116.133 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -58.08 -23.12 53.44 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.967 0.907 . . . . 25.0 113.394 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 51.9 mmm-85 -70.69 -17.43 62.84 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.166 -0.334 . . . . 25.0 111.282 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.68 159.27 23.68 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.992 -0.443 . . . . 25.0 111.992 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -162.3 164.58 27.44 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 106.098 -1.815 . . . . 25.0 106.098 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -154.1 157.66 39.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.346 0.593 . . . . 25.0 109.592 173.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -83.75 154.79 23.4 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.444 -0.947 . . . . 25.0 108.444 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.5 p -71.3 91.44 0.98 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.083 0.944 . . . . 25.0 110.812 177.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.8 tpt85 -61.91 -47.29 91.72 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 118.877 2.917 . . . . 25.0 118.877 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.91 161.09 33.45 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 CA-C-N 118.709 0.575 . . . . 25.0 112.888 -175.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.32 156.27 44.18 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.358 -1.349 . . . . 25.0 107.358 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.89 135.59 33.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.984 0.421 . . . . 25.0 111.174 -178.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.75 0.31 57.5 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.975 0.893 . . . . 25.0 110.558 177.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.3 m -120.58 171.62 8.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 106.55 -1.648 . . . . 25.0 106.55 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.37 27.46 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 117.515 2.413 . . . . 25.0 117.515 -175.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -88.19 66.54 8.52 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.577 -0.897 . . . . 25.0 108.577 176.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.88 136.43 57.84 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.277 -1.379 . . . . 25.0 107.277 176.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.1 m -144.58 163.06 35.03 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.614 -0.266 . . . . 25.0 110.86 -172.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -69.05 161.8 28.25 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.975 0.417 . . . . 25.0 110.7 177.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -156.37 163.55 32.06 Favored Glycine 0 CA--C 1.511 -0.167 0 N-CA-C 106.173 -2.771 . . . . 25.0 106.173 174.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.4 tp -66.91 -36.43 77.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 119.117 1.458 . . . . 25.0 111.484 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.2 t -69.01 -40.06 80.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 121.153 -0.967 . . . . 25.0 108.542 175.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -65.09 -27.87 69.06 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 113.739 1.015 . . . . 25.0 113.739 -177.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -93.84 -27.5 16.4 Favored 'General case' 0 C--O 1.209 -1.058 0 N-CA-C 113.052 0.76 . . . . 25.0 113.052 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 94.7 m -107.84 -20.28 13.25 Favored 'General case' 0 C--O 1.212 -0.903 0 N-CA-C 115.421 1.638 . . . . 25.0 115.421 -177.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 37.8 t -106.3 -47.68 3.75 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.719 0.691 . . . . 25.0 110.201 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -73.78 -27.63 61.24 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.058 0.456 . . . . 25.0 110.103 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 55.3 mtp85 -136.29 -179.69 5.83 Favored 'General case' 0 C--O 1.214 -0.813 0 N-CA-C 109.055 -0.72 . . . . 25.0 109.055 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.2 t -91.62 150.32 21.22 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.598 -1.26 . . . . 25.0 107.598 173.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 28.0 p -133.74 175.17 9.69 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.158 0.504 . . . . 25.0 111.795 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -129.48 160.2 33.92 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.933 -0.48 . . . . 25.0 110.584 -175.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.2 tp -54.46 -52.08 62.98 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.745 1.387 . . . . 25.0 114.745 -177.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.22 -37.12 84.17 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-O 121.083 0.468 . . . . 25.0 111.143 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.9 tp -66.5 -46.72 75.3 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.626 -0.509 . . . . 25.0 109.626 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 tt -62.11 -35.14 77.81 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.021 0.439 . . . . 25.0 111.693 -175.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -59.47 -24.24 63.4 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.324 0.861 . . . . 25.0 113.324 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 35.1 p -70.61 -14.15 62.37 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.27 0.841 . . . . 25.0 113.27 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -93.26 6.39 48.23 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.562 0.578 . . . . 25.0 112.562 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 65.7 m -79.02 159.97 27.37 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.964 0.411 . . . . 25.0 110.311 176.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.0 163.57 26.57 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.473 0.654 . . . . 25.0 111.426 -175.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.3 p -114.51 154.08 46.6 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 108.952 -0.759 . . . . 25.0 108.952 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.22 162.81 37.89 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 120.476 0.784 . . . . 25.0 113.429 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.64 165.87 15.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.047 -0.524 . . . . 25.0 110.417 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -67.23 159.45 29.07 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.499 -0.556 . . . . 25.0 109.499 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 t 61.0 34.51 19.32 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 122.765 1.269 . . . . 25.0 111.302 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 C--O 1.302 3.852 0 CA-C-O 112.976 -3.393 . . . . 25.0 111.199 176.381 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 124.13 1.919 . . . . 25.0 113.894 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -73.11 152.15 41.32 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 113.977 -1.465 . . . . 25.0 110.497 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -60.98 146.76 87.07 Favored Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 113.004 0.742 . . . . 25.0 113.004 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -79.88 176.85 9.0 Favored 'Trans proline' 0 C--O 1.238 0.486 0 N-CA-C 110.579 -0.585 . . . . 25.0 110.579 174.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.0 t -145.77 38.48 1.11 Allowed 'General case' 0 C--O 1.218 -0.588 0 CA-C-O 120.938 0.399 . . . . 25.0 110.927 175.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -89.52 -34.43 16.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.637 0.732 . . . . 25.0 110.819 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.7 p -130.98 158.04 41.35 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.049 -0.978 . . . . 25.0 109.718 -177.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.7 mt -142.55 139.05 31.27 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 108.424 -0.954 . . . . 25.0 108.424 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -132.39 -156.82 0.78 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.916 -0.314 . . . . 25.0 110.232 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -44.6 131.65 7.5 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 114.546 0.579 . . . . 25.0 114.546 -175.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.95 -57.82 4.56 Favored Glycine 0 C--O 1.216 -0.993 0 O-C-N 122.827 -0.219 . . . . 25.0 113.479 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -64.93 -38.49 91.14 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.763 0.792 . . . . 25.0 112.564 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.1 tp -68.38 -37.28 80.27 Favored 'General case' 0 C--O 1.211 -0.968 0 N-CA-C 109.31 -0.626 . . . . 25.0 109.31 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.8 t -69.84 -38.31 75.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.647 -0.706 . . . . 25.0 109.85 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -58.95 -46.85 87.02 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.507 0.67 . . . . 25.0 109.3 174.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.5 m -65.38 -38.48 90.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.156 -0.475 . . . . 25.0 112.052 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.6 mt -61.98 -40.11 94.48 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.486 -0.759 . . . . 25.0 109.422 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -67.43 -35.43 79.22 Favored 'General case' 0 C--O 1.217 -0.637 0 O-C-N 122.166 -0.334 . . . . 25.0 111.069 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -66.31 -51.14 60.35 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 122.071 -0.393 . . . . 25.0 112.059 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.2 t -71.0 -42.61 76.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.29 0.478 . . . . 25.0 112.29 -174.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 51.2 m -86.76 -22.26 26.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.26 0.552 . . . . 25.0 112.069 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.19 -149.11 48.05 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-O 122.208 0.893 . . . . 25.0 112.4 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -64.51 -6.26 7.08 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.234 -0.983 . . . . 25.0 113.086 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.0 mmp_? -77.69 -20.51 53.51 Favored 'General case' 0 C--O 1.217 -0.648 0 O-C-N 120.971 -1.08 . . . . 25.0 111.595 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.68 176.77 51.62 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.638 -0.985 . . . . 25.0 110.638 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -153.76 169.22 23.87 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.079 -0.711 . . . . 25.0 109.079 -174.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -124.13 143.04 50.71 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.895 -0.78 . . . . 25.0 108.895 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -100.42 145.68 27.93 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.313 -0.625 . . . . 25.0 109.313 -176.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 48.5 t -132.49 144.69 50.62 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.227 -0.656 . . . . 25.0 109.227 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -141.06 136.69 16.22 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.078 -0.51 . . . . 25.0 110.005 -173.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -70.74 145.13 50.69 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 117.041 -1.506 . . . . 25.0 113.031 177.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -151.12 16.67 0.75 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.652 -0.704 . . . . 25.0 109.489 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.3 m -93.05 3.29 55.99 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.117 1.154 . . . . 25.0 114.117 -174.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? 68.32 -30.07 0.17 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.727 1.611 . . . . 25.0 114.355 -176.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.7 m -129.43 151.24 35.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.319 -0.993 . . . . 25.0 108.319 174.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 56.4 m -134.44 111.33 10.05 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.485 -0.561 . . . . 25.0 109.485 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -92.84 -11.62 33.14 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.382 0.61 . . . . 25.0 109.917 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -151.92 161.6 42.38 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 100.491 -3.892 . . . . 25.0 100.491 175.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 26.0 m -64.74 139.87 58.81 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.773 0.715 . . . . 25.0 109.139 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 -103.13 -26.2 13.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.119 0.485 . . . . 25.0 112.06 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.34 169.17 31.54 Favored Glycine 0 C--O 1.223 -0.569 0 N-CA-C 116.535 1.374 . . . . 25.0 116.535 -177.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.496 HD11 ' HG ' ' A' ' 56' ' ' LEU . 6.0 tp -57.0 -35.27 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 N-CA-C 113.462 0.912 . . . . 25.0 113.462 -175.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -71.08 -26.52 27.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 O-C-N 120.391 -1.443 . . . . 25.0 110.581 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -77.75 -38.64 46.51 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 121.731 -0.606 . . . . 25.0 110.839 -177.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -81.11 -25.79 36.69 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.098 -0.641 . . . . 25.0 112.242 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 78.5 m -102.91 -19.63 14.57 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.883 1.808 . . . . 25.0 115.883 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 18.9 t -113.2 -39.89 4.05 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.057 0.844 . . . . 25.0 111.617 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -83.57 -16.98 43.3 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.268 -0.641 . . . . 25.0 109.268 177.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 17.9 mtt85 -142.58 179.89 6.7 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 106.636 -1.616 . . . . 25.0 106.636 171.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.2 p -93.34 151.14 19.96 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.237 -1.394 . . . . 25.0 107.237 171.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 26.2 p -128.98 162.55 27.34 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.848 0.356 . . . . 25.0 111.778 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -101.59 158.24 16.23 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.742 -0.663 . . . . 25.0 110.539 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.9 tp -58.69 -43.78 90.08 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.32 0.489 . . . . 25.0 112.32 176.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.07 -34.13 74.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.934 0.397 . . . . 25.0 110.38 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.5 tp -69.01 -46.63 67.52 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.021 -0.733 . . . . 25.0 109.021 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.496 ' HG ' HD11 ' A' ' 42' ' ' ILE . 4.2 tt -60.85 -33.72 73.5 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.22 0.534 . . . . 25.0 110.814 -177.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -60.89 -24.43 65.97 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.827 1.047 . . . . 25.0 113.827 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.3 p -71.28 -14.25 62.16 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.168 0.803 . . . . 25.0 113.168 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -91.4 0.06 57.57 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 112.087 0.403 . . . . 25.0 112.087 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 83.1 m -70.57 149.86 46.67 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.525 -0.546 . . . . 25.0 109.525 176.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.06 154.14 39.34 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.226 -0.657 . . . . 25.0 109.226 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.4 p -67.94 147.53 98.47 Favored Pre-proline 0 N--CA 1.447 -0.59 0 N-CA-C 108.861 -0.792 . . . . 25.0 108.861 177.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.31 163.35 38.26 Favored 'Trans proline' 0 CA--C 1.522 -0.12 0 C-N-CA 119.937 0.425 . . . . 25.0 111.741 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.89 152.65 15.62 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.277 -0.874 . . . . 25.0 111.004 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -131.64 152.73 50.61 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.915 -1.142 . . . . 25.0 107.915 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.2 t -162.53 80.56 0.51 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.774 0.797 . . . . 25.0 109.186 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.298 3.633 0 CA-C-O 115.016 -2.421 . . . . 25.0 113.364 -175.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.01 0 CA-C-O 123.233 1.492 . . . . 25.0 114.29 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -117.32 164.28 15.07 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.164 -0.925 . . . . 25.0 108.525 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 55.5 ptt85 -108.81 154.32 41.86 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.626 -0.261 . . . . 25.0 110.618 -176.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -72.33 160.86 45.98 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 118.39 -0.607 . . . . 25.0 112.406 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.2 t -132.98 51.38 2.16 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.639 -0.709 . . . . 25.0 110.32 -176.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -70.94 -36.28 72.55 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.769 0.655 . . . . 25.0 112.769 -174.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.6 p -127.39 145.53 50.78 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.051 -1.092 . . . . 25.0 108.051 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -132.19 -100.37 0.28 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.503 -0.771 . . . . 25.0 109.104 -176.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 68.22 178.56 0.24 Allowed 'General case' 0 C--O 1.217 -0.618 0 C-N-CA 124.729 1.212 . . . . 25.0 111.247 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.69 28.7 65.83 Favored Glycine 0 C--O 1.219 -0.839 0 C-N-CA 120.842 -0.694 . . . . 25.0 114.274 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.8 -20.96 35.85 Favored Glycine 0 C--O 1.221 -0.672 0 CA-C-O 119.681 -0.511 . . . . 25.0 113.607 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -62.23 -27.62 69.12 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 117.867 0.834 . . . . 25.0 110.483 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.77 -43.09 94.51 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 116.071 -0.513 . . . . 25.0 111.007 177.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 74.9 t -66.66 -38.85 82.45 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.844 0 N-CA-C 108.847 -0.798 . . . . 25.0 108.847 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -58.79 -48.11 82.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.956 0.407 . . . . 25.0 110.536 177.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.4 m -63.27 -40.37 97.21 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.954 -0.466 . . . . 25.0 111.545 177.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.0 mt -63.08 -36.98 85.41 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 121.944 -0.473 . . . . 25.0 110.777 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -69.14 -38.64 78.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.857 0.361 . . . . 25.0 110.384 176.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -64.01 -39.1 93.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.206 0.526 . . . . 25.0 111.015 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 79.7 t -79.77 -43.46 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 112.377 0.51 . . . . 25.0 112.377 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.5 m -148.98 34.62 0.75 Allowed 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 115.14 1.533 . . . . 25.0 115.14 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.55 -46.98 93.2 Favored Glycine 0 C--O 1.223 -0.573 0 C-N-CA 119.858 -1.163 . . . . 25.0 113.555 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -61.97 -43.85 97.98 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.535 0.683 . . . . 25.0 112.552 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -83.09 -8.7 59.49 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.786 0.661 . . . . 25.0 112.786 -177.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.96 157.69 23.78 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-O 122.091 0.828 . . . . 25.0 111.264 -175.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -153.2 162.43 41.31 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 106.769 -1.567 . . . . 25.0 106.769 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -120.17 152.64 37.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 122.268 1.032 . . . . 25.0 113.18 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -122.65 166.96 14.04 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.501 -1.666 . . . . 25.0 106.501 -176.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.3 t -122.69 128.15 50.2 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.285 -1.376 . . . . 25.0 107.285 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -142.63 137.65 15.49 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.539 -0.541 . . . . 25.0 109.539 -172.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -72.87 148.47 45.92 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 116.676 -1.749 . . . . 25.0 112.401 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.26 12.4 9.5 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.942 -0.572 . . . . 25.0 110.302 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.3 t -154.59 165.4 36.61 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.033 -1.099 . . . . 25.0 108.033 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -69.88 -30.22 67.62 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.25 0.344 . . . . 25.0 111.448 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -84.43 155.09 3.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.167 0.508 . . . . 25.0 111.454 -175.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.0 t -132.67 137.06 46.83 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.345 -0.984 . . . . 25.0 108.345 177.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -127.48 44.88 2.83 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-O 121.505 0.669 . . . . 25.0 109.363 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.5 ttm-85 52.61 53.92 11.44 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 117.261 2.319 . . . . 25.0 117.261 176.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 26.7 p -78.94 156.5 28.51 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.651 -0.704 . . . . 25.0 109.219 172.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -95.9 154.69 17.1 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 106.952 -1.499 . . . . 25.0 106.952 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -163.39 162.82 35.19 Favored Glycine 0 C--O 1.225 -0.427 0 C-N-CA 120.54 -0.838 . . . . 25.0 112.232 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.2 tp -61.72 -37.38 77.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 117.033 0.417 . . . . 25.0 111.183 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.5 p -65.29 -28.88 45.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 O-C-N 121.588 -0.695 . . . . 25.0 110.575 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.4 -25.12 63.99 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.468 -0.77 . . . . 25.0 111.088 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -99.15 -26.59 14.15 Favored 'General case' 0 C--O 1.199 -1.554 0 N-CA-C 114.251 1.204 . . . . 25.0 114.251 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 82.8 m -113.57 8.59 17.75 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.26 1.208 . . . . 25.0 114.26 -177.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 40.0 t -133.09 -56.72 0.92 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.82 0.343 . . . . 25.0 110.253 176.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -72.34 -24.84 61.35 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.316 0.579 . . . . 25.0 110.15 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 97.0 mtt-85 -136.86 -178.64 5.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.743 -1.206 . . . . 25.0 107.743 177.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.4 p -97.76 152.09 19.5 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 124.01 0.819 . . . . 25.0 109.114 174.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 27.3 p -134.91 -178.63 5.17 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.038 -0.727 . . . . 25.0 109.038 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -139.45 167.55 21.83 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.623 -1.251 . . . . 25.0 107.623 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 68.3 tp -58.33 -40.41 82.07 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 123.261 0.624 . . . . 25.0 111.92 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.53 -42.6 99.06 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.091 0.472 . . . . 25.0 110.673 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.8 tp -70.68 -44.65 66.56 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.709 -0.478 . . . . 25.0 109.709 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.0 tt -60.07 -34.1 72.97 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 121.947 -0.471 . . . . 25.0 111.556 -177.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -61.64 -26.78 68.22 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.996 0.739 . . . . 25.0 112.996 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.8 p -70.29 -14.56 62.65 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 121.589 -0.695 . . . . 25.0 112.824 -178.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -93.42 7.85 42.87 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.008 0.432 . . . . 25.0 111.217 177.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 23.8 t -67.91 159.03 31.36 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.139 -1.43 . . . . 25.0 107.139 172.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.64 166.62 23.29 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 110.132 -0.322 . . . . 25.0 110.132 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.5 p 70.09 149.2 0.12 Allowed Pre-proline 0 N--CA 1.485 1.276 0 C-N-CA 126.084 1.754 . . . . 25.0 112.744 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -73.08 145.65 39.88 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 115.989 -2.207 . . . . 25.0 115.627 -175.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.89 137.88 55.6 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.007 -1.452 . . . . 25.0 110.107 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 69.4 tttt 50.59 38.79 19.74 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.625 0.77 . . . . 25.0 112.912 176.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.9 m 51.12 43.33 29.15 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.885 1.069 . . . . 25.0 113.885 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 C--O 1.297 3.561 0 CA-C-O 115.016 -2.421 . . . . 25.0 112.314 176.557 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 122.814 1.292 . . . . 25.0 113.957 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -124.05 174.64 7.48 Favored 'General case' 0 C--O 1.227 -0.122 0 CA-C-N 115.481 -0.781 . . . . 25.0 109.848 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.44 153.55 44.11 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 108.826 -0.805 . . . . 25.0 108.826 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -73.19 161.37 43.25 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 118.516 -0.522 . . . . 25.0 113.227 -177.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.5 t -142.97 78.15 1.6 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.258 -1.016 . . . . 25.0 108.258 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -75.36 -7.09 53.08 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.696 0.76 . . . . 25.0 112.448 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.6 p -118.1 149.19 41.42 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.507 -0.923 . . . . 25.0 108.507 176.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.1 mt -137.17 129.71 30.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.699 -0.682 . . . . 25.0 109.654 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.4 t -162.88 -172.81 3.21 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.971 -1.492 . . . . 25.0 106.971 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.34 30.81 75.14 Favored Glycine 0 C--O 1.22 -0.768 0 C-N-CA 120.787 -0.721 . . . . 25.0 114.535 174.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.29 -25.34 9.28 Favored Glycine 0 C--O 1.221 -0.667 0 C-N-CA 121.138 -0.553 . . . . 25.0 114.047 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -65.05 -27.03 68.52 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.239 1.02 . . . . 25.0 110.409 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 27.6 tp -61.46 -40.01 92.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.967 -0.56 . . . . 25.0 110.167 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 90.5 t -71.97 -36.38 57.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.273 -0.421 . . . . 25.0 109.982 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.0 -45.36 93.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.43 0.634 . . . . 25.0 109.368 176.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.5 m -63.18 -40.03 96.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.109 -0.496 . . . . 25.0 111.113 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.0 mt -61.65 -38.27 87.09 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.752 -0.593 . . . . 25.0 110.472 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -67.52 -39.56 85.09 Favored 'General case' 0 C--O 1.219 -0.538 0 O-C-N 122.004 -0.435 . . . . 25.0 110.8 175.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -66.63 -46.81 74.6 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.722 0.638 . . . . 25.0 112.722 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.4 t -71.58 -42.46 71.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 111.683 0.253 . . . . 25.0 111.683 -176.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 34.9 m -90.39 -26.51 19.87 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.223 0.823 . . . . 25.0 113.223 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.23 -145.74 49.41 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-O 122.204 0.891 . . . . 25.0 113.479 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -58.24 -17.85 22.19 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.918 1.081 . . . . 25.0 113.918 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -69.14 -23.05 63.92 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.735 -0.603 . . . . 25.0 112.371 -177.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.03 173.41 49.85 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 110.232 -1.147 . . . . 25.0 110.232 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -151.3 168.36 25.0 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 122.481 -0.423 . . . . 25.0 110.577 -177.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -112.71 158.96 19.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.404 0.621 . . . . 25.0 110.548 177.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -127.05 176.56 7.25 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.398 -1.334 . . . . 25.0 107.398 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.3 m -56.53 -24.43 46.63 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 117.033 2.235 . . . . 25.0 117.033 -174.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.27 150.72 0.1 Allowed Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 115.138 1.533 . . . . 25.0 115.138 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.62 146.38 54.73 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 116.733 -1.712 . . . . 25.0 114.47 -175.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.94 177.33 7.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.712 -0.676 . . . . 25.0 109.853 -178.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.6 m -68.39 170.69 8.46 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.067 -0.515 . . . . 25.0 112.071 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.8 mmt-85 -65.71 -26.01 67.57 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.562 0.578 . . . . 25.0 112.562 177.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.68 171.67 15.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 123.095 0.558 . . . . 25.0 110.969 -172.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.9 p 42.89 46.33 4.57 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.145 0.978 . . . . 25.0 113.548 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -83.29 50.22 1.71 Allowed 'General case' 0 C--O 1.213 -0.866 0 CA-C-N 115.618 -0.719 . . . . 25.0 112.165 -175.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -82.72 47.34 1.18 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.854 0.835 . . . . 25.0 112.462 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.5 p -103.3 156.68 17.55 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.29 -0.868 . . . . 25.0 109.313 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -75.07 156.43 36.12 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.509 -0.923 . . . . 25.0 108.509 175.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -164.18 138.88 5.52 Favored Glycine 0 C--O 1.224 -0.473 0 C-N-CA 120.617 -0.802 . . . . 25.0 111.94 174.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.0 tp -64.41 -32.28 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 122.511 -0.405 . . . . 25.0 110.088 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.9 -32.64 59.05 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.463 0 O-C-N 121.842 -0.536 . . . . 25.0 110.479 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -74.06 -34.2 63.96 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 121.616 -0.678 . . . . 25.0 110.208 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -71.94 -40.66 68.57 Favored 'General case' 0 C--O 1.21 -0.978 0 C-N-CA 120.21 -0.596 . . . . 25.0 112.182 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 76.6 m -103.13 -21.69 13.86 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 116.992 2.219 . . . . 25.0 116.992 -172.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 47.3 t -105.56 -44.71 4.62 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.638 0.653 . . . . 25.0 110.584 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -81.42 -23.02 37.82 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.061 0.458 . . . . 25.0 110.011 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.29 -179.37 5.63 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 109.117 -0.698 . . . . 25.0 109.117 176.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.6 t -89.01 149.14 23.39 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.759 -1.2 . . . . 25.0 107.759 175.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 21.5 p -139.25 161.41 37.49 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.135 0.493 . . . . 25.0 112.261 178.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -112.56 161.38 16.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.331 -0.85 . . . . 25.0 111.124 -176.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 68.5 tp -58.35 -45.02 88.97 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.125 -0.489 . . . . 25.0 111.897 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.24 -39.46 90.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.889 0.376 . . . . 25.0 111.023 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.8 tp -68.8 -45.39 71.39 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.831 -0.433 . . . . 25.0 109.831 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.0 tt -60.01 -35.96 76.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.202 0.525 . . . . 25.0 110.961 -177.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -60.63 -25.28 66.17 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.226 0.824 . . . . 25.0 113.226 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.8 p -74.69 -14.03 60.69 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.402 -0.811 . . . . 25.0 112.982 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -91.93 2.26 56.66 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.604 0.24 . . . . 25.0 111.161 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 72.3 m -71.39 157.41 38.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.175 -0.676 . . . . 25.0 109.175 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.2 158.86 17.73 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.053 -0.721 . . . . 25.0 109.053 177.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 p 67.95 153.99 0.14 Allowed Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 125.313 1.445 . . . . 25.0 111.637 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.03 155.92 56.62 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 117.397 -1.269 . . . . 25.0 114.931 -174.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.68 103.34 1.71 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.098 -0.955 . . . . 25.0 111.037 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -73.27 161.25 30.73 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.824 -0.625 . . . . 25.0 110.4 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.4 m 51.42 54.29 11.35 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.815 1.413 . . . . 25.0 114.815 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 . . . . . 0 C--O 1.291 3.271 0 CA-C-O 113.771 -3.014 . . . . 25.0 111.265 173.841 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.854 0 CA-C-O 123.202 1.477 . . . . 25.0 114.31 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -130.89 160.75 33.54 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.192 -1.04 . . . . 25.0 108.192 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.55 143.16 78.66 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 120.512 0.196 . . . . 25.0 110.994 -177.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -77.2 159.67 33.26 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 118.038 -0.842 . . . . 25.0 112.525 177.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.5 m -131.67 75.24 1.63 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.995 -0.548 . . . . 25.0 111.962 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.12 -17.65 61.96 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.524 0.678 . . . . 25.0 110.357 178.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.1 p -130.88 154.78 47.72 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 101.795 -3.409 . . . . 25.0 101.795 172.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.5 tp -134.59 128.59 33.49 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.997 -0.372 . . . . 25.0 109.997 -172.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.74 168.4 23.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.8 0.333 . . . . 25.0 111.164 -173.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.37 -143.69 48.67 Favored Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 120.691 -0.766 . . . . 25.0 113.39 175.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.38 -21.15 75.85 Favored Glycine 0 C--O 1.213 -1.172 0 C-N-CA 121.284 -0.484 . . . . 25.0 113.197 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -69.35 -27.19 65.13 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 117.618 0.709 . . . . 25.0 109.325 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.27 -43.53 67.0 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 121.522 0.677 . . . . 25.0 109.528 174.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.5 t -64.15 -38.5 82.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.164 -0.926 . . . . 25.0 110.057 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -61.59 -48.36 81.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.164 0.507 . . . . 25.0 110.94 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 50.2 m -63.59 -35.94 82.16 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.966 -0.459 . . . . 25.0 111.293 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.6 mt -64.61 -39.77 94.3 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.707 -0.479 . . . . 25.0 109.707 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -67.32 -36.73 82.08 Favored 'General case' 0 C--O 1.219 -0.508 0 O-C-N 121.79 -0.569 . . . . 25.0 110.586 176.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -64.9 -51.56 61.29 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 121.923 -0.485 . . . . 25.0 111.753 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -73.48 -30.78 30.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 112.847 0.684 . . . . 25.0 112.847 -174.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.5 m -99.08 -22.05 15.88 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.16 0.8 . . . . 25.0 113.16 -177.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.39 -163.47 53.86 Favored Glycine 0 C--N 1.321 -0.303 0 CA-C-O 121.834 0.685 . . . . 25.0 111.887 -177.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -71.32 -7.17 45.3 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.751 0.821 . . . . 25.0 111.444 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 -72.66 -9.7 58.92 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.526 -0.761 . . . . 25.0 111.849 -177.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.53 163.05 34.13 Favored Glycine 0 C--O 1.23 -0.12 0 N-CA-C 115.098 0.799 . . . . 25.0 115.098 172.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -153.46 166.73 31.77 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.659 -1.237 . . . . 25.0 107.659 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -118.87 143.01 47.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.061 0.457 . . . . 25.0 110.154 177.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -104.69 146.04 29.5 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.205 -1.406 . . . . 25.0 107.205 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.42 ' H ' HG22 ' A' ' 42' ' ' ILE . 42.3 t -143.69 149.39 37.14 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.565 0.221 . . . . 25.0 110.662 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.8 ppt_? -154.23 153.87 28.88 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 107.945 -1.131 . . . . 25.0 107.945 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -70.67 154.1 64.33 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 118.419 -0.587 . . . . 25.0 112.533 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -107.39 18.54 21.45 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.552 0.575 . . . . 25.0 112.552 -175.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.8 t -150.63 166.08 31.4 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.624 -0.88 . . . . 25.0 108.624 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -65.98 -18.16 65.15 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.768 0.427 . . . . 25.0 110.882 177.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.7 m -118.34 134.47 61.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.313 0.578 . . . . 25.0 109.488 176.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.5 p -104.69 46.52 0.91 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.775 0.798 . . . . 25.0 111.466 -177.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 68.1 mtt85 -66.25 -16.61 64.16 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.194 -0.457 . . . . 25.0 111.21 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -149.73 178.38 8.92 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 103.047 -2.946 . . . . 25.0 103.047 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.7 m 57.16 58.09 4.14 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.347 1.24 . . . . 25.0 114.347 177.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.3 tpp180 -63.92 140.85 58.91 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.933 -1.485 . . . . 25.0 108.346 174.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -117.9 165.4 12.67 Favored Glycine 0 C--N 1.32 -0.335 0 CA-C-N 115.809 -0.632 . . . . 25.0 112.651 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.424 HD13 ' CD2' ' A' ' 59' ' ' TYR . 7.2 tp -67.01 -35.17 73.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.728 -0.842 . . . . 25.0 108.728 177.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.2 p -66.76 -32.12 56.6 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 N-CA-C 109.334 -0.617 . . . . 25.0 109.334 178.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -72.68 -36.97 68.03 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.381 -0.824 . . . . 25.0 110.364 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -72.83 -39.48 66.55 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.861 0.689 . . . . 25.0 112.861 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 47.4 m -104.6 -22.37 13.26 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 116.547 2.054 . . . . 25.0 116.547 -171.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 33.8 t -104.72 -44.5 4.84 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.388 0.54 . . . . 25.0 110.689 -177.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -80.79 -18.63 46.95 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.865 0.364 . . . . 25.0 110.635 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 45.1 mtt-85 -141.49 172.46 12.66 Favored 'General case' 0 C--O 1.207 -1.152 0 N-CA-C 106.102 -1.814 . . . . 25.0 106.102 174.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 34.8 t -84.57 150.66 25.06 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.664 -0.495 . . . . 25.0 109.664 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -113.15 167.23 10.71 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 121.454 0.645 . . . . 25.0 112.738 -178.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -126.41 151.91 47.05 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.183 -1.784 . . . . 25.0 106.183 175.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 35.1 tp -59.72 -44.29 93.8 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.71 0.633 . . . . 25.0 112.71 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.34 -38.18 88.53 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-O 121.043 0.449 . . . . 25.0 111.174 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.1 tp -65.07 -45.03 86.99 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.309 -0.626 . . . . 25.0 109.309 177.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.0 tt -64.01 -33.24 75.29 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.172 0.51 . . . . 25.0 110.836 -177.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -62.34 -24.76 67.52 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.432 0.901 . . . . 25.0 113.432 178.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.7 p -69.01 -14.44 63.04 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.538 -0.726 . . . . 25.0 112.291 -177.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.424 ' CD2' HD13 ' A' ' 42' ' ' ILE . 72.0 m-85 -92.43 5.82 49.29 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.448 -0.342 . . . . 25.0 111.559 178.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 83.7 m -72.23 156.67 38.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.184 0.516 . . . . 25.0 110.216 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.44 163.13 19.66 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.588 -0.893 . . . . 25.0 108.588 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.3 p -69.62 131.66 89.61 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 107.909 -1.145 . . . . 25.0 107.909 178.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -72.39 155.19 55.79 Favored 'Trans proline' 0 C--N 1.343 0.253 0 N-CA-C 115.228 1.203 . . . . 25.0 115.228 -175.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.31 164.2 26.89 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.871 -1.058 . . . . 25.0 109.261 176.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -80.7 66.2 6.13 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.028 0.442 . . . . 25.0 111.958 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.5 m -92.89 61.78 3.57 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.73 0.776 . . . . 25.0 111.078 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 . . . . . 0 C--O 1.291 3.282 0 CA-C-O 113.994 -2.908 . . . . 25.0 111.626 -179.981 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.853 0 CA-C-O 123.145 1.45 . . . . 25.0 114.261 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -74.5 162.85 28.41 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 108.246 -1.02 . . . . 25.0 108.246 176.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.3 ptp85 -59.81 143.46 87.19 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 109.838 -0.43 . . . . 25.0 109.838 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -73.67 160.03 44.67 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 117.764 -1.024 . . . . 25.0 112.522 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.0 m -121.13 82.89 1.99 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.434 -0.95 . . . . 25.0 108.434 177.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -62.98 -26.1 68.68 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.251 0.548 . . . . 25.0 110.63 -178.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 p -119.49 117.47 28.51 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 102.556 -3.127 . . . . 25.0 102.556 168.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.9 tp -86.74 106.2 17.5 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.943 0.878 . . . . 25.0 109.155 -174.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -154.56 -163.65 1.64 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.955 -1.021 . . . . 25.0 108.814 -173.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.77 33.3 84.77 Favored Glycine 0 C--O 1.218 -0.879 0 N-CA-C 114.937 0.735 . . . . 25.0 114.937 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.63 -25.37 7.41 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.999 -0.62 . . . . 25.0 113.311 -178.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -63.45 -31.15 72.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.562 0.681 . . . . 25.0 109.224 177.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 33.2 tp -61.79 -41.86 98.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.923 -0.58 . . . . 25.0 111.448 176.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.9 t -67.52 -41.5 85.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.267 -0.642 . . . . 25.0 109.267 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -61.67 -40.61 95.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.397 0.618 . . . . 25.0 109.966 177.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.8 m -66.69 -40.58 88.58 Favored 'General case' 0 C--O 1.215 -0.725 0 O-C-N 121.933 -0.479 . . . . 25.0 111.216 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.4 mt -62.21 -38.82 90.62 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.63 -0.669 . . . . 25.0 110.563 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -67.04 -39.69 87.01 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.197 -0.456 . . . . 25.0 110.453 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -66.76 -47.75 71.23 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.27 0.47 . . . . 25.0 112.27 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.9 t -67.5 -43.68 87.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.405 0.52 . . . . 25.0 112.405 -175.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -95.26 -15.93 22.83 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.511 0.93 . . . . 25.0 113.511 -176.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.01 -142.87 46.16 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-O 122.067 0.815 . . . . 25.0 112.595 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -71.1 0.36 7.82 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.052 1.13 . . . . 25.0 114.052 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -75.39 -20.41 58.95 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.462 -0.774 . . . . 25.0 110.95 178.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.8 162.07 34.65 Favored Glycine 0 C--O 1.225 -0.448 0 N-CA-C 111.869 -0.492 . . . . 25.0 111.869 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -149.1 167.97 24.47 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.214 -1.032 . . . . 25.0 108.214 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -120.85 152.26 38.62 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.614 0.721 . . . . 25.0 110.79 174.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -128.04 155.44 44.34 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.764 -1.199 . . . . 25.0 107.764 -176.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.5 p -78.15 63.26 3.05 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 108.282 -1.007 . . . . 25.0 108.282 172.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -82.5 156.87 68.21 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.34 -0.846 . . . . 25.0 111.55 -172.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -70.15 154.34 66.29 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 117.852 -0.966 . . . . 25.0 113.841 -178.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -157.6 177.28 11.57 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 105.05 -2.204 . . . . 25.0 105.05 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.5 m -77.99 -83.79 0.08 Allowed 'General case' 0 C--O 1.215 -0.722 0 N-CA-C 118.266 2.691 . . . . 25.0 118.266 -176.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 -67.08 1.04 2.2 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 114.1 -1.409 . . . . 25.0 114.495 -171.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 17.1 m -68.66 153.82 8.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 114.959 -1.019 . . . . 25.0 110.271 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.1 m -103.31 13.64 33.34 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 115.593 -0.73 . . . . 25.0 111.716 -174.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 52.54 44.19 30.28 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.662 -0.699 . . . . 25.0 112.077 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -67.11 160.78 25.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.189 -0.914 . . . . 25.0 110.802 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 t -72.63 176.29 5.62 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.625 -0.716 . . . . 25.0 112.011 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? 66.02 127.05 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.424 1.89 . . . . 25.0 113.484 -176.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 163.96 162.92 15.75 Favored Glycine 0 C--N 1.315 -0.591 0 N-CA-C 108.673 -1.771 . . . . 25.0 108.673 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.0 tp -56.68 -34.28 42.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 112.896 0.702 . . . . 25.0 112.896 -174.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.77 -32.54 58.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 121.563 -0.711 . . . . 25.0 110.804 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -76.44 -32.1 58.25 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 121.368 -0.832 . . . . 25.0 111.343 -177.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -82.91 -27.71 30.45 Favored 'General case' 0 C--O 1.214 -0.766 0 C-N-CA 120.258 -0.577 . . . . 25.0 112.371 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 99.8 m -107.45 -28.97 9.51 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 116.335 1.976 . . . . 25.0 116.335 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 73.6 m -94.98 -41.75 8.99 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.819 0.736 . . . . 25.0 111.019 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -90.82 -18.27 25.16 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.204 0.526 . . . . 25.0 111.118 -177.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 80.3 mtm-85 -135.94 174.93 10.07 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 105.853 -1.906 . . . . 25.0 105.853 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.5 p -91.86 149.07 21.77 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.45 -1.315 . . . . 25.0 107.45 173.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 28.9 p -133.16 163.95 28.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.891 0.377 . . . . 25.0 111.385 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -124.16 166.23 16.18 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.099 -0.501 . . . . 25.0 110.344 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.3 tp -54.03 -48.97 69.94 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.651 1.352 . . . . 25.0 114.651 -176.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.13 -41.46 96.77 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 121.124 0.488 . . . . 25.0 111.122 -177.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.9 tp -65.9 -44.97 83.64 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.065 0.46 . . . . 25.0 109.93 177.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 tt -61.1 -35.02 75.89 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.128 0.489 . . . . 25.0 111.535 -178.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -61.81 -26.76 68.31 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.341 0.867 . . . . 25.0 113.341 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.6 p -68.25 -14.25 62.85 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 113.011 0.745 . . . . 25.0 113.011 -178.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -94.89 13.16 25.69 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 120.939 0.399 . . . . 25.0 111.721 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 2.2 m -61.77 162.36 8.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.231 0.538 . . . . 25.0 109.926 170.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.15 163.54 26.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.792 0.329 . . . . 25.0 110.666 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.9 p 70.07 152.4 0.14 Allowed Pre-proline 0 N--CA 1.481 1.086 0 C-N-CA 126.075 1.75 . . . . 25.0 111.602 -178.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.81 156.91 56.25 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 116.405 -1.93 . . . . 25.0 113.18 -177.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.83 125.03 22.58 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.344 -0.984 . . . . 25.0 108.344 178.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 51.0 tttt -132.07 17.9 4.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.825 0.822 . . . . 25.0 109.992 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 62.1 m -154.23 148.48 25.94 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 105.348 -2.093 . . . . 25.0 105.348 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 . . . . . 0 C--O 1.293 3.366 0 CA-C-O 113.111 -3.328 . . . . 25.0 112.376 -178.38 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.923 0 CA-C-O 123.287 1.518 . . . . 25.0 114.28 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -86.0 171.7 11.22 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.202 -0.936 . . . . 25.0 108.718 176.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 81.0 mtt85 -58.66 143.88 81.08 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 109.353 -0.61 . . . . 25.0 109.353 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -78.26 163.27 27.79 Favored 'Trans proline' 0 C--N 1.346 0.397 0 O-C-N 122.038 0.494 . . . . 25.0 113.234 -177.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.5 t -121.35 84.13 2.19 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 107.768 -1.197 . . . . 25.0 107.768 176.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -78.31 -11.29 59.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.979 0.419 . . . . 25.0 112.017 -177.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.6 p -94.17 150.89 19.9 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.856 -0.794 . . . . 25.0 108.856 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.2 tp -81.07 104.03 11.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 122.228 1.013 . . . . 25.0 111.337 -175.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 t -153.47 -164.03 1.81 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.943 -1.026 . . . . 25.0 110.051 -173.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.17 23.0 63.6 Favored Glycine 0 C--O 1.214 -1.098 0 N-CA-C 115.642 1.017 . . . . 25.0 115.642 174.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.42 -26.47 24.23 Favored Glycine 0 C--O 1.218 -0.85 0 CA-C-O 119.577 -0.568 . . . . 25.0 112.801 -178.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.99 -28.64 67.86 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.796 0.808 . . . . 25.0 110.4 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 30.7 tp -60.95 -40.16 92.29 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.522 -0.763 . . . . 25.0 111.236 176.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 82.5 t -69.58 -41.27 80.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.012 -0.736 . . . . 25.0 109.012 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -64.0 -40.82 97.22 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.914 0.864 . . . . 25.0 109.925 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.3 m -66.83 -40.06 87.87 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.726 -0.67 . . . . 25.0 110.456 178.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.7 mt -62.62 -37.87 87.96 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.118 -0.363 . . . . 25.0 110.415 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -62.32 -45.68 92.14 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.829 -0.544 . . . . 25.0 110.115 175.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -66.9 -45.8 76.86 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.125 0.787 . . . . 25.0 113.125 -176.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.4 t -69.26 -38.5 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 120.875 0.369 . . . . 25.0 111.357 -177.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.5 m -88.06 -24.37 23.47 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.579 0.955 . . . . 25.0 113.579 -175.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.76 -144.42 38.36 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-O 121.693 0.607 . . . . 25.0 113.707 177.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -65.29 -12.08 48.05 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.135 0.791 . . . . 25.0 113.135 -178.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.9 mtm180 -79.88 -22.88 42.34 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.383 0.882 . . . . 25.0 113.383 -173.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.78 179.26 52.85 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-O 122.068 0.815 . . . . 25.0 111.612 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -160.46 173.56 15.4 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.176 -1.416 . . . . 25.0 107.176 -175.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -146.37 161.04 41.22 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.241 0.543 . . . . 25.0 109.707 173.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -95.36 139.29 31.86 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.99 -0.745 . . . . 25.0 108.99 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.78 -23.22 63.32 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.86 0.689 . . . . 25.0 112.86 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.03 149.5 36.98 Favored Pre-proline 0 N--CA 1.468 0.427 0 N-CA-C 108.643 -0.873 . . . . 25.0 108.643 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.8 144.83 55.07 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 117.476 -1.216 . . . . 25.0 114.086 -178.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.15 107.52 8.43 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.492 -0.558 . . . . 25.0 109.492 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.6 t -153.52 161.2 42.46 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.175 -0.676 . . . . 25.0 109.175 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.32 -22.68 63.76 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.265 0.555 . . . . 25.0 110.711 176.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.9 m -109.12 159.21 8.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.504 -0.771 . . . . 25.0 110.379 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.6 t -99.59 147.71 25.07 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.261 -1.385 . . . . 25.0 107.261 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -126.19 34.04 4.92 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.219 -0.66 . . . . 25.0 109.219 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 48.9 ptt85 38.17 46.71 0.89 Allowed 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 122.913 1.339 . . . . 25.0 114.126 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.07 129.71 37.96 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 113.584 -1.643 . . . . 25.0 111.004 -178.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -68.84 164.31 22.26 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.26 0.35 . . . . 25.0 110.847 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 145.6 -157.68 27.43 Favored Glycine 0 C--O 1.224 -0.508 0 C-N-CA 120.993 -0.622 . . . . 25.0 113.288 177.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.2 tp -50.35 -34.9 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 113.026 0.75 . . . . 25.0 113.026 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.9 t -68.03 -42.86 85.62 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.694 0 O-C-N 121.262 -0.899 . . . . 25.0 110.597 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -65.54 -36.45 83.84 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.735 0.779 . . . . 25.0 110.245 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -73.63 -38.4 65.06 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 113.588 0.958 . . . . 25.0 113.588 -179.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 73.6 m -105.38 -21.96 13.13 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 116.722 2.119 . . . . 25.0 116.722 -174.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.6 t -104.35 -36.55 7.56 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 118.094 0.406 . . . . 25.0 111.131 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -91.53 -24.59 19.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.901 0.382 . . . . 25.0 110.072 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 42.1 mtm105 -125.15 172.73 9.27 Favored 'General case' 0 C--O 1.208 -1.081 0 N-CA-C 106.622 -1.621 . . . . 25.0 106.622 168.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.4 m -79.27 -10.62 59.86 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 116.993 2.22 . . . . 25.0 116.993 -174.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 64.25 -173.17 0.17 Allowed 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 114.391 1.256 . . . . 25.0 114.391 -176.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.78 151.61 35.11 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 105.277 -2.12 . . . . 25.0 105.277 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.9 tp -64.35 -40.94 96.86 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.188 0.518 . . . . 25.0 111.314 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.15 -39.59 86.56 Favored 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 109.367 -0.605 . . . . 25.0 109.367 -177.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.7 tp -63.9 -45.11 90.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.367 -0.833 . . . . 25.0 110.449 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.2 tt -61.54 -36.48 80.7 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.156 0.503 . . . . 25.0 111.139 -176.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -61.78 -23.48 66.23 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.829 1.048 . . . . 25.0 113.829 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 36.8 p -72.23 -14.31 61.75 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.054 0.761 . . . . 25.0 113.054 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -95.65 8.27 43.9 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.151 0.501 . . . . 25.0 112.348 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 73.3 m -75.07 155.34 37.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.897 0.379 . . . . 25.0 110.264 174.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.08 167.38 11.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.532 -0.303 . . . . 25.0 110.236 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.4 p 67.3 156.17 0.14 Allowed Pre-proline 0 N--CA 1.483 1.18 0 C-N-CA 125.908 1.683 . . . . 25.0 113.683 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.81 168.41 24.67 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 117.295 -1.336 . . . . 25.0 113.079 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.01 140.7 58.89 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.907 -0.775 . . . . 25.0 108.907 176.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -89.66 8.12 33.14 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.321 -0.4 . . . . 25.0 110.89 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.0 p -156.8 158.57 37.05 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.159 -1.052 . . . . 25.0 108.159 -177.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 C--O 1.293 3.36 0 CA-C-O 113.906 -2.95 . . . . 25.0 111.309 175.417 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.884 0 CA-C-O 122.63 1.205 . . . . 25.0 113.612 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -74.24 159.4 32.53 Favored 'General case' 0 CA--C 1.526 0.022 0 N-CA-C 108.836 -0.802 . . . . 25.0 108.836 178.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -115.42 147.01 37.77 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 110.05 -0.352 . . . . 25.0 110.05 -177.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.29 160.13 26.18 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 CA-C-O 121.438 0.516 . . . . 25.0 113.137 -177.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.7 m -118.16 84.74 2.22 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 104.877 -2.268 . . . . 25.0 104.877 174.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -64.61 -21.29 66.68 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 116.278 1.955 . . . . 25.0 116.278 -169.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.9 p 36.1 68.33 0.25 Allowed 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 124.007 1.861 . . . . 25.0 113.635 -176.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.4 tp -74.03 109.84 7.84 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 111.658 -2.519 . . . . 25.0 108.962 -176.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.5 t -140.46 168.34 20.04 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.218 -0.901 . . . . 25.0 113.135 -169.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.78 -143.16 47.5 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.022 -0.608 . . . . 25.0 112.172 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.98 -23.75 71.3 Favored Glycine 0 C--O 1.213 -1.167 0 C-N-CA 121.047 -0.597 . . . . 25.0 113.073 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -65.36 -35.62 81.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.827 0.813 . . . . 25.0 110.347 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 41.2 tp -66.38 -43.31 86.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.381 0.61 . . . . 25.0 109.625 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.8 t -67.08 -39.67 83.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.78 -0.645 . . . . 25.0 110.289 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -64.16 -43.44 95.16 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.115 0.483 . . . . 25.0 110.294 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.8 m -62.76 -41.26 99.13 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.143 -0.348 . . . . 25.0 110.609 177.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.4 mt -60.73 -37.22 81.01 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.792 -0.568 . . . . 25.0 110.501 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -71.79 -34.74 69.66 Favored 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 112.072 0.397 . . . . 25.0 112.072 176.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -64.93 -38.26 90.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.285 0.564 . . . . 25.0 110.259 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.1 t -74.29 -42.51 50.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 112.795 0.665 . . . . 25.0 112.795 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.9 m -140.65 -4.87 1.22 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 118.775 2.879 . . . . 25.0 118.775 -176.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.59 170.45 29.06 Favored Glycine 0 C--O 1.218 -0.895 0 O-C-N 121.551 -0.718 . . . . 25.0 112.996 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -62.93 -47.31 83.78 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.003 1.112 . . . . 25.0 114.003 -175.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 45.0 mtm-85 -82.55 -6.03 59.09 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 124.156 0.982 . . . . 25.0 108.995 176.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.9 9.88 58.84 Favored Glycine 0 C--O 1.214 -1.133 0 CA-C-N 114.89 -1.05 . . . . 25.0 115.467 -170.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -152.59 164.15 38.22 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 119.254 1.527 . . . . 25.0 111.338 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -130.22 143.09 50.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.842 -0.617 . . . . 25.0 110.69 172.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.12 152.31 20.65 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.894 -1.521 . . . . 25.0 106.894 174.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 81.1 p -72.46 -9.51 58.63 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.997 0.74 . . . . 25.0 112.997 178.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 64.18 131.9 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.829 0 N-CA-C 116.194 1.924 . . . . 25.0 116.194 175.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.21 132.69 23.1 Favored 'Trans proline' 0 C--O 1.238 0.511 0 C-N-CA 115.899 -2.267 . . . . 25.0 111.992 174.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -164.07 171.18 15.49 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.703 -1.221 . . . . 25.0 107.703 -177.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.406 ' C ' ' H ' ' A' ' 35' ' ' VAL . 1.0 OUTLIER -83.14 -168.93 2.28 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.377 -0.601 . . . . 25.0 109.377 173.319 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.6 ttt85 67.01 -4.09 0.86 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.955 1.302 . . . . 25.0 112.79 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.406 ' H ' ' C ' ' A' ' 33' ' ' SER . 27.2 m -69.86 151.61 9.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 114.826 -1.079 . . . . 25.0 109.295 178.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.6 m -101.28 5.69 42.52 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 113.187 0.81 . . . . 25.0 113.187 -172.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.7 mmm-85 51.81 33.71 11.84 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.714 1.375 . . . . 25.0 114.714 177.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 61.7 mtm180 -116.57 145.69 43.18 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 100.428 -3.916 . . . . 25.0 100.428 170.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.9 m -52.66 110.72 0.54 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.989 0.805 . . . . 25.0 112.492 -175.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -139.27 -14.21 1.14 Allowed 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 114.399 1.259 . . . . 25.0 114.399 -176.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -118.0 159.88 14.04 Favored Glycine 0 C--N 1.312 -0.787 0 CA-C-N 113.862 -1.517 . . . . 25.0 111.884 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.2 tp -55.6 -39.05 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 114.132 1.16 . . . . 25.0 114.132 -175.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.6 p -71.81 -27.79 28.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 O-C-N 120.426 -1.421 . . . . 25.0 110.49 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -77.74 -27.51 50.48 Favored 'General case' 0 C--N 1.317 -0.806 0 O-C-N 121.676 -0.64 . . . . 25.0 112.556 -176.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -94.21 -31.17 14.23 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.26 -0.427 . . . . 25.0 111.367 177.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 84.0 m -95.26 -28.05 15.2 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 115.122 1.527 . . . . 25.0 115.122 -176.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.8 t -110.23 -47.82 3.25 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.79 0.663 . . . . 25.0 112.79 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -72.9 -29.85 63.46 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.911 -0.774 . . . . 25.0 108.911 177.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -118.53 -164.76 1.05 Allowed 'General case' 0 C--O 1.209 -1.042 0 N-CA-C 104.846 -2.279 . . . . 25.0 104.846 167.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.4 m -121.74 147.56 45.75 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 106.425 -1.695 . . . . 25.0 106.425 169.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.1 p -123.74 165.05 17.93 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.501 0.501 . . . . 25.0 110.761 -175.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -103.2 158.56 16.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.62 -0.718 . . . . 25.0 109.484 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.1 tp -59.81 -38.37 81.78 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.659 0.614 . . . . 25.0 112.659 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.77 -41.72 99.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.664 0.268 . . . . 25.0 110.51 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.5 tp -65.86 -46.47 78.35 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.444 -0.946 . . . . 25.0 108.444 177.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.3 tt -56.42 -36.19 68.69 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.454 0.538 . . . . 25.0 112.454 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -63.16 -22.29 66.77 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 113.401 0.889 . . . . 25.0 113.401 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.2 p -73.5 -19.04 61.03 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.58 -0.7 . . . . 25.0 112.22 -178.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -82.32 4.99 21.63 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 120.837 0.351 . . . . 25.0 111.788 176.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 16.5 t -61.6 144.7 53.99 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.055 -0.72 . . . . 25.0 109.055 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.1 149.04 42.37 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.438 -0.801 . . . . 25.0 110.328 177.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.4 p 67.71 135.45 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 125.975 1.71 . . . . 25.0 111.427 -176.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.06 165.44 19.22 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 120.464 0.776 . . . . 25.0 112.795 -176.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.02 134.41 56.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.318 0.58 . . . . 25.0 110.471 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.96 151.68 36.19 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.019 -0.734 . . . . 25.0 109.019 -176.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.6 t 51.92 46.18 27.02 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.67 0.748 . . . . 25.0 112.951 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 . . . . . 0 C--O 1.304 3.933 0 CA-C-O 114.276 -2.774 . . . . 25.0 113.508 -179.321 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.208 -1.108 0 CA-C-O 123.708 1.718 . . . . 25.0 114.728 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -69.02 -21.51 64.12 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.899 -1.046 . . . . 25.0 111.954 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -106.55 140.4 21.29 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.053 -0.976 . . . . 25.0 108.847 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.74 163.23 34.07 Favored 'Trans proline' 0 C--N 1.347 0.488 0 O-C-N 122.184 0.57 . . . . 25.0 113.206 -177.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.5 m -124.04 32.56 5.52 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.777 0.798 . . . . 25.0 111.839 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -91.66 -16.36 27.13 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.238 -0.892 . . . . 25.0 110.691 -177.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.7 p -121.29 152.21 39.18 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.692 -1.14 . . . . 25.0 108.424 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -127.01 -94.26 0.46 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.397 -0.964 . . . . 25.0 108.397 -178.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 69.51 -165.84 0.17 Allowed 'General case' 0 C--O 1.212 -0.884 0 N-CA-C 107.264 -1.384 . . . . 25.0 107.264 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.95 23.82 5.77 Favored Glycine 0 C--O 1.217 -0.929 0 N-CA-C 119.133 2.413 . . . . 25.0 119.133 175.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.63 -25.6 15.33 Favored Glycine 0 C--O 1.217 -0.911 0 CA-C-N 118.191 0.995 . . . . 25.0 112.485 -176.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -59.81 -29.92 68.57 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.184 0.993 . . . . 25.0 110.183 175.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.1 tp -61.43 -37.98 85.48 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.132 -0.94 . . . . 25.0 112.062 176.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.5 t -68.57 -41.37 82.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.145 -0.687 . . . . 25.0 109.145 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.44 -43.48 98.79 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.433 -0.58 . . . . 25.0 109.433 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.9 m -64.28 -39.56 94.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.568 -0.287 . . . . 25.0 110.714 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.8 mt -65.84 -38.39 88.75 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.824 -0.548 . . . . 25.0 110.85 178.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -66.21 -39.57 89.73 Favored 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 110.183 -0.302 . . . . 25.0 110.183 176.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -66.12 -44.01 85.48 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.499 0.555 . . . . 25.0 112.499 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.3 t -76.51 -41.06 34.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.368 0.507 . . . . 25.0 112.368 -176.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 40.3 m -93.29 -31.12 14.82 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.851 1.056 . . . . 25.0 113.851 -174.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.69 -137.91 49.01 Favored Glycine 0 CA--C 1.518 0.256 0 CA-C-O 121.89 0.716 . . . . 25.0 113.346 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -55.71 -25.26 39.24 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.172 1.175 . . . . 25.0 114.172 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -65.72 -21.38 66.52 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.904 -0.497 . . . . 25.0 111.967 -177.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.12 172.77 46.81 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 110.353 -1.099 . . . . 25.0 110.353 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -155.12 169.9 23.06 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.851 -0.796 . . . . 25.0 108.851 -177.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -140.98 155.87 46.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.793 0.806 . . . . 25.0 111.273 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -96.18 162.21 13.62 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.81 -1.552 . . . . 25.0 106.81 175.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.1 t 56.2 -100.55 0.11 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.378 0.671 . . . . 25.0 112.223 -176.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -166.36 159.56 12.15 Favored Pre-proline 0 C--O 1.238 0.465 0 N-CA-C 103.588 -2.745 . . . . 25.0 103.588 176.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.3 -178.29 3.2 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 118.138 -0.775 . . . . 25.0 113.139 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.45 135.39 57.24 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.269 0.557 . . . . 25.0 109.819 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.8 m -148.86 148.53 29.99 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.643 -1.984 . . . . 25.0 105.643 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -72.19 -32.57 66.92 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-O 120.996 0.427 . . . . 25.0 111.93 -177.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.6 m -72.54 148.17 9.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-O 121.735 0.779 . . . . 25.0 113.051 -177.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 p -78.13 67.93 4.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.993 0.901 . . . . 25.0 111.69 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.0 mmt-85 -125.9 57.14 1.38 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.494 0.664 . . . . 25.0 112.03 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.3 mtt180 -93.81 66.55 3.71 Favored 'General case' 0 C--O 1.213 -0.847 0 N-CA-C 106.112 -1.81 . . . . 25.0 106.112 170.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 t -144.85 25.21 1.46 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.834 -1.075 . . . . 25.0 110.259 -175.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -144.73 159.19 43.25 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.14 -1.059 . . . . 25.0 108.14 176.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 172.25 163.18 25.69 Favored Glycine 0 CA--C 1.5 -0.852 0 C-N-CA 120.699 -0.763 . . . . 25.0 112.634 175.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.6 tp -61.62 -32.89 55.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 111.925 0.343 . . . . 25.0 111.925 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.3 t -66.37 -38.7 82.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 121.519 -0.738 . . . . 25.0 109.423 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.04 -28.35 68.79 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 121.601 -0.687 . . . . 25.0 111.439 178.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -85.29 -36.1 21.06 Favored 'General case' 0 C--O 1.207 -1.132 0 N-CA-C 113.702 1.001 . . . . 25.0 113.702 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 82.9 m -114.88 7.77 15.78 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 115.532 1.679 . . . . 25.0 115.532 -172.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 30.3 t -132.49 -53.9 0.95 Allowed 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 109.545 -0.539 . . . . 25.0 109.545 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -73.66 -24.22 59.95 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.213 0.53 . . . . 25.0 110.067 176.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -136.53 176.66 8.5 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.046 -1.094 . . . . 25.0 108.046 175.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.9 m -91.09 151.06 21.15 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.85 0.719 . . . . 25.0 109.108 173.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.8 p -136.87 178.54 7.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.868 0.366 . . . . 25.0 110.194 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -145.95 168.63 20.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.556 -0.905 . . . . 25.0 108.556 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.7 tp -52.16 -48.28 65.02 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 115.073 1.509 . . . . 25.0 115.073 -173.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.84 -42.22 88.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.92 0.39 . . . . 25.0 111.559 -177.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.7 tp -69.63 -45.35 68.69 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.958 0.409 . . . . 25.0 110.139 178.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 tt -60.5 -36.08 77.48 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.857 0.361 . . . . 25.0 111.618 -177.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -61.0 -24.56 66.24 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.585 0.957 . . . . 25.0 113.585 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.0 p -70.58 -14.21 62.4 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 121.678 -0.639 . . . . 25.0 112.719 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -92.81 2.48 56.74 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 122.276 0.23 . . . . 25.0 111.609 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 81.6 m -72.21 152.16 42.41 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.222 -1.399 . . . . 25.0 107.222 173.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.9 167.51 12.76 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.866 -0.791 . . . . 25.0 108.866 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.5 p 67.6 150.15 0.12 Allowed Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 125.614 1.566 . . . . 25.0 111.406 -175.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.83 151.54 57.22 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 114.787 -3.008 . . . . 25.0 113.246 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.13 134.12 42.84 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.097 -1.075 . . . . 25.0 108.097 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -121.24 -29.0 4.59 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.693 0.627 . . . . 25.0 112.693 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.3 t 69.27 138.43 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.881 1.272 . . . . 25.0 111.834 -177.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 . . . . . 0 C--O 1.304 3.933 0 CA-C-O 115.858 -2.02 . . . . 25.0 114.366 -177.503 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.832 0 CA-C-O 122.432 1.11 . . . . 25.0 113.68 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -96.6 177.17 5.75 Favored 'General case' 0 C--O 1.225 -0.189 0 N-CA-C 108.712 -0.847 . . . . 25.0 108.712 178.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -59.73 147.76 77.44 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.355 -0.384 . . . . 25.0 110.958 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.88 -179.14 5.1 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 120.529 0.819 . . . . 25.0 111.139 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.0 m 55.9 58.72 4.21 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 121.798 0.809 . . . . 25.0 112.134 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -63.8 -24.76 67.89 Favored 'General case' 0 C--O 1.213 -0.819 0 CA-C-N 115.013 -0.994 . . . . 25.0 113.156 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -74.48 124.4 26.51 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 108.487 -0.931 . . . . 25.0 108.487 178.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.6 mt -114.36 126.0 54.5 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 122.347 1.07 . . . . 25.0 111.14 -175.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -159.06 -174.77 4.9 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 106.25 -1.759 . . . . 25.0 106.25 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.01 31.73 77.63 Favored Glycine 0 C--O 1.215 -1.059 0 C-N-CA 120.823 -0.703 . . . . 25.0 114.339 175.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.95 -22.27 19.2 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 121.069 -0.586 . . . . 25.0 114.245 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -65.51 -28.49 69.22 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.607 1.203 . . . . 25.0 110.353 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.0 tp -61.91 -41.82 98.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.088 -0.506 . . . . 25.0 110.361 174.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.6 t -68.85 -40.61 81.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.495 -0.557 . . . . 25.0 109.495 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -61.85 -36.76 82.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.063 0.459 . . . . 25.0 110.328 178.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.2 m -70.38 -39.95 74.27 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-N 116.527 -0.306 . . . . 25.0 111.168 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.2 mt -62.06 -38.21 87.93 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.469 -0.769 . . . . 25.0 110.59 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -65.13 -42.55 93.75 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 116.692 -0.231 . . . . 25.0 110.681 176.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -64.97 -45.69 84.62 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.927 0.343 . . . . 25.0 111.927 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.4 t -70.7 -42.95 77.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.049 0.388 . . . . 25.0 112.049 -176.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -98.09 -21.65 16.66 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 116.11 1.893 . . . . 25.0 116.11 -173.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.4 -142.77 47.52 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.457 -0.878 . . . . 25.0 113.306 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -68.08 -11.08 58.39 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 114.474 1.287 . . . . 25.0 114.474 -176.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -66.43 -22.68 66.22 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.582 -0.699 . . . . 25.0 111.97 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.28 167.82 43.84 Favored Glycine 0 C--O 1.227 -0.339 0 N-CA-C 111.179 -0.768 . . . . 25.0 111.179 -178.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -152.98 165.47 35.42 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 122.053 -0.674 . . . . 25.0 109.275 -177.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -105.28 147.4 28.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.574 0.702 . . . . 25.0 111.461 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -141.95 140.03 32.65 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.41 -1.33 . . . . 25.0 107.41 179.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.4 t -136.23 134.79 38.48 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.191 -1.04 . . . . 25.0 108.191 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.97 154.23 20.07 Favored Pre-proline 0 C--O 1.24 0.556 0 N-CA-C 105.829 -1.915 . . . . 25.0 105.829 -179.027 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.55 163.01 27.21 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 114.981 -2.88 . . . . 25.0 111.986 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.4 1.11 12.34 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.133 -1.062 . . . . 25.0 108.133 174.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 p -99.87 162.45 12.98 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.925 -1.139 . . . . 25.0 107.925 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -63.23 -23.85 67.61 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.238 0.459 . . . . 25.0 112.238 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.1 m -115.73 151.81 17.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 109.497 -0.557 . . . . 25.0 109.497 178.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.0 m -85.5 71.04 10.82 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 113.559 0.948 . . . . 25.0 113.559 -175.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.6 mtt85 -78.38 -10.14 59.56 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.57 0.952 . . . . 25.0 113.57 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -90.43 150.59 21.77 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-O 121.184 0.516 . . . . 25.0 111.519 -174.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.76 -175.02 1.94 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.654 -1.157 . . . . 25.0 112.915 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -44.34 140.46 2.25 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 115.04 1.496 . . . . 25.0 115.04 -176.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -153.12 172.2 32.08 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 108.754 -1.739 . . . . 25.0 108.754 174.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.2 tp -59.32 -33.09 49.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 120.919 0.39 . . . . 25.0 111.426 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.22 -35.79 75.03 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 O-C-N 121.565 -0.709 . . . . 25.0 110.576 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -66.52 -35.66 80.78 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 121.507 -0.746 . . . . 25.0 111.312 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -89.15 -21.44 23.33 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 114.52 1.304 . . . . 25.0 114.52 -173.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -120.27 -10.84 9.28 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 116.913 2.19 . . . . 25.0 116.913 178.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 41.9 t -103.87 -38.35 7.06 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.654 0.661 . . . . 25.0 109.503 173.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -99.47 -11.28 21.22 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 122.085 0.945 . . . . 25.0 111.48 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -132.92 174.25 10.54 Favored 'General case' 0 C--O 1.212 -0.887 0 N-CA-C 103.563 -2.754 . . . . 25.0 103.563 168.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.5 m -88.36 -18.16 29.03 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 117.898 2.555 . . . . 25.0 117.898 -173.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 46.96 -173.69 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 117.117 2.265 . . . . 25.0 117.117 -173.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -152.9 165.88 34.1 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 105.621 -1.992 . . . . 25.0 105.621 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 42.4 tp -63.97 -37.2 86.54 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.471 0.915 . . . . 25.0 113.471 -176.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.76 -43.89 71.29 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.118 -0.697 . . . . 25.0 109.118 -174.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.2 tp -61.25 -41.92 97.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.001 -0.545 . . . . 25.0 110.161 175.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 tt -60.15 -36.8 78.34 Favored 'General case' 0 C--N 1.318 -0.775 0 O-C-N 121.738 -0.601 . . . . 25.0 110.702 -178.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -64.4 -27.09 68.77 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.938 0.718 . . . . 25.0 112.938 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 33.1 p -71.29 -14.14 62.12 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.033 0.753 . . . . 25.0 113.033 -178.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -85.47 5.8 29.64 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.563 0.209 . . . . 25.0 111.563 176.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.4 m -61.51 155.41 22.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.835 0.826 . . . . 25.0 111.18 173.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.19 151.87 19.14 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.393 -1.336 . . . . 25.0 107.393 170.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.2 p 67.68 147.62 0.11 Allowed Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 125.889 1.675 . . . . 25.0 113.902 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -78.48 165.57 25.08 Favored 'Trans proline' 0 C--N 1.348 0.543 0 N-CA-C 113.463 0.524 . . . . 25.0 113.463 -177.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.53 160.3 30.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.625 -0.716 . . . . 25.0 110.312 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -83.69 158.56 21.78 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.781 -0.645 . . . . 25.0 110.433 177.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 36.1 p -86.21 63.09 7.82 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.41 0.624 . . . . 25.0 110.763 175.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.3 3.73 0 CA-C-O 113.953 -2.927 . . . . 25.0 113.228 -177.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 124.76 2.219 . . . . 25.0 114.185 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -75.61 173.58 10.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 112.805 -1.998 . . . . 25.0 110.829 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -62.13 151.4 81.24 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.181 -0.463 . . . . 25.0 111.655 -178.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.12 -176.91 3.3 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 120.97 1.113 . . . . 25.0 112.201 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.6 t 63.34 49.25 3.28 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.052 0.845 . . . . 25.0 113.213 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -68.57 -16.73 63.96 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.675 -0.861 . . . . 25.0 108.675 172.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.4 p -84.68 141.34 30.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.622 -0.717 . . . . 25.0 109.068 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.69 133.62 49.58 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.895 -0.593 . . . . 25.0 109.584 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 66.9 m -127.2 -60.46 1.2 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 115.363 1.616 . . . . 25.0 115.363 -177.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.73 -134.96 4.6 Favored Glycine 0 C--O 1.222 -0.613 0 N-CA-C 114.635 0.614 . . . . 25.0 114.635 -173.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.99 -21.02 60.83 Favored Glycine 0 C--O 1.218 -0.881 0 C-N-CA 121.115 -0.564 . . . . 25.0 112.711 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -64.59 -33.3 75.6 Favored 'General case' 0 C--O 1.214 -0.802 0 O-C-N 122.178 -0.601 . . . . 25.0 110.503 176.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.4 tp -68.85 -39.68 79.77 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.689 -0.485 . . . . 25.0 109.689 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.95 -40.83 90.45 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 N-CA-C 108.983 -0.747 . . . . 25.0 108.983 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.68 -49.14 78.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.862 -0.153 . . . . 25.0 111.048 176.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.3 m -60.99 -41.18 95.97 Favored 'General case' 0 C--O 1.219 -0.551 0 C-N-CA 121.12 -0.232 . . . . 25.0 111.005 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.1 mt -63.72 -40.4 96.67 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 121.782 -0.574 . . . . 25.0 110.557 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -68.04 -35.39 78.17 Favored 'General case' 0 C--O 1.217 -0.628 0 O-C-N 121.955 -0.466 . . . . 25.0 110.653 177.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -66.99 -44.77 79.54 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.971 -0.455 . . . . 25.0 112.064 178.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.8 t -79.91 -42.68 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 O-C-N 121.886 -0.509 . . . . 25.0 111.629 -177.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.0 m -89.93 -22.28 22.05 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 114.042 1.127 . . . . 25.0 114.042 -174.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.82 -164.71 54.82 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 109.878 -1.289 . . . . 25.0 109.878 -176.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -73.01 0.79 10.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.519 0.676 . . . . 25.0 112.777 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -67.92 -15.91 63.83 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.66 -0.65 . . . . 25.0 111.403 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.6 173.45 39.82 Favored Glycine 0 CA--C 1.508 -0.366 0 N-CA-C 111.642 -0.583 . . . . 25.0 111.642 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -159.65 166.7 30.07 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.416 -0.586 . . . . 25.0 109.416 -176.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -101.8 143.42 31.73 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.782 -0.645 . . . . 25.0 109.869 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -117.87 172.54 7.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.074 -0.512 . . . . 25.0 109.875 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.1 t -73.71 67.43 1.15 Allowed 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.502 0.926 . . . . 25.0 113.502 -176.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.58 -47.6 0.37 Allowed Pre-proline 0 N--CA 1.475 0.8 0 N-CA-C 118.874 2.916 . . . . 25.0 118.874 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.55 149.67 62.25 Favored 'Trans proline' 0 C--N 1.344 0.305 0 CA-C-N 119.027 0.688 . . . . 25.0 112.609 -176.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -161.75 174.74 12.8 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.623 -0.88 . . . . 25.0 108.623 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.05 -179.86 4.01 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.78 0.675 . . . . 25.0 110.815 175.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.92 -26.18 48.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.359 0.599 . . . . 25.0 110.157 175.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.3 m -94.1 -160.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 107.004 -1.48 . . . . 25.0 107.004 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.8 p -73.11 -135.51 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 109.083 -0.71 . . . . 25.0 109.083 170.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.8 mmt-85 55.74 50.27 14.59 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.39 0.614 . . . . 25.0 111.492 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 81.9 mtt85 -57.57 132.87 54.51 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.257 -1.016 . . . . 25.0 108.257 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.5 p -121.68 141.87 50.72 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.139 -0.319 . . . . 25.0 110.139 -175.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.2 ptt180 57.91 175.84 0.06 Allowed 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.197 1.554 . . . . 25.0 115.197 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.7 153.52 14.69 Favored Glycine 0 C--O 1.216 -1.019 0 N-CA-C 111.245 -0.742 . . . . 25.0 111.245 176.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.2 tp -57.2 -32.58 40.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 113.688 0.996 . . . . 25.0 113.688 -173.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.0 t -67.42 -38.61 81.06 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 O-C-N 121.297 -0.877 . . . . 25.0 109.238 176.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -66.53 -34.68 78.46 Favored 'General case' 0 C--O 1.215 -0.731 0 O-C-N 121.334 -0.854 . . . . 25.0 110.666 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -77.47 -39.42 46.63 Favored 'General case' 0 C--O 1.21 -1.008 0 N-CA-C 113.093 0.775 . . . . 25.0 113.093 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 83.6 m -102.71 -10.87 18.82 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 116.675 2.102 . . . . 25.0 116.675 -172.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 31.6 t -118.12 -43.02 2.76 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 120.889 0.375 . . . . 25.0 111.684 -178.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -78.09 -15.15 59.15 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.128 0.49 . . . . 25.0 110.597 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 17.7 ptt-85 -157.65 178.91 9.74 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 103.342 -2.836 . . . . 25.0 103.342 174.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.4 m -86.79 155.74 20.18 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 118.039 0.381 . . . . 25.0 110.791 178.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.8 p -133.24 177.63 7.53 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.582 -0.896 . . . . 25.0 108.582 177.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -129.52 164.16 24.36 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.746 -0.835 . . . . 25.0 108.746 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 68.6 tp -56.22 -41.99 76.55 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.558 0.743 . . . . 25.0 112.283 177.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.79 -40.03 95.69 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 121.929 -0.482 . . . . 25.0 110.511 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.0 tp -69.86 -44.81 69.07 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.919 -0.771 . . . . 25.0 108.919 178.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.7 tt -59.47 -35.25 73.72 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 121.581 -0.7 . . . . 25.0 111.655 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -60.53 -28.12 68.16 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.589 0.589 . . . . 25.0 112.589 177.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.2 p -71.43 -15.75 62.36 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.902 0.705 . . . . 25.0 112.902 -177.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -90.56 -0.86 57.83 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 121.181 -0.208 . . . . 25.0 111.35 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 82.3 m -72.39 147.54 46.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.467 0.651 . . . . 25.0 110.925 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.25 163.32 15.44 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.537 -1.283 . . . . 25.0 107.537 175.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.9 p -118.05 145.76 37.6 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 107.649 -1.241 . . . . 25.0 107.649 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -61.26 143.13 98.09 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 120.944 1.096 . . . . 25.0 112.691 177.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.97 88.76 3.1 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.826 -0.625 . . . . 25.0 109.888 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.3 ttmt 53.83 45.66 27.36 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 116.024 -0.534 . . . . 25.0 111.711 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.9 t -52.79 -46.79 67.77 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.957 0.885 . . . . 25.0 112.59 -178.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 . . . . . 0 C--O 1.292 3.301 0 CA-C-O 113.599 -3.096 . . . . 25.0 110.268 175.803 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 123.492 1.615 . . . . 25.0 114.457 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -88.68 168.28 12.65 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.225 -0.922 . . . . 25.0 109.465 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 66.8 mtp85 -60.74 138.35 93.28 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 109.929 -0.397 . . . . 25.0 109.929 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -84.28 168.11 11.85 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 120.699 0.932 . . . . 25.0 112.747 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.1 m -146.12 91.85 2.12 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.978 -0.749 . . . . 25.0 108.978 176.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.48 -37.59 74.26 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.824 0.821 . . . . 25.0 110.393 -176.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.4 p -113.91 145.24 41.77 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.659 -1.155 . . . . 25.0 107.929 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -126.71 134.74 50.6 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.137 -0.938 . . . . 25.0 108.58 -176.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -145.91 -46.83 0.21 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.074 0.768 . . . . 25.0 113.074 -177.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.89 -146.85 9.48 Favored Glycine 0 C--O 1.225 -0.459 0 C-N-CA 121.174 -0.536 . . . . 25.0 111.97 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -58.12 -23.71 53.03 Favored Glycine 0 C--O 1.212 -1.269 0 C-N-CA 121.236 -0.507 . . . . 25.0 113.301 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -59.17 -27.02 65.29 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.388 0.514 . . . . 25.0 112.388 176.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 45.9 tp -68.69 -43.2 76.6 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.256 -0.646 . . . . 25.0 109.256 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.88 -39.65 86.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.627 -0.879 . . . . 25.0 108.627 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -64.01 -44.7 91.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.214 0.531 . . . . 25.0 110.657 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.3 m -66.39 -37.03 84.35 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 121.812 -0.555 . . . . 25.0 110.351 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.3 mt -63.54 -37.67 88.2 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 121.912 -0.492 . . . . 25.0 110.373 177.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -66.11 -37.95 86.99 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 122.316 -0.24 . . . . 25.0 110.981 175.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -66.39 -47.88 71.89 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 122.03 -0.418 . . . . 25.0 112.071 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.7 t -77.98 -38.62 24.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 113.167 0.803 . . . . 25.0 113.167 -173.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 50.8 t -89.41 -17.04 29.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.938 0.875 . . . . 25.0 110.801 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.96 -169.72 55.04 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 109.773 -1.331 . . . . 25.0 109.773 -176.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -67.84 3.59 1.44 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.464 1.283 . . . . 25.0 114.464 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -25.25 68.22 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 121.757 -0.589 . . . . 25.0 112.446 -178.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.93 158.72 34.77 Favored Glycine 0 C--O 1.219 -0.83 0 N-CA-C 108.417 -1.873 . . . . 25.0 108.417 -174.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -152.82 169.17 23.45 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.012 -1.477 . . . . 25.0 107.012 -173.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -135.96 142.71 44.6 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.97 -0.381 . . . . 25.0 109.97 176.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -160.72 162.55 32.56 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.475 -0.935 . . . . 25.0 108.475 178.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.0 t 49.49 46.38 23.44 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 115.107 1.521 . . . . 25.0 115.107 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.7 133.66 62.25 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.469 -0.787 . . . . 25.0 112.103 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.22 160.87 46.11 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 114.675 -3.083 . . . . 25.0 111.741 173.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -153.77 170.5 20.79 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.888 -1.153 . . . . 25.0 107.888 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m 58.53 175.02 0.06 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 116.974 2.213 . . . . 25.0 116.974 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -100.97 -8.93 21.97 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.374 -0.83 . . . . 25.0 110.785 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.1 m -127.4 -177.31 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.197 -1.409 . . . . 25.0 107.197 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 m -70.65 -135.16 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 122.995 0.518 . . . . 25.0 111.566 173.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 57.54 35.7 26.07 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.66 0.784 . . . . 25.0 111.392 178.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.8 149.78 30.14 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.474 0.916 . . . . 25.0 113.474 -177.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.4 m -75.42 173.51 10.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.178 -0.919 . . . . 25.0 113.338 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -65.06 164.56 12.66 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.7 -0.682 . . . . 25.0 110.206 174.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.3 -178.58 35.38 Favored Glycine 0 C--O 1.223 -0.544 0 N-CA-C 110.823 -0.911 . . . . 25.0 110.823 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.5 tt -62.48 -27.07 42.07 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 N-CA-C 113.973 1.101 . . . . 25.0 113.973 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.6 p -63.68 -30.83 50.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 O-C-N 120.832 -1.167 . . . . 25.0 109.535 177.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -71.78 -27.34 62.89 Favored 'General case' 0 C--O 1.218 -0.585 0 O-C-N 121.294 -0.879 . . . . 25.0 110.547 177.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -87.4 -32.45 19.54 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.397 -0.819 . . . . 25.0 113.141 -176.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 94.0 m -109.32 -15.33 14.28 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 115.266 1.58 . . . . 25.0 115.266 -176.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 31.8 t -113.68 -50.45 2.84 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.651 0.659 . . . . 25.0 111.653 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -68.83 -30.27 68.77 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.301 0.572 . . . . 25.0 109.853 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.43 173.46 11.48 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 105.471 -2.048 . . . . 25.0 105.471 170.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.9 t -86.46 148.51 25.52 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.364 0.529 . . . . 25.0 110.459 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 20.6 p -114.66 -178.47 3.38 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 122.56 0.344 . . . . 25.0 110.892 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -134.45 162.97 30.75 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.506 -0.553 . . . . 25.0 109.506 -177.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -51.51 -53.9 32.76 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.868 1.062 . . . . 25.0 113.868 -176.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.45 -32.85 74.69 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 121.014 0.435 . . . . 25.0 111.943 -174.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.4 tp -69.2 -47.49 64.71 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.94 -0.763 . . . . 25.0 108.94 176.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.2 tt -61.6 -34.82 76.3 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.464 0.649 . . . . 25.0 111.182 -177.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -58.92 -24.8 62.84 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.645 0.98 . . . . 25.0 113.645 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.3 p -69.02 -19.01 64.11 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.34 0.867 . . . . 25.0 113.34 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -89.6 5.44 45.63 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.107 0.479 . . . . 25.0 111.71 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 31.7 t -64.71 150.98 46.25 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.562 -1.273 . . . . 25.0 107.562 173.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.46 140.82 58.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.32 0.581 . . . . 25.0 110.904 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.3 p -68.86 135.74 89.9 Favored Pre-proline 0 N--CA 1.445 -0.713 0 N-CA-C 107.405 -1.331 . . . . 25.0 107.405 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.28 152.66 75.6 Favored 'Trans proline' 0 CA--C 1.517 -0.348 0 CA-C-O 121.614 0.589 . . . . 25.0 113.368 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.86 48.38 0.95 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.104 -0.953 . . . . 25.0 111.848 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 64.5 tttt 53.87 35.31 21.37 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.776 0.83 . . . . 25.0 111.418 -177.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.5 t -147.81 145.64 28.83 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 106.872 -1.529 . . . . 25.0 106.872 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 . . . . . 0 C--O 1.295 3.483 0 CA-C-O 114.816 -2.516 . . . . 25.0 113.069 -176.6 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.205 -1.252 0 CA-C-O 123.403 1.573 . . . . 25.0 114.769 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -67.26 -24.37 65.78 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 114.992 -1.004 . . . . 25.0 112.699 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -117.27 146.35 38.05 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.598 -0.728 . . . . 25.0 110.386 -179.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -77.43 162.93 30.34 Favored 'Trans proline' 0 C--N 1.345 0.395 0 N-CA-C 114.644 0.978 . . . . 25.0 114.644 -175.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 75.6 m -140.67 76.51 1.56 Allowed 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 108.212 -1.033 . . . . 25.0 108.212 176.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.09 -9.33 58.51 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.286 1.588 . . . . 25.0 115.286 -173.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.4 p 37.85 84.95 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 116.478 2.029 . . . . 25.0 116.478 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.5 mt -61.48 122.68 15.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.685 -1.143 . . . . 25.0 111.64 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -161.94 -168.84 2.03 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 106.595 -1.631 . . . . 25.0 106.595 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.78 32.71 80.16 Favored Glycine 0 C--O 1.213 -1.165 0 N-CA-C 116.088 1.195 . . . . 25.0 116.088 171.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.33 -35.8 3.73 Favored Glycine 0 C--O 1.218 -0.858 0 CA-C-N 117.46 0.63 . . . . 25.0 113.609 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -59.02 -32.05 69.37 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.792 0.796 . . . . 25.0 110.592 178.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 44.0 tp -60.38 -38.55 84.28 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.748 -0.66 . . . . 25.0 110.872 176.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.8 t -71.93 -41.29 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.2 -0.454 . . . . 25.0 110.15 -177.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -62.93 -39.28 94.13 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.928 -0.767 . . . . 25.0 108.928 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 32.5 m -63.7 -43.11 97.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.869 -0.605 . . . . 25.0 110.214 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.7 mt -62.95 -39.58 95.05 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 121.691 -0.631 . . . . 25.0 111.079 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -63.65 -43.75 95.83 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.824 -0.35 . . . . 25.0 110.108 177.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -65.08 -47.11 78.43 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.602 0.593 . . . . 25.0 112.602 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.2 t -70.05 -41.42 79.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 120.879 0.371 . . . . 25.0 111.552 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 66.2 m -83.7 -30.98 26.33 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.142 0.793 . . . . 25.0 113.142 -175.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.71 -134.84 35.35 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.658 -0.782 . . . . 25.0 112.427 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -64.9 -13.54 57.06 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 114.08 1.141 . . . . 25.0 114.08 -178.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -78.42 -25.87 46.16 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 116.05 1.87 . . . . 25.0 116.05 -176.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.52 177.0 49.76 Favored Glycine 0 C--O 1.227 -0.303 0 N-CA-C 110.636 -0.986 . . . . 25.0 110.636 -175.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -154.67 169.43 23.92 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 114.023 1.12 . . . . 25.0 114.023 -175.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -106.21 143.01 34.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.349 -0.841 . . . . 25.0 110.959 176.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -130.7 171.02 13.56 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.028 -0.73 . . . . 25.0 109.028 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.8 t -99.63 137.57 37.93 Favored 'General case' 0 C--O 1.22 -0.454 0 N-CA-C 109.238 -0.653 . . . . 25.0 109.238 177.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.596 ' H ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -139.69 -52.33 0.02 OUTLIER Pre-proline 0 N--CA 1.476 0.837 0 N-CA-C 117.643 2.461 . . . . 25.0 117.643 -177.563 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.596 ' HD2' ' H ' ' A' ' 30' ' ' ARG . 97.7 Cg_endo -77.94 156.69 30.75 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 CA-C-N 118.592 0.533 . . . . 25.0 112.919 -178.112 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -100.93 143.65 30.82 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.471 -0.937 . . . . 25.0 108.471 175.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.9 m -105.45 157.03 17.64 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.156 -1.424 . . . . 25.0 107.156 175.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -64.09 -28.85 70.06 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 111.78 0.289 . . . . 25.0 111.78 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.16 164.42 31.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.403 -0.962 . . . . 25.0 108.403 178.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.0 p -75.15 -165.4 0.39 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 122.441 0.296 . . . . 25.0 110.966 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 45.39 36.65 2.47 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 115.598 1.703 . . . . 25.0 115.598 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.8 mtt-85 -122.5 148.87 44.65 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.106 -0.497 . . . . 25.0 111.016 175.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.7 t 63.71 178.58 0.16 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.964 1.306 . . . . 25.0 113.419 177.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -100.71 159.87 14.82 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 106.208 -1.775 . . . . 25.0 106.208 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -167.71 118.42 0.78 Allowed Glycine 0 C--O 1.223 -0.585 0 C-N-CA 119.248 -1.453 . . . . 25.0 114.431 176.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.4 tp -62.24 -34.77 65.65 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.57 0 N-CA-C 108.646 -0.872 . . . . 25.0 108.646 176.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.04 -42.73 87.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 O-C-N 121.891 -0.506 . . . . 25.0 110.026 176.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -69.49 -19.01 63.74 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 121.21 -0.931 . . . . 25.0 113.474 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -101.29 -20.55 15.18 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 114.285 1.217 . . . . 25.0 114.285 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 78.8 m -110.72 -27.71 8.77 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.311 1.597 . . . . 25.0 115.311 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 63.0 m -97.85 -46.15 6.05 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 118.541 0.61 . . . . 25.0 110.665 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -72.76 -27.54 62.08 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.338 0.589 . . . . 25.0 110.464 -176.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -149.17 172.2 15.21 Favored 'General case' 0 C--O 1.21 -1.01 0 N-CA-C 104.845 -2.279 . . . . 25.0 104.845 176.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.2 t -81.16 156.14 25.85 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 117.753 0.251 . . . . 25.0 110.661 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 26.9 p -134.89 176.54 8.56 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.455 -0.572 . . . . 25.0 109.455 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -131.98 164.05 27.02 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.69 -0.856 . . . . 25.0 108.69 -177.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.6 tp -56.68 -42.27 78.76 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 123.32 0.648 . . . . 25.0 112.383 177.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.9 -40.54 96.75 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-O 121.095 0.474 . . . . 25.0 110.625 -177.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.2 tp -69.22 -44.15 72.65 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.473 -0.566 . . . . 25.0 109.473 178.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 tt -60.44 -34.56 74.16 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.955 0.407 . . . . 25.0 110.975 -176.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -60.12 -30.09 69.04 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.237 0.828 . . . . 25.0 113.237 177.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.3 p -71.49 -14.02 61.99 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.893 0.701 . . . . 25.0 112.893 -177.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -86.8 -2.95 58.97 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 112.187 0.44 . . . . 25.0 112.187 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 79.4 m -69.9 154.0 42.54 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.32 -0.993 . . . . 25.0 108.32 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.36 166.35 13.35 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.241 -1.022 . . . . 25.0 108.241 178.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.3 p 62.0 154.55 0.11 Allowed Pre-proline 0 N--CA 1.483 1.189 0 N-CA-C 116.574 2.064 . . . . 25.0 116.574 174.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.05 163.67 32.64 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 116.639 -1.774 . . . . 25.0 112.997 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.9 159.28 23.12 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.156 -0.475 . . . . 25.0 110.364 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.8 tptt 65.02 22.22 12.38 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.198 0.999 . . . . 25.0 112.24 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 96.5 p -152.95 161.75 42.16 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.707 -1.96 . . . . 25.0 105.707 174.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 . . . . . 0 C--O 1.285 2.931 0 CA-C-O 112.923 -3.418 . . . . 25.0 108.797 174.09 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.804 0 CA-C-O 122.659 1.219 . . . . 25.0 114.078 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -113.54 165.22 12.71 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-N 115.698 -0.683 . . . . 25.0 109.18 178.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -109.01 149.6 39.85 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 111.912 0.338 . . . . 25.0 111.912 -176.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -76.09 -177.07 3.39 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 120.448 0.765 . . . . 25.0 111.831 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.0 t 58.16 46.53 15.84 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.673 0.749 . . . . 25.0 111.733 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -72.52 -25.18 61.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.236 -0.893 . . . . 25.0 112.093 -178.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.9 p -84.77 151.82 24.11 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 122.168 0.985 . . . . 25.0 112.792 -177.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.0 mt -123.61 135.47 53.97 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 114.49 -1.232 . . . . 25.0 109.75 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.19 162.49 40.78 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.246 -1.39 . . . . 25.0 107.246 177.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.68 -144.5 48.91 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.477 -0.868 . . . . 25.0 112.424 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.95 -21.07 67.39 Favored Glycine 0 C--O 1.216 -0.971 0 CA-C-O 119.551 -0.583 . . . . 25.0 114.063 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -67.07 -38.48 85.84 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.398 1.099 . . . . 25.0 110.317 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tt -67.48 -43.64 80.49 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.114 -1.069 . . . . 25.0 108.114 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.0 t -62.07 -42.69 95.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.648 -0.706 . . . . 25.0 111.152 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -62.13 -39.39 92.4 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.941 0.401 . . . . 25.0 110.285 178.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.2 m -67.47 -41.22 84.97 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.213 -0.292 . . . . 25.0 110.213 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.9 mt -60.83 -41.08 95.06 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 122.038 -0.414 . . . . 25.0 110.3 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -68.75 -34.72 76.06 Favored 'General case' 0 C--O 1.217 -0.647 0 O-C-N 122.396 -0.19 . . . . 25.0 111.367 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -67.22 -46.71 72.99 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.96 -0.463 . . . . 25.0 111.609 176.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.9 t -71.49 -39.69 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 120.981 0.419 . . . . 25.0 111.769 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 9.1 t -96.93 -24.2 15.95 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.525 1.305 . . . . 25.0 114.525 -172.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.24 -160.34 49.62 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 110.515 -1.034 . . . . 25.0 110.515 -174.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.79 0.53 5.54 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.683 0.994 . . . . 25.0 113.683 -177.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -69.04 -16.78 63.78 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 114.863 1.431 . . . . 25.0 114.863 -173.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.2 164.87 40.66 Favored Glycine 0 C--O 1.22 -0.781 0 N-CA-C 110.919 -0.872 . . . . 25.0 110.919 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -153.38 168.3 26.52 Favored 'General case' 0 C--N 1.322 -0.629 0 O-C-N 121.947 -0.737 . . . . 25.0 110.768 -174.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -100.21 158.38 15.91 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.697 -0.853 . . . . 25.0 108.697 177.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -141.78 -178.01 5.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.193 0.521 . . . . 25.0 111.204 -175.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.1 t -55.82 137.09 50.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.576 -0.738 . . . . 25.0 110.905 178.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.9 ppt_? -141.7 160.53 55.94 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.571 -0.741 . . . . 25.0 110.071 -175.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.99 164.95 32.36 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 117.691 -1.072 . . . . 25.0 113.867 -177.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.43 145.54 49.43 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.185 -1.043 . . . . 25.0 108.185 177.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 64.8 p -84.29 -176.4 6.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.205 0.526 . . . . 25.0 111.245 -176.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -69.36 -17.46 63.69 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 115.015 1.487 . . . . 25.0 115.015 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.4 m -83.36 -171.96 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.938 0.399 . . . . 25.0 110.209 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.54 -160.83 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.628 0.771 . . . . 25.0 112.463 174.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 59.93 29.11 18.69 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.924 0.889 . . . . 25.0 111.598 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 47.6 mtt180 -76.72 132.23 39.2 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-O 120.905 0.383 . . . . 25.0 110.121 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.4 t -162.08 152.55 17.19 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 102.002 -3.333 . . . . 25.0 102.002 173.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -93.97 -40.47 10.1 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.172 0.434 . . . . 25.0 112.172 -176.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.31 -159.12 18.95 Favored Glycine 0 C--O 1.216 -1.026 0 CA-C-O 119.725 -0.486 . . . . 25.0 111.951 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.2 tp -52.37 -27.63 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 115.081 1.512 . . . . 25.0 115.081 -177.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.1 t -66.89 -34.23 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 O-C-N 120.916 -1.115 . . . . 25.0 110.166 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -67.51 -35.12 78.51 Favored 'General case' 0 C--N 1.319 -0.754 0 O-C-N 121.808 -0.557 . . . . 25.0 109.911 176.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -73.99 -43.63 57.41 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.99 0.737 . . . . 25.0 112.99 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 81.0 m -105.5 -14.83 15.18 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 116.129 1.9 . . . . 25.0 116.129 -171.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.7 t -113.18 -42.93 3.44 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.515 0.598 . . . . 25.0 111.425 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -83.56 -20.93 32.93 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.33 0.586 . . . . 25.0 110.101 176.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 94.1 mtm-85 -131.85 -176.42 4.05 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 103.42 -2.807 . . . . 25.0 103.42 173.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.4 m -109.61 151.9 26.23 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 104.819 -2.289 . . . . 25.0 104.819 171.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 27.6 p -129.22 163.33 25.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.723 0.297 . . . . 25.0 110.943 -174.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -114.12 169.57 8.92 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.975 -0.75 . . . . 25.0 108.975 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 61.9 tp -55.06 -45.77 75.35 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.685 0.794 . . . . 25.0 111.784 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.87 -42.62 99.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.013 0.435 . . . . 25.0 111.382 -176.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.2 tp -68.86 -45.57 70.7 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.305 0.574 . . . . 25.0 109.607 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 tt -61.1 -33.61 73.64 Favored 'General case' 0 C--N 1.317 -0.806 0 O-C-N 121.891 -0.506 . . . . 25.0 111.04 -178.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -63.3 -24.67 67.96 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.511 0.93 . . . . 25.0 113.511 178.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.5 p -70.85 -14.37 62.38 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.137 -0.977 . . . . 25.0 111.856 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -97.87 0.63 47.0 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.399 -0.364 . . . . 25.0 110.963 177.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 29.5 t -76.9 148.55 36.36 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.036 -1.098 . . . . 25.0 108.036 174.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -95.62 139.09 32.36 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.096 -0.705 . . . . 25.0 109.096 174.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.433 ' HB ' ' HD2' ' A' ' 63' ' ' PRO . 5.3 p 66.11 159.46 0.13 Allowed Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 124.562 1.145 . . . . 25.0 112.722 176.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' A' ' 62' ' ' THR . 92.7 Cg_endo -71.74 163.31 39.33 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 118.31 -0.66 . . . . 25.0 113.362 -177.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.2 122.8 14.73 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.423 0.63 . . . . 25.0 111.065 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -68.42 -19.02 64.57 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.252 1.204 . . . . 25.0 114.252 -177.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.1 t -159.56 90.61 0.95 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.948 0.404 . . . . 25.0 111.282 -177.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 . . . . . 0 C--O 1.302 3.861 0 CA-C-O 115.854 -2.022 . . . . 25.0 114.246 178.455 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.3 m . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 121.36 0.6 . . . . 25.0 112.555 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.39 -146.09 50.07 Favored Glycine 0 C--O 1.227 -0.303 0 CA-C-N 115.892 -0.594 . . . . 25.0 114.373 172.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.59 -23.52 72.18 Favored Glycine 0 C--O 1.211 -1.321 0 C-N-CA 121.124 -0.56 . . . . 25.0 112.937 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -69.13 -27.39 65.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.649 0.725 . . . . 25.0 110.66 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.6 tp -70.73 -39.88 73.11 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.91 -0.774 . . . . 25.0 108.91 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 69.2 t -67.18 -41.04 86.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.065 -0.516 . . . . 25.0 109.883 178.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -59.17 -46.22 88.97 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 122.889 0.476 . . . . 25.0 110.191 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 48.2 m -63.04 -39.93 96.21 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 116.528 -0.305 . . . . 25.0 111.467 177.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.4 mt -62.0 -39.2 91.44 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 121.622 -0.674 . . . . 25.0 110.56 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -69.01 -38.17 79.1 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 116.934 -0.121 . . . . 25.0 110.724 176.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -65.64 -44.78 85.37 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.06 -0.4 . . . . 25.0 112.054 177.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.1 t -72.79 -39.35 59.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.154 0.428 . . . . 25.0 112.154 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 t -98.7 -15.7 19.28 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 115.033 1.494 . . . . 25.0 115.033 -176.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.24 -142.31 37.27 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-O 122.101 0.834 . . . . 25.0 113.3 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -72.95 -11.23 60.5 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 123.615 0.766 . . . . 25.0 112.886 -177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.7 mtp180 . . . . . 0 C--N 1.325 -0.492 0 N-CA-C 114.066 1.136 . . . . 25.0 114.066 -172.583 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.7 m . . . . . 0 C--O 1.238 0.468 0 CA-C-O 121.21 0.529 . . . . 25.0 111.671 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.45 -143.54 48.28 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-O 121.917 0.732 . . . . 25.0 114.861 172.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.4 -23.04 71.67 Favored Glycine 0 C--O 1.21 -1.394 0 CA-C-N 115.112 -0.544 . . . . 25.0 113.49 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -69.94 -28.78 65.85 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 118.126 0.963 . . . . 25.0 109.402 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.23 -42.43 84.05 Favored 'General case' 0 C--O 1.216 -0.68 0 N-CA-C 107.604 -1.258 . . . . 25.0 107.604 177.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.5 t -64.87 -40.76 90.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.057 -0.974 . . . . 25.0 110.793 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -60.67 -48.65 80.83 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 122.189 0.995 . . . . 25.0 108.647 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.9 m -59.61 -41.58 90.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.667 -0.697 . . . . 25.0 111.314 177.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.6 mt -64.43 -39.94 94.8 Favored 'General case' 0 CA--C 1.539 0.519 0 O-C-N 121.826 -0.546 . . . . 25.0 111.09 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -65.55 -35.98 82.45 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 118.293 0.497 . . . . 25.0 109.747 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -68.78 -49.55 57.67 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 120.091 -0.644 . . . . 25.0 112.717 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.8 t -70.45 -42.74 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 O-C-N 122.098 -0.376 . . . . 25.0 111.37 -175.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 58.3 m -87.68 -16.84 33.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.787 0.803 . . . . 25.0 111.357 -175.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.59 -167.09 53.81 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 108.795 -1.722 . . . . 25.0 108.795 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -71.09 0.22 8.11 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 122.061 0.934 . . . . 25.0 112.74 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.6 mtm180 . . . . . 0 N--CA 1.479 0.996 0 N-CA-C 113.181 0.808 . . . . 25.0 113.181 178.344 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.224 -0.248 0 N-CA-C 109.891 -0.411 . . . . 25.0 109.891 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.52 31.61 79.22 Favored Glycine 0 C--O 1.217 -0.923 0 C-N-CA 120.791 -0.719 . . . . 25.0 114.01 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.73 -24.88 15.29 Favored Glycine 0 C--O 1.224 -0.527 0 C-N-CA 121.239 -0.505 . . . . 25.0 113.143 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.39 -28.22 69.09 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.512 0.673 . . . . 25.0 110.057 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.36 -43.69 96.96 Favored 'General case' 0 C--O 1.216 -0.68 0 CA-C-N 116.04 -0.527 . . . . 25.0 110.886 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 80.5 t -67.53 -40.26 84.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.67 -0.695 . . . . 25.0 109.418 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -61.05 -47.17 87.6 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.274 0.559 . . . . 25.0 110.096 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.7 m -61.05 -42.07 97.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.114 -0.494 . . . . 25.0 111.077 177.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.9 mt -63.54 -38.78 92.43 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.916 -0.49 . . . . 25.0 110.89 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -67.54 -37.46 82.75 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 121.136 -0.226 . . . . 25.0 110.461 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -68.1 -45.86 72.56 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 122.033 -0.417 . . . . 25.0 112.075 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 82.1 t -70.77 -42.7 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 112.048 0.388 . . . . 25.0 112.048 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.3 m -96.99 -15.49 21.06 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.958 1.096 . . . . 25.0 113.958 -173.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.18 -161.79 49.8 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-O 122.424 1.013 . . . . 25.0 112.789 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -68.76 0.55 4.17 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.405 -0.897 . . . . 25.0 113.173 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? . . . . . 0 C--N 1.324 -0.524 0 O-C-N 121.165 -0.959 . . . . 25.0 111.511 -179.391 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.518 -0.271 0 N-CA-C 105.973 -1.862 . . . . 25.0 105.973 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.66 32.61 79.23 Favored Glycine 0 C--O 1.218 -0.897 0 C-N-CA 120.481 -0.866 . . . . 25.0 114.232 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.0 -25.54 19.32 Favored Glycine 0 C--O 1.219 -0.804 0 C-N-CA 121.045 -0.598 . . . . 25.0 113.969 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -63.95 -27.78 69.37 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 118.199 0.999 . . . . 25.0 110.583 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 24.6 tp -65.62 -40.57 92.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.064 -0.517 . . . . 25.0 110.178 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 85.1 t -69.49 -39.4 78.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.361 -0.607 . . . . 25.0 109.361 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -59.62 -46.39 89.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.685 0.755 . . . . 25.0 109.778 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.0 m -63.56 -39.66 94.99 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.971 -0.559 . . . . 25.0 111.299 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.5 mt -63.03 -38.19 90.18 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.905 -0.497 . . . . 25.0 110.976 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -66.37 -39.17 88.94 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.208 -0.293 . . . . 25.0 110.208 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -65.94 -48.04 72.69 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.599 0.592 . . . . 25.0 112.599 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.3 t -71.96 -41.59 68.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 112.024 0.379 . . . . 25.0 112.024 -175.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.0 m -90.65 -18.38 25.21 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.151 0.797 . . . . 25.0 113.151 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.36 -138.19 48.66 Favored Glycine 0 C--N 1.322 -0.218 0 CA-C-O 122.253 0.918 . . . . 25.0 113.917 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -70.56 -13.34 62.06 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.795 0.838 . . . . 25.0 112.486 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.5 mtp180 . . . . . 0 C--N 1.323 -0.544 0 N-CA-C 113.124 0.787 . . . . 25.0 113.124 -171.825 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.222 -0.379 0 N-CA-C 109.763 -0.458 . . . . 25.0 109.763 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.12 31.13 79.68 Favored Glycine 0 C--O 1.218 -0.868 0 N-CA-C 114.78 0.672 . . . . 25.0 114.78 174.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.74 -25.05 20.93 Favored Glycine 0 C--O 1.22 -0.777 0 C-N-CA 121.027 -0.606 . . . . 25.0 113.203 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -63.77 -28.27 69.76 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.724 0.774 . . . . 25.0 109.532 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 35.0 tp -63.67 -39.54 94.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.794 -0.639 . . . . 25.0 111.004 176.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.5 t -70.63 -39.88 76.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.352 -0.61 . . . . 25.0 109.352 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -61.07 -48.2 82.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.418 0.628 . . . . 25.0 110.028 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.6 m -61.55 -40.03 93.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.039 -0.528 . . . . 25.0 110.829 178.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.1 mt -62.97 -37.06 85.61 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 121.81 -0.556 . . . . 25.0 111.458 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -64.45 -45.98 85.08 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.688 -0.486 . . . . 25.0 109.688 175.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -63.46 -46.18 87.4 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.977 0.732 . . . . 25.0 112.977 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.7 t -71.42 -40.56 72.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 111.887 0.328 . . . . 25.0 111.887 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 77.0 m -86.64 -30.31 21.87 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.45 1.278 . . . . 25.0 114.45 -174.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.14 -127.55 45.15 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.227 -0.987 . . . . 25.0 115.224 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -56.47 -33.1 65.6 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 116.362 1.986 . . . . 25.0 116.362 -173.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 . . . . . 0 C--N 1.323 -0.546 0 N-CA-C 114.058 1.133 . . . . 25.0 114.058 -174.322 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.838 0.351 . . . . 25.0 111.518 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.37 -146.46 48.81 Favored Glycine 0 C--N 1.324 -0.127 0 C-N-CA 120.746 -0.74 . . . . 25.0 111.624 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.75 -26.4 69.91 Favored Glycine 0 C--O 1.21 -1.37 0 C-N-CA 121.006 -0.616 . . . . 25.0 112.471 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -61.12 -30.93 70.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.695 0.747 . . . . 25.0 111.222 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.83 -44.91 68.98 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 109.326 -0.62 . . . . 25.0 109.326 178.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.2 t -63.71 -43.07 97.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.573 -0.739 . . . . 25.0 109.979 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -62.72 -41.73 99.3 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.563 0.697 . . . . 25.0 110.216 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 48.2 m -68.62 -38.9 80.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.34 -0.391 . . . . 25.0 110.293 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.8 mt -63.54 -37.18 86.32 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 121.964 -0.46 . . . . 25.0 110.364 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -65.48 -42.16 92.51 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 110.292 -0.262 . . . . 25.0 110.292 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -64.84 -45.66 85.17 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.595 0.591 . . . . 25.0 112.595 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.2 t -73.77 -43.37 53.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 111.788 0.292 . . . . 25.0 111.788 -176.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 69.3 m -87.45 -28.44 22.09 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.291 0.849 . . . . 25.0 113.291 -175.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.14 -142.46 41.34 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.572 -0.823 . . . . 25.0 112.34 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -66.55 -18.77 65.55 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 123.911 0.884 . . . . 25.0 113.11 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 . . . . . 0 C--N 1.326 -0.426 0 N-CA-C 112.114 0.413 . . . . 25.0 112.114 -178.692 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.517 -0.308 0 N-CA-C 107.487 -1.301 . . . . 25.0 107.487 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.28 -145.36 49.55 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.238 -0.982 . . . . 25.0 110.724 -178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.87 -24.63 70.13 Favored Glycine 0 C--O 1.205 -1.676 0 C-N-CA 120.974 -0.631 . . . . 25.0 113.255 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -61.02 -34.98 75.68 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.314 1.057 . . . . 25.0 111.473 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 25.5 tp -69.38 -39.88 77.76 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.153 -0.684 . . . . 25.0 109.153 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 89.2 t -66.9 -40.43 85.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.741 -0.663 . . . . 25.0 110.203 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -61.76 -40.68 96.01 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.031 -0.729 . . . . 25.0 109.031 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.2 m -68.39 -38.75 81.63 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 116.245 -0.434 . . . . 25.0 110.854 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.6 mt -61.61 -36.95 82.18 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 121.585 -0.697 . . . . 25.0 109.971 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -68.77 -37.82 79.6 Favored 'General case' 0 C--O 1.216 -0.683 0 O-C-N 122.27 -0.269 . . . . 25.0 111.436 174.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -65.85 -41.12 92.09 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.821 -0.55 . . . . 25.0 112.224 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.6 t -77.48 -37.24 24.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 112.286 0.476 . . . . 25.0 112.286 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 70.0 m -129.56 -37.53 1.58 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.895 1.813 . . . . 25.0 115.895 -175.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 51.21 -109.7 0.83 Allowed Glycine 0 N--CA 1.462 0.416 0 N-CA-C 116.133 1.213 . . . . 25.0 116.133 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -58.08 -23.12 53.44 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.967 0.907 . . . . 25.0 113.394 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 51.9 mmm-85 . . . . . 0 C--N 1.326 -0.423 0 O-C-N 122.166 -0.334 . . . . 25.0 111.282 179.061 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.467 0.377 0 N-CA-C 110.232 -0.285 . . . . 25.0 110.232 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -44.6 131.65 7.5 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 114.546 0.579 . . . . 25.0 114.546 -175.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.95 -57.82 4.56 Favored Glycine 0 C--O 1.216 -0.993 0 O-C-N 122.827 -0.219 . . . . 25.0 113.479 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -64.93 -38.49 91.14 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.763 0.792 . . . . 25.0 112.564 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.1 tp -68.38 -37.28 80.27 Favored 'General case' 0 C--O 1.211 -0.968 0 N-CA-C 109.31 -0.626 . . . . 25.0 109.31 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.8 t -69.84 -38.31 75.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.647 -0.706 . . . . 25.0 109.85 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -58.95 -46.85 87.02 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.507 0.67 . . . . 25.0 109.3 174.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.5 m -65.38 -38.48 90.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.156 -0.475 . . . . 25.0 112.052 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.6 mt -61.98 -40.11 94.48 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.486 -0.759 . . . . 25.0 109.422 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -67.43 -35.43 79.22 Favored 'General case' 0 C--O 1.217 -0.637 0 O-C-N 122.166 -0.334 . . . . 25.0 111.069 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -66.31 -51.14 60.35 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 122.071 -0.393 . . . . 25.0 112.059 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.2 t -71.0 -42.61 76.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.29 0.478 . . . . 25.0 112.29 -174.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 51.2 m -86.76 -22.26 26.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.26 0.552 . . . . 25.0 112.069 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.19 -149.11 48.05 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-O 122.208 0.893 . . . . 25.0 112.4 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -64.51 -6.26 7.08 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.234 -0.983 . . . . 25.0 113.086 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.0 mmp_? . . . . . 0 C--O 1.217 -0.648 0 O-C-N 120.971 -1.08 . . . . 25.0 111.595 -179.8 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.217 -0.618 0 CA-C-O 120.818 0.342 . . . . 25.0 111.247 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.69 28.7 65.83 Favored Glycine 0 C--O 1.219 -0.839 0 C-N-CA 120.842 -0.694 . . . . 25.0 114.274 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.8 -20.96 35.85 Favored Glycine 0 C--O 1.221 -0.672 0 CA-C-O 119.681 -0.511 . . . . 25.0 113.607 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -62.23 -27.62 69.12 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 117.867 0.834 . . . . 25.0 110.483 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.77 -43.09 94.51 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 116.071 -0.513 . . . . 25.0 111.007 177.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 74.9 t -66.66 -38.85 82.45 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.844 0 N-CA-C 108.847 -0.798 . . . . 25.0 108.847 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -58.79 -48.11 82.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.956 0.407 . . . . 25.0 110.536 177.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.4 m -63.27 -40.37 97.21 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.954 -0.466 . . . . 25.0 111.545 177.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.0 mt -63.08 -36.98 85.41 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 121.944 -0.473 . . . . 25.0 110.777 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -69.14 -38.64 78.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.857 0.361 . . . . 25.0 110.384 176.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -64.01 -39.1 93.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.206 0.526 . . . . 25.0 111.015 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 79.7 t -79.77 -43.46 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 112.377 0.51 . . . . 25.0 112.377 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.5 m -148.98 34.62 0.75 Allowed 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 115.14 1.533 . . . . 25.0 115.14 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.55 -46.98 93.2 Favored Glycine 0 C--O 1.223 -0.573 0 C-N-CA 119.858 -1.163 . . . . 25.0 113.555 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -61.97 -43.85 97.98 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.535 0.683 . . . . 25.0 112.552 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 . . . . . 0 C--N 1.324 -0.503 0 N-CA-C 112.786 0.661 . . . . 25.0 112.786 -177.137 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.223 -0.292 0 N-CA-C 106.971 -1.492 . . . . 25.0 106.971 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.34 30.81 75.14 Favored Glycine 0 C--O 1.22 -0.768 0 C-N-CA 120.787 -0.721 . . . . 25.0 114.535 174.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.29 -25.34 9.28 Favored Glycine 0 C--O 1.221 -0.667 0 C-N-CA 121.138 -0.553 . . . . 25.0 114.047 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -65.05 -27.03 68.52 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.239 1.02 . . . . 25.0 110.409 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 27.6 tp -61.46 -40.01 92.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.967 -0.56 . . . . 25.0 110.167 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 90.5 t -71.97 -36.38 57.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.273 -0.421 . . . . 25.0 109.982 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.0 -45.36 93.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.43 0.634 . . . . 25.0 109.368 176.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.5 m -63.18 -40.03 96.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.109 -0.496 . . . . 25.0 111.113 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.0 mt -61.65 -38.27 87.09 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.752 -0.593 . . . . 25.0 110.472 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -67.52 -39.56 85.09 Favored 'General case' 0 C--O 1.219 -0.538 0 O-C-N 122.004 -0.435 . . . . 25.0 110.8 175.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -66.63 -46.81 74.6 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.722 0.638 . . . . 25.0 112.722 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.4 t -71.58 -42.46 71.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 111.683 0.253 . . . . 25.0 111.683 -176.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 34.9 m -90.39 -26.51 19.87 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.223 0.823 . . . . 25.0 113.223 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.23 -145.74 49.41 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-O 122.204 0.891 . . . . 25.0 113.479 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -58.24 -17.85 22.19 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.918 1.081 . . . . 25.0 113.918 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 . . . . . 0 C--N 1.328 -0.346 0 O-C-N 121.735 -0.603 . . . . 25.0 112.371 -177.741 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.226 -0.172 0 CA-C-O 120.8 0.333 . . . . 25.0 111.164 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.37 -143.69 48.67 Favored Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 120.691 -0.766 . . . . 25.0 113.39 175.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.38 -21.15 75.85 Favored Glycine 0 C--O 1.213 -1.172 0 C-N-CA 121.284 -0.484 . . . . 25.0 113.197 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -69.35 -27.19 65.13 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 117.618 0.709 . . . . 25.0 109.325 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.27 -43.53 67.0 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 121.522 0.677 . . . . 25.0 109.528 174.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.5 t -64.15 -38.5 82.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.164 -0.926 . . . . 25.0 110.057 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -61.59 -48.36 81.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.164 0.507 . . . . 25.0 110.94 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 50.2 m -63.59 -35.94 82.16 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.966 -0.459 . . . . 25.0 111.293 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.6 mt -64.61 -39.77 94.3 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.707 -0.479 . . . . 25.0 109.707 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -67.32 -36.73 82.08 Favored 'General case' 0 C--O 1.219 -0.508 0 O-C-N 121.79 -0.569 . . . . 25.0 110.586 176.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -64.9 -51.56 61.29 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 121.923 -0.485 . . . . 25.0 111.753 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -73.48 -30.78 30.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 112.847 0.684 . . . . 25.0 112.847 -174.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.5 m -99.08 -22.05 15.88 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.16 0.8 . . . . 25.0 113.16 -177.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.39 -163.47 53.86 Favored Glycine 0 C--N 1.321 -0.303 0 CA-C-O 121.834 0.685 . . . . 25.0 111.887 -177.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -71.32 -7.17 45.3 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.751 0.821 . . . . 25.0 111.444 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 115.526 -0.761 . . . . 25.0 111.849 -177.641 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.224 -0.268 0 N-CA-C 108.814 -0.81 . . . . 25.0 108.814 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.77 33.3 84.77 Favored Glycine 0 C--O 1.218 -0.879 0 N-CA-C 114.937 0.735 . . . . 25.0 114.937 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.63 -25.37 7.41 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.999 -0.62 . . . . 25.0 113.311 -178.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -63.45 -31.15 72.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.562 0.681 . . . . 25.0 109.224 177.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 33.2 tp -61.79 -41.86 98.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.923 -0.58 . . . . 25.0 111.448 176.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.9 t -67.52 -41.5 85.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.267 -0.642 . . . . 25.0 109.267 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -61.67 -40.61 95.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.397 0.618 . . . . 25.0 109.966 177.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.8 m -66.69 -40.58 88.58 Favored 'General case' 0 C--O 1.215 -0.725 0 O-C-N 121.933 -0.479 . . . . 25.0 111.216 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.4 mt -62.21 -38.82 90.62 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.63 -0.669 . . . . 25.0 110.563 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -67.04 -39.69 87.01 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.197 -0.456 . . . . 25.0 110.453 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -66.76 -47.75 71.23 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.27 0.47 . . . . 25.0 112.27 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.9 t -67.5 -43.68 87.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.405 0.52 . . . . 25.0 112.405 -175.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -95.26 -15.93 22.83 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.511 0.93 . . . . 25.0 113.511 -176.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.01 -142.87 46.16 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-O 122.067 0.815 . . . . 25.0 112.595 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -71.1 0.36 7.82 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.052 1.13 . . . . 25.0 114.052 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 . . . . . 0 C--N 1.328 -0.328 0 O-C-N 121.462 -0.774 . . . . 25.0 110.95 178.781 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.219 -0.512 0 N-CA-C 110.051 -0.352 . . . . 25.0 110.051 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.17 23.0 63.6 Favored Glycine 0 C--O 1.214 -1.098 0 N-CA-C 115.642 1.017 . . . . 25.0 115.642 174.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.42 -26.47 24.23 Favored Glycine 0 C--O 1.218 -0.85 0 CA-C-O 119.577 -0.568 . . . . 25.0 112.801 -178.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.99 -28.64 67.86 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.796 0.808 . . . . 25.0 110.4 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 30.7 tp -60.95 -40.16 92.29 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.522 -0.763 . . . . 25.0 111.236 176.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 82.5 t -69.58 -41.27 80.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.012 -0.736 . . . . 25.0 109.012 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -64.0 -40.82 97.22 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.914 0.864 . . . . 25.0 109.925 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.3 m -66.83 -40.06 87.87 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.726 -0.67 . . . . 25.0 110.456 178.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.7 mt -62.62 -37.87 87.96 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.118 -0.363 . . . . 25.0 110.415 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -62.32 -45.68 92.14 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.829 -0.544 . . . . 25.0 110.115 175.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -66.9 -45.8 76.86 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.125 0.787 . . . . 25.0 113.125 -176.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.4 t -69.26 -38.5 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 120.875 0.369 . . . . 25.0 111.357 -177.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.5 m -88.06 -24.37 23.47 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.579 0.955 . . . . 25.0 113.579 -175.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.76 -144.42 38.36 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-O 121.693 0.607 . . . . 25.0 113.707 177.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -65.29 -12.08 48.05 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.135 0.791 . . . . 25.0 113.135 -178.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.9 mtm180 . . . . . 0 C--N 1.323 -0.579 0 N-CA-C 113.383 0.882 . . . . 25.0 113.383 -173.497 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.456 -0.172 0 N-CA-C 113.135 0.791 . . . . 25.0 113.135 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.78 -143.16 47.5 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.022 -0.608 . . . . 25.0 112.172 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.98 -23.75 71.3 Favored Glycine 0 C--O 1.213 -1.167 0 C-N-CA 121.047 -0.597 . . . . 25.0 113.073 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -65.36 -35.62 81.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.827 0.813 . . . . 25.0 110.347 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 41.2 tp -66.38 -43.31 86.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.381 0.61 . . . . 25.0 109.625 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.8 t -67.08 -39.67 83.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.78 -0.645 . . . . 25.0 110.289 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -64.16 -43.44 95.16 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.115 0.483 . . . . 25.0 110.294 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.8 m -62.76 -41.26 99.13 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.143 -0.348 . . . . 25.0 110.609 177.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.4 mt -60.73 -37.22 81.01 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.792 -0.568 . . . . 25.0 110.501 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -71.79 -34.74 69.66 Favored 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 112.072 0.397 . . . . 25.0 112.072 176.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -64.93 -38.26 90.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.285 0.564 . . . . 25.0 110.259 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.1 t -74.29 -42.51 50.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 112.795 0.665 . . . . 25.0 112.795 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.9 m -140.65 -4.87 1.22 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 118.775 2.879 . . . . 25.0 118.775 -176.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.59 170.45 29.06 Favored Glycine 0 C--O 1.218 -0.895 0 O-C-N 121.551 -0.718 . . . . 25.0 112.996 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -62.93 -47.31 83.78 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.003 1.112 . . . . 25.0 114.003 -175.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 45.0 mtm-85 . . . . . 0 C--N 1.317 -0.829 0 C-N-CA 124.156 0.982 . . . . 25.0 108.995 176.556 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.212 -0.884 0 N-CA-C 107.264 -1.384 . . . . 25.0 107.264 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.95 23.82 5.77 Favored Glycine 0 C--O 1.217 -0.929 0 N-CA-C 119.133 2.413 . . . . 25.0 119.133 175.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.63 -25.6 15.33 Favored Glycine 0 C--O 1.217 -0.911 0 CA-C-N 118.191 0.995 . . . . 25.0 112.485 -176.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -59.81 -29.92 68.57 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.184 0.993 . . . . 25.0 110.183 175.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.1 tp -61.43 -37.98 85.48 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.132 -0.94 . . . . 25.0 112.062 176.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.5 t -68.57 -41.37 82.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.145 -0.687 . . . . 25.0 109.145 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.44 -43.48 98.79 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.433 -0.58 . . . . 25.0 109.433 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.9 m -64.28 -39.56 94.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.568 -0.287 . . . . 25.0 110.714 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.8 mt -65.84 -38.39 88.75 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.824 -0.548 . . . . 25.0 110.85 178.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -66.21 -39.57 89.73 Favored 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 110.183 -0.302 . . . . 25.0 110.183 176.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -66.12 -44.01 85.48 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.499 0.555 . . . . 25.0 112.499 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.3 t -76.51 -41.06 34.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.368 0.507 . . . . 25.0 112.368 -176.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 40.3 m -93.29 -31.12 14.82 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.851 1.056 . . . . 25.0 113.851 -174.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.69 -137.91 49.01 Favored Glycine 0 CA--C 1.518 0.256 0 CA-C-O 121.89 0.716 . . . . 25.0 113.346 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -55.71 -25.26 39.24 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.172 1.175 . . . . 25.0 114.172 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 . . . . . 0 N--CA 1.468 0.463 0 O-C-N 121.904 -0.497 . . . . 25.0 111.967 -177.339 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 106.25 -1.759 . . . . 25.0 106.25 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.01 31.73 77.63 Favored Glycine 0 C--O 1.215 -1.059 0 C-N-CA 120.823 -0.703 . . . . 25.0 114.339 175.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.95 -22.27 19.2 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 121.069 -0.586 . . . . 25.0 114.245 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -65.51 -28.49 69.22 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.607 1.203 . . . . 25.0 110.353 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.0 tp -61.91 -41.82 98.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.088 -0.506 . . . . 25.0 110.361 174.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.6 t -68.85 -40.61 81.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.495 -0.557 . . . . 25.0 109.495 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -61.85 -36.76 82.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.063 0.459 . . . . 25.0 110.328 178.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.2 m -70.38 -39.95 74.27 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-N 116.527 -0.306 . . . . 25.0 111.168 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.2 mt -62.06 -38.21 87.93 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.469 -0.769 . . . . 25.0 110.59 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -65.13 -42.55 93.75 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 116.692 -0.231 . . . . 25.0 110.681 176.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -64.97 -45.69 84.62 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.927 0.343 . . . . 25.0 111.927 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.4 t -70.7 -42.95 77.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.049 0.388 . . . . 25.0 112.049 -176.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -98.09 -21.65 16.66 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 116.11 1.893 . . . . 25.0 116.11 -173.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.4 -142.77 47.52 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.457 -0.878 . . . . 25.0 113.306 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -68.08 -11.08 58.39 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 114.474 1.287 . . . . 25.0 114.474 -176.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 . . . . . 0 N--CA 1.467 0.378 0 O-C-N 121.582 -0.699 . . . . 25.0 111.97 -178.732 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 66.9 m . . . . . 0 N--CA 1.473 0.716 0 N-CA-C 115.363 1.616 . . . . 25.0 115.363 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.73 -134.96 4.6 Favored Glycine 0 C--O 1.222 -0.613 0 N-CA-C 114.635 0.614 . . . . 25.0 114.635 -173.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.99 -21.02 60.83 Favored Glycine 0 C--O 1.218 -0.881 0 C-N-CA 121.115 -0.564 . . . . 25.0 112.711 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -64.59 -33.3 75.6 Favored 'General case' 0 C--O 1.214 -0.802 0 O-C-N 122.178 -0.601 . . . . 25.0 110.503 176.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.4 tp -68.85 -39.68 79.77 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.689 -0.485 . . . . 25.0 109.689 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.95 -40.83 90.45 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 N-CA-C 108.983 -0.747 . . . . 25.0 108.983 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.68 -49.14 78.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.862 -0.153 . . . . 25.0 111.048 176.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.3 m -60.99 -41.18 95.97 Favored 'General case' 0 C--O 1.219 -0.551 0 C-N-CA 121.12 -0.232 . . . . 25.0 111.005 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.1 mt -63.72 -40.4 96.67 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 121.782 -0.574 . . . . 25.0 110.557 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -68.04 -35.39 78.17 Favored 'General case' 0 C--O 1.217 -0.628 0 O-C-N 121.955 -0.466 . . . . 25.0 110.653 177.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -66.99 -44.77 79.54 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.971 -0.455 . . . . 25.0 112.064 178.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.8 t -79.91 -42.68 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 O-C-N 121.886 -0.509 . . . . 25.0 111.629 -177.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.0 m -89.93 -22.28 22.05 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 114.042 1.127 . . . . 25.0 114.042 -174.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.82 -164.71 54.82 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 109.878 -1.289 . . . . 25.0 109.878 -176.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -73.01 0.79 10.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.519 0.676 . . . . 25.0 112.777 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 . . . . . 0 C--N 1.326 -0.419 0 O-C-N 121.66 -0.65 . . . . 25.0 111.403 179.193 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.469 0.491 0 N-CA-C 113.074 0.768 . . . . 25.0 113.074 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.89 -146.85 9.48 Favored Glycine 0 C--O 1.225 -0.459 0 C-N-CA 121.174 -0.536 . . . . 25.0 111.97 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -58.12 -23.71 53.03 Favored Glycine 0 C--O 1.212 -1.269 0 C-N-CA 121.236 -0.507 . . . . 25.0 113.301 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -59.17 -27.02 65.29 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.388 0.514 . . . . 25.0 112.388 176.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 45.9 tp -68.69 -43.2 76.6 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.256 -0.646 . . . . 25.0 109.256 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.88 -39.65 86.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.627 -0.879 . . . . 25.0 108.627 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -64.01 -44.7 91.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.214 0.531 . . . . 25.0 110.657 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.3 m -66.39 -37.03 84.35 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 121.812 -0.555 . . . . 25.0 110.351 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.3 mt -63.54 -37.67 88.2 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 121.912 -0.492 . . . . 25.0 110.373 177.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -66.11 -37.95 86.99 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 122.316 -0.24 . . . . 25.0 110.981 175.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -66.39 -47.88 71.89 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 122.03 -0.418 . . . . 25.0 112.071 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.7 t -77.98 -38.62 24.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 113.167 0.803 . . . . 25.0 113.167 -173.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 50.8 t -89.41 -17.04 29.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.938 0.875 . . . . 25.0 110.801 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.96 -169.72 55.04 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 109.773 -1.331 . . . . 25.0 109.773 -176.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -67.84 3.59 1.44 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.464 1.283 . . . . 25.0 114.464 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.354 0 O-C-N 121.757 -0.589 . . . . 25.0 112.446 -178.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 106.595 -1.631 . . . . 25.0 106.595 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.78 32.71 80.16 Favored Glycine 0 C--O 1.213 -1.165 0 N-CA-C 116.088 1.195 . . . . 25.0 116.088 171.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.33 -35.8 3.73 Favored Glycine 0 C--O 1.218 -0.858 0 CA-C-N 117.46 0.63 . . . . 25.0 113.609 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -59.02 -32.05 69.37 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.792 0.796 . . . . 25.0 110.592 178.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 44.0 tp -60.38 -38.55 84.28 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.748 -0.66 . . . . 25.0 110.872 176.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.8 t -71.93 -41.29 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.2 -0.454 . . . . 25.0 110.15 -177.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -62.93 -39.28 94.13 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.928 -0.767 . . . . 25.0 108.928 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 32.5 m -63.7 -43.11 97.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.869 -0.605 . . . . 25.0 110.214 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.7 mt -62.95 -39.58 95.05 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 121.691 -0.631 . . . . 25.0 111.079 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -63.65 -43.75 95.83 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.824 -0.35 . . . . 25.0 110.108 177.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -65.08 -47.11 78.43 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.602 0.593 . . . . 25.0 112.602 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.2 t -70.05 -41.42 79.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 120.879 0.371 . . . . 25.0 111.552 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 66.2 m -83.7 -30.98 26.33 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.142 0.793 . . . . 25.0 113.142 -175.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.71 -134.84 35.35 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.658 -0.782 . . . . 25.0 112.427 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -64.9 -13.54 57.06 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 114.08 1.141 . . . . 25.0 114.08 -178.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 . . . . . 0 C--N 1.326 -0.434 0 N-CA-C 116.05 1.87 . . . . 25.0 116.05 -176.459 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 107.246 -1.39 . . . . 25.0 107.246 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.68 -144.5 48.91 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.477 -0.868 . . . . 25.0 112.424 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.95 -21.07 67.39 Favored Glycine 0 C--O 1.216 -0.971 0 CA-C-O 119.551 -0.583 . . . . 25.0 114.063 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -67.07 -38.48 85.84 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.398 1.099 . . . . 25.0 110.317 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tt -67.48 -43.64 80.49 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.114 -1.069 . . . . 25.0 108.114 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.0 t -62.07 -42.69 95.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.648 -0.706 . . . . 25.0 111.152 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -62.13 -39.39 92.4 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.941 0.401 . . . . 25.0 110.285 178.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.2 m -67.47 -41.22 84.97 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.213 -0.292 . . . . 25.0 110.213 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.9 mt -60.83 -41.08 95.06 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 122.038 -0.414 . . . . 25.0 110.3 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -68.75 -34.72 76.06 Favored 'General case' 0 C--O 1.217 -0.647 0 O-C-N 122.396 -0.19 . . . . 25.0 111.367 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -67.22 -46.71 72.99 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.96 -0.463 . . . . 25.0 111.609 176.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.9 t -71.49 -39.69 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 120.981 0.419 . . . . 25.0 111.769 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 9.1 t -96.93 -24.2 15.95 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.525 1.305 . . . . 25.0 114.525 -172.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.24 -160.34 49.62 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 110.515 -1.034 . . . . 25.0 110.515 -174.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.79 0.53 5.54 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.683 0.994 . . . . 25.0 113.683 -177.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 . . . . . 0 C--N 1.326 -0.444 0 N-CA-C 114.863 1.431 . . . . 25.0 114.863 -173.157 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.207 -1.139 0 CA-C-O 122.853 1.311 . . . . 25.0 113.978 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -77.92 -22.64 49.31 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 122.132 0.968 . . . . 25.0 111.757 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -79.18 147.05 68.49 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.339 -0.846 . . . . 25.0 108.732 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.11 152.32 27.65 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 118.346 -0.636 . . . . 25.0 112.968 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.1 m -97.45 35.29 1.66 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.404 -0.817 . . . . 25.0 111.037 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -76.41 -17.06 59.54 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.264 1.209 . . . . 25.0 114.264 -173.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.5 p 54.78 173.6 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.684 1.194 . . . . 25.0 113.406 -174.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.1 tp -138.9 109.32 6.52 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.561 0.696 . . . . 25.0 110.425 -175.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.3 m -132.86 167.98 19.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.337 -0.847 . . . . 25.0 112.555 -172.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.39 -146.09 50.07 Favored Glycine 0 C--O 1.227 -0.303 0 CA-C-N 115.892 -0.594 . . . . 25.0 114.373 172.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.59 -23.52 72.18 Favored Glycine 0 C--O 1.211 -1.321 0 C-N-CA 121.124 -0.56 . . . . 25.0 112.937 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -69.13 -27.39 65.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.649 0.725 . . . . 25.0 110.66 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.6 tp -70.73 -39.88 73.11 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.91 -0.774 . . . . 25.0 108.91 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 69.2 t -67.18 -41.04 86.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.065 -0.516 . . . . 25.0 109.883 178.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -59.17 -46.22 88.97 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 122.889 0.476 . . . . 25.0 110.191 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 48.2 m -63.04 -39.93 96.21 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-N 116.528 -0.305 . . . . 25.0 111.467 177.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.4 mt -62.0 -39.2 91.44 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 121.622 -0.674 . . . . 25.0 110.56 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -69.01 -38.17 79.1 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 116.934 -0.121 . . . . 25.0 110.724 176.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -65.64 -44.78 85.37 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.06 -0.4 . . . . 25.0 112.054 177.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 71.1 t -72.79 -39.35 59.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.154 0.428 . . . . 25.0 112.154 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.8 t -98.7 -15.7 19.28 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 115.033 1.494 . . . . 25.0 115.033 -176.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.24 -142.31 37.27 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-O 122.101 0.834 . . . . 25.0 113.3 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -72.95 -11.23 60.5 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 123.615 0.766 . . . . 25.0 112.886 -177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.7 mtp180 -72.52 -15.05 61.78 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 114.066 1.136 . . . . 25.0 114.066 -172.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.43 168.97 45.42 Favored Glycine 0 C--O 1.226 -0.395 0 C-N-CA 121.07 -0.586 . . . . 25.0 112.508 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -151.77 168.37 25.27 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 122.29 -0.535 . . . . 25.0 110.075 -175.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.428 ' CE1' ' HA ' ' A' ' 61' ' ' ALA . 34.3 m-85 -114.51 159.6 20.19 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.126 -0.694 . . . . 25.0 109.126 175.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -128.03 177.4 6.91 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.546 -0.297 . . . . 25.0 110.201 -175.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 m -59.71 129.56 42.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.56 0.219 . . . . 25.0 110.898 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.28 -52.14 1.87 Allowed Pre-proline 0 N--CA 1.469 0.499 0 N-CA-C 115.722 1.749 . . . . 25.0 115.722 176.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -83.73 151.66 13.03 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 N-CA-C 113.637 0.591 . . . . 25.0 113.637 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.12 26.0 0.89 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.013 -1.477 . . . . 25.0 107.013 174.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.9 p -90.41 147.21 23.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.2 -0.909 . . . . 25.0 113.405 -170.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.05 -29.84 68.06 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 115.804 -0.635 . . . . 25.0 110.333 173.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.7 m -85.17 166.2 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.706 -0.679 . . . . 25.0 111.487 -176.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.19 90.5 0.21 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 115.047 1.499 . . . . 25.0 115.047 -176.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -131.63 60.02 1.68 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.351 -0.981 . . . . 25.0 108.351 174.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -60.78 136.94 58.22 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.553 -0.536 . . . . 25.0 109.553 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.1 t -163.39 -178.34 5.84 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 105.881 -1.896 . . . . 25.0 105.881 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -82.79 165.44 19.87 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.086 -1.079 . . . . 25.0 108.086 175.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 178.93 137.23 2.82 Favored Glycine 0 C--O 1.221 -0.711 0 N-CA-C 110.058 -1.217 . . . . 25.0 110.058 175.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.451 HD11 ' HG ' ' A' ' 56' ' ' LEU . 7.6 tp -62.03 -29.4 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-O 121.459 0.647 . . . . 25.0 111.926 -177.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.4 t -68.09 -35.16 70.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 O-C-N 121.112 -0.992 . . . . 25.0 109.865 176.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -68.1 -29.61 68.58 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.904 0.705 . . . . 25.0 112.904 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -99.8 -27.43 13.64 Favored 'General case' 0 C--O 1.21 -0.997 0 N-CA-C 113.491 0.923 . . . . 25.0 113.491 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 75.2 m -102.18 -19.71 14.98 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 115.14 1.533 . . . . 25.0 115.14 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 47.6 t -113.25 -49.17 2.92 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 117.733 0.242 . . . . 25.0 111.631 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -74.58 -29.15 61.22 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.377 0.608 . . . . 25.0 109.39 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -125.49 -171.33 2.35 Favored 'General case' 0 C--O 1.215 -0.718 0 N-CA-C 105.944 -1.873 . . . . 25.0 105.944 172.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.6 t -113.59 145.16 41.7 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.66 -1.607 . . . . 25.0 106.66 173.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 29.2 p -123.99 168.63 12.57 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 122.569 0.347 . . . . 25.0 110.164 -175.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.76 165.29 13.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.453 -0.34 . . . . 25.0 110.537 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.5 tp -57.94 -42.23 84.45 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.763 1.023 . . . . 25.0 113.763 -176.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.49 -37.06 84.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.165 0.507 . . . . 25.0 110.094 -176.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.2 tp -69.26 -46.02 68.29 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.854 -0.612 . . . . 25.0 109.592 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.451 ' HG ' HD11 ' A' ' 42' ' ' ILE . 2.9 tt -58.97 -35.8 73.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.278 0.561 . . . . 25.0 111.638 -177.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -61.65 -23.63 66.19 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.572 0.953 . . . . 25.0 113.572 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.7 p -70.35 -14.11 62.43 Favored 'General case' 0 C--N 1.322 -0.587 0 O-C-N 121.536 -0.727 . . . . 25.0 112.765 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -87.69 6.98 32.16 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.02 0.378 . . . . 25.0 112.02 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.9 m -58.89 148.82 28.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.888 0.375 . . . . 25.0 110.176 172.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.428 ' HA ' ' CE1' ' A' ' 27' ' ' TYR . . . -75.32 155.15 36.87 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.731 -0.84 . . . . 25.0 108.731 176.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.4 p -73.67 146.24 85.54 Favored Pre-proline 0 N--CA 1.443 -0.817 0 CA-C-N 116.111 -0.495 . . . . 25.0 110.665 -177.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.93 149.98 48.94 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 121.934 1.756 . . . . 25.0 112.816 174.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.46 161.03 19.15 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.352 -0.981 . . . . 25.0 108.352 176.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -146.49 149.92 34.58 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 106.883 -1.525 . . . . 25.0 106.883 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.2 t -150.1 148.81 29.43 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 105.224 -2.139 . . . . 25.0 105.224 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 . . . . . 1 C--O 1.307 4.101 0 CA-C-O 114.02 -2.895 . . . . 25.0 111.642 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 124.131 1.92 . . . . 25.0 114.211 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -99.82 -164.82 1.16 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 114.624 -1.171 . . . . 25.0 111.06 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -60.9 147.87 84.52 Favored Pre-proline 0 C--N 1.329 -0.305 0 C-N-CA 122.348 0.259 . . . . 25.0 111.33 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -75.89 152.69 36.98 Favored 'Trans proline' 0 C--N 1.344 0.305 0 N-CA-C 113.943 0.709 . . . . 25.0 113.943 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.4 p -82.38 46.62 1.06 Allowed 'General case' 0 C--O 1.209 -1.041 0 C-N-CA 124.24 1.016 . . . . 25.0 113.165 -176.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -76.91 -57.2 3.98 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.28 0.474 . . . . 25.0 112.28 -177.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.7 p -141.84 163.33 33.18 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 109.873 -0.417 . . . . 25.0 109.873 -175.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.2 tp -128.5 115.03 17.52 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 123.298 0.639 . . . . 25.0 109.556 -176.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 30.7 m -133.3 166.23 22.98 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.21 0.529 . . . . 25.0 111.671 -173.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.45 -143.54 48.28 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-O 121.917 0.732 . . . . 25.0 114.861 172.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.4 -23.04 71.67 Favored Glycine 0 C--O 1.21 -1.394 0 CA-C-N 115.112 -0.544 . . . . 25.0 113.49 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -69.94 -28.78 65.85 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 118.126 0.963 . . . . 25.0 109.402 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.23 -42.43 84.05 Favored 'General case' 0 C--O 1.216 -0.68 0 N-CA-C 107.604 -1.258 . . . . 25.0 107.604 177.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.5 t -64.87 -40.76 90.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.057 -0.974 . . . . 25.0 110.793 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -60.67 -48.65 80.83 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 122.189 0.995 . . . . 25.0 108.647 178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.9 m -59.61 -41.58 90.69 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.667 -0.697 . . . . 25.0 111.314 177.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.6 mt -64.43 -39.94 94.8 Favored 'General case' 0 CA--C 1.539 0.519 0 O-C-N 121.826 -0.546 . . . . 25.0 111.09 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -65.55 -35.98 82.45 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-N 118.293 0.497 . . . . 25.0 109.747 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -68.78 -49.55 57.67 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 120.091 -0.644 . . . . 25.0 112.717 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.8 t -70.45 -42.74 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 O-C-N 122.098 -0.376 . . . . 25.0 111.37 -175.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 58.3 m -87.68 -16.84 33.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.787 0.803 . . . . 25.0 111.357 -175.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.59 -167.09 53.81 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 108.795 -1.722 . . . . 25.0 108.795 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -71.09 0.22 8.11 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 122.061 0.934 . . . . 25.0 112.74 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 12.6 mtm180 -73.05 -10.12 59.46 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.181 0.808 . . . . 25.0 113.181 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.63 170.74 44.67 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-O 122.229 0.905 . . . . 25.0 113.254 177.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -155.33 169.54 23.98 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.073 -1.454 . . . . 25.0 107.073 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -111.16 142.86 42.79 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.376 -0.972 . . . . 25.0 108.376 173.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -114.48 150.58 34.59 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.863 -0.792 . . . . 25.0 108.863 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.428 ' H ' HG22 ' A' ' 42' ' ' ILE . 10.9 t 58.05 -137.07 0.92 Allowed 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.589 -0.523 . . . . 25.0 109.589 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.8 ppt_? -135.69 158.23 74.61 Favored Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 108.983 -0.747 . . . . 25.0 108.983 -177.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -71.93 160.6 47.26 Favored 'Trans proline' 0 C--N 1.354 0.862 0 N-CA-C 115.051 1.135 . . . . 25.0 115.051 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.0 65.9 2.12 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 113.422 0.897 . . . . 25.0 113.422 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.4 m -70.12 138.02 51.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.569 -0.287 . . . . 25.0 110.728 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 12.3 mpt_? -92.16 -28.27 17.18 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.265 0.555 . . . . 25.0 110.69 175.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.3 m -90.14 159.11 2.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 CA-C-N 115.765 -0.652 . . . . 25.0 111.678 -178.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.0 m -72.61 56.55 0.39 Allowed 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 114.175 1.176 . . . . 25.0 114.175 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -113.55 77.42 1.05 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 104.575 -2.38 . . . . 25.0 104.575 174.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 -54.58 111.85 0.89 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.812 0.815 . . . . 25.0 110.567 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.3 m -100.6 139.37 36.38 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.759 -1.2 . . . . 25.0 107.759 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.88 160.58 21.1 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.141 -0.689 . . . . 25.0 109.141 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -131.95 160.1 23.48 Favored Glycine 0 C--O 1.225 -0.44 0 N-CA-C 111.501 -0.639 . . . . 25.0 111.501 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.428 HG22 ' H ' ' A' ' 29' ' ' SER . 7.7 tp -57.25 -33.87 44.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 112.726 0.639 . . . . 25.0 112.726 -175.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.41 -27.22 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 O-C-N 121.458 -0.776 . . . . 25.0 111.211 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -71.51 -42.74 67.62 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 120.795 -1.191 . . . . 25.0 109.451 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -83.12 -26.61 30.84 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 119.061 -1.055 . . . . 25.0 112.356 -175.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 70.3 m -98.66 -22.31 15.99 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 116.75 2.13 . . . . 25.0 116.75 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 35.8 t -113.0 -41.9 3.66 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 118.644 0.656 . . . . 25.0 112.426 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -79.2 -24.9 42.83 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 109.304 -0.628 . . . . 25.0 109.304 175.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 28.9 mtt180 -131.36 175.51 9.07 Favored 'General case' 0 C--O 1.215 -0.761 0 N-CA-C 104.803 -2.295 . . . . 25.0 104.803 175.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.5 t -94.17 152.81 18.46 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 106.376 -1.712 . . . . 25.0 106.376 172.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.6 p -134.71 165.99 23.97 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 123.591 0.557 . . . . 25.0 111.413 -177.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -121.77 163.97 18.22 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.403 0.52 . . . . 25.0 112.403 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.4 tp -53.1 -44.21 67.45 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.582 0.956 . . . . 25.0 113.582 -176.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.58 -40.01 90.14 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.658 0.742 . . . . 25.0 111.699 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.4 tp -69.82 -45.09 68.63 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 121.866 -0.521 . . . . 25.0 110.981 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 tt -59.14 -35.07 72.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.709 0.29 . . . . 25.0 111.397 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -62.28 -23.54 66.77 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 113.652 0.982 . . . . 25.0 113.652 177.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.2 p -76.34 -15.24 60.01 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 121.352 -0.842 . . . . 25.0 113.067 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -90.26 -0.29 57.56 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.485 -0.76 . . . . 25.0 111.271 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 78.4 m -70.51 147.1 49.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.428 0.632 . . . . 25.0 110.34 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.51 152.74 39.32 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 122.712 1.244 . . . . 25.0 111.192 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 51.6 p -119.68 137.48 25.64 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 102.736 -3.061 . . . . 25.0 102.736 171.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.07 168.15 25.49 Favored 'Trans proline' 0 C--N 1.35 0.612 0 O-C-N 122.264 0.613 . . . . 25.0 111.293 -175.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -63.64 143.85 57.5 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.601 -1.259 . . . . 25.0 107.601 175.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -69.86 -43.6 71.55 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.046 0.758 . . . . 25.0 113.046 -175.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.7 t -164.97 136.09 4.06 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 106.487 -1.672 . . . . 25.0 106.487 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 . . . . . 0 C--O 1.288 3.101 0 CA-C-O 113.396 -3.192 . . . . 25.0 109.39 174.536 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 123.751 1.738 . . . . 25.0 114.806 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -88.89 163.28 15.69 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 120.905 -1.122 . . . . 25.0 109.13 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -62.95 141.02 97.59 Favored Pre-proline 0 N--CA 1.468 0.427 0 N-CA-C 109.272 -0.64 . . . . 25.0 109.272 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -79.84 156.76 24.07 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 N-CA-C 114.626 0.972 . . . . 25.0 114.626 -173.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.2 p -89.11 40.84 1.0 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.195 -0.911 . . . . 25.0 110.387 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.99 -22.58 63.12 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.046 0.758 . . . . 25.0 113.046 -175.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.5 p 58.36 174.6 0.06 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 114.739 1.385 . . . . 25.0 114.739 -177.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.4 tp -142.9 111.58 6.34 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.587 -1.634 . . . . 25.0 106.587 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -159.81 -171.11 3.13 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.837 -0.62 . . . . 25.0 109.891 -173.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.52 31.61 79.22 Favored Glycine 0 C--O 1.217 -0.923 0 C-N-CA 120.791 -0.719 . . . . 25.0 114.01 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.73 -24.88 15.29 Favored Glycine 0 C--O 1.224 -0.527 0 C-N-CA 121.239 -0.505 . . . . 25.0 113.143 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.39 -28.22 69.09 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.512 0.673 . . . . 25.0 110.057 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.36 -43.69 96.96 Favored 'General case' 0 C--O 1.216 -0.68 0 CA-C-N 116.04 -0.527 . . . . 25.0 110.886 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 80.5 t -67.53 -40.26 84.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.67 -0.695 . . . . 25.0 109.418 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -61.05 -47.17 87.6 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.274 0.559 . . . . 25.0 110.096 177.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.7 m -61.05 -42.07 97.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.114 -0.494 . . . . 25.0 111.077 177.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.9 mt -63.54 -38.78 92.43 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.916 -0.49 . . . . 25.0 110.89 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -67.54 -37.46 82.75 Favored 'General case' 0 C--O 1.219 -0.525 0 C-N-CA 121.136 -0.226 . . . . 25.0 110.461 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -68.1 -45.86 72.56 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 122.033 -0.417 . . . . 25.0 112.075 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 82.1 t -70.77 -42.7 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 112.048 0.388 . . . . 25.0 112.048 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.3 m -96.99 -15.49 21.06 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.958 1.096 . . . . 25.0 113.958 -173.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.18 -161.79 49.8 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-O 122.424 1.013 . . . . 25.0 112.789 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -68.76 0.55 4.17 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.405 -0.897 . . . . 25.0 113.173 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -83.41 -11.67 57.31 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 121.165 -0.959 . . . . 25.0 111.511 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.96 174.08 46.66 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-O 121.939 0.744 . . . . 25.0 112.934 173.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -156.47 167.98 28.77 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.428 -0.582 . . . . 25.0 109.428 -174.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -100.49 147.27 26.07 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.48 0.657 . . . . 25.0 109.727 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -125.47 -177.96 4.07 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.757 -0.831 . . . . 25.0 108.757 -175.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.1 t -54.93 126.45 24.49 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.715 -0.846 . . . . 25.0 108.715 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -97.11 132.17 26.2 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.072 -0.513 . . . . 25.0 111.178 -170.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.2 153.83 70.87 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 118.182 -0.745 . . . . 25.0 113.612 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -70.2 168.34 15.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.498 -0.774 . . . . 25.0 110.552 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.0 m -145.59 165.26 29.19 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 105.804 -1.924 . . . . 25.0 105.804 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.4 mtm105 -65.52 -25.09 67.3 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.098 0.408 . . . . 25.0 111.104 178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.8 m -88.92 145.55 7.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.283 -1.006 . . . . 25.0 108.283 175.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.6 m -75.11 70.22 2.07 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.907 0.706 . . . . 25.0 112.907 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.5 mmt180 -126.47 32.85 5.1 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.275 0.559 . . . . 25.0 110.011 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -72.07 158.24 36.31 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.026 -1.101 . . . . 25.0 108.026 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 73.8 p -146.84 159.39 43.58 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.003 -0.739 . . . . 25.0 109.003 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -67.96 140.69 56.42 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 108.332 -0.988 . . . . 25.0 108.332 178.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.76 161.56 14.44 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-O 121.536 0.52 . . . . 25.0 112.576 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.0 tp -65.3 -30.27 49.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 121.164 0.506 . . . . 25.0 110.259 178.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 72.2 t -64.7 -40.11 87.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 121.393 -0.817 . . . . 25.0 109.182 175.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -63.46 -27.15 69.09 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 114.724 1.379 . . . . 25.0 114.724 -178.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -101.65 -25.01 14.02 Favored 'General case' 0 C--O 1.206 -1.189 0 N-CA-C 112.793 0.664 . . . . 25.0 112.793 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 72.7 m -106.27 -24.0 12.41 Favored 'General case' 0 C--O 1.213 -0.834 0 N-CA-C 114.67 1.359 . . . . 25.0 114.67 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 44.9 t -104.27 -46.27 4.46 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 118.463 0.574 . . . . 25.0 110.874 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -72.5 -33.53 67.0 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.186 0.517 . . . . 25.0 109.899 177.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -134.07 -178.51 5.06 Favored 'General case' 0 C--O 1.213 -0.862 0 N-CA-C 107.412 -1.329 . . . . 25.0 107.412 177.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.7 p -93.08 154.51 18.06 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.143 -0.688 . . . . 25.0 109.143 175.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 32.1 p -139.04 164.88 28.6 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 122.434 0.293 . . . . 25.0 110.369 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -106.06 158.19 16.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.186 -0.461 . . . . 25.0 111.286 -178.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 63.0 tp -59.13 -45.48 90.83 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.684 0.624 . . . . 25.0 112.684 178.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.81 -37.02 82.85 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-O 120.901 0.381 . . . . 25.0 111.07 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.1 tp -68.5 -45.15 73.1 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.121 -0.696 . . . . 25.0 109.121 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 tt -60.53 -34.04 73.54 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.052 0.453 . . . . 25.0 111.023 -178.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 53.1 tt0 -62.5 -24.65 67.59 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.48 0.918 . . . . 25.0 113.48 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.6 p -76.66 -14.26 59.98 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.391 -0.818 . . . . 25.0 111.667 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -85.24 1.14 49.5 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.124 0.416 . . . . 25.0 112.124 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 80.6 m -70.2 152.73 43.93 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.98 0.419 . . . . 25.0 110.119 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.15 164.58 16.3 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.432 0.634 . . . . 25.0 110.706 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.9 p -66.2 142.92 98.12 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 115.696 -0.684 . . . . 25.0 109.916 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -69.93 154.59 66.89 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 CA-C-O 121.46 0.525 . . . . 25.0 113.032 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -124.8 160.71 28.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.12 -0.945 . . . . 25.0 109.564 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -76.66 151.43 36.16 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.884 -0.784 . . . . 25.0 108.884 177.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.2 p -154.37 146.53 23.73 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 104.831 -2.285 . . . . 25.0 104.831 174.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 . . . . . 1 C--O 1.307 4.084 0 CA-C-O 114.53 -2.652 . . . . 25.0 111.564 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.205 -1.281 0 CA-C-O 124.463 2.078 . . . . 25.0 112.521 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -66.03 -18.84 65.61 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 112.5 -2.136 . . . . 25.0 111.509 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.48 149.11 71.52 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 114.743 -1.117 . . . . 25.0 111.763 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -71.68 177.28 7.07 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 121.378 1.385 . . . . 25.0 112.015 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.2 p 53.9 69.43 0.71 Allowed 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 122.277 1.037 . . . . 25.0 110.564 -177.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -65.43 -16.55 63.74 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.303 1.223 . . . . 25.0 114.303 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.05 152.1 43.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.465 0.65 . . . . 25.0 111.119 -176.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.9 mt -129.3 130.1 45.73 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 115.008 -0.996 . . . . 25.0 109.721 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -166.09 -179.35 5.1 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 105.973 -1.862 . . . . 25.0 105.973 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.66 32.61 79.23 Favored Glycine 0 C--O 1.218 -0.897 0 C-N-CA 120.481 -0.866 . . . . 25.0 114.232 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.0 -25.54 19.32 Favored Glycine 0 C--O 1.219 -0.804 0 C-N-CA 121.045 -0.598 . . . . 25.0 113.969 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -63.95 -27.78 69.37 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 118.199 0.999 . . . . 25.0 110.583 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 24.6 tp -65.62 -40.57 92.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.064 -0.517 . . . . 25.0 110.178 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 85.1 t -69.49 -39.4 78.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.361 -0.607 . . . . 25.0 109.361 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -59.62 -46.39 89.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.685 0.755 . . . . 25.0 109.778 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.0 m -63.56 -39.66 94.99 Favored 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.971 -0.559 . . . . 25.0 111.299 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.5 mt -63.03 -38.19 90.18 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.905 -0.497 . . . . 25.0 110.976 178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -66.37 -39.17 88.94 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.208 -0.293 . . . . 25.0 110.208 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -65.94 -48.04 72.69 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.599 0.592 . . . . 25.0 112.599 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.3 t -71.96 -41.59 68.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 112.024 0.379 . . . . 25.0 112.024 -175.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.0 m -90.65 -18.38 25.21 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.151 0.797 . . . . 25.0 113.151 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.36 -138.19 48.66 Favored Glycine 0 C--N 1.322 -0.218 0 CA-C-O 122.253 0.918 . . . . 25.0 113.917 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -70.56 -13.34 62.06 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.795 0.838 . . . . 25.0 112.486 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.5 mtp180 -79.22 -16.03 57.13 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.124 0.787 . . . . 25.0 113.124 -171.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.5 171.4 48.02 Favored Glycine 0 C--O 1.226 -0.358 0 C-N-CA 121.07 -0.586 . . . . 25.0 113.536 174.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -158.11 166.11 33.29 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.489 -0.56 . . . . 25.0 109.489 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -130.46 153.93 48.28 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.863 0.69 . . . . 25.0 112.863 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -103.74 137.15 42.17 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.613 0.721 . . . . 25.0 111.604 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.96 65.73 8.81 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.358 -0.837 . . . . 25.0 113.15 -177.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.03 147.84 49.04 Favored Pre-proline 0 N--CA 1.472 0.631 0 O-C-N 121.866 -0.522 . . . . 25.0 110.37 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.89 162.28 39.59 Favored 'Trans proline' 0 C--N 1.349 0.601 0 O-C-N 121.796 0.366 . . . . 25.0 112.981 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.88 19.58 8.48 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.32 0.581 . . . . 25.0 110.411 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 p -92.08 161.55 14.72 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.575 -0.528 . . . . 25.0 109.575 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 41.7 mtt180 -62.08 -23.57 66.59 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 112.346 0.498 . . . . 25.0 112.346 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.6 m -122.45 143.3 35.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 108.973 -0.751 . . . . 25.0 108.973 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 52.7 m -115.26 85.77 2.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.335 -0.393 . . . . 25.0 110.153 -178.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -69.46 -42.65 74.62 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 121.003 -0.279 . . . . 25.0 111.421 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -151.68 158.19 43.09 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 106.695 -1.594 . . . . 25.0 106.695 176.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.31 154.62 21.79 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 103.391 -2.818 . . . . 25.0 103.391 166.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.1 ptp85 -127.47 -177.65 4.16 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.097 0.777 . . . . 25.0 113.097 -173.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.42 -111.94 4.58 Favored Glycine 0 C--O 1.227 -0.287 0 CA-C-N 116.117 -0.492 . . . . 25.0 113.839 172.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.0 tp -61.23 -34.34 60.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 112.22 0.452 . . . . 25.0 112.22 -177.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.5 t -73.56 -39.24 53.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 O-C-N 121.1 -1.0 . . . . 25.0 109.97 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -65.05 -44.15 89.95 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.241 0.543 . . . . 25.0 111.686 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.63 -30.1 56.74 Favored 'General case' 0 C--O 1.208 -1.105 0 N-CA-C 113.667 0.988 . . . . 25.0 113.667 -175.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 90.9 m -108.97 -20.22 13.12 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 115.652 1.723 . . . . 25.0 115.652 -175.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.3 t -109.09 -47.64 3.4 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.782 0.719 . . . . 25.0 110.701 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -75.24 -33.97 61.36 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.517 -0.473 . . . . 25.0 110.154 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 52.7 mtp180 -129.0 -178.89 4.81 Favored 'General case' 0 C--O 1.214 -0.79 0 N-CA-C 109.043 -0.725 . . . . 25.0 109.043 172.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.0 m -89.54 149.76 22.74 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 123.687 0.617 . . . . 25.0 109.686 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 26.3 p -129.99 166.72 19.5 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.224 0.535 . . . . 25.0 111.984 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -117.2 160.5 20.96 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.812 -0.631 . . . . 25.0 110.12 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 61.6 tp -56.98 -48.5 78.27 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.188 1.181 . . . . 25.0 114.188 -177.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.53 -37.71 84.74 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-O 120.974 0.416 . . . . 25.0 111.455 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.4 tp -67.79 -47.07 70.16 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.318 -0.401 . . . . 25.0 110.048 178.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.7 tt -60.88 -35.24 76.12 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.371 0.605 . . . . 25.0 110.622 -177.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -60.56 -21.91 63.08 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.901 1.074 . . . . 25.0 113.901 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.5 p -73.77 -14.27 61.09 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.338 -0.851 . . . . 25.0 112.594 -178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -92.64 6.25 48.05 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 112.344 0.498 . . . . 25.0 112.344 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 72.6 m -71.06 153.22 42.76 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.452 -1.314 . . . . 25.0 107.452 172.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -70.73 149.92 46.44 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.387 0.613 . . . . 25.0 110.431 -176.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.0 p -113.46 147.49 37.6 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 108.49 -0.93 . . . . 25.0 108.49 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.46 159.18 43.51 Favored 'Trans proline' 0 C--N 1.343 0.272 0 CA-C-O 121.53 0.554 . . . . 25.0 113.267 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.51 161.07 17.17 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.749 -0.834 . . . . 25.0 108.749 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -81.77 153.53 26.45 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.839 -1.171 . . . . 25.0 107.839 177.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 72.5 p -141.98 154.5 45.08 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 105.789 -1.93 . . . . 25.0 105.789 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 . . . . . 0 C--O 1.3 3.732 0 CA-C-O 116.553 -1.689 . . . . 25.0 111.299 -176.144 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 123.943 1.83 . . . . 25.0 114.903 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -79.08 160.39 27.1 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 120.71 -1.244 . . . . 25.0 109.219 178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 70.6 mtt-85 -66.06 145.72 99.0 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.27 -0.423 . . . . 25.0 110.015 -178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -74.72 162.02 38.4 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 118.275 -0.683 . . . . 25.0 112.956 -177.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.3 m -133.3 91.73 2.91 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 107.538 -1.282 . . . . 25.0 107.538 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -76.73 -6.43 52.17 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 114.335 1.235 . . . . 25.0 114.335 -174.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.6 p -109.44 155.05 21.77 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.421 -0.955 . . . . 25.0 108.421 177.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.3 tp -88.69 103.96 16.43 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 122.35 1.071 . . . . 25.0 110.839 -173.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 t -156.01 -169.42 3.07 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.618 -1.174 . . . . 25.0 109.763 -172.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.12 31.13 79.68 Favored Glycine 0 C--O 1.218 -0.868 0 N-CA-C 114.78 0.672 . . . . 25.0 114.78 174.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.74 -25.05 20.93 Favored Glycine 0 C--O 1.22 -0.777 0 C-N-CA 121.027 -0.606 . . . . 25.0 113.203 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -63.77 -28.27 69.76 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.724 0.774 . . . . 25.0 109.532 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 35.0 tp -63.67 -39.54 94.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.794 -0.639 . . . . 25.0 111.004 176.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.5 t -70.63 -39.88 76.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.352 -0.61 . . . . 25.0 109.352 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -61.07 -48.2 82.8 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.418 0.628 . . . . 25.0 110.028 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.6 m -61.55 -40.03 93.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.039 -0.528 . . . . 25.0 110.829 178.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.1 mt -62.97 -37.06 85.61 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 121.81 -0.556 . . . . 25.0 111.458 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -64.45 -45.98 85.08 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.688 -0.486 . . . . 25.0 109.688 175.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -63.46 -46.18 87.4 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.977 0.732 . . . . 25.0 112.977 -178.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.7 t -71.42 -40.56 72.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 111.887 0.328 . . . . 25.0 111.887 -176.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 77.0 m -86.64 -30.31 21.87 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.45 1.278 . . . . 25.0 114.45 -174.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.14 -127.55 45.15 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.227 -0.987 . . . . 25.0 115.224 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -56.47 -33.1 65.6 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 116.362 1.986 . . . . 25.0 116.362 -173.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -82.19 -15.68 52.34 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 114.058 1.133 . . . . 25.0 114.058 -174.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.47 -177.97 52.24 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 109.831 -1.308 . . . . 25.0 109.831 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -157.14 169.49 24.66 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.793 -0.447 . . . . 25.0 109.793 -175.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -153.98 155.1 34.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.475 0.655 . . . . 25.0 110.458 174.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -87.31 134.95 33.49 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.321 -2.103 . . . . 25.0 105.321 176.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.5 t -142.02 137.0 30.81 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.361 0.504 . . . . 25.0 112.361 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.6 145.56 8.62 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 106.794 -1.558 . . . . 25.0 106.794 175.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.59 142.0 35.47 Favored 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 114.038 -3.508 . . . . 25.0 112.001 175.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -96.68 -18.64 19.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.461 0.648 . . . . 25.0 110.652 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.0 m 60.24 163.28 0.06 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 113.028 -1.896 . . . . 25.0 115.694 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -69.33 -26.52 64.75 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.67 0.748 . . . . 25.0 110.869 -176.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.5 m -118.51 164.83 14.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 103.369 -2.826 . . . . 25.0 103.369 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 4.1 m -70.46 65.01 0.29 Allowed 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 115.44 1.645 . . . . 25.0 115.44 -175.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 43.0 mmt180 -127.46 65.7 1.32 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.996 -1.112 . . . . 25.0 107.996 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -68.98 150.47 47.66 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.711 -1.218 . . . . 25.0 107.711 176.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.1 m -153.98 161.72 41.75 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 118.128 0.422 . . . . 25.0 111.363 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 48.01 -161.41 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 117.013 2.227 . . . . 25.0 117.013 172.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.2 168.25 23.96 Favored Glycine 0 CA--C 1.51 -0.265 0 CA-C-N 115.832 -0.622 . . . . 25.0 111.937 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.7 tp -56.39 -35.94 45.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 122.69 0.396 . . . . 25.0 111.864 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.2 -35.66 72.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 O-C-N 121.59 -0.694 . . . . 25.0 111.511 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -68.04 -35.57 78.47 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 121.164 -0.96 . . . . 25.0 110.878 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -86.25 -35.62 19.88 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 113.944 1.09 . . . . 25.0 113.944 -175.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 98.1 m -103.09 -22.38 13.78 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 115.644 1.72 . . . . 25.0 115.644 -176.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 44.4 t -104.44 -43.33 5.21 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.222 0.464 . . . . 25.0 111.508 -178.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -88.5 -16.88 31.56 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.534 0.683 . . . . 25.0 110.265 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -134.66 177.58 7.67 Favored 'General case' 0 C--O 1.218 -0.569 0 N-CA-C 105.96 -1.867 . . . . 25.0 105.96 173.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.4 p -94.46 153.9 17.7 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 106.849 -1.537 . . . . 25.0 106.849 171.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.411 ' HB2' HD23 ' A' ' 55' ' ' LEU . 27.0 p -138.46 165.83 25.83 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.319 0.489 . . . . 25.0 112.319 -176.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -100.17 155.9 17.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.662 -0.699 . . . . 25.0 111.058 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 35.6 tp -58.04 -44.61 87.46 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.306 0.854 . . . . 25.0 113.306 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.5 -38.33 86.94 Favored 'General case' 0 C--O 1.218 -0.577 0 CA-C-O 120.857 0.36 . . . . 25.0 111.286 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.411 HD23 ' HB2' ' A' ' 51' ' ' CYS . 5.3 tp -66.34 -43.75 85.2 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.248 -0.649 . . . . 25.0 109.248 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.2 tt -58.65 -37.02 75.07 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.129 0.49 . . . . 25.0 111.209 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -63.21 -19.68 64.74 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.312 1.227 . . . . 25.0 114.312 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.1 p -75.25 -14.01 60.48 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 121.304 -0.872 . . . . 25.0 112.827 -178.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -93.36 8.03 42.09 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.039 0.447 . . . . 25.0 111.648 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 65.3 m -72.83 155.18 40.18 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.603 -0.888 . . . . 25.0 108.603 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.11 -169.82 2.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.536 0.684 . . . . 25.0 111.727 -176.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.8 p -91.15 134.93 29.03 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 108.021 -1.103 . . . . 25.0 108.021 176.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.8 147.24 74.74 Favored 'Trans proline' 0 C--O 1.236 0.391 0 N-CA-C 115.668 1.372 . . . . 25.0 115.668 -177.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.14 78.41 4.56 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.758 -1.11 . . . . 25.0 110.56 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.7 ttpt 57.42 45.33 20.01 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.791 0.805 . . . . 25.0 110.639 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 59.0 p -134.67 160.58 37.66 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 104.633 -2.358 . . . . 25.0 104.633 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 . . . . . 0 C--O 1.293 3.384 0 CA-C-O 113.952 -2.928 . . . . 25.0 110.854 -175.742 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.212 -0.881 0 CA-C-O 123.291 1.52 . . . . 25.0 113.971 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -96.59 163.05 13.19 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 115.236 -0.893 . . . . 25.0 109.3 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -108.66 150.2 40.44 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.471 -0.332 . . . . 25.0 110.442 -178.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -76.21 175.97 10.65 Favored 'Trans proline' 0 C--N 1.348 0.506 0 N-CA-C 113.617 0.583 . . . . 25.0 113.617 -177.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.6 t 75.29 114.52 0.06 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.615 1.566 . . . . 25.0 113.198 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -83.12 -6.84 59.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.233 -0.894 . . . . 25.0 110.757 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.9 p -117.87 148.93 41.65 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.297 -1.001 . . . . 25.0 108.297 177.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.1 tp -114.76 119.66 37.4 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.617 -0.883 . . . . 25.0 108.617 -176.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.33 167.32 26.41 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.004 -0.543 . . . . 25.0 111.518 -173.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.37 -146.46 48.81 Favored Glycine 0 C--N 1.324 -0.127 0 C-N-CA 120.746 -0.74 . . . . 25.0 111.624 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.75 -26.4 69.91 Favored Glycine 0 C--O 1.21 -1.37 0 C-N-CA 121.006 -0.616 . . . . 25.0 112.471 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -61.12 -30.93 70.67 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.695 0.747 . . . . 25.0 111.222 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.83 -44.91 68.98 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 109.326 -0.62 . . . . 25.0 109.326 178.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.2 t -63.71 -43.07 97.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.573 -0.739 . . . . 25.0 109.979 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -62.72 -41.73 99.3 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.563 0.697 . . . . 25.0 110.216 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 48.2 m -68.62 -38.9 80.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.34 -0.391 . . . . 25.0 110.293 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.8 mt -63.54 -37.18 86.32 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 121.964 -0.46 . . . . 25.0 110.364 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -65.48 -42.16 92.51 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 110.292 -0.262 . . . . 25.0 110.292 175.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -64.84 -45.66 85.17 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.595 0.591 . . . . 25.0 112.595 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 92.2 t -73.77 -43.37 53.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 111.788 0.292 . . . . 25.0 111.788 -176.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 69.3 m -87.45 -28.44 22.09 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.291 0.849 . . . . 25.0 113.291 -175.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.14 -142.46 41.34 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.572 -0.823 . . . . 25.0 112.34 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -66.55 -18.77 65.55 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 123.911 0.884 . . . . 25.0 113.11 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -66.58 -21.76 66.14 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.114 0.413 . . . . 25.0 112.114 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.8 173.29 49.32 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.976 -0.631 . . . . 25.0 112.103 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -158.43 170.57 21.93 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.677 -0.86 . . . . 25.0 108.677 -176.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.87 158.57 43.75 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 122.08 0.943 . . . . 25.0 112.776 175.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -97.96 136.83 37.67 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 105.577 -2.009 . . . . 25.0 105.577 174.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.4 t -76.29 83.05 3.06 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.689 0.626 . . . . 25.0 112.689 -177.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.08 -42.54 0.86 Allowed Pre-proline 0 CA--C 1.554 1.134 0 N-CA-C 119.047 2.98 . . . . 25.0 119.047 176.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -80.91 -169.5 0.81 Allowed 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.246 1.964 . . . . 25.0 114.093 -175.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . 72.78 -123.18 0.05 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.215 1.406 . . . . 25.0 113.819 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.2 m -54.99 127.34 28.49 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 113.709 1.003 . . . . 25.0 113.709 -171.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -68.15 -24.65 65.01 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.36 -0.836 . . . . 25.0 112.74 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.2 m -118.8 140.99 40.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.836 0.827 . . . . 25.0 112.815 -174.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.8 m -87.89 33.7 0.72 Allowed 'General case' 0 C--O 1.217 -0.618 0 CA-C-N 115.251 -0.886 . . . . 25.0 112.554 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -75.41 -8.66 57.29 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 122.135 -0.353 . . . . 25.0 111.516 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -132.26 138.91 48.06 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.433 -1.692 . . . . 25.0 106.433 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.6 m -76.54 52.64 0.81 Allowed 'General case' 0 C--O 1.217 -0.657 0 N-CA-C 117.703 2.483 . . . . 25.0 117.703 -171.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 57.1 ttm-85 -65.47 -42.25 92.46 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.337 -0.847 . . . . 25.0 111.58 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.7 144.15 28.72 Favored Glycine 0 C--O 1.222 -0.597 0 C-N-CA 120.902 -0.666 . . . . 25.0 113.717 -174.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.6 tp -56.58 -36.95 49.91 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.608 0 CA-C-N 114.663 -0.768 . . . . 25.0 110.767 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.15 -39.46 85.62 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.524 0 O-C-N 121.575 -0.703 . . . . 25.0 110.2 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -69.47 -26.53 64.62 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 121.238 -0.914 . . . . 25.0 111.893 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -85.74 -39.92 16.65 Favored 'General case' 0 C--O 1.208 -1.123 0 C-N-CA 121.058 -0.257 . . . . 25.0 111.174 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 73.2 m -101.01 -21.06 15.14 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 116.763 2.135 . . . . 25.0 116.763 -173.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.4 t -111.24 -41.71 4.1 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 118.453 0.57 . . . . 25.0 111.661 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -80.18 -17.18 53.11 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.154 0.502 . . . . 25.0 109.847 176.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -144.36 179.55 7.18 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 103.902 -2.629 . . . . 25.0 103.902 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.6 m -98.13 154.92 17.41 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.05 -1.093 . . . . 25.0 108.05 173.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 22.6 p -139.23 162.2 35.55 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 110.484 -0.191 . . . . 25.0 110.484 -178.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -112.95 164.52 13.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.93 -0.577 . . . . 25.0 112.285 -176.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.9 tp -54.92 -45.84 74.83 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.519 -0.764 . . . . 25.0 112.97 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.8 -41.01 94.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.723 0.296 . . . . 25.0 111.218 -177.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.6 tp -69.84 -46.17 66.2 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.172 0.511 . . . . 25.0 109.867 178.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.2 tt -59.52 -34.6 72.83 Favored 'General case' 0 C--N 1.32 -0.675 0 O-C-N 121.906 -0.496 . . . . 25.0 111.393 -175.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -62.3 -21.7 65.45 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.899 1.074 . . . . 25.0 113.899 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 37.5 p -73.85 -14.19 61.04 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.473 -0.767 . . . . 25.0 112.354 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -89.91 5.08 47.92 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 112.354 0.501 . . . . 25.0 112.354 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 69.1 m -70.94 156.38 39.68 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.356 -0.609 . . . . 25.0 109.356 175.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.44 163.07 16.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.567 0.699 . . . . 25.0 112.35 -177.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.3 p -93.32 138.36 23.11 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.454 -0.793 . . . . 25.0 109.765 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.71 146.3 60.07 Favored 'Trans proline' 0 C--N 1.346 0.417 0 N-CA-C 115.987 1.495 . . . . 25.0 115.987 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -86.69 64.96 8.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.643 -1.162 . . . . 25.0 112.374 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt 58.83 25.99 14.25 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 121.782 0.801 . . . . 25.0 112.295 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 43.5 t -144.71 118.03 9.01 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 104.919 -2.252 . . . . 25.0 104.919 175.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 . . . . . 0 C--O 1.3 3.719 0 CA-C-O 114.981 -2.438 . . . . 25.0 115.021 -171.112 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.934 0 CA-C-O 123.131 1.443 . . . . 25.0 114.142 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -79.81 159.72 26.4 Favored 'General case' 0 C--O 1.231 0.103 0 O-C-N 121.242 -0.911 . . . . 25.0 108.981 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 86.3 mtt85 -70.77 147.33 94.26 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.089 -0.708 . . . . 25.0 109.089 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -77.27 155.23 32.74 Favored 'Trans proline' 0 C--N 1.344 0.309 0 N-CA-C 113.532 0.551 . . . . 25.0 113.532 -176.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.8 m -116.0 60.09 0.72 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.371 -0.831 . . . . 25.0 110.892 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -64.97 -38.93 92.58 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.737 0.779 . . . . 25.0 109.307 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.2 p -123.44 147.79 46.8 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.653 -1.158 . . . . 25.0 109.341 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.9 mt -138.11 137.17 37.45 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 114.79 -1.096 . . . . 25.0 108.913 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -154.81 162.38 41.13 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 107.487 -1.301 . . . . 25.0 107.487 178.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.28 -145.36 49.55 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.238 -0.982 . . . . 25.0 110.724 -178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.87 -24.63 70.13 Favored Glycine 0 C--O 1.205 -1.676 0 C-N-CA 120.974 -0.631 . . . . 25.0 113.255 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -61.02 -34.98 75.68 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.314 1.057 . . . . 25.0 111.473 -177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 25.5 tp -69.38 -39.88 77.76 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.153 -0.684 . . . . 25.0 109.153 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 89.2 t -66.9 -40.43 85.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.741 -0.663 . . . . 25.0 110.203 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -61.76 -40.68 96.01 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.031 -0.729 . . . . 25.0 109.031 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.2 m -68.39 -38.75 81.63 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 116.245 -0.434 . . . . 25.0 110.854 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.6 mt -61.61 -36.95 82.18 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 121.585 -0.697 . . . . 25.0 109.971 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -68.77 -37.82 79.6 Favored 'General case' 0 C--O 1.216 -0.683 0 O-C-N 122.27 -0.269 . . . . 25.0 111.436 174.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -65.85 -41.12 92.09 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.821 -0.55 . . . . 25.0 112.224 177.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.6 t -77.48 -37.24 24.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 112.286 0.476 . . . . 25.0 112.286 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 70.0 m -129.56 -37.53 1.58 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 115.895 1.813 . . . . 25.0 115.895 -175.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 51.21 -109.7 0.83 Allowed Glycine 0 N--CA 1.462 0.416 0 N-CA-C 116.133 1.213 . . . . 25.0 116.133 174.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 48.1 m-20 -58.08 -23.12 53.44 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.967 0.907 . . . . 25.0 113.394 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 51.9 mmm-85 -70.69 -17.43 62.84 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.166 -0.334 . . . . 25.0 111.282 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.68 159.27 23.68 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.992 -0.443 . . . . 25.0 111.992 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -162.3 164.58 27.44 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 106.098 -1.815 . . . . 25.0 106.098 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -154.1 157.66 39.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.346 0.593 . . . . 25.0 109.592 173.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -83.75 154.79 23.4 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.444 -0.947 . . . . 25.0 108.444 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.5 p -71.3 91.44 0.98 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 122.083 0.944 . . . . 25.0 110.812 177.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.8 tpt85 -61.91 -47.29 91.72 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 118.877 2.917 . . . . 25.0 118.877 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.91 161.09 33.45 Favored 'Trans proline' 0 N--CA 1.462 -0.335 0 CA-C-N 118.709 0.575 . . . . 25.0 112.888 -175.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.32 156.27 44.18 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.358 -1.349 . . . . 25.0 107.358 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.89 135.59 33.63 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.984 0.421 . . . . 25.0 111.174 -178.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.75 0.31 57.5 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.975 0.893 . . . . 25.0 110.558 177.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.3 m -120.58 171.62 8.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 106.55 -1.648 . . . . 25.0 106.55 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.37 27.46 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 117.515 2.413 . . . . 25.0 117.515 -175.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -88.19 66.54 8.52 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.577 -0.897 . . . . 25.0 108.577 176.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.88 136.43 57.84 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.277 -1.379 . . . . 25.0 107.277 176.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.1 m -144.58 163.06 35.03 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.614 -0.266 . . . . 25.0 110.86 -172.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -69.05 161.8 28.25 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.975 0.417 . . . . 25.0 110.7 177.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -156.37 163.55 32.06 Favored Glycine 0 CA--C 1.511 -0.167 0 N-CA-C 106.173 -2.771 . . . . 25.0 106.173 174.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.4 tp -66.91 -36.43 77.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 119.117 1.458 . . . . 25.0 111.484 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.2 t -69.01 -40.06 80.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 121.153 -0.967 . . . . 25.0 108.542 175.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -65.09 -27.87 69.06 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 113.739 1.015 . . . . 25.0 113.739 -177.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -93.84 -27.5 16.4 Favored 'General case' 0 C--O 1.209 -1.058 0 N-CA-C 113.052 0.76 . . . . 25.0 113.052 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 94.7 m -107.84 -20.28 13.25 Favored 'General case' 0 C--O 1.212 -0.903 0 N-CA-C 115.421 1.638 . . . . 25.0 115.421 -177.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 37.8 t -106.3 -47.68 3.75 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 118.719 0.691 . . . . 25.0 110.201 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -73.78 -27.63 61.24 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.058 0.456 . . . . 25.0 110.103 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 55.3 mtp85 -136.29 -179.69 5.83 Favored 'General case' 0 C--O 1.214 -0.813 0 N-CA-C 109.055 -0.72 . . . . 25.0 109.055 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.2 t -91.62 150.32 21.22 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.598 -1.26 . . . . 25.0 107.598 173.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 28.0 p -133.74 175.17 9.69 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.158 0.504 . . . . 25.0 111.795 -178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -129.48 160.2 33.92 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.933 -0.48 . . . . 25.0 110.584 -175.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.2 tp -54.46 -52.08 62.98 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.745 1.387 . . . . 25.0 114.745 -177.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.22 -37.12 84.17 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-O 121.083 0.468 . . . . 25.0 111.143 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.9 tp -66.5 -46.72 75.3 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.626 -0.509 . . . . 25.0 109.626 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 tt -62.11 -35.14 77.81 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.021 0.439 . . . . 25.0 111.693 -175.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -59.47 -24.24 63.4 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.324 0.861 . . . . 25.0 113.324 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 35.1 p -70.61 -14.15 62.37 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 113.27 0.841 . . . . 25.0 113.27 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -93.26 6.39 48.23 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.562 0.578 . . . . 25.0 112.562 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 65.7 m -79.02 159.97 27.37 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.964 0.411 . . . . 25.0 110.311 176.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.0 163.57 26.57 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.473 0.654 . . . . 25.0 111.426 -175.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.3 p -114.51 154.08 46.6 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 108.952 -0.759 . . . . 25.0 108.952 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.22 162.81 37.89 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 120.476 0.784 . . . . 25.0 113.429 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.64 165.87 15.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.047 -0.524 . . . . 25.0 110.417 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -67.23 159.45 29.07 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.499 -0.556 . . . . 25.0 109.499 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 t 61.0 34.51 19.32 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 122.765 1.269 . . . . 25.0 111.302 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 C--O 1.302 3.852 0 CA-C-O 112.976 -3.393 . . . . 25.0 111.199 176.381 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 124.13 1.919 . . . . 25.0 113.894 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -73.11 152.15 41.32 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 113.977 -1.465 . . . . 25.0 110.497 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -60.98 146.76 87.07 Favored Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 113.004 0.742 . . . . 25.0 113.004 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -79.88 176.85 9.0 Favored 'Trans proline' 0 C--O 1.238 0.486 0 N-CA-C 110.579 -0.585 . . . . 25.0 110.579 174.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.0 t -145.77 38.48 1.11 Allowed 'General case' 0 C--O 1.218 -0.588 0 CA-C-O 120.938 0.399 . . . . 25.0 110.927 175.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -89.52 -34.43 16.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.637 0.732 . . . . 25.0 110.819 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.7 p -130.98 158.04 41.35 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.049 -0.978 . . . . 25.0 109.718 -177.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.7 mt -142.55 139.05 31.27 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 108.424 -0.954 . . . . 25.0 108.424 -178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -132.39 -156.82 0.78 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.916 -0.314 . . . . 25.0 110.232 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -44.6 131.65 7.5 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 114.546 0.579 . . . . 25.0 114.546 -175.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.95 -57.82 4.56 Favored Glycine 0 C--O 1.216 -0.993 0 O-C-N 122.827 -0.219 . . . . 25.0 113.479 -177.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -64.93 -38.49 91.14 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.763 0.792 . . . . 25.0 112.564 -178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.1 tp -68.38 -37.28 80.27 Favored 'General case' 0 C--O 1.211 -0.968 0 N-CA-C 109.31 -0.626 . . . . 25.0 109.31 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.8 t -69.84 -38.31 75.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.647 -0.706 . . . . 25.0 109.85 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -58.95 -46.85 87.02 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.507 0.67 . . . . 25.0 109.3 174.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.5 m -65.38 -38.48 90.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.156 -0.475 . . . . 25.0 112.052 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.6 mt -61.98 -40.11 94.48 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.486 -0.759 . . . . 25.0 109.422 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -67.43 -35.43 79.22 Favored 'General case' 0 C--O 1.217 -0.637 0 O-C-N 122.166 -0.334 . . . . 25.0 111.069 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -66.31 -51.14 60.35 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 122.071 -0.393 . . . . 25.0 112.059 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.2 t -71.0 -42.61 76.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.29 0.478 . . . . 25.0 112.29 -174.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 51.2 m -86.76 -22.26 26.06 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.26 0.552 . . . . 25.0 112.069 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.19 -149.11 48.05 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-O 122.208 0.893 . . . . 25.0 112.4 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -64.51 -6.26 7.08 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.234 -0.983 . . . . 25.0 113.086 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.0 mmp_? -77.69 -20.51 53.51 Favored 'General case' 0 C--O 1.217 -0.648 0 O-C-N 120.971 -1.08 . . . . 25.0 111.595 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.68 176.77 51.62 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.638 -0.985 . . . . 25.0 110.638 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -153.76 169.22 23.87 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.079 -0.711 . . . . 25.0 109.079 -174.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -124.13 143.04 50.71 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.895 -0.78 . . . . 25.0 108.895 174.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -100.42 145.68 27.93 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.313 -0.625 . . . . 25.0 109.313 -176.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 48.5 t -132.49 144.69 50.62 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.227 -0.656 . . . . 25.0 109.227 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -141.06 136.69 16.22 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.078 -0.51 . . . . 25.0 110.005 -173.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -70.74 145.13 50.69 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 117.041 -1.506 . . . . 25.0 113.031 177.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -151.12 16.67 0.75 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.652 -0.704 . . . . 25.0 109.489 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.3 m -93.05 3.29 55.99 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.117 1.154 . . . . 25.0 114.117 -174.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? 68.32 -30.07 0.17 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.727 1.611 . . . . 25.0 114.355 -176.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.7 m -129.43 151.24 35.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.319 -0.993 . . . . 25.0 108.319 174.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 56.4 m -134.44 111.33 10.05 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.485 -0.561 . . . . 25.0 109.485 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -92.84 -11.62 33.14 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.382 0.61 . . . . 25.0 109.917 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -151.92 161.6 42.38 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 100.491 -3.892 . . . . 25.0 100.491 175.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 26.0 m -64.74 139.87 58.81 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.773 0.715 . . . . 25.0 109.139 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 -103.13 -26.2 13.11 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.119 0.485 . . . . 25.0 112.06 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -152.34 169.17 31.54 Favored Glycine 0 C--O 1.223 -0.569 0 N-CA-C 116.535 1.374 . . . . 25.0 116.535 -177.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.496 HD11 ' HG ' ' A' ' 56' ' ' LEU . 6.0 tp -57.0 -35.27 47.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 N-CA-C 113.462 0.912 . . . . 25.0 113.462 -175.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -71.08 -26.52 27.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 O-C-N 120.391 -1.443 . . . . 25.0 110.581 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -77.75 -38.64 46.51 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 121.731 -0.606 . . . . 25.0 110.839 -177.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -81.11 -25.79 36.69 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.098 -0.641 . . . . 25.0 112.242 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 78.5 m -102.91 -19.63 14.57 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 115.883 1.808 . . . . 25.0 115.883 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 18.9 t -113.2 -39.89 4.05 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.057 0.844 . . . . 25.0 111.617 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -83.57 -16.98 43.3 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.268 -0.641 . . . . 25.0 109.268 177.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 17.9 mtt85 -142.58 179.89 6.7 Favored 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 106.636 -1.616 . . . . 25.0 106.636 171.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.2 p -93.34 151.14 19.96 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 107.237 -1.394 . . . . 25.0 107.237 171.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 26.2 p -128.98 162.55 27.34 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.848 0.356 . . . . 25.0 111.778 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -101.59 158.24 16.23 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.742 -0.663 . . . . 25.0 110.539 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.9 tp -58.69 -43.78 90.08 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.32 0.489 . . . . 25.0 112.32 176.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.07 -34.13 74.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.934 0.397 . . . . 25.0 110.38 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.5 tp -69.01 -46.63 67.52 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.021 -0.733 . . . . 25.0 109.021 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.496 ' HG ' HD11 ' A' ' 42' ' ' ILE . 4.2 tt -60.85 -33.72 73.5 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.22 0.534 . . . . 25.0 110.814 -177.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -60.89 -24.43 65.97 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.827 1.047 . . . . 25.0 113.827 178.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.3 p -71.28 -14.25 62.16 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.168 0.803 . . . . 25.0 113.168 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -91.4 0.06 57.57 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 112.087 0.403 . . . . 25.0 112.087 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 83.1 m -70.57 149.86 46.67 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.525 -0.546 . . . . 25.0 109.525 176.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -74.06 154.14 39.34 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.226 -0.657 . . . . 25.0 109.226 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 38.4 p -67.94 147.53 98.47 Favored Pre-proline 0 N--CA 1.447 -0.59 0 N-CA-C 108.861 -0.792 . . . . 25.0 108.861 177.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.31 163.35 38.26 Favored 'Trans proline' 0 CA--C 1.522 -0.12 0 C-N-CA 119.937 0.425 . . . . 25.0 111.741 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.89 152.65 15.62 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.277 -0.874 . . . . 25.0 111.004 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -131.64 152.73 50.61 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.915 -1.142 . . . . 25.0 107.915 -178.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.2 t -162.53 80.56 0.51 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.774 0.797 . . . . 25.0 109.186 -176.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.298 3.633 0 CA-C-O 115.016 -2.421 . . . . 25.0 113.364 -175.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.01 0 CA-C-O 123.233 1.492 . . . . 25.0 114.29 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -117.32 164.28 15.07 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-N 115.164 -0.925 . . . . 25.0 108.525 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 55.5 ptt85 -108.81 154.32 41.86 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.626 -0.261 . . . . 25.0 110.618 -176.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -72.33 160.86 45.98 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 118.39 -0.607 . . . . 25.0 112.406 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.2 t -132.98 51.38 2.16 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.639 -0.709 . . . . 25.0 110.32 -176.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -70.94 -36.28 72.55 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.769 0.655 . . . . 25.0 112.769 -174.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.6 p -127.39 145.53 50.78 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.051 -1.092 . . . . 25.0 108.051 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -132.19 -100.37 0.28 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.503 -0.771 . . . . 25.0 109.104 -176.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 68.22 178.56 0.24 Allowed 'General case' 0 C--O 1.217 -0.618 0 C-N-CA 124.729 1.212 . . . . 25.0 111.247 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.69 28.7 65.83 Favored Glycine 0 C--O 1.219 -0.839 0 C-N-CA 120.842 -0.694 . . . . 25.0 114.274 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.8 -20.96 35.85 Favored Glycine 0 C--O 1.221 -0.672 0 CA-C-O 119.681 -0.511 . . . . 25.0 113.607 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -62.23 -27.62 69.12 Favored 'General case' 0 C--O 1.215 -0.72 0 CA-C-N 117.867 0.834 . . . . 25.0 110.483 177.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.77 -43.09 94.51 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 116.071 -0.513 . . . . 25.0 111.007 177.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 74.9 t -66.66 -38.85 82.45 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.844 0 N-CA-C 108.847 -0.798 . . . . 25.0 108.847 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -58.79 -48.11 82.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.956 0.407 . . . . 25.0 110.536 177.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.4 m -63.27 -40.37 97.21 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.954 -0.466 . . . . 25.0 111.545 177.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.0 mt -63.08 -36.98 85.41 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 121.944 -0.473 . . . . 25.0 110.777 179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -69.14 -38.64 78.9 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.857 0.361 . . . . 25.0 110.384 176.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -64.01 -39.1 93.35 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.206 0.526 . . . . 25.0 111.015 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 79.7 t -79.77 -43.46 22.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 112.377 0.51 . . . . 25.0 112.377 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.5 m -148.98 34.62 0.75 Allowed 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 115.14 1.533 . . . . 25.0 115.14 -172.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.55 -46.98 93.2 Favored Glycine 0 C--O 1.223 -0.573 0 C-N-CA 119.858 -1.163 . . . . 25.0 113.555 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -61.97 -43.85 97.98 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.535 0.683 . . . . 25.0 112.552 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -83.09 -8.7 59.49 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.786 0.661 . . . . 25.0 112.786 -177.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.96 157.69 23.78 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-O 122.091 0.828 . . . . 25.0 111.264 -175.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -153.2 162.43 41.31 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 106.769 -1.567 . . . . 25.0 106.769 178.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -120.17 152.64 37.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 122.268 1.032 . . . . 25.0 113.18 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -122.65 166.96 14.04 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.501 -1.666 . . . . 25.0 106.501 -176.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.3 t -122.69 128.15 50.2 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.285 -1.376 . . . . 25.0 107.285 177.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -142.63 137.65 15.49 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.539 -0.541 . . . . 25.0 109.539 -172.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -72.87 148.47 45.92 Favored 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 116.676 -1.749 . . . . 25.0 112.401 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.26 12.4 9.5 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.942 -0.572 . . . . 25.0 110.302 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.3 t -154.59 165.4 36.61 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.033 -1.099 . . . . 25.0 108.033 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -69.88 -30.22 67.62 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.25 0.344 . . . . 25.0 111.448 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -84.43 155.09 3.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.167 0.508 . . . . 25.0 111.454 -175.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.0 t -132.67 137.06 46.83 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.345 -0.984 . . . . 25.0 108.345 177.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.6 mtp180 -127.48 44.88 2.83 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-O 121.505 0.669 . . . . 25.0 109.363 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.5 ttm-85 52.61 53.92 11.44 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 117.261 2.319 . . . . 25.0 117.261 176.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 26.7 p -78.94 156.5 28.51 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.651 -0.704 . . . . 25.0 109.219 172.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.2 tpp180 -95.9 154.69 17.1 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 106.952 -1.499 . . . . 25.0 106.952 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -163.39 162.82 35.19 Favored Glycine 0 C--O 1.225 -0.427 0 C-N-CA 120.54 -0.838 . . . . 25.0 112.232 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.2 tp -61.72 -37.38 77.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 117.033 0.417 . . . . 25.0 111.183 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.5 p -65.29 -28.88 45.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 O-C-N 121.588 -0.695 . . . . 25.0 110.575 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.4 -25.12 63.99 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 121.468 -0.77 . . . . 25.0 111.088 178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -99.15 -26.59 14.15 Favored 'General case' 0 C--O 1.199 -1.554 0 N-CA-C 114.251 1.204 . . . . 25.0 114.251 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 82.8 m -113.57 8.59 17.75 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.26 1.208 . . . . 25.0 114.26 -177.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 40.0 t -133.09 -56.72 0.92 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.82 0.343 . . . . 25.0 110.253 176.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -72.34 -24.84 61.35 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.316 0.579 . . . . 25.0 110.15 177.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 97.0 mtt-85 -136.86 -178.64 5.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.743 -1.206 . . . . 25.0 107.743 177.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.4 p -97.76 152.09 19.5 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 124.01 0.819 . . . . 25.0 109.114 174.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 27.3 p -134.91 -178.63 5.17 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.038 -0.727 . . . . 25.0 109.038 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -139.45 167.55 21.83 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.623 -1.251 . . . . 25.0 107.623 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 68.3 tp -58.33 -40.41 82.07 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 123.261 0.624 . . . . 25.0 111.92 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.53 -42.6 99.06 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.091 0.472 . . . . 25.0 110.673 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.8 tp -70.68 -44.65 66.56 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.709 -0.478 . . . . 25.0 109.709 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.0 tt -60.07 -34.1 72.97 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 121.947 -0.471 . . . . 25.0 111.556 -177.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -61.64 -26.78 68.22 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.996 0.739 . . . . 25.0 112.996 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.8 p -70.29 -14.56 62.65 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 121.589 -0.695 . . . . 25.0 112.824 -178.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -93.42 7.85 42.87 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.008 0.432 . . . . 25.0 111.217 177.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 23.8 t -67.91 159.03 31.36 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.139 -1.43 . . . . 25.0 107.139 172.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -75.64 166.62 23.29 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 110.132 -0.322 . . . . 25.0 110.132 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.5 p 70.09 149.2 0.12 Allowed Pre-proline 0 N--CA 1.485 1.276 0 C-N-CA 126.084 1.754 . . . . 25.0 112.744 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -73.08 145.65 39.88 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 115.989 -2.207 . . . . 25.0 115.627 -175.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.89 137.88 55.6 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.007 -1.452 . . . . 25.0 110.107 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 69.4 tttt 50.59 38.79 19.74 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.625 0.77 . . . . 25.0 112.912 176.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.9 m 51.12 43.33 29.15 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.885 1.069 . . . . 25.0 113.885 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 C--O 1.297 3.561 0 CA-C-O 115.016 -2.421 . . . . 25.0 112.314 176.557 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 122.814 1.292 . . . . 25.0 113.957 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -124.05 174.64 7.48 Favored 'General case' 0 C--O 1.227 -0.122 0 CA-C-N 115.481 -0.781 . . . . 25.0 109.848 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.44 153.55 44.11 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 108.826 -0.805 . . . . 25.0 108.826 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -73.19 161.37 43.25 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 118.516 -0.522 . . . . 25.0 113.227 -177.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.5 t -142.97 78.15 1.6 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.258 -1.016 . . . . 25.0 108.258 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -75.36 -7.09 53.08 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.696 0.76 . . . . 25.0 112.448 -176.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.6 p -118.1 149.19 41.42 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.507 -0.923 . . . . 25.0 108.507 176.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.1 mt -137.17 129.71 30.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.699 -0.682 . . . . 25.0 109.654 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.4 t -162.88 -172.81 3.21 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.971 -1.492 . . . . 25.0 106.971 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.34 30.81 75.14 Favored Glycine 0 C--O 1.22 -0.768 0 C-N-CA 120.787 -0.721 . . . . 25.0 114.535 174.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.29 -25.34 9.28 Favored Glycine 0 C--O 1.221 -0.667 0 C-N-CA 121.138 -0.553 . . . . 25.0 114.047 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -65.05 -27.03 68.52 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 118.239 1.02 . . . . 25.0 110.409 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 27.6 tp -61.46 -40.01 92.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.967 -0.56 . . . . 25.0 110.167 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 90.5 t -71.97 -36.38 57.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.273 -0.421 . . . . 25.0 109.982 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.0 -45.36 93.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.43 0.634 . . . . 25.0 109.368 176.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.5 m -63.18 -40.03 96.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.109 -0.496 . . . . 25.0 111.113 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.0 mt -61.65 -38.27 87.09 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.752 -0.593 . . . . 25.0 110.472 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -67.52 -39.56 85.09 Favored 'General case' 0 C--O 1.219 -0.538 0 O-C-N 122.004 -0.435 . . . . 25.0 110.8 175.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -66.63 -46.81 74.6 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.722 0.638 . . . . 25.0 112.722 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.4 t -71.58 -42.46 71.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 111.683 0.253 . . . . 25.0 111.683 -176.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 34.9 m -90.39 -26.51 19.87 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.223 0.823 . . . . 25.0 113.223 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.23 -145.74 49.41 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-O 122.204 0.891 . . . . 25.0 113.479 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -58.24 -17.85 22.19 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.918 1.081 . . . . 25.0 113.918 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -69.14 -23.05 63.92 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.735 -0.603 . . . . 25.0 112.371 -177.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.03 173.41 49.85 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 110.232 -1.147 . . . . 25.0 110.232 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -151.3 168.36 25.0 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 122.481 -0.423 . . . . 25.0 110.577 -177.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -112.71 158.96 19.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.404 0.621 . . . . 25.0 110.548 177.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -127.05 176.56 7.25 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.398 -1.334 . . . . 25.0 107.398 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.3 m -56.53 -24.43 46.63 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 117.033 2.235 . . . . 25.0 117.033 -174.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.27 150.72 0.1 Allowed Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 115.138 1.533 . . . . 25.0 115.138 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.62 146.38 54.73 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 116.733 -1.712 . . . . 25.0 114.47 -175.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.94 177.33 7.63 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.712 -0.676 . . . . 25.0 109.853 -178.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.6 m -68.39 170.69 8.46 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.067 -0.515 . . . . 25.0 112.071 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.8 mmt-85 -65.71 -26.01 67.57 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.562 0.578 . . . . 25.0 112.562 177.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.68 171.67 15.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 123.095 0.558 . . . . 25.0 110.969 -172.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.9 p 42.89 46.33 4.57 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.145 0.978 . . . . 25.0 113.548 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -83.29 50.22 1.71 Allowed 'General case' 0 C--O 1.213 -0.866 0 CA-C-N 115.618 -0.719 . . . . 25.0 112.165 -175.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -82.72 47.34 1.18 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.854 0.835 . . . . 25.0 112.462 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.5 p -103.3 156.68 17.55 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.29 -0.868 . . . . 25.0 109.313 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.8 ptp180 -75.07 156.43 36.12 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.509 -0.923 . . . . 25.0 108.509 175.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -164.18 138.88 5.52 Favored Glycine 0 C--O 1.224 -0.473 0 C-N-CA 120.617 -0.802 . . . . 25.0 111.94 174.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.0 tp -64.41 -32.28 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 122.511 -0.405 . . . . 25.0 110.088 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.9 -32.64 59.05 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.463 0 O-C-N 121.842 -0.536 . . . . 25.0 110.479 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -74.06 -34.2 63.96 Favored 'General case' 0 CA--C 1.507 -0.694 0 O-C-N 121.616 -0.678 . . . . 25.0 110.208 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -71.94 -40.66 68.57 Favored 'General case' 0 C--O 1.21 -0.978 0 C-N-CA 120.21 -0.596 . . . . 25.0 112.182 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 76.6 m -103.13 -21.69 13.86 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 116.992 2.219 . . . . 25.0 116.992 -172.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 47.3 t -105.56 -44.71 4.62 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.638 0.653 . . . . 25.0 110.584 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -81.42 -23.02 37.82 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.061 0.458 . . . . 25.0 110.011 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.29 -179.37 5.63 Favored 'General case' 0 C--O 1.219 -0.507 0 N-CA-C 109.117 -0.698 . . . . 25.0 109.117 176.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.6 t -89.01 149.14 23.39 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.759 -1.2 . . . . 25.0 107.759 175.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 21.5 p -139.25 161.41 37.49 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.135 0.493 . . . . 25.0 112.261 178.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -112.56 161.38 16.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.331 -0.85 . . . . 25.0 111.124 -176.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 68.5 tp -58.35 -45.02 88.97 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.125 -0.489 . . . . 25.0 111.897 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.24 -39.46 90.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.889 0.376 . . . . 25.0 111.023 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.8 tp -68.8 -45.39 71.39 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.831 -0.433 . . . . 25.0 109.831 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.0 tt -60.01 -35.96 76.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.202 0.525 . . . . 25.0 110.961 -177.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -60.63 -25.28 66.17 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.226 0.824 . . . . 25.0 113.226 177.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.8 p -74.69 -14.03 60.69 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.402 -0.811 . . . . 25.0 112.982 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -91.93 2.26 56.66 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.604 0.24 . . . . 25.0 111.161 178.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 72.3 m -71.39 157.41 38.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.175 -0.676 . . . . 25.0 109.175 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.2 158.86 17.73 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.053 -0.721 . . . . 25.0 109.053 177.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 p 67.95 153.99 0.14 Allowed Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 125.313 1.445 . . . . 25.0 111.637 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -72.03 155.92 56.62 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 117.397 -1.269 . . . . 25.0 114.931 -174.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.68 103.34 1.71 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.098 -0.955 . . . . 25.0 111.037 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -73.27 161.25 30.73 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.824 -0.625 . . . . 25.0 110.4 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.4 m 51.42 54.29 11.35 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 114.815 1.413 . . . . 25.0 114.815 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 . . . . . 0 C--O 1.291 3.271 0 CA-C-O 113.771 -3.014 . . . . 25.0 111.265 173.841 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.854 0 CA-C-O 123.202 1.477 . . . . 25.0 114.31 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -130.89 160.75 33.54 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.192 -1.04 . . . . 25.0 108.192 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.55 143.16 78.66 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 120.512 0.196 . . . . 25.0 110.994 -177.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -77.2 159.67 33.26 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 118.038 -0.842 . . . . 25.0 112.525 177.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.5 m -131.67 75.24 1.63 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.995 -0.548 . . . . 25.0 111.962 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.12 -17.65 61.96 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.524 0.678 . . . . 25.0 110.357 178.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.1 p -130.88 154.78 47.72 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 101.795 -3.409 . . . . 25.0 101.795 172.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.5 tp -134.59 128.59 33.49 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.997 -0.372 . . . . 25.0 109.997 -172.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.74 168.4 23.01 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.8 0.333 . . . . 25.0 111.164 -173.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.37 -143.69 48.67 Favored Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 120.691 -0.766 . . . . 25.0 113.39 175.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.38 -21.15 75.85 Favored Glycine 0 C--O 1.213 -1.172 0 C-N-CA 121.284 -0.484 . . . . 25.0 113.197 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -69.35 -27.19 65.13 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 117.618 0.709 . . . . 25.0 109.325 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.27 -43.53 67.0 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-O 121.522 0.677 . . . . 25.0 109.528 174.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.5 t -64.15 -38.5 82.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.164 -0.926 . . . . 25.0 110.057 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -61.59 -48.36 81.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.164 0.507 . . . . 25.0 110.94 177.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 50.2 m -63.59 -35.94 82.16 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.966 -0.459 . . . . 25.0 111.293 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.6 mt -64.61 -39.77 94.3 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.707 -0.479 . . . . 25.0 109.707 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -67.32 -36.73 82.08 Favored 'General case' 0 C--O 1.219 -0.508 0 O-C-N 121.79 -0.569 . . . . 25.0 110.586 176.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -64.9 -51.56 61.29 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 121.923 -0.485 . . . . 25.0 111.753 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -73.48 -30.78 30.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 112.847 0.684 . . . . 25.0 112.847 -174.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.5 m -99.08 -22.05 15.88 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.16 0.8 . . . . 25.0 113.16 -177.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.39 -163.47 53.86 Favored Glycine 0 C--N 1.321 -0.303 0 CA-C-O 121.834 0.685 . . . . 25.0 111.887 -177.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -71.32 -7.17 45.3 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 123.751 0.821 . . . . 25.0 111.444 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 -72.66 -9.7 58.92 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.526 -0.761 . . . . 25.0 111.849 -177.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.53 163.05 34.13 Favored Glycine 0 C--O 1.23 -0.12 0 N-CA-C 115.098 0.799 . . . . 25.0 115.098 172.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -153.46 166.73 31.77 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.659 -1.237 . . . . 25.0 107.659 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -118.87 143.01 47.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.061 0.457 . . . . 25.0 110.154 177.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -104.69 146.04 29.5 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.205 -1.406 . . . . 25.0 107.205 176.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.42 ' H ' HG22 ' A' ' 42' ' ' ILE . 42.3 t -143.69 149.39 37.14 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.565 0.221 . . . . 25.0 110.662 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.8 ppt_? -154.23 153.87 28.88 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 107.945 -1.131 . . . . 25.0 107.945 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -70.67 154.1 64.33 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 118.419 -0.587 . . . . 25.0 112.533 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -107.39 18.54 21.45 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.552 0.575 . . . . 25.0 112.552 -175.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.8 t -150.63 166.08 31.4 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.624 -0.88 . . . . 25.0 108.624 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -65.98 -18.16 65.15 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.768 0.427 . . . . 25.0 110.882 177.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.7 m -118.34 134.47 61.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.313 0.578 . . . . 25.0 109.488 176.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.5 p -104.69 46.52 0.91 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.775 0.798 . . . . 25.0 111.466 -177.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 68.1 mtt85 -66.25 -16.61 64.16 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.194 -0.457 . . . . 25.0 111.21 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -149.73 178.38 8.92 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 103.047 -2.946 . . . . 25.0 103.047 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.7 m 57.16 58.09 4.14 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.347 1.24 . . . . 25.0 114.347 177.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.3 tpp180 -63.92 140.85 58.91 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.933 -1.485 . . . . 25.0 108.346 174.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -117.9 165.4 12.67 Favored Glycine 0 C--N 1.32 -0.335 0 CA-C-N 115.809 -0.632 . . . . 25.0 112.651 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.424 HD13 ' CD2' ' A' ' 59' ' ' TYR . 7.2 tp -67.01 -35.17 73.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.728 -0.842 . . . . 25.0 108.728 177.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.2 p -66.76 -32.12 56.6 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 N-CA-C 109.334 -0.617 . . . . 25.0 109.334 178.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -72.68 -36.97 68.03 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.381 -0.824 . . . . 25.0 110.364 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -72.83 -39.48 66.55 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.861 0.689 . . . . 25.0 112.861 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 47.4 m -104.6 -22.37 13.26 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 116.547 2.054 . . . . 25.0 116.547 -171.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 33.8 t -104.72 -44.5 4.84 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 118.388 0.54 . . . . 25.0 110.689 -177.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -80.79 -18.63 46.95 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.865 0.364 . . . . 25.0 110.635 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 45.1 mtt-85 -141.49 172.46 12.66 Favored 'General case' 0 C--O 1.207 -1.152 0 N-CA-C 106.102 -1.814 . . . . 25.0 106.102 174.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 34.8 t -84.57 150.66 25.06 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.664 -0.495 . . . . 25.0 109.664 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -113.15 167.23 10.71 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-O 121.454 0.645 . . . . 25.0 112.738 -178.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -126.41 151.91 47.05 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.183 -1.784 . . . . 25.0 106.183 175.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 35.1 tp -59.72 -44.29 93.8 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.71 0.633 . . . . 25.0 112.71 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.34 -38.18 88.53 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-O 121.043 0.449 . . . . 25.0 111.174 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.1 tp -65.07 -45.03 86.99 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.309 -0.626 . . . . 25.0 109.309 177.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.0 tt -64.01 -33.24 75.29 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.172 0.51 . . . . 25.0 110.836 -177.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -62.34 -24.76 67.52 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.432 0.901 . . . . 25.0 113.432 178.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.7 p -69.01 -14.44 63.04 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.538 -0.726 . . . . 25.0 112.291 -177.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.424 ' CD2' HD13 ' A' ' 42' ' ' ILE . 72.0 m-85 -92.43 5.82 49.29 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.448 -0.342 . . . . 25.0 111.559 178.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 83.7 m -72.23 156.67 38.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.184 0.516 . . . . 25.0 110.216 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.44 163.13 19.66 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.588 -0.893 . . . . 25.0 108.588 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.3 p -69.62 131.66 89.61 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 107.909 -1.145 . . . . 25.0 107.909 178.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -72.39 155.19 55.79 Favored 'Trans proline' 0 C--N 1.343 0.253 0 N-CA-C 115.228 1.203 . . . . 25.0 115.228 -175.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.31 164.2 26.89 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.871 -1.058 . . . . 25.0 109.261 176.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -80.7 66.2 6.13 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.028 0.442 . . . . 25.0 111.958 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.5 m -92.89 61.78 3.57 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.73 0.776 . . . . 25.0 111.078 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 . . . . . 0 C--O 1.291 3.282 0 CA-C-O 113.994 -2.908 . . . . 25.0 111.626 -179.981 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -0.853 0 CA-C-O 123.145 1.45 . . . . 25.0 114.261 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -74.5 162.85 28.41 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 108.246 -1.02 . . . . 25.0 108.246 176.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 11.3 ptp85 -59.81 143.46 87.19 Favored Pre-proline 0 CA--C 1.539 0.538 0 N-CA-C 109.838 -0.43 . . . . 25.0 109.838 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -73.67 160.03 44.67 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 117.764 -1.024 . . . . 25.0 112.522 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.0 m -121.13 82.89 1.99 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.434 -0.95 . . . . 25.0 108.434 177.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -62.98 -26.1 68.68 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.251 0.548 . . . . 25.0 110.63 -178.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 p -119.49 117.47 28.51 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 102.556 -3.127 . . . . 25.0 102.556 168.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 45.9 tp -86.74 106.2 17.5 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.943 0.878 . . . . 25.0 109.155 -174.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -154.56 -163.65 1.64 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.955 -1.021 . . . . 25.0 108.814 -173.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.77 33.3 84.77 Favored Glycine 0 C--O 1.218 -0.879 0 N-CA-C 114.937 0.735 . . . . 25.0 114.937 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.63 -25.37 7.41 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.999 -0.62 . . . . 25.0 113.311 -178.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -63.45 -31.15 72.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.562 0.681 . . . . 25.0 109.224 177.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 33.2 tp -61.79 -41.86 98.26 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.923 -0.58 . . . . 25.0 111.448 176.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.9 t -67.52 -41.5 85.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.267 -0.642 . . . . 25.0 109.267 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -61.67 -40.61 95.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.397 0.618 . . . . 25.0 109.966 177.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.8 m -66.69 -40.58 88.58 Favored 'General case' 0 C--O 1.215 -0.725 0 O-C-N 121.933 -0.479 . . . . 25.0 111.216 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.4 mt -62.21 -38.82 90.62 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 121.63 -0.669 . . . . 25.0 110.563 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -67.04 -39.69 87.01 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.197 -0.456 . . . . 25.0 110.453 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -66.76 -47.75 71.23 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 112.27 0.47 . . . . 25.0 112.27 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.9 t -67.5 -43.68 87.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.405 0.52 . . . . 25.0 112.405 -175.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -95.26 -15.93 22.83 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.511 0.93 . . . . 25.0 113.511 -176.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.01 -142.87 46.16 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-O 122.067 0.815 . . . . 25.0 112.595 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -71.1 0.36 7.82 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.052 1.13 . . . . 25.0 114.052 -178.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.3 mmm180 -75.39 -20.41 58.95 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.462 -0.774 . . . . 25.0 110.95 178.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.8 162.07 34.65 Favored Glycine 0 C--O 1.225 -0.448 0 N-CA-C 111.869 -0.492 . . . . 25.0 111.869 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -149.1 167.97 24.47 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.214 -1.032 . . . . 25.0 108.214 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -120.85 152.26 38.62 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.614 0.721 . . . . 25.0 110.79 174.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -128.04 155.44 44.34 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.764 -1.199 . . . . 25.0 107.764 -176.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.5 p -78.15 63.26 3.05 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 108.282 -1.007 . . . . 25.0 108.282 172.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -82.5 156.87 68.21 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.34 -0.846 . . . . 25.0 111.55 -172.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -70.15 154.34 66.29 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 117.852 -0.966 . . . . 25.0 113.841 -178.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -157.6 177.28 11.57 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 105.05 -2.204 . . . . 25.0 105.05 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.5 m -77.99 -83.79 0.08 Allowed 'General case' 0 C--O 1.215 -0.722 0 N-CA-C 118.266 2.691 . . . . 25.0 118.266 -176.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 -67.08 1.04 2.2 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 114.1 -1.409 . . . . 25.0 114.495 -171.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 17.1 m -68.66 153.82 8.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 114.959 -1.019 . . . . 25.0 110.271 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.1 m -103.31 13.64 33.34 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 115.593 -0.73 . . . . 25.0 111.716 -174.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 52.54 44.19 30.28 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.662 -0.699 . . . . 25.0 112.077 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -67.11 160.78 25.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.189 -0.914 . . . . 25.0 110.802 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 t -72.63 176.29 5.62 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.625 -0.716 . . . . 25.0 112.011 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? 66.02 127.05 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.424 1.89 . . . . 25.0 113.484 -176.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 163.96 162.92 15.75 Favored Glycine 0 C--N 1.315 -0.591 0 N-CA-C 108.673 -1.771 . . . . 25.0 108.673 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.0 tp -56.68 -34.28 42.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 112.896 0.702 . . . . 25.0 112.896 -174.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.77 -32.54 58.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 121.563 -0.711 . . . . 25.0 110.804 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -76.44 -32.1 58.25 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 121.368 -0.832 . . . . 25.0 111.343 -177.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -82.91 -27.71 30.45 Favored 'General case' 0 C--O 1.214 -0.766 0 C-N-CA 120.258 -0.577 . . . . 25.0 112.371 -177.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 99.8 m -107.45 -28.97 9.51 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 116.335 1.976 . . . . 25.0 116.335 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 73.6 m -94.98 -41.75 8.99 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 118.819 0.736 . . . . 25.0 111.019 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -90.82 -18.27 25.16 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.204 0.526 . . . . 25.0 111.118 -177.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 80.3 mtm-85 -135.94 174.93 10.07 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 105.853 -1.906 . . . . 25.0 105.853 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.5 p -91.86 149.07 21.77 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.45 -1.315 . . . . 25.0 107.45 173.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 28.9 p -133.16 163.95 28.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.891 0.377 . . . . 25.0 111.385 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -124.16 166.23 16.18 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.099 -0.501 . . . . 25.0 110.344 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.3 tp -54.03 -48.97 69.94 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 114.651 1.352 . . . . 25.0 114.651 -176.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.13 -41.46 96.77 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 121.124 0.488 . . . . 25.0 111.122 -177.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.9 tp -65.9 -44.97 83.64 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.065 0.46 . . . . 25.0 109.93 177.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 tt -61.1 -35.02 75.89 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.128 0.489 . . . . 25.0 111.535 -178.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -61.81 -26.76 68.31 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.341 0.867 . . . . 25.0 113.341 177.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.6 p -68.25 -14.25 62.85 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 113.011 0.745 . . . . 25.0 113.011 -178.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -94.89 13.16 25.69 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 120.939 0.399 . . . . 25.0 111.721 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 2.2 m -61.77 162.36 8.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.231 0.538 . . . . 25.0 109.926 170.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.15 163.54 26.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.792 0.329 . . . . 25.0 110.666 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.9 p 70.07 152.4 0.14 Allowed Pre-proline 0 N--CA 1.481 1.086 0 C-N-CA 126.075 1.75 . . . . 25.0 111.602 -178.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.81 156.91 56.25 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 116.405 -1.93 . . . . 25.0 113.18 -177.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.83 125.03 22.58 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.344 -0.984 . . . . 25.0 108.344 178.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 51.0 tttt -132.07 17.9 4.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.825 0.822 . . . . 25.0 109.992 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 62.1 m -154.23 148.48 25.94 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 105.348 -2.093 . . . . 25.0 105.348 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 . . . . . 0 C--O 1.293 3.366 0 CA-C-O 113.111 -3.328 . . . . 25.0 112.376 -178.38 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.923 0 CA-C-O 123.287 1.518 . . . . 25.0 114.28 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -86.0 171.7 11.22 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.202 -0.936 . . . . 25.0 108.718 176.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 81.0 mtt85 -58.66 143.88 81.08 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 109.353 -0.61 . . . . 25.0 109.353 177.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -78.26 163.27 27.79 Favored 'Trans proline' 0 C--N 1.346 0.397 0 O-C-N 122.038 0.494 . . . . 25.0 113.234 -177.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.5 t -121.35 84.13 2.19 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 107.768 -1.197 . . . . 25.0 107.768 176.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -78.31 -11.29 59.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.979 0.419 . . . . 25.0 112.017 -177.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.6 p -94.17 150.89 19.9 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.856 -0.794 . . . . 25.0 108.856 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.2 tp -81.07 104.03 11.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 122.228 1.013 . . . . 25.0 111.337 -175.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 t -153.47 -164.03 1.81 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.943 -1.026 . . . . 25.0 110.051 -173.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.17 23.0 63.6 Favored Glycine 0 C--O 1.214 -1.098 0 N-CA-C 115.642 1.017 . . . . 25.0 115.642 174.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.42 -26.47 24.23 Favored Glycine 0 C--O 1.218 -0.85 0 CA-C-O 119.577 -0.568 . . . . 25.0 112.801 -178.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -59.99 -28.64 67.86 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.796 0.808 . . . . 25.0 110.4 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 30.7 tp -60.95 -40.16 92.29 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.522 -0.763 . . . . 25.0 111.236 176.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 82.5 t -69.58 -41.27 80.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.012 -0.736 . . . . 25.0 109.012 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -64.0 -40.82 97.22 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.914 0.864 . . . . 25.0 109.925 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 44.3 m -66.83 -40.06 87.87 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.726 -0.67 . . . . 25.0 110.456 178.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.7 mt -62.62 -37.87 87.96 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.118 -0.363 . . . . 25.0 110.415 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -62.32 -45.68 92.14 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.829 -0.544 . . . . 25.0 110.115 175.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -66.9 -45.8 76.86 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.125 0.787 . . . . 25.0 113.125 -176.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.4 t -69.26 -38.5 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 120.875 0.369 . . . . 25.0 111.357 -177.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 46.5 m -88.06 -24.37 23.47 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 113.579 0.955 . . . . 25.0 113.579 -175.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.76 -144.42 38.36 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-O 121.693 0.607 . . . . 25.0 113.707 177.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -65.29 -12.08 48.05 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.135 0.791 . . . . 25.0 113.135 -178.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.9 mtm180 -79.88 -22.88 42.34 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.383 0.882 . . . . 25.0 113.383 -173.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.78 179.26 52.85 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-O 122.068 0.815 . . . . 25.0 111.612 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -160.46 173.56 15.4 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.176 -1.416 . . . . 25.0 107.176 -175.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -146.37 161.04 41.22 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.241 0.543 . . . . 25.0 109.707 173.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -95.36 139.29 31.86 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.99 -0.745 . . . . 25.0 108.99 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.78 -23.22 63.32 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.86 0.689 . . . . 25.0 112.86 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.03 149.5 36.98 Favored Pre-proline 0 N--CA 1.468 0.427 0 N-CA-C 108.643 -0.873 . . . . 25.0 108.643 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.8 144.83 55.07 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 117.476 -1.216 . . . . 25.0 114.086 -178.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.15 107.52 8.43 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.492 -0.558 . . . . 25.0 109.492 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.6 t -153.52 161.2 42.46 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.175 -0.676 . . . . 25.0 109.175 179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.32 -22.68 63.76 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.265 0.555 . . . . 25.0 110.711 176.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 35.9 m -109.12 159.21 8.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.504 -0.771 . . . . 25.0 110.379 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.6 t -99.59 147.71 25.07 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.261 -1.385 . . . . 25.0 107.261 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -126.19 34.04 4.92 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.219 -0.66 . . . . 25.0 109.219 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 48.9 ptt85 38.17 46.71 0.89 Allowed 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 122.913 1.339 . . . . 25.0 114.126 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.07 129.71 37.96 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 113.584 -1.643 . . . . 25.0 111.004 -178.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -68.84 164.31 22.26 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.26 0.35 . . . . 25.0 110.847 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 145.6 -157.68 27.43 Favored Glycine 0 C--O 1.224 -0.508 0 C-N-CA 120.993 -0.622 . . . . 25.0 113.288 177.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.2 tp -50.35 -34.9 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 113.026 0.75 . . . . 25.0 113.026 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.9 t -68.03 -42.86 85.62 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.694 0 O-C-N 121.262 -0.899 . . . . 25.0 110.597 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -65.54 -36.45 83.84 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.735 0.779 . . . . 25.0 110.245 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -73.63 -38.4 65.06 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 113.588 0.958 . . . . 25.0 113.588 -179.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 73.6 m -105.38 -21.96 13.13 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 116.722 2.119 . . . . 25.0 116.722 -174.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 53.6 t -104.35 -36.55 7.56 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 118.094 0.406 . . . . 25.0 111.131 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -91.53 -24.59 19.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.901 0.382 . . . . 25.0 110.072 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 42.1 mtm105 -125.15 172.73 9.27 Favored 'General case' 0 C--O 1.208 -1.081 0 N-CA-C 106.622 -1.621 . . . . 25.0 106.622 168.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.4 m -79.27 -10.62 59.86 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 116.993 2.22 . . . . 25.0 116.993 -174.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 64.25 -173.17 0.17 Allowed 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 114.391 1.256 . . . . 25.0 114.391 -176.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.78 151.61 35.11 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 105.277 -2.12 . . . . 25.0 105.277 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 64.9 tp -64.35 -40.94 96.86 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.188 0.518 . . . . 25.0 111.314 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.15 -39.59 86.56 Favored 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 109.367 -0.605 . . . . 25.0 109.367 -177.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.7 tp -63.9 -45.11 90.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.367 -0.833 . . . . 25.0 110.449 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.2 tt -61.54 -36.48 80.7 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.156 0.503 . . . . 25.0 111.139 -176.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -61.78 -23.48 66.23 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.829 1.048 . . . . 25.0 113.829 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 36.8 p -72.23 -14.31 61.75 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.054 0.761 . . . . 25.0 113.054 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -95.65 8.27 43.9 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.151 0.501 . . . . 25.0 112.348 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 73.3 m -75.07 155.34 37.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.897 0.379 . . . . 25.0 110.264 174.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.08 167.38 11.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.532 -0.303 . . . . 25.0 110.236 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.4 p 67.3 156.17 0.14 Allowed Pre-proline 0 N--CA 1.483 1.18 0 C-N-CA 125.908 1.683 . . . . 25.0 113.683 178.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.81 168.41 24.67 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 117.295 -1.336 . . . . 25.0 113.079 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.01 140.7 58.89 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.907 -0.775 . . . . 25.0 108.907 176.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -89.66 8.12 33.14 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.321 -0.4 . . . . 25.0 110.89 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.0 p -156.8 158.57 37.05 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.159 -1.052 . . . . 25.0 108.159 -177.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 C--O 1.293 3.36 0 CA-C-O 113.906 -2.95 . . . . 25.0 111.309 175.417 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.884 0 CA-C-O 122.63 1.205 . . . . 25.0 113.612 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -74.24 159.4 32.53 Favored 'General case' 0 CA--C 1.526 0.022 0 N-CA-C 108.836 -0.802 . . . . 25.0 108.836 178.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -115.42 147.01 37.77 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 110.05 -0.352 . . . . 25.0 110.05 -177.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.29 160.13 26.18 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 CA-C-O 121.438 0.516 . . . . 25.0 113.137 -177.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.7 m -118.16 84.74 2.22 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 104.877 -2.268 . . . . 25.0 104.877 174.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -64.61 -21.29 66.68 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 116.278 1.955 . . . . 25.0 116.278 -169.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.9 p 36.1 68.33 0.25 Allowed 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 124.007 1.861 . . . . 25.0 113.635 -176.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.4 tp -74.03 109.84 7.84 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 111.658 -2.519 . . . . 25.0 108.962 -176.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.5 t -140.46 168.34 20.04 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.218 -0.901 . . . . 25.0 113.135 -169.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.78 -143.16 47.5 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.022 -0.608 . . . . 25.0 112.172 176.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.98 -23.75 71.3 Favored Glycine 0 C--O 1.213 -1.167 0 C-N-CA 121.047 -0.597 . . . . 25.0 113.073 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -65.36 -35.62 81.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 117.827 0.813 . . . . 25.0 110.347 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 41.2 tp -66.38 -43.31 86.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.381 0.61 . . . . 25.0 109.625 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.8 t -67.08 -39.67 83.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.78 -0.645 . . . . 25.0 110.289 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -64.16 -43.44 95.16 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.115 0.483 . . . . 25.0 110.294 178.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.8 m -62.76 -41.26 99.13 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.143 -0.348 . . . . 25.0 110.609 177.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 13.4 mt -60.73 -37.22 81.01 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.792 -0.568 . . . . 25.0 110.501 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -71.79 -34.74 69.66 Favored 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 112.072 0.397 . . . . 25.0 112.072 176.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -64.93 -38.26 90.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.285 0.564 . . . . 25.0 110.259 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.1 t -74.29 -42.51 50.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 112.795 0.665 . . . . 25.0 112.795 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 3.9 m -140.65 -4.87 1.22 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 118.775 2.879 . . . . 25.0 118.775 -176.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.59 170.45 29.06 Favored Glycine 0 C--O 1.218 -0.895 0 O-C-N 121.551 -0.718 . . . . 25.0 112.996 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -62.93 -47.31 83.78 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.003 1.112 . . . . 25.0 114.003 -175.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 45.0 mtm-85 -82.55 -6.03 59.09 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 124.156 0.982 . . . . 25.0 108.995 176.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.9 9.88 58.84 Favored Glycine 0 C--O 1.214 -1.133 0 CA-C-N 114.89 -1.05 . . . . 25.0 115.467 -170.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -152.59 164.15 38.22 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 119.254 1.527 . . . . 25.0 111.338 177.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -130.22 143.09 50.58 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.842 -0.617 . . . . 25.0 110.69 172.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.12 152.31 20.65 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.894 -1.521 . . . . 25.0 106.894 174.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 81.1 p -72.46 -9.51 58.63 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.997 0.74 . . . . 25.0 112.997 178.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 64.18 131.9 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.829 0 N-CA-C 116.194 1.924 . . . . 25.0 116.194 175.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.21 132.69 23.1 Favored 'Trans proline' 0 C--O 1.238 0.511 0 C-N-CA 115.899 -2.267 . . . . 25.0 111.992 174.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -164.07 171.18 15.49 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.703 -1.221 . . . . 25.0 107.703 -177.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.406 ' C ' ' H ' ' A' ' 35' ' ' VAL . 1.0 OUTLIER -83.14 -168.93 2.28 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.377 -0.601 . . . . 25.0 109.377 173.319 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.6 ttt85 67.01 -4.09 0.86 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.955 1.302 . . . . 25.0 112.79 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.406 ' H ' ' C ' ' A' ' 33' ' ' SER . 27.2 m -69.86 151.61 9.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 114.826 -1.079 . . . . 25.0 109.295 178.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.6 m -101.28 5.69 42.52 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 113.187 0.81 . . . . 25.0 113.187 -172.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.7 mmm-85 51.81 33.71 11.84 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.714 1.375 . . . . 25.0 114.714 177.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 61.7 mtm180 -116.57 145.69 43.18 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 100.428 -3.916 . . . . 25.0 100.428 170.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.9 m -52.66 110.72 0.54 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.989 0.805 . . . . 25.0 112.492 -175.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -139.27 -14.21 1.14 Allowed 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 114.399 1.259 . . . . 25.0 114.399 -176.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -118.0 159.88 14.04 Favored Glycine 0 C--N 1.312 -0.787 0 CA-C-N 113.862 -1.517 . . . . 25.0 111.884 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.2 tp -55.6 -39.05 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 N-CA-C 114.132 1.16 . . . . 25.0 114.132 -175.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.6 p -71.81 -27.79 28.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 O-C-N 120.426 -1.421 . . . . 25.0 110.49 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -77.74 -27.51 50.48 Favored 'General case' 0 C--N 1.317 -0.806 0 O-C-N 121.676 -0.64 . . . . 25.0 112.556 -176.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -94.21 -31.17 14.23 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.26 -0.427 . . . . 25.0 111.367 177.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 84.0 m -95.26 -28.05 15.2 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 115.122 1.527 . . . . 25.0 115.122 -176.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 51.8 t -110.23 -47.82 3.25 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.79 0.663 . . . . 25.0 112.79 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -72.9 -29.85 63.46 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.911 -0.774 . . . . 25.0 108.911 177.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 94.8 mtt-85 -118.53 -164.76 1.05 Allowed 'General case' 0 C--O 1.209 -1.042 0 N-CA-C 104.846 -2.279 . . . . 25.0 104.846 167.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 58.4 m -121.74 147.56 45.75 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 106.425 -1.695 . . . . 25.0 106.425 169.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.1 p -123.74 165.05 17.93 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.501 0.501 . . . . 25.0 110.761 -175.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -103.2 158.56 16.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.62 -0.718 . . . . 25.0 109.484 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.1 tp -59.81 -38.37 81.78 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.659 0.614 . . . . 25.0 112.659 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.77 -41.72 99.36 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.664 0.268 . . . . 25.0 110.51 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.5 tp -65.86 -46.47 78.35 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.444 -0.946 . . . . 25.0 108.444 177.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.3 tt -56.42 -36.19 68.69 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.454 0.538 . . . . 25.0 112.454 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -63.16 -22.29 66.77 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 113.401 0.889 . . . . 25.0 113.401 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.2 p -73.5 -19.04 61.03 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.58 -0.7 . . . . 25.0 112.22 -178.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -82.32 4.99 21.63 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 120.837 0.351 . . . . 25.0 111.788 176.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 16.5 t -61.6 144.7 53.99 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.055 -0.72 . . . . 25.0 109.055 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.1 149.04 42.37 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.438 -0.801 . . . . 25.0 110.328 177.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 26.4 p 67.71 135.45 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 125.975 1.71 . . . . 25.0 111.427 -176.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -64.06 165.44 19.22 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 120.464 0.776 . . . . 25.0 112.795 -176.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.02 134.41 56.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.318 0.58 . . . . 25.0 110.471 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.96 151.68 36.19 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.019 -0.734 . . . . 25.0 109.019 -176.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.6 t 51.92 46.18 27.02 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.67 0.748 . . . . 25.0 112.951 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 . . . . . 0 C--O 1.304 3.933 0 CA-C-O 114.276 -2.774 . . . . 25.0 113.508 -179.321 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.208 -1.108 0 CA-C-O 123.708 1.718 . . . . 25.0 114.728 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -69.02 -21.51 64.12 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.899 -1.046 . . . . 25.0 111.954 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -106.55 140.4 21.29 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.053 -0.976 . . . . 25.0 108.847 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.74 163.23 34.07 Favored 'Trans proline' 0 C--N 1.347 0.488 0 O-C-N 122.184 0.57 . . . . 25.0 113.206 -177.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.5 m -124.04 32.56 5.52 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.777 0.798 . . . . 25.0 111.839 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -91.66 -16.36 27.13 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.238 -0.892 . . . . 25.0 110.691 -177.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.7 p -121.29 152.21 39.18 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.692 -1.14 . . . . 25.0 108.424 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -127.01 -94.26 0.46 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.397 -0.964 . . . . 25.0 108.397 -178.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 69.51 -165.84 0.17 Allowed 'General case' 0 C--O 1.212 -0.884 0 N-CA-C 107.264 -1.384 . . . . 25.0 107.264 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 49.95 23.82 5.77 Favored Glycine 0 C--O 1.217 -0.929 0 N-CA-C 119.133 2.413 . . . . 25.0 119.133 175.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.63 -25.6 15.33 Favored Glycine 0 C--O 1.217 -0.911 0 CA-C-N 118.191 0.995 . . . . 25.0 112.485 -176.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -59.81 -29.92 68.57 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.184 0.993 . . . . 25.0 110.183 175.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.1 tp -61.43 -37.98 85.48 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.132 -0.94 . . . . 25.0 112.062 176.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.5 t -68.57 -41.37 82.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.145 -0.687 . . . . 25.0 109.145 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.44 -43.48 98.79 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.433 -0.58 . . . . 25.0 109.433 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.9 m -64.28 -39.56 94.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.568 -0.287 . . . . 25.0 110.714 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.8 mt -65.84 -38.39 88.75 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.824 -0.548 . . . . 25.0 110.85 178.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -66.21 -39.57 89.73 Favored 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 110.183 -0.302 . . . . 25.0 110.183 176.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -66.12 -44.01 85.48 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.499 0.555 . . . . 25.0 112.499 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.3 t -76.51 -41.06 34.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.368 0.507 . . . . 25.0 112.368 -176.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 40.3 m -93.29 -31.12 14.82 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.851 1.056 . . . . 25.0 113.851 -174.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.69 -137.91 49.01 Favored Glycine 0 CA--C 1.518 0.256 0 CA-C-O 121.89 0.716 . . . . 25.0 113.346 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -55.71 -25.26 39.24 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.172 1.175 . . . . 25.0 114.172 179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -65.72 -21.38 66.52 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.904 -0.497 . . . . 25.0 111.967 -177.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.12 172.77 46.81 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 110.353 -1.099 . . . . 25.0 110.353 -179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -155.12 169.9 23.06 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.851 -0.796 . . . . 25.0 108.851 -177.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -140.98 155.87 46.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.793 0.806 . . . . 25.0 111.273 178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -96.18 162.21 13.62 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.81 -1.552 . . . . 25.0 106.81 175.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.1 t 56.2 -100.55 0.11 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.378 0.671 . . . . 25.0 112.223 -176.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -166.36 159.56 12.15 Favored Pre-proline 0 C--O 1.238 0.465 0 N-CA-C 103.588 -2.745 . . . . 25.0 103.588 176.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.3 -178.29 3.2 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 118.138 -0.775 . . . . 25.0 113.139 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.45 135.39 57.24 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.269 0.557 . . . . 25.0 109.819 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.8 m -148.86 148.53 29.99 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.643 -1.984 . . . . 25.0 105.643 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -72.19 -32.57 66.92 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-O 120.996 0.427 . . . . 25.0 111.93 -177.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 30.6 m -72.54 148.17 9.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.788 0 CA-C-O 121.735 0.779 . . . . 25.0 113.051 -177.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.1 p -78.13 67.93 4.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.993 0.901 . . . . 25.0 111.69 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 89.0 mmt-85 -125.9 57.14 1.38 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.494 0.664 . . . . 25.0 112.03 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.3 mtt180 -93.81 66.55 3.71 Favored 'General case' 0 C--O 1.213 -0.847 0 N-CA-C 106.112 -1.81 . . . . 25.0 106.112 170.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.5 t -144.85 25.21 1.46 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.834 -1.075 . . . . 25.0 110.259 -175.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -144.73 159.19 43.25 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.14 -1.059 . . . . 25.0 108.14 176.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 172.25 163.18 25.69 Favored Glycine 0 CA--C 1.5 -0.852 0 C-N-CA 120.699 -0.763 . . . . 25.0 112.634 175.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.6 tp -61.62 -32.89 55.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 111.925 0.343 . . . . 25.0 111.925 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.3 t -66.37 -38.7 82.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 121.519 -0.738 . . . . 25.0 109.423 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.04 -28.35 68.79 Favored 'General case' 0 C--N 1.32 -0.708 0 O-C-N 121.601 -0.687 . . . . 25.0 111.439 178.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -85.29 -36.1 21.06 Favored 'General case' 0 C--O 1.207 -1.132 0 N-CA-C 113.702 1.001 . . . . 25.0 113.702 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 82.9 m -114.88 7.77 15.78 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 115.532 1.679 . . . . 25.0 115.532 -172.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 30.3 t -132.49 -53.9 0.95 Allowed 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 109.545 -0.539 . . . . 25.0 109.545 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -73.66 -24.22 59.95 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.213 0.53 . . . . 25.0 110.067 176.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -136.53 176.66 8.5 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.046 -1.094 . . . . 25.0 108.046 175.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.9 m -91.09 151.06 21.15 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 123.85 0.719 . . . . 25.0 109.108 173.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.8 p -136.87 178.54 7.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.868 0.366 . . . . 25.0 110.194 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -145.95 168.63 20.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.556 -0.905 . . . . 25.0 108.556 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.7 tp -52.16 -48.28 65.02 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 115.073 1.509 . . . . 25.0 115.073 -173.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.84 -42.22 88.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.92 0.39 . . . . 25.0 111.559 -177.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.7 tp -69.63 -45.35 68.69 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.958 0.409 . . . . 25.0 110.139 178.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 tt -60.5 -36.08 77.48 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.857 0.361 . . . . 25.0 111.618 -177.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -61.0 -24.56 66.24 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.585 0.957 . . . . 25.0 113.585 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.0 p -70.58 -14.21 62.4 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 121.678 -0.639 . . . . 25.0 112.719 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -92.81 2.48 56.74 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 122.276 0.23 . . . . 25.0 111.609 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 81.6 m -72.21 152.16 42.41 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.222 -1.399 . . . . 25.0 107.222 173.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.9 167.51 12.76 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.866 -0.791 . . . . 25.0 108.866 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 7.5 p 67.6 150.15 0.12 Allowed Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 125.614 1.566 . . . . 25.0 111.406 -175.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.83 151.54 57.22 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 114.787 -3.008 . . . . 25.0 113.246 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.13 134.12 42.84 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.097 -1.075 . . . . 25.0 108.097 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -121.24 -29.0 4.59 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.693 0.627 . . . . 25.0 112.693 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.3 t 69.27 138.43 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.881 1.272 . . . . 25.0 111.834 -177.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 . . . . . 0 C--O 1.304 3.933 0 CA-C-O 115.858 -2.02 . . . . 25.0 114.366 -177.503 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.832 0 CA-C-O 122.432 1.11 . . . . 25.0 113.68 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -96.6 177.17 5.75 Favored 'General case' 0 C--O 1.225 -0.189 0 N-CA-C 108.712 -0.847 . . . . 25.0 108.712 178.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -59.73 147.76 77.44 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.355 -0.384 . . . . 25.0 110.958 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -76.88 -179.14 5.1 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 120.529 0.819 . . . . 25.0 111.139 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.0 m 55.9 58.72 4.21 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 121.798 0.809 . . . . 25.0 112.134 178.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -63.8 -24.76 67.89 Favored 'General case' 0 C--O 1.213 -0.819 0 CA-C-N 115.013 -0.994 . . . . 25.0 113.156 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.2 p -74.48 124.4 26.51 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 108.487 -0.931 . . . . 25.0 108.487 178.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.6 mt -114.36 126.0 54.5 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 122.347 1.07 . . . . 25.0 111.14 -175.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -159.06 -174.77 4.9 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 106.25 -1.759 . . . . 25.0 106.25 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.01 31.73 77.63 Favored Glycine 0 C--O 1.215 -1.059 0 C-N-CA 120.823 -0.703 . . . . 25.0 114.339 175.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.95 -22.27 19.2 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 121.069 -0.586 . . . . 25.0 114.245 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -65.51 -28.49 69.22 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.607 1.203 . . . . 25.0 110.353 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.0 tp -61.91 -41.82 98.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.088 -0.506 . . . . 25.0 110.361 174.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.6 t -68.85 -40.61 81.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.495 -0.557 . . . . 25.0 109.495 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -61.85 -36.76 82.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.063 0.459 . . . . 25.0 110.328 178.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.2 m -70.38 -39.95 74.27 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-N 116.527 -0.306 . . . . 25.0 111.168 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.2 mt -62.06 -38.21 87.93 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.469 -0.769 . . . . 25.0 110.59 177.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -65.13 -42.55 93.75 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 116.692 -0.231 . . . . 25.0 110.681 176.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -64.97 -45.69 84.62 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.927 0.343 . . . . 25.0 111.927 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.4 t -70.7 -42.95 77.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 112.049 0.388 . . . . 25.0 112.049 -176.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -98.09 -21.65 16.66 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 116.11 1.893 . . . . 25.0 116.11 -173.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.4 -142.77 47.52 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.457 -0.878 . . . . 25.0 113.306 -178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -68.08 -11.08 58.39 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 114.474 1.287 . . . . 25.0 114.474 -176.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -66.43 -22.68 66.22 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.582 -0.699 . . . . 25.0 111.97 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.28 167.82 43.84 Favored Glycine 0 C--O 1.227 -0.339 0 N-CA-C 111.179 -0.768 . . . . 25.0 111.179 -178.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -152.98 165.47 35.42 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 122.053 -0.674 . . . . 25.0 109.275 -177.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -105.28 147.4 28.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.574 0.702 . . . . 25.0 111.461 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -141.95 140.03 32.65 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.41 -1.33 . . . . 25.0 107.41 179.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.4 t -136.23 134.79 38.48 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.191 -1.04 . . . . 25.0 108.191 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.97 154.23 20.07 Favored Pre-proline 0 C--O 1.24 0.556 0 N-CA-C 105.829 -1.915 . . . . 25.0 105.829 -179.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.55 163.01 27.21 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 114.981 -2.88 . . . . 25.0 111.986 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -117.4 1.11 12.34 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.133 -1.062 . . . . 25.0 108.133 174.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 p -99.87 162.45 12.98 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.925 -1.139 . . . . 25.0 107.925 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -63.23 -23.85 67.61 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.238 0.459 . . . . 25.0 112.238 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.1 m -115.73 151.81 17.46 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 109.497 -0.557 . . . . 25.0 109.497 178.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.0 m -85.5 71.04 10.82 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 113.559 0.948 . . . . 25.0 113.559 -175.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.6 mtt85 -78.38 -10.14 59.56 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.57 0.952 . . . . 25.0 113.57 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -90.43 150.59 21.77 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-O 121.184 0.516 . . . . 25.0 111.519 -174.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.76 -175.02 1.94 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.654 -1.157 . . . . 25.0 112.915 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -44.34 140.46 2.25 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 115.04 1.496 . . . . 25.0 115.04 -176.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -153.12 172.2 32.08 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 108.754 -1.739 . . . . 25.0 108.754 174.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.2 tp -59.32 -33.09 49.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 120.919 0.39 . . . . 25.0 111.426 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.22 -35.79 75.03 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 O-C-N 121.565 -0.709 . . . . 25.0 110.576 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -66.52 -35.66 80.78 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 121.507 -0.746 . . . . 25.0 111.312 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -89.15 -21.44 23.33 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 114.52 1.304 . . . . 25.0 114.52 -173.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -120.27 -10.84 9.28 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 116.913 2.19 . . . . 25.0 116.913 178.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 41.9 t -103.87 -38.35 7.06 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 118.654 0.661 . . . . 25.0 109.503 173.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -99.47 -11.28 21.22 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 122.085 0.945 . . . . 25.0 111.48 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -132.92 174.25 10.54 Favored 'General case' 0 C--O 1.212 -0.887 0 N-CA-C 103.563 -2.754 . . . . 25.0 103.563 168.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.5 m -88.36 -18.16 29.03 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 117.898 2.555 . . . . 25.0 117.898 -173.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 46.96 -173.69 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 117.117 2.265 . . . . 25.0 117.117 -173.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -152.9 165.88 34.1 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 105.621 -1.992 . . . . 25.0 105.621 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 42.4 tp -63.97 -37.2 86.54 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.471 0.915 . . . . 25.0 113.471 -176.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.76 -43.89 71.29 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.118 -0.697 . . . . 25.0 109.118 -174.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.2 tp -61.25 -41.92 97.74 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.001 -0.545 . . . . 25.0 110.161 175.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 tt -60.15 -36.8 78.34 Favored 'General case' 0 C--N 1.318 -0.775 0 O-C-N 121.738 -0.601 . . . . 25.0 110.702 -178.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -64.4 -27.09 68.77 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.938 0.718 . . . . 25.0 112.938 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 33.1 p -71.29 -14.14 62.12 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.033 0.753 . . . . 25.0 113.033 -178.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -85.47 5.8 29.64 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.563 0.209 . . . . 25.0 111.563 176.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 1.4 m -61.51 155.41 22.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.835 0.826 . . . . 25.0 111.18 173.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.19 151.87 19.14 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.393 -1.336 . . . . 25.0 107.393 170.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.2 p 67.68 147.62 0.11 Allowed Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 125.889 1.675 . . . . 25.0 113.902 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -78.48 165.57 25.08 Favored 'Trans proline' 0 C--N 1.348 0.543 0 N-CA-C 113.463 0.524 . . . . 25.0 113.463 -177.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.53 160.3 30.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.625 -0.716 . . . . 25.0 110.312 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -83.69 158.56 21.78 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.781 -0.645 . . . . 25.0 110.433 177.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 36.1 p -86.21 63.09 7.82 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.41 0.624 . . . . 25.0 110.763 175.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.3 3.73 0 CA-C-O 113.953 -2.927 . . . . 25.0 113.228 -177.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 124.76 2.219 . . . . 25.0 114.185 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -75.61 173.58 10.85 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 112.805 -1.998 . . . . 25.0 110.829 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -62.13 151.4 81.24 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.181 -0.463 . . . . 25.0 111.655 -178.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.12 -176.91 3.3 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 120.97 1.113 . . . . 25.0 112.201 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.6 t 63.34 49.25 3.28 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 124.052 0.845 . . . . 25.0 113.213 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -68.57 -16.73 63.96 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.675 -0.861 . . . . 25.0 108.675 172.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.4 p -84.68 141.34 30.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.622 -0.717 . . . . 25.0 109.068 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.69 133.62 49.58 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.895 -0.593 . . . . 25.0 109.584 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 66.9 m -127.2 -60.46 1.2 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 115.363 1.616 . . . . 25.0 115.363 -177.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.73 -134.96 4.6 Favored Glycine 0 C--O 1.222 -0.613 0 N-CA-C 114.635 0.614 . . . . 25.0 114.635 -173.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.99 -21.02 60.83 Favored Glycine 0 C--O 1.218 -0.881 0 C-N-CA 121.115 -0.564 . . . . 25.0 112.711 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -64.59 -33.3 75.6 Favored 'General case' 0 C--O 1.214 -0.802 0 O-C-N 122.178 -0.601 . . . . 25.0 110.503 176.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 22.4 tp -68.85 -39.68 79.77 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.689 -0.485 . . . . 25.0 109.689 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.1 t -62.95 -40.83 90.45 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 N-CA-C 108.983 -0.747 . . . . 25.0 108.983 177.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.68 -49.14 78.7 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.862 -0.153 . . . . 25.0 111.048 176.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.3 m -60.99 -41.18 95.97 Favored 'General case' 0 C--O 1.219 -0.551 0 C-N-CA 121.12 -0.232 . . . . 25.0 111.005 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.1 mt -63.72 -40.4 96.67 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 121.782 -0.574 . . . . 25.0 110.557 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -68.04 -35.39 78.17 Favored 'General case' 0 C--O 1.217 -0.628 0 O-C-N 121.955 -0.466 . . . . 25.0 110.653 177.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -66.99 -44.77 79.54 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.971 -0.455 . . . . 25.0 112.064 178.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 85.8 t -79.91 -42.68 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 O-C-N 121.886 -0.509 . . . . 25.0 111.629 -177.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 36.0 m -89.93 -22.28 22.05 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 114.042 1.127 . . . . 25.0 114.042 -174.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.82 -164.71 54.82 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 109.878 -1.289 . . . . 25.0 109.878 -176.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -73.01 0.79 10.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.519 0.676 . . . . 25.0 112.777 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -67.92 -15.91 63.83 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.66 -0.65 . . . . 25.0 111.403 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.6 173.45 39.82 Favored Glycine 0 CA--C 1.508 -0.366 0 N-CA-C 111.642 -0.583 . . . . 25.0 111.642 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -159.65 166.7 30.07 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.416 -0.586 . . . . 25.0 109.416 -176.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -101.8 143.42 31.73 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.782 -0.645 . . . . 25.0 109.869 177.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -117.87 172.54 7.32 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.074 -0.512 . . . . 25.0 109.875 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.1 t -73.71 67.43 1.15 Allowed 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.502 0.926 . . . . 25.0 113.502 -176.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.58 -47.6 0.37 Allowed Pre-proline 0 N--CA 1.475 0.8 0 N-CA-C 118.874 2.916 . . . . 25.0 118.874 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.55 149.67 62.25 Favored 'Trans proline' 0 C--N 1.344 0.305 0 CA-C-N 119.027 0.688 . . . . 25.0 112.609 -176.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -161.75 174.74 12.8 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.623 -0.88 . . . . 25.0 108.623 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.05 -179.86 4.01 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 123.78 0.675 . . . . 25.0 110.815 175.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.92 -26.18 48.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.359 0.599 . . . . 25.0 110.157 175.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.3 m -94.1 -160.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 107.004 -1.48 . . . . 25.0 107.004 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.8 p -73.11 -135.51 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 109.083 -0.71 . . . . 25.0 109.083 170.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 76.8 mmt-85 55.74 50.27 14.59 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.39 0.614 . . . . 25.0 111.492 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 81.9 mtt85 -57.57 132.87 54.51 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.257 -1.016 . . . . 25.0 108.257 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 27.5 p -121.68 141.87 50.72 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 110.139 -0.319 . . . . 25.0 110.139 -175.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 7.2 ptt180 57.91 175.84 0.06 Allowed 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 115.197 1.554 . . . . 25.0 115.197 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.7 153.52 14.69 Favored Glycine 0 C--O 1.216 -1.019 0 N-CA-C 111.245 -0.742 . . . . 25.0 111.245 176.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.2 tp -57.2 -32.58 40.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 113.688 0.996 . . . . 25.0 113.688 -173.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 71.0 t -67.42 -38.61 81.06 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 O-C-N 121.297 -0.877 . . . . 25.0 109.238 176.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -66.53 -34.68 78.46 Favored 'General case' 0 C--O 1.215 -0.731 0 O-C-N 121.334 -0.854 . . . . 25.0 110.666 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -77.47 -39.42 46.63 Favored 'General case' 0 C--O 1.21 -1.008 0 N-CA-C 113.093 0.775 . . . . 25.0 113.093 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 83.6 m -102.71 -10.87 18.82 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 116.675 2.102 . . . . 25.0 116.675 -172.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 31.6 t -118.12 -43.02 2.76 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 120.889 0.375 . . . . 25.0 111.684 -178.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -78.09 -15.15 59.15 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.128 0.49 . . . . 25.0 110.597 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 17.7 ptt-85 -157.65 178.91 9.74 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 103.342 -2.836 . . . . 25.0 103.342 174.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.4 m -86.79 155.74 20.18 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 118.039 0.381 . . . . 25.0 110.791 178.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.8 p -133.24 177.63 7.53 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.582 -0.896 . . . . 25.0 108.582 177.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -129.52 164.16 24.36 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.746 -0.835 . . . . 25.0 108.746 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 68.6 tp -56.22 -41.99 76.55 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.558 0.743 . . . . 25.0 112.283 177.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.79 -40.03 95.69 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 121.929 -0.482 . . . . 25.0 110.511 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.0 tp -69.86 -44.81 69.07 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.919 -0.771 . . . . 25.0 108.919 178.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.7 tt -59.47 -35.25 73.72 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 121.581 -0.7 . . . . 25.0 111.655 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -60.53 -28.12 68.16 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.589 0.589 . . . . 25.0 112.589 177.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.2 p -71.43 -15.75 62.36 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.902 0.705 . . . . 25.0 112.902 -177.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -90.56 -0.86 57.83 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 121.181 -0.208 . . . . 25.0 111.35 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 82.3 m -72.39 147.54 46.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.467 0.651 . . . . 25.0 110.925 177.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.25 163.32 15.44 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.537 -1.283 . . . . 25.0 107.537 175.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 32.9 p -118.05 145.76 37.6 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 107.649 -1.241 . . . . 25.0 107.649 -178.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -61.26 143.13 98.09 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 120.944 1.096 . . . . 25.0 112.691 177.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -103.97 88.76 3.1 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.826 -0.625 . . . . 25.0 109.888 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.3 ttmt 53.83 45.66 27.36 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 116.024 -0.534 . . . . 25.0 111.711 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.9 t -52.79 -46.79 67.77 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.957 0.885 . . . . 25.0 112.59 -178.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 . . . . . 0 C--O 1.292 3.301 0 CA-C-O 113.599 -3.096 . . . . 25.0 110.268 175.803 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 123.492 1.615 . . . . 25.0 114.457 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -88.68 168.28 12.65 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.225 -0.922 . . . . 25.0 109.465 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 66.8 mtp85 -60.74 138.35 93.28 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 109.929 -0.397 . . . . 25.0 109.929 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -84.28 168.11 11.85 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 120.699 0.932 . . . . 25.0 112.747 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.1 m -146.12 91.85 2.12 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.978 -0.749 . . . . 25.0 108.978 176.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.48 -37.59 74.26 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.824 0.821 . . . . 25.0 110.393 -176.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.4 p -113.91 145.24 41.77 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.659 -1.155 . . . . 25.0 107.929 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -126.71 134.74 50.6 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.137 -0.938 . . . . 25.0 108.58 -176.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -145.91 -46.83 0.21 Allowed 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.074 0.768 . . . . 25.0 113.074 -177.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.89 -146.85 9.48 Favored Glycine 0 C--O 1.225 -0.459 0 C-N-CA 121.174 -0.536 . . . . 25.0 111.97 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -58.12 -23.71 53.03 Favored Glycine 0 C--O 1.212 -1.269 0 C-N-CA 121.236 -0.507 . . . . 25.0 113.301 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -59.17 -27.02 65.29 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.388 0.514 . . . . 25.0 112.388 176.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 45.9 tp -68.69 -43.2 76.6 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.256 -0.646 . . . . 25.0 109.256 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.88 -39.65 86.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.627 -0.879 . . . . 25.0 108.627 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -64.01 -44.7 91.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.214 0.531 . . . . 25.0 110.657 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.3 m -66.39 -37.03 84.35 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 121.812 -0.555 . . . . 25.0 110.351 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.3 mt -63.54 -37.67 88.2 Favored 'General case' 0 C--N 1.323 -0.553 0 O-C-N 121.912 -0.492 . . . . 25.0 110.373 177.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -66.11 -37.95 86.99 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 122.316 -0.24 . . . . 25.0 110.981 175.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -66.39 -47.88 71.89 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 122.03 -0.418 . . . . 25.0 112.071 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.7 t -77.98 -38.62 24.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 113.167 0.803 . . . . 25.0 113.167 -173.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 50.8 t -89.41 -17.04 29.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.938 0.875 . . . . 25.0 110.801 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.96 -169.72 55.04 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 109.773 -1.331 . . . . 25.0 109.773 -176.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -67.84 3.59 1.44 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.464 1.283 . . . . 25.0 114.464 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -25.25 68.22 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 121.757 -0.589 . . . . 25.0 112.446 -178.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.93 158.72 34.77 Favored Glycine 0 C--O 1.219 -0.83 0 N-CA-C 108.417 -1.873 . . . . 25.0 108.417 -174.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -152.82 169.17 23.45 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.012 -1.477 . . . . 25.0 107.012 -173.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -135.96 142.71 44.6 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.97 -0.381 . . . . 25.0 109.97 176.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -160.72 162.55 32.56 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.475 -0.935 . . . . 25.0 108.475 178.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.0 t 49.49 46.38 23.44 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 115.107 1.521 . . . . 25.0 115.107 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.7 133.66 62.25 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.469 -0.787 . . . . 25.0 112.103 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.22 160.87 46.11 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 114.675 -3.083 . . . . 25.0 111.741 173.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -153.77 170.5 20.79 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.888 -1.153 . . . . 25.0 107.888 -179.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m 58.53 175.02 0.06 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 116.974 2.213 . . . . 25.0 116.974 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -100.97 -8.93 21.97 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.374 -0.83 . . . . 25.0 110.785 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.1 m -127.4 -177.31 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.197 -1.409 . . . . 25.0 107.197 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.9 m -70.65 -135.16 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 122.995 0.518 . . . . 25.0 111.566 173.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 57.54 35.7 26.07 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.66 0.784 . . . . 25.0 111.392 178.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.8 149.78 30.14 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.474 0.916 . . . . 25.0 113.474 -177.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.4 m -75.42 173.51 10.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.178 -0.919 . . . . 25.0 113.338 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -65.06 164.56 12.66 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.7 -0.682 . . . . 25.0 110.206 174.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.3 -178.58 35.38 Favored Glycine 0 C--O 1.223 -0.544 0 N-CA-C 110.823 -0.911 . . . . 25.0 110.823 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.5 tt -62.48 -27.07 42.07 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.585 0 N-CA-C 113.973 1.101 . . . . 25.0 113.973 -178.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.6 p -63.68 -30.83 50.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 O-C-N 120.832 -1.167 . . . . 25.0 109.535 177.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -71.78 -27.34 62.89 Favored 'General case' 0 C--O 1.218 -0.585 0 O-C-N 121.294 -0.879 . . . . 25.0 110.547 177.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -87.4 -32.45 19.54 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.397 -0.819 . . . . 25.0 113.141 -176.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 94.0 m -109.32 -15.33 14.28 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 115.266 1.58 . . . . 25.0 115.266 -176.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 31.8 t -113.68 -50.45 2.84 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.651 0.659 . . . . 25.0 111.653 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -68.83 -30.27 68.77 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.301 0.572 . . . . 25.0 109.853 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -141.43 173.46 11.48 Favored 'General case' 0 C--O 1.215 -0.736 0 N-CA-C 105.471 -2.048 . . . . 25.0 105.471 170.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.9 t -86.46 148.51 25.52 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.364 0.529 . . . . 25.0 110.459 178.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 20.6 p -114.66 -178.47 3.38 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 122.56 0.344 . . . . 25.0 110.892 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -134.45 162.97 30.75 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.506 -0.553 . . . . 25.0 109.506 -177.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -51.51 -53.9 32.76 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.868 1.062 . . . . 25.0 113.868 -176.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.45 -32.85 74.69 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 121.014 0.435 . . . . 25.0 111.943 -174.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.4 tp -69.2 -47.49 64.71 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.94 -0.763 . . . . 25.0 108.94 176.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.2 tt -61.6 -34.82 76.3 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.464 0.649 . . . . 25.0 111.182 -177.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -58.92 -24.8 62.84 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.645 0.98 . . . . 25.0 113.645 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.3 p -69.02 -19.01 64.11 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.34 0.867 . . . . 25.0 113.34 -177.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -89.6 5.44 45.63 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.107 0.479 . . . . 25.0 111.71 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 31.7 t -64.71 150.98 46.25 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.562 -1.273 . . . . 25.0 107.562 173.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.46 140.82 58.0 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.32 0.581 . . . . 25.0 110.904 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.3 p -68.86 135.74 89.9 Favored Pre-proline 0 N--CA 1.445 -0.713 0 N-CA-C 107.405 -1.331 . . . . 25.0 107.405 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.28 152.66 75.6 Favored 'Trans proline' 0 CA--C 1.517 -0.348 0 CA-C-O 121.614 0.589 . . . . 25.0 113.368 -177.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.86 48.38 0.95 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.104 -0.953 . . . . 25.0 111.848 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 64.5 tttt 53.87 35.31 21.37 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.776 0.83 . . . . 25.0 111.418 -177.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.5 t -147.81 145.64 28.83 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 106.872 -1.529 . . . . 25.0 106.872 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 . . . . . 0 C--O 1.295 3.483 0 CA-C-O 114.816 -2.516 . . . . 25.0 113.069 -176.6 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.205 -1.252 0 CA-C-O 123.403 1.573 . . . . 25.0 114.769 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -67.26 -24.37 65.78 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 114.992 -1.004 . . . . 25.0 112.699 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 69.1 mtp180 -117.27 146.35 38.05 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.598 -0.728 . . . . 25.0 110.386 -179.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -77.43 162.93 30.34 Favored 'Trans proline' 0 C--N 1.345 0.395 0 N-CA-C 114.644 0.978 . . . . 25.0 114.644 -175.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 75.6 m -140.67 76.51 1.56 Allowed 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 108.212 -1.033 . . . . 25.0 108.212 176.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.09 -9.33 58.51 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.286 1.588 . . . . 25.0 115.286 -173.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.4 p 37.85 84.95 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 116.478 2.029 . . . . 25.0 116.478 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.5 mt -61.48 122.68 15.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.685 -1.143 . . . . 25.0 111.64 -179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -161.94 -168.84 2.03 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 106.595 -1.631 . . . . 25.0 106.595 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.78 32.71 80.16 Favored Glycine 0 C--O 1.213 -1.165 0 N-CA-C 116.088 1.195 . . . . 25.0 116.088 171.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.33 -35.8 3.73 Favored Glycine 0 C--O 1.218 -0.858 0 CA-C-N 117.46 0.63 . . . . 25.0 113.609 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -59.02 -32.05 69.37 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.792 0.796 . . . . 25.0 110.592 178.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 44.0 tp -60.38 -38.55 84.28 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.748 -0.66 . . . . 25.0 110.872 176.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.8 t -71.93 -41.29 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.2 -0.454 . . . . 25.0 110.15 -177.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -62.93 -39.28 94.13 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.928 -0.767 . . . . 25.0 108.928 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 32.5 m -63.7 -43.11 97.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.869 -0.605 . . . . 25.0 110.214 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.7 mt -62.95 -39.58 95.05 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 121.691 -0.631 . . . . 25.0 111.079 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -63.65 -43.75 95.83 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.824 -0.35 . . . . 25.0 110.108 177.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -65.08 -47.11 78.43 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.602 0.593 . . . . 25.0 112.602 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.2 t -70.05 -41.42 79.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 120.879 0.371 . . . . 25.0 111.552 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 66.2 m -83.7 -30.98 26.33 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.142 0.793 . . . . 25.0 113.142 -175.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.71 -134.84 35.35 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.658 -0.782 . . . . 25.0 112.427 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -64.9 -13.54 57.06 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 114.08 1.141 . . . . 25.0 114.08 -178.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -78.42 -25.87 46.16 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 116.05 1.87 . . . . 25.0 116.05 -176.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.52 177.0 49.76 Favored Glycine 0 C--O 1.227 -0.303 0 N-CA-C 110.636 -0.986 . . . . 25.0 110.636 -175.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -154.67 169.43 23.92 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 114.023 1.12 . . . . 25.0 114.023 -175.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -106.21 143.01 34.94 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.349 -0.841 . . . . 25.0 110.959 176.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -130.7 171.02 13.56 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.028 -0.73 . . . . 25.0 109.028 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.8 t -99.63 137.57 37.93 Favored 'General case' 0 C--O 1.22 -0.454 0 N-CA-C 109.238 -0.653 . . . . 25.0 109.238 177.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.596 ' H ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -139.69 -52.33 0.02 OUTLIER Pre-proline 0 N--CA 1.476 0.837 0 N-CA-C 117.643 2.461 . . . . 25.0 117.643 -177.563 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.596 ' HD2' ' H ' ' A' ' 30' ' ' ARG . 97.7 Cg_endo -77.94 156.69 30.75 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 CA-C-N 118.592 0.533 . . . . 25.0 112.919 -178.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -100.93 143.65 30.82 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.471 -0.937 . . . . 25.0 108.471 175.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.9 m -105.45 157.03 17.64 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 107.156 -1.424 . . . . 25.0 107.156 175.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -64.09 -28.85 70.06 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 111.78 0.289 . . . . 25.0 111.78 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.16 164.42 31.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.403 -0.962 . . . . 25.0 108.403 178.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.0 p -75.15 -165.4 0.39 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 122.441 0.296 . . . . 25.0 110.966 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 45.39 36.65 2.47 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 115.598 1.703 . . . . 25.0 115.598 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.8 mtt-85 -122.5 148.87 44.65 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.106 -0.497 . . . . 25.0 111.016 175.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.7 t 63.71 178.58 0.16 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.964 1.306 . . . . 25.0 113.419 177.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -100.71 159.87 14.82 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 106.208 -1.775 . . . . 25.0 106.208 177.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -167.71 118.42 0.78 Allowed Glycine 0 C--O 1.223 -0.585 0 C-N-CA 119.248 -1.453 . . . . 25.0 114.431 176.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.4 tp -62.24 -34.77 65.65 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.57 0 N-CA-C 108.646 -0.872 . . . . 25.0 108.646 176.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.04 -42.73 87.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 O-C-N 121.891 -0.506 . . . . 25.0 110.026 176.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -69.49 -19.01 63.74 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 121.21 -0.931 . . . . 25.0 113.474 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -101.29 -20.55 15.18 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 114.285 1.217 . . . . 25.0 114.285 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 78.8 m -110.72 -27.71 8.77 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.311 1.597 . . . . 25.0 115.311 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 63.0 m -97.85 -46.15 6.05 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 118.541 0.61 . . . . 25.0 110.665 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -72.76 -27.54 62.08 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.338 0.589 . . . . 25.0 110.464 -176.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -149.17 172.2 15.21 Favored 'General case' 0 C--O 1.21 -1.01 0 N-CA-C 104.845 -2.279 . . . . 25.0 104.845 176.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.2 t -81.16 156.14 25.85 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 117.753 0.251 . . . . 25.0 110.661 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 26.9 p -134.89 176.54 8.56 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.455 -0.572 . . . . 25.0 109.455 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -131.98 164.05 27.02 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.69 -0.856 . . . . 25.0 108.69 -177.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.6 tp -56.68 -42.27 78.76 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 123.32 0.648 . . . . 25.0 112.383 177.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.9 -40.54 96.75 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-O 121.095 0.474 . . . . 25.0 110.625 -177.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.2 tp -69.22 -44.15 72.65 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.473 -0.566 . . . . 25.0 109.473 178.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 tt -60.44 -34.56 74.16 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.955 0.407 . . . . 25.0 110.975 -176.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -60.12 -30.09 69.04 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.237 0.828 . . . . 25.0 113.237 177.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 31.3 p -71.49 -14.02 61.99 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.893 0.701 . . . . 25.0 112.893 -177.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -86.8 -2.95 58.97 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 112.187 0.44 . . . . 25.0 112.187 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 79.4 m -69.9 154.0 42.54 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.32 -0.993 . . . . 25.0 108.32 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.36 166.35 13.35 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.241 -1.022 . . . . 25.0 108.241 178.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.3 p 62.0 154.55 0.11 Allowed Pre-proline 0 N--CA 1.483 1.189 0 N-CA-C 116.574 2.064 . . . . 25.0 116.574 174.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.05 163.67 32.64 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 116.639 -1.774 . . . . 25.0 112.997 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.9 159.28 23.12 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.156 -0.475 . . . . 25.0 110.364 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.8 tptt 65.02 22.22 12.38 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.198 0.999 . . . . 25.0 112.24 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 96.5 p -152.95 161.75 42.16 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.707 -1.96 . . . . 25.0 105.707 174.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 . . . . . 0 C--O 1.285 2.931 0 CA-C-O 112.923 -3.418 . . . . 25.0 108.797 174.09 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.214 -0.804 0 CA-C-O 122.659 1.219 . . . . 25.0 114.078 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -113.54 165.22 12.71 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-N 115.698 -0.683 . . . . 25.0 109.18 178.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -109.01 149.6 39.85 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 111.912 0.338 . . . . 25.0 111.912 -176.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -76.09 -177.07 3.39 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 120.448 0.765 . . . . 25.0 111.831 177.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.0 t 58.16 46.53 15.84 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.673 0.749 . . . . 25.0 111.733 178.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -72.52 -25.18 61.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.236 -0.893 . . . . 25.0 112.093 -178.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.9 p -84.77 151.82 24.11 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 122.168 0.985 . . . . 25.0 112.792 -177.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.0 mt -123.61 135.47 53.97 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 114.49 -1.232 . . . . 25.0 109.75 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -151.19 162.49 40.78 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 107.246 -1.39 . . . . 25.0 107.246 177.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.68 -144.5 48.91 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.477 -0.868 . . . . 25.0 112.424 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.95 -21.07 67.39 Favored Glycine 0 C--O 1.216 -0.971 0 CA-C-O 119.551 -0.583 . . . . 25.0 114.063 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -67.07 -38.48 85.84 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 118.398 1.099 . . . . 25.0 110.317 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.2 tt -67.48 -43.64 80.49 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.114 -1.069 . . . . 25.0 108.114 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.0 t -62.07 -42.69 95.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.648 -0.706 . . . . 25.0 111.152 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -62.13 -39.39 92.4 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.941 0.401 . . . . 25.0 110.285 178.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 27.2 m -67.47 -41.22 84.97 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.213 -0.292 . . . . 25.0 110.213 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.9 mt -60.83 -41.08 95.06 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 122.038 -0.414 . . . . 25.0 110.3 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -68.75 -34.72 76.06 Favored 'General case' 0 C--O 1.217 -0.647 0 O-C-N 122.396 -0.19 . . . . 25.0 111.367 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -67.22 -46.71 72.99 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.96 -0.463 . . . . 25.0 111.609 176.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.9 t -71.49 -39.69 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 120.981 0.419 . . . . 25.0 111.769 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 9.1 t -96.93 -24.2 15.95 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.525 1.305 . . . . 25.0 114.525 -172.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.24 -160.34 49.62 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 110.515 -1.034 . . . . 25.0 110.515 -174.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.79 0.53 5.54 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.683 0.994 . . . . 25.0 113.683 -177.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -69.04 -16.78 63.78 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 114.863 1.431 . . . . 25.0 114.863 -173.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.2 164.87 40.66 Favored Glycine 0 C--O 1.22 -0.781 0 N-CA-C 110.919 -0.872 . . . . 25.0 110.919 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -153.38 168.3 26.52 Favored 'General case' 0 C--N 1.322 -0.629 0 O-C-N 121.947 -0.737 . . . . 25.0 110.768 -174.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -100.21 158.38 15.91 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.697 -0.853 . . . . 25.0 108.697 177.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -141.78 -178.01 5.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.193 0.521 . . . . 25.0 111.204 -175.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.1 t -55.82 137.09 50.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.576 -0.738 . . . . 25.0 110.905 178.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.9 ppt_? -141.7 160.53 55.94 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.571 -0.741 . . . . 25.0 110.071 -175.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.99 164.95 32.36 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 117.691 -1.072 . . . . 25.0 113.867 -177.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -124.43 145.54 49.43 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.185 -1.043 . . . . 25.0 108.185 177.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 64.8 p -84.29 -176.4 6.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.205 0.526 . . . . 25.0 111.245 -176.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -69.36 -17.46 63.69 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 115.015 1.487 . . . . 25.0 115.015 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.4 m -83.36 -171.96 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.938 0.399 . . . . 25.0 110.209 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.54 -160.83 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.628 0.771 . . . . 25.0 112.463 174.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 59.93 29.11 18.69 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.924 0.889 . . . . 25.0 111.598 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 47.6 mtt180 -76.72 132.23 39.2 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-O 120.905 0.383 . . . . 25.0 110.121 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.4 t -162.08 152.55 17.19 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 102.002 -3.333 . . . . 25.0 102.002 173.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 -93.97 -40.47 10.1 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.172 0.434 . . . . 25.0 112.172 -176.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.31 -159.12 18.95 Favored Glycine 0 C--O 1.216 -1.026 0 CA-C-O 119.725 -0.486 . . . . 25.0 111.951 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.2 tp -52.37 -27.63 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 115.081 1.512 . . . . 25.0 115.081 -177.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.1 t -66.89 -34.23 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 O-C-N 120.916 -1.115 . . . . 25.0 110.166 177.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -67.51 -35.12 78.51 Favored 'General case' 0 C--N 1.319 -0.754 0 O-C-N 121.808 -0.557 . . . . 25.0 109.911 176.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -73.99 -43.63 57.41 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.99 0.737 . . . . 25.0 112.99 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 81.0 m -105.5 -14.83 15.18 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 116.129 1.9 . . . . 25.0 116.129 -171.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.7 t -113.18 -42.93 3.44 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.515 0.598 . . . . 25.0 111.425 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -83.56 -20.93 32.93 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.33 0.586 . . . . 25.0 110.101 176.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 94.1 mtm-85 -131.85 -176.42 4.05 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 103.42 -2.807 . . . . 25.0 103.42 173.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.4 m -109.61 151.9 26.23 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 104.819 -2.289 . . . . 25.0 104.819 171.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 27.6 p -129.22 163.33 25.83 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.723 0.297 . . . . 25.0 110.943 -174.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -114.12 169.57 8.92 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.975 -0.75 . . . . 25.0 108.975 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 61.9 tp -55.06 -45.77 75.35 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.685 0.794 . . . . 25.0 111.784 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.87 -42.62 99.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.013 0.435 . . . . 25.0 111.382 -176.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.2 tp -68.86 -45.57 70.7 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.305 0.574 . . . . 25.0 109.607 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 tt -61.1 -33.61 73.64 Favored 'General case' 0 C--N 1.317 -0.806 0 O-C-N 121.891 -0.506 . . . . 25.0 111.04 -178.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -63.3 -24.67 67.96 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.511 0.93 . . . . 25.0 113.511 178.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.5 p -70.85 -14.37 62.38 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.137 -0.977 . . . . 25.0 111.856 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -97.87 0.63 47.0 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.399 -0.364 . . . . 25.0 110.963 177.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 29.5 t -76.9 148.55 36.36 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.036 -1.098 . . . . 25.0 108.036 174.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -95.62 139.09 32.36 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.096 -0.705 . . . . 25.0 109.096 174.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.433 ' HB ' ' HD2' ' A' ' 63' ' ' PRO . 5.3 p 66.11 159.46 0.13 Allowed Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 124.562 1.145 . . . . 25.0 112.722 176.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' A' ' 62' ' ' THR . 92.7 Cg_endo -71.74 163.31 39.33 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 118.31 -0.66 . . . . 25.0 113.362 -177.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.2 122.8 14.73 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.423 0.63 . . . . 25.0 111.065 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -68.42 -19.02 64.57 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 114.252 1.204 . . . . 25.0 114.252 -177.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.1 t -159.56 90.61 0.95 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.948 0.404 . . . . 25.0 111.282 -177.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 . . . . . 0 C--O 1.302 3.861 0 CA-C-O 115.854 -2.022 . . . . 25.0 114.246 178.455 . . . . . . . . 0 0 . 1 stop_ save_